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There is currently a large increase in the speed of production of DNA sequence data as next 
generation sequencing technologies become more widespread. As such there is a need for 
rapid computational techniques to functionally annotate data as it is generated.  One 
computational method for the functional annotation of protein-coding genes is via detection 
of interaction partners. If the putative partner has a functional annotation then this annotation 
can be extended to the initial protein via the established principle of “guilt by association”.   
This work presents a method for rapid detection of functional interaction partners for 
proteins through the use of the comparative method. Functional links are sought between 
proteins through analysis of their patterns of presence and absence amongst a set of 54 
eukaryotic organisms. These links can be either direct or indirect protein interactions. These 
patterns are analysed in the context of a phylogenetic tree. 
The method used is a heuristic combination of an established accurate methodology 
involving comparison of models of evolution the parameters of which are estimated using 
maximum likelihood, with a novel technique involving the reconstruction of ancestral states 
using Dollo parsimony and analysis of these reconstructions through the use of logistic 
regression. The methodology achieves comparable specificity to the use of gene co- 
expression as a means to predict functional linkage between proteins. 
The application of this method permitted a genome-wide analysis of the human 
genome, which would have otherwise demanded a potentially prohibitive amount of 
computational resource.  
Proteins within the human genome were clustered into orthologous groups. 10 of 
these proteins, which were ubiquitous across all 54 eukaryotes, were used to reconstruct a 
phylogeny. An application of the heuristic predicted a set of functional protein interactions in 
human cells. 1,142 functional interactions were predicted. Of these predictions 1,131 were 
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Chapter 1  
Introduction to computational annotation of protein coding genes 
1.1 History 
The discovery in the 1940s (Avery et al. 1944) and confirmation in the 1950s (Hershey and 
Chase 1952) of DNA (deoxyribonucleic acid) as the physical basis for inheritance was a 
milestone in biological research. It provided for a means to examine the materials and 
processes underlying phenotypic traits and provided a conceptual link to the other natural 
sciences. This was rapidly followed by the elucidation of the three dimensional structure of 
B-DNA (Watson and Crick 1953) which is the form of DNA prevalent in living cells as it is 
conducive to nucleosome formation (Richmond and Davey 2003). This structure was the now 
famous double helix. It had been previously established (Beadle and Tatum 1941) that genes 
exist as discrete regions within the genome whose sequence codes for the sequence of a 
corresponding chain of amino acids. The genome of an organism is the full set of hereditary 
material it possesses (Alberts 2010). This is RNA in the case of some viruses and DNA in the 
case of all other types of cellular organism (Brown 2006). The discovery of the genetic code 
(Crick et al. 1961) provided information on the mechanism for this production which 
operates via initial intermediary transcription into RNA (ribonucleic acid) and then 
translation into proteins. (Some genes also code for RNA products such as tRNAs and other 
non-coding RNAs (Brown 2006)).  
The first feasible method for determining the sequence of DNA was the Maxam-
Gilbert chemical degradation method (Maxam and Gilbert 1977). This method was however 
supplanted by the near simultaneous invention of the chain termination reaction method by 
Frederick Sanger (Sanger et al. 1977) of DNA sequencing which was both safer and more 
efficient (Brown 2006). This led to the first full genome of an organism to be sequenced, 
which was bacteriophage fX174 (Sanger et al. 1978). Another contribution by Sanger was 
that of shotgun sequencing. This entails the shattering of a piece of DNA into random 
fragments and the sequencing of those fragments. The sequences of the fragments are then 
assembled through searching for overlaps between them. This method facilitated the 
sequencing of number of relatively larger viral and prokaryotic genomes such as 
Bacteriophage MS2 (Fiers et al. 1976). 




In 1996 Saccharomyces cerevisiae was the first eukaryotic genome to be sequenced (Goffeau 
et al. 1996) via a large collaborative effort. This was followed by the publication of the first 
multi cellular eukaryotic genome Caenorhabditis elegans in 1998 (C. elegans Sequencing 
Consortium 1998) and the draft genomes of the vertebrate Homo sapiens soon followed in 
2001 (Venter et al. 2001). The application of industrial streamlining and automation to 
sequencing efforts over the last 20 years as well as more recently with the onset of next 
generation sequencing technologies there has been almost exponential growth to sequence 
databases such as NCBI GenBank (Benson et al. 2009). Sequence data without further 
processing and annotation cannot shed any light on either biological function or evolutionary 
relationships between organisms. This means that there has been a focus on the development 
of highly accurate high throughput methods for functional annotation of genes and other 
functional genomic elements in recent years as the parity between rates of data generation 
and rates of accurate and verifiable annotation becomes more divergent (Zhu et al. 2007). 
1.2 DNA/RNA 
DNA itself is made up of a linear backbone of alternating deoxyribose sugar and phosphate 
residues (Strachan and Read 2004). There is a nitrogenous base attached to the 1’ (one prime) 
carbon of each individual sugar residue. There are two forms of nitrogenous base present 
within DNA.  One form possesses a single interlocked heterocyclic ring of carbon and 
nitrogen atoms. Bases that exist in this conformation are known as pyrimidines (Strachan and 
Read 2004). The second form of base consists of two interlocked heterocyclic rings of carbon 
and nitrogen atoms. These bases are known as purines (Strachan and Read 2004). There are 
two pyrimidines represented within DNA (Strachan and Read 2004). These are cytosine and 
thymine commonly represented by the abbreviations C and T respectively (Brown 2006). 
There are also two purines present, adenine and guanine represented as A and G (Brown 
2006). The stability of the double helix structure of DNA is maintained through hydrogen 
bond formation between the pyrimidine-purine pair C and G and hydrogen bond formation 
between the remaining pyrimidine-purine pair T and A as well as base stacking interactions 
between adjacent bases (Yakovchuk et al. 2006). Due to structural constraints base pairing 
can only occur between a pyrimidine and a purine (Brown 2006).  
The linear backbone of DNA/RNA is maintained by a phosphodiester bond formed 
between the 3’ (3 prime) carbon atom of the sugar and the 5’ (5 prime) carbon of the 
succeeding sugar (Strachan and Read 2004). The backbone is terminated by a sugar where 
the 5’ carbon is not linked to a succeeding sugar residue. This point is known as the 5’ end. 




Similarly the other end of the molecule lacks a phosphodiester bond on the 3’ carbon and is 
known as the 3’ end (Strachan and Read 2004).  The sequence of DNA is usually described 
in the 5’!3’ direction, as this is the direction of DNA replication as well as transcription of 
RNA using DNA as a template (Strachan and Read 2004). Thus a feature along a DNA 
molecule is referred to as being upstream of another feature if it is closer to the 5’ end.  The 
length of a DNA molecule is measured in units of individual base pairs (bp). 
  DNA is a biopolymer and as such can be fully represented by the sequence of its 
constituent nucleotide bases. Determination of this sequence for a complete organism 
effectively represents the DNA blueprints for the construction of that organism, i.e. the amino 
acid sequences of its constituent proteins and RNA molecules, as well as the regulatory 
sequences that regulate production of these molecules both spatially and temporally. 
1.2.1 RNA 
RNA is constructed of similar residues, however the sugar is a ribose as opposed to 
deoxyribose and the pyrimidine base thymine is replaced with the base uracil commonly 
represented by the abbreviation U (Strachan and Read 2004). There is a diverse population of 
RNA molecules produced by the eukaryotic genome. These molecules are involved with a 
number of processes essential to life, including protein synthesis and regulation of gene 
expression. A breakdown of general RNA types and their functions is presented in Table 1.1.  
 
Abbreviated Name     Full name           Primary Function 
mRNA Messenger RNA Provides a template for protein 
synthesis.  
tRNA Transfer RNA Connection of mRNA to relevant 
amino acid during protein synthesis.  
rRNA Ribosomal RNA Component of protein synthesising 
organelles known as ribosomes. 
snRNA Small nuclear RNA Component of RNA-protein machine 
(involved in post transcriptional 
modification of mRNA) known as the 
spliceosome.  
snoRNA Small nucleolar RNA Involved in the modification of rRNA 
and snRNA  
miRNA Micro RNA Involved in the regulation of RNA 
stability and translation.  
siRNA Short interfering RNA Involved in the targeted degradation of 
RNA. 
 




Table 1.1: General types of RNA molecules with function (Blow 2004). 
 
1.3 Proteins 
Protein molecules are polymers comprised of one or more chains of amino acids. A chain of 
amino acids can also be referred to as a polypeptide chain. Amino acids are molecules that 
consist of an amino group, a carboxylic group, an R group and a hydrogen atom (Berg et al. 
2001). These components are all linked to a central carbon atom known as the ! carbon 
(Berg et al. 2001).  A polypeptide chain is formed when a peptide bond is formed between 
the amino group of one amino acid and the carboxyl group of another. All polypeptide chains 
have a free amino group at one end and a free carboxyl group at the other. These are known 
as the N-terminus and C-terminus respectively (Alberts 2002). The sequence of a polypeptide 
chain is presented as moving from the N-terminus to the C-terminus (Alberts 2002). A linear 
polypeptide chain is also considered the primary structure of a protein (Brown 2006). 
  It is the R group that distinguishes amino acids (Berg et al. 2001). R groups vary in 
factors such as “size, shape, charge, hydrogen-bonding capacity, hydrophobic 
character, and chemical reactivity” (Berg et al. 2001). There are 20 naturally occurring 
amino acids that are typically utilised by living cells (Alberts 2002).  
1.3.1 Protein secondary structure 
The interactions of the R, carboxyl, and amine groups of individual amino acids in a 
polypeptide chain with each other cause polypeptide chains to fold into characteristic 
conformations. These conformations are known as the secondary structure of a protein. There 
are two main types of secondary structure (Brown 2006).  
• The ! helix: This is a structure formed by interactions between the carboxyl groups 
and amine groups of amino acids which are separated by a number intermediate 
amino acids (Berg et al. 2001).  
• The " sheet: This is a structure formed by the interactions between two polypeptide 
chains running either parallel or anti parallel to each other (Brown 2006).  
• Random coils: In the absence of particular structural imperatives polypeptide chains 
can take on any number of shapes that are sterically possible. These shapes are 
referred to as random coils (Shortle and Ackerman 2001). 




1.3.2 Protein tertiary structure  
The tertiary structure of a protein is formed by the folding up of the secondary structural 
constructs formed by the polypeptide chain into a three dimensional configuration (Brown 
2006).  This configuration is held together a number of chemical forces including hydrogen 
bonding between individual amino acids and the interactions of hydrophobic amino acids 
with water (Brown 2006).   
1.3.3 Protein quaternary structure 
The quaternary structure of a protein is formed by the interactions of multiple polypeptide 
chains. Quaternary structure is a hallmark of proteins with a complex function (Brown 2006). 
1.3.4 Protein domains 
A protein domain can be defined as “a substructure produced by any part of 
a polypeptide chain that can fold independently into a compact, stable structure” (Alberts 
2002). There are a number of recurrent protein domains that are functionally important within 
the eukaryotic cell. These include: 
• Helix turn helix: This is a domain comprised of two ! helices separated by a short 
strand of amino acids. It is functionally important due to its ability to bind DNA 
(Brennan and Matthews 1989). 
• Transmembrane domain: This is a domain consisting of ! helical structures capable 
of passing through the lipid bilayer (cell membrane) that surrounds the cell. These are 
crucially important in facilitating cell-cell communication and relaying information 
about the external environment into a cell (Brown 2006). 
1.3.5 Protein motifs 
Protein motifs are conceptually similar to protein domains in that they are distinct 
substructures within a protein molecule (Brown 2006). In contrast with domains they are not 
able to form outside of the context of the overall protein. Functionally important protein 
motifs include: 
• Leucine zipper:  This motif is important in that it facilitates the formation of protein 
quartenary structure by the dimerisation of two leucine rich regions of separate 
polypeptides (Brown 2006). It is a motif that is found in a number of proteins that 
bind DNA (Brown 2006).  




• Zinc finger: The zinc finger motif is a set of polypeptide chains whose interactions is 
stabilised by the presence of zinc ions. It is also present in DNA binding proteins 
(Brown 2006). 
1.4 Genes 
As mentioned above the blueprints for the production of given protein and RNA molecules 
within an organism are contained in subsections of its genome known as genes. A current 
more specific definition of a gene presented by Pesole (Pesole 2008) defines them as  “a 
discrete genomic region whose transcription is regulated by one or more promoters 
and distal regulatory elements and which contains the information for the synthesis of 
functional proteins or non-coding RNAs, related by the sharing of a portion of genetic 
information at the level of the ultimate products (proteins or RNAs)”.  
1.4.1 Structure of a gene 
As implied by that definition a gene is made up of two distinct parts. These are firstly a 
transcribed area, which is the portion of DNA that is actually converted into RNA and 
secondly regulatory regions, which can occur either upstream or down stream of the 
transcribed region. Regulatory regions within the vicinity of a gene provide recognition 
signals for proteins known as transcription factors. These proteins regulate the transcription 
rate of a gene by either carrying out the actual transcription, or by binding to DNA and either 
promoting or silencing transcription (Maston et al. 2006).  As the binding of the proteins to 
these regions provides this functionality, the regions are known as transcription factor 
binding sites.  








Figure 1.1: General structure of a gene. Adapted from (Maston et al. 2006). 
1.4.1.1 Regulatory region of a gene 
A typical regulatory region associated with a gene consists of a promoter element and distal 
regulatory elements (Maston et al. 2006).  The promoter element consists of a core promoter 
and proximal promoter elements and typically spans less than 1 kb (kilobase) pairs (Maston 
et al. 2006).  The core promoter of a gene is the region of DNA at which the proteins 
primarily responsible for transcription bind and initiate the process of transcription.  Well-
studied elements of the eukaryotic core promoter include the TATA box and the initiator or 
Inr sequence (Brown 2006;Strachan and Read 2004). The TATA box generally has a 
consensus sequence of 5!-TATAWAW-3! where W is A or T (Brown 2006). The INR 
sequence has a consensus 5!-YYCARR-3!, where Y is C or T, and R is A or G (Brown 2006). 
The TATA box and Inr sequence are generally present upstream of a large number of 
eukaryotic genes. Generally most of the elements of the core promoter are generally 
comprised of near identical DNA sequences.  
The proximal promoter is generally located a few hundred base pairs upstream of the 
core promoter element (Maston et al. 2006). This region of DNA typically contains binding 
sites for other proteins, which contribute to the transcription of the gene but are not the 
primary mechanism (Maston et al. 2006). 
Distal regulatory tend to be further away from the transcribed portion of the gene and 
contains elements that either activate or repress the transcription of the gene. Elements that 
activate transcription are known as enhancers and conversely elements that repress it are 
known as silencers (Raab and Kamakaka 2010).  




1.4.2 Transcription  
A family of enzymes known as RNA polymerases carry out the process of transcription of 
DNA into RNA in eukaryotic cells (Brown 2006). This process is known as transcription as 
the fundamental chemical language is not changed (Alberts 2002). There are three RNA 
polymerases typically encoded by the eukaryotic genome (Strachan and Read 2004). RNA 
polymerase I and RNA polymerase III tend to transcribe genes which code for functional 
RNA molecules, while RNA polymerase II is generally utilised for the production of RNA 
which is further translated into a protein (Alberts 1998). Transcription proceeds via the 
following general steps (Brown 2006): 
• A protein known as TATA binding protein (TBP) binds to the TATA box sequence. 
This causes a bend in the DNA molecule. 
• This bend provides a recognition signal for other transcription factors to bind to the 
DNA creating a structure known as the preinitiation complex (PIC) (Brown 2006). 
The formation of the PIC also disrupts base pairing thus creating a single stranded 
DNA template from which the RNA molecule is synthesised. 
• RNA polymerase binds to the PIC and them moves along the single strand on DNA 
creating a complementary RNA molecule that conforms to base pairing rules. This 
RNA molecule is known as the primary transcript. 
1.4.2.1 Post Transcriptional processing 
After the primary transcript has been produced it is subjected to further modifications.  In the 
case of primary transcripts associated with protein coding gene the primary transcript is also 
known as pre-mRNA (messenger RNA). In order to explain why these modifications occur it 
is necessary to understand how RNA molecules specify corresponding polypeptide 
molecules.  
1.4.2.1.1 Genetic Code 
It was established in work by Francis Crick (Crick et al. 1961) that polypeptide chains are 
specified by RNA molecules via triplets of nucleotides known as codons. As there are only 
twenty naturally occurring amino acids in eukaryotic proteins, and 43 =64 possible triplets 
from the 4 nucleotide types, the genetic code is redundant. Three of the codons specify the 
termination of the polypeptide chain and the remaining 61 specify amino acids.  
The table below presents the genetic code  





Table 1.2: The genetic code (Brown 2006). 
The process by which these codons are translated into these amino acids will be presented in 
the next section. This code is widely utilised though there are a number of exceptions where a 
different code is utilised, e.g. in translation of mitochondrial genes (Knight et al. 2001). 
1.4.2.1.2 Open reading frames 
Given this code a sequence of triplets that specify a chain of amino acids commencing with a 
start codon and ending with a stop codon can be defined as an open reading frame (ORF) 
(Brown 2006).  An open reading frame can exist in 6 possible orientations as there are two 
strands to a DNA molecule and an ORF can start from the first, second or third nucleotide 
within either strand as illustrated below. 







Figure 1.2: Starting positions for possible ORFs within a double stranded DNA molecule. 
1.4.2.1.3 Exons/Introns 
ORFs as discussed above are subsections of the primary transcript or pre-mRNA molecule. 
ORFs are interrupted within pre-mRNA by sections known as introns (Brown 2006). The 
sections of the ORF thus separated by the introns are known as exons (Brown 2006). Thus in 
order to produce a molecule containing the full-uninterrupted ORF it is necessary to excise 
the introns and splice the exons together as shown in Figure 1.4.   
 
Figure 1.3: Exons and introns within a pre-mRNA molecule. 







Figure 1.4: Exons post splicing. 
 
  
Figure 1.5: Exons post splicing in an alternate configuration. 
 
It is not necessary however for all the exons within a given ORF to be utilised (Brown 2006) 
as shown in Figure 1.5. Different permutations of exons can be created to produce different 
protein molecules. This process is known as alternative splicing and is responsible for the 
disparity between the number of genes within a eukaryotic genome and the number of 
proteins it is capable of producing (Strachan and Read 2004). Alternate splicing is a feature 
of higher eukaryotes and contributes to overall protein diversity (Black 2003).  Estimates of 
how many human gene products are alternately spliced include 60% (Black 2003) and 74% 
(Johnson et al. 2003). 
1.4.2.2 Post Transcriptional processing (cont) 
Having now discussed the necessity of posttranscriptional modification it is now possible to 
move on to the mechanisms by which splicing is carried out as well as covering other 
elements of posttranscriptional processing.  
1.4.2.2.1 RNA splicing 
As mentioned above the primary transcript or pre-mRNA is treated so as to excise intronic 
sequences and splice together exonic sequences. In order for this process to occur a necessary 
first step is the recognition of the borders between exons and introns.  These areas are known 
as splice junctions (Strachan and Read 2004). It has been observed in a large number of cases 




that introns in pre-mRNA commence with the sequence GU and end with the sequence AG 
(Strachan and Read 2004).  These dinucleotides are not in themselves sufficient to signal a 
splice junction (Strachan and Read 2004) as splice junctions have been observed to show a 
greater degree of conservation (Breathnach et al. 1978). In vertebrates the following motifs 
have been observed at splice junctions (Brown 2006). 
• 5! splice site 5!-AG"GUAAGU-3! 
• 3! splice site 5!-PyPyPyPyPyPyNCAG"-3! 
In these consensus sequences the " symbol indicates the border between an exon and 
intron or vice versa (Brown 2006). Py indicates that the nucleotide is a pyrimidine and N 
indicates that any nucleotide could be present at this position (Brown 2006). In addition to 
the conserved sequences at splice junctions introns also contain a conserved sequence around 
40bp away from the end on the intron known as the branch sequence (Strachan and Read 
2004). A large RNA-protein complex known as the spliceosome actually carries out the 
actual process of RNA splicing (Strachan and Read 2004). The spliceosome is one of the 
largest molecular machines in the human cell containing  ~170 distinct proteins (Valadkhan 
and Jaladat 2010). 
The process of RNA splicing typically involves the following sequence (Brown 2006; 
Strachan and Read 2004): 
• Cleavage of the 5’ splice junction detaching the exon from the intron at one end. 
• The attachment of the cleaved 5’ end to the branch sequence forming a lariat like 
structure. 
• Removal of the intronic lariat like RNA structure and the ligation of the two 
exons. 
1.4.2.2.2 Capping 
Another step in posttranscriptional modification of protein-coding genes is capping. This 
process is the first step in posttranscriptional processing of eukaryotic pre-mRNAs (Alberts 
2002). This entails the addition of a methylated nucleoside (a nucleoside is a molecule 
consisting of a deoxyribose or ribose sugar bound to a nitrogenous base (Brown 2006)) to the 




first 5’ prime end of the transcript (Strachan and Read 2004). This process protects the 
transcript from rapid degradation via ribonuclease digestion (Strachan and Read 2004). 
1.4.2.2.3 Polyadenylation 
Post the termination of transcription the primary transcript is also modified via the addition of 
about 200 adenosine nucleotides to the 3’ end of the transcript (Alberts 2002). This structure 
is known as a poly-A tail.  The process is thought to facilitate the transport of the mature 
mRNA molecule into the cytoplasm (Strachan and Read 2004). 
1.4.3 Translation 
After a transcript associated with a protein-coding gene has been transcribed and processed, it 
then migrates to the cytoplasm, where a process known as translation occurs. This process 
entails the production a polypeptide chain that is specified by the transcript via the genetic 
code.  The mature mRNA molecule is not synonymous with an ORF (Strachan and Read 
2004).  Generally an ORF is a subsection within the mature transcript. The ORF is flanked by 
sequences known as the 5’ UTR and 3’UTR (UTR=untranslated regions) (Brown 2006) as 
illustrated in Figure 1.6.  
 
 
Figure 1.6: Schematic of mature mRNA. 
The process of translation occurs at cytoplasmic structures known as ribosomes. Ribosomes 
are large RNA-protein complexes, which consist of two subunits (Strachan and Read 2004).  




The larger subunit is known as the 60S subunit and consists of three different types of 
ribosomal RNA (rRNA) molecule and up to 50 ribosomal proteins (Strachan and Read 2004). 
The smaller subunit is known as the 40S subunit and contains a single rRNA molecule and 
over 30 ribosomal proteins (Strachan and Read 2004). The two subunits of the ribosome exist 
as separate entities and attach for the process of translation.  
The other molecule that provides the physical basis for the implementation of the 
genetic code is transfer RNA (tRNA). tRNA has a secondary structure consisting of four 
double helical structures as illustrated in Figure 1.7. tRNA attaches to an amino acid at its 3’ 
end.  The anticodon arm of the tRNA molecule has a triplet sequence, which is 
complementary to the codon of the amino acid to which it is bound. Thus tRNA attaches 
codons to their corresponding amino acids. 
 
Figure 1.7: Structure of a tRNA molecule. Adapted from (Alberts 2008). 
 
The process of translation typically proceeds via the following steps (Strachan and Read 
2004):  
• The two subunits of the ribosome attach to each other and also to a mature mRNA 
molecule at the methylated cap at the 5’ end. 




• The mRNA molecule is then pulled through the ribosome. 
• When a start codon is encountered a tRNA molecule with an anticodon arm 
complementary to the start codon enters the ribosome. This tRNA molecule will 
have the relevant amino acid pre-bound to it.  
• The next tRNA corresponding to next codon will then enter the ribosome. 
• The amino acid attached to the first tRNA will detach from the tRNA and attach 
to the amino acid attached to the 3’ end of the second tRNA. 
• This process is iterated constructing a polypeptide chain or protein molecule. 
• When a stop codon is encountered an enzyme known as a release factor causes the 
ribosome to disassociate and release the protein molecule.  
• In order to prevent premature folding of proteins during translation the emerging 
polypeptide chain is stabilised by proteins known as chaperones (Alberts 2008).   
1.5 Genomics 
The term genome can de defined as the “entire genetic complement of a living organism” 
(Brown 2006). The field of study around ascertaining information about the genome of a 
living organism is thus known as genomics. The primary step of any full genomic study is the 
determination of the DNA sequence of the genome of the organism in question. Once this has 
been determined the next step is annotating the sequence. 
1.5.1 Genome annotation 
The full genome of an organism is generally a mosaic of functional and non-functional 
elements. The percentage of an organism’s genome that is functional is variable. In the case 
of the human genome it has been calculated that potentially between 2.56% and 3.25% is 
functional (Lunter et al. 2006). 
Functional elements in a genome include: 
• Genes. 
• DNA binding sites.  
• CpG Islands: These are stretches of the dinucleotide repeat CG. These areas of DNA 
are subject to methylation, which is a form of epigenetic control over gene 
transcription (Kawaji and Hayashizaki 2008). 




Genome annotation can be described as the systematic location of these functional 
elements within a genome sequence (structural annotation) and the ascertainment of that 
function (functional annotation). The location of functional elements is based on the principle 
of sequence specifying function. Thus the sequence of a functional element will vary in some 
detectable way from the remainder of the background sequence.  
 
1.5.2 Genome and cDNA assembly  
The initial challenge post the generation of sequencing data is the fact that the output of DNA 
sequencing is generally reads of short stretches of DNA. These reads range in length from > 
700 bp long for Sanger sequencing (Hert et al. 2008) and ~200bp for pyro sequencing 
(Sundquist et al. 2007) and down to ~50bp for ligation based sequencing methods 
(McKernan et al. 2009). 
These short reads have to be assembled into a full sequence for the whole genome. 
This process is known as contig assembly. Contig assembly is carried out through scanning a 
set of short reads for overlaps. The discovery of an overlap indicates that two fragments are 
contiguous and should be connected. This process is necessary both at the level of the full 
genome as well at the level of the individual gene (Wang et al. 2005a).  
 
1.5.3 Gene detection 
Given a fully sequenced and assembled genome lacking annotation there are a number of 
computational techniques available to delineate coding sequence. These can be divided into 
two main subtypes: extrinsic and intrinsic (Borodovsky et al. 1994). Extrinsic methods utilise 
comparisons of sequence data to an external reference point while intrinsic methods evaluate 
sequences based on properties that are internal to the sequence (Borodovsky et al. 1994).  
Construction of a cDNA library is one of the standard methods of extrinsic gene 
detection. cDNA stands for complementary DNA and is created through application of an 
enzyme known as reverse transcriptase to mature mRNA. Reverse transcriptase as the name 
implies reverses the process of transcription and creates a DNA strand complementary to the 
single stranded mRNA. Further steps are then taken in order to create a double stranded DNA 
molecule (Strachan and Read 2004). 
 A library of cDNA sequences is compiled through the collection of mRNA molecules 
from cells under various experimental conditions. This RNA is then converted to cDNA 
using the enzyme reverse transcriptase. The resultant cDNA is then amplified using the 




polymerase chain reaction (PCR) (Mount 2004) and then sequenced. The library of sequences 
thus generated corresponds to the sequence of protein coding genes within the genome minus 
the introns. These sequences are then systematically mapped onto the genomic sequence 
using local alignment algorithms. This technique is known as cis-alignment. There are a 
number of local sequence programs that can be used to carry out these alignments. Exonerate 
is one such program. It utilises a bounded dynamic programming approach (Slater and Birney 
2005) to generate local alignments. Dynamic programming is discussed in more detail later in 
this chapter. Another program, which can be utilised, is Spidey (hosted by the NCBI). This 
program employs the Blast heuristic algorithm (Altschul et al. 1990) to generate its 
alignments. SIM4 is another program that utilises an algorithm based on Blast but tailored to 
the specific problem of mapping cDNA to genomic DNA by factoring in introns and 
potential sequencing errors (Florea et al. 1998).  
The Ensembl automatic genome annotation system (Curwen et al. 2004;Potter et al. 
2004) uses the algorithm GeneWise (Birney et al. 2004) to map cDNA to full genomic data 
and the algorithm GenomeWise (Birney et al. 2004) to create a final putative structure for the 
gene in question post the initial alignment. cis alignment can be considered to be one of the 
most reliable methods for protein coding gene detection/prediction (Brent 2008). 
In cases where cDNA libraries are not available or incomplete for the organism under 
consideration it is also possible to use cDNA sequences of homologous genes from either the 
same species or a different species in order to detect coding sequence. This technique is also 
referred to as trans-alignment and is central to various gene prediction tools (Brent 2008). 
The GeneWise (Birney et al. 2004), algorithm is also used in this context by the Ensembl 
pipeline (Potter et al. 2004). Extrinsic methods for genome annotation are far more cost and 
labour intensive as opposed to the strictly in-silico intrinsic approach. 
Intrinsic approaches to gene detection are predominantly computational and as such 
require an explicit definition/description in order to delineate between coding and non-coding 
sequence (Picardi and Pesole 2010). Picardi (Picardi and Pesole 2010) gives a good working 
definition of a gene for detection purposes, which defines a gene as a transcribed region of 
DNA whose expression is regulated by cis acting elements such as upstream promoters.  
Examples of tasks undertaken as a part of intrinsic gene detection include: 
• ORF (Open Reading Frame) detection: Detection of a potential ORF in genomic 
DNA is an indicator of a potential gene (Mount 2004). As prokaryotes in most cases 
(exceptions are pointed out in (Edgell et al. 2000)) lack exons and introns ORF 




detection drastically reduces the search space for potential genes in the case of 
prokaryotes. 
• Promoter regions detection: Genes are typically associated with one to several 
promoter regions. In prokaryotes these include the upstream Pribnow box with the 
consensus sequence TATAAT. This sequence is homologous to the eukaryotic 
TATA box (Berg et al. 2007). Detection of these motifs within a sequence upstream 
of an ORF strengthens the case for a potential gene.   
• Internal splice junction detection: As the sequence of exon intron borders is broadly 
conserved discovery of splice junctions can also contribute to the case for a 
prospective gene.   
These features can be can be detected within a stretch of sequence using various 
techniques to model sequence motifs ranging from simple regular expressions to hidden 
Markov models and position weight matrices (Picardi and Pesole 2010). Examples of specific 
applications of the intrinsic approach to gene prediction include SNAP (Korf 2004) and 
Genscan (Burge and Karlin 1997) both of which utilise Markov models in order to detect 
delineating features of genes. The primary weaknesses of the intrinsic approach lie in the fact 
that that it requires a representative sample of protein coding genes specifically from the 
organism under consideration in order to operate (Aubourg and Rouze 2001).   
1.5.4 Functional annotation of genes 
After a putative gene has been identified the next stage is determination of the exact 
biological role of the product coded for. This process can be carried out computationally or 
by entirely laboratory based techniques. 
1.5.4.1 Laboratory based techniques 
Laboratory based techniques for determination of biological function involve alteration of the 
gene in question either in the organism of study (in the case of prokaryotes, unicellular 
eukaryotes as well as higher eukaryotes which are deemed suitable) or in the case of 
organisms where modification would be impractical or unethical such as Homo sapiens 
alteration of the homologous gene in a model organism. The main model organism of choice 
for study of mammalian gene function is Mus musculus (Kim et al. 2010). The main 
alterations that are possible include: 




• Knockouts: This entails the removal of the gene in order to observe the effects of its 
absence. This technique is only effective if the gene in question is not essential to 
organism survival and has a visible/measurable effect on phenotype (Moore 1999). 
• Alteration in expression: In cases where the gene in question is essential to the 
survival of the organism, alterations can be made to the cis-regulatory regions of the 
gene in question in order to affect levels of expression (Capecchi 2005). 
• In order to physically pinpoint specific tissues (in the case of multi-cellular 
organisms) or areas within a cell that a protein is active it is possible to place a 
reporter gene such as GFP (green fluorescent protein) upstream of the promoter 
region of the gene of interest (Chalfie et al. 1994).  
• Detection of genetic interactions: The interaction of two non-essential genes (and 
hence their associated proteins) can be detected if the mutation of both genes leads to 
lethality (von Mering et al. 2002). This method has been applied to a large-scale study 
in Saccharomyces cerevisiae in order to characterise its set of genetic interactions 
(Ooi et al. 2006). The detection of an interaction partner of known function can aid in 
the determination of the function of an unknown gene. 
1.5.4.2 Computational methods for functional annotation of genes 
Computational methods to determine gene function have only become applicable relatively 
recently as most computational methods depend on comparison of novel sequence data with 
sequence of known function. Computational methods of functional annotation of genes can 
be split into a number of broad categories (Pellegrini 2001). 
• Alignment based methods. 
• Genome Context methods. 
1.5.4.2.1 Alignment based methods 
Sequence alignment is a problem that has been at the heart of bioinformatics since the 
inception of the field. The basic sequence alignment problem is searching two strings for 
areas of similarity (Mount 2004). The products of genes with similar/identical sequences are 
extremely likely to carry out the same function. Genes that share a significant degree of 
sequence similarity are potentially homologous (descended from a recent common ancestral 
gene) to each other. Using these methods the results of laboratory-based annotations only 
need to be carried out on one representative of a given set of identical sequences and the 




derived functional annotation can be applied to all members. Alignment methods can be 
applied at either the gene or the protein level. 
There are three primary ways of carrying out pairwise sequence alignments. 
• Dot matrix analysis: This method entails arranging one sequence horizontally and the 
other sequence vertically perpendicular, starting from the left end of the horizontal 
sequence. Matches between the two sequences are then marked with a dot. Areas of 
similarity can then be viewed as diagonal lines between the two sequences (Mount 
2004). 
• Dynamic programming: Dynamic programming is a programming paradigm which 
entails the reduction of a large problem to a series of sub-problems whose solutions 
are constructed incrementally and summed to provide the overall solution (Russell et 
al. 2003). In terms of sequence alignment it entails the construction of a matrix 
similar to the dot matrix and calculating a path through it, where the next step in the 
path is determined only by the state of the current cell and its neighbouring cells.  
Two popular dynamic programming algorithms utilised in pairwise alignment of 
sequences are the Needleman-Wunsch algorithm (Needleman and Wunsch 1970) 
which returns an optimal global alignment of two sequences and the previously 
mentioned Smith-Waterman algorithm (Smith and Waterman 1981) which provides 
an optimised local alignment. Both of these algorithms are proven to return the 
optimal alignment between two sequences (Mount 2004). 
• Heuristic Algorithms: Both the dynamic programming algorithms mentioned above 
are O(n2) in terms of both memory utilisation as well as time taken to run (Mount 
2004). As such heuristic algorithms such as Blast (Altschul et al. 1990) and Fasta 
(Pearson and Lipman 1988) were developed as usable alternatives. The Fasta 
algorithm constructs a sequence alignment by searching for matching sequence 
patterns called k-tuples. These patterns are k consecutive matches between the two 
sequences. These matches are then extended to provide the alignment (Krane and 
Raymer 2003). Blast constructs an alignment in a similar manner by locating short 
matches and then building an alignment around it. The difference between Blast and 
Fasta is that while Fasta examines all possible k-tuples the Blast algorithm is 
restricted to only examining matches that are significant and score over a given 
threshold (Mount 2004). These matches have to be of a length to achieve 
significance. This is 3 for proteins and 11 for DNA. Significance for proteins is 




judged through use of the BLOSUM62 substitution matrix (Mount 2004). Given the 
rapid expansion of most of the large sequence databases it is typical to use heuristic 
algorithms as a search tool. 
• Profile Hidden Markov models have been used by Eddy (Eddy 1998) to create a 
scoring system, which allows detection of remotely homologous sequences. Hidden 
Markov models score the probability of a discrete chain of events based on model 
parameters whose values are unknown (Durbin 1998).     
 
Alignment methods can also be applied to the three dimensional structures of protein 
molecules as well as sequence (Hasegawa and Holm 2009). This method is potentially useful 
in cases where sequence divergence reaches a point where two proteins can no longer be 
identified as homologous. However as the rate of structure generation lags behind sequence 
generation by a considerable degree this method can only be applied in a small subset of 
cases. 
Detection of a significant alignment with a gene of known function can be used to attach 
the same function to a gene of known function. Martin (Martin et al. 2004) used GO terms 
(Ashburner et al. 2000) in conjunction with Blast (Altschul et al. 1990) to achieve this with 
some success. There is however a danger with alignment based methods of a “Chinese 
whispers” effect where if for example a gene p with known function a displayed 90 % 
identity using some form of pairwise alignment algorithm with gene q of unknown function. 
Assigning function a to gene q would seem to be intuitively legitimate. However if gene q 
was assigned function a and the process was iterated a number of times a situation could arise 
where a gene x would be assigned function a with little or no sequence similarity to the 
original protein p. Examples of incorrect annotation by automated methods of homology 
detection occur in the case of genes where translations of the antisense strand of the coding 
region are entered into databases such as GenBank (Linial 2003).  
1.5.4.2.2 Genome context methods 
The recent proliferation of genome data has made it possible to detect and assign function to 
proteins through examination of their genomic context. Genome context methods compare 
and contrast the context of a gene between genomes (i.e. the arrangement of its homologues) 
in other genomes. Context methods are based on the principle of “guilt by association” which 
is the hypothesis that genes, which show proximity or association by some measure, e.g. 
phyletic distribution or chromosomal ordering are functionally associated (Aravind 2000). 




Thus through demonstration of functional association or interaction between one gene/protein 
of known function with one of unknown function, the latter entity may be annotated with the 
function of the former. 
1.5.4.2.2.1 Rosetta stone  
The Rosetta stone method or detection of domain fusion was recognised through work by 
Marcotte (Marcotte et al. 1999) and Enright (Enright et al. 1999) which showed that sets of 
separate proteins in one organism which exist in a unified (fused) homologous form in 
another organism are likely to be interaction partners. As fusion events are comparatively 
rare and generally affect genes that are tightly functionally coupled this method is effective at 
detection of interaction partners (Kensche et al. 2008). However the rareness of these events 
lowers the overall coverage of this method. 
1.5.4.2.2.2 Gene neighbour  
Examination of the genomes of nine bacterial and archaeal genomes by Dandekar (Dandekar 
et al. 1998) showed that the proteins encoded by genes which showed conserved physical 
order along a chromosome tended to interact physically. 
1.5.4.2.2.3 Interolog detection 
A term introduced by Walhout (Walhout et al. 2000) an interolog is a pair of proteins that 
interact in a given organism. If both proteins involved in the interaction are conserved in 
another organism a similar interaction can be inferred in the second organism. This method 
has shown comparable accuracy with large-scale experimental data (Yu et al. 2004b). 
1.5.4.2.2.4 Phylogenetic profiling  
Phylogenetic profiling is a method that operates on the “hypothesis that functionally linked 
proteins evolve in a correlated manner” (Pellegrini et al. 1999). Consider for example a 
group of genes/proteins, which exist as a self-contained modular group and are associated 
with a particular cellular function. If this associated function was no longer needed by a given 
set of organisms the selective pressure to maintain all the genes/proteins within that group 
would be lowered thus leading to an eventual correlated cascade of losses for the genes in 
question. Genes are primarily lost through psdeudogenisation, which is the conversion of a 
functional gene to a non-functional copy.  This can be caused by mutations that cause the 
premature truncation of a transcript through the creation of a premature stop codon or a 




mutation in upstream cis-regulatory sequences thus removing the potential for transcription 
(Brown 2006). Pseudogenes can also be formed through retrotransposition of mature mRNA 
(Graur et al. 1989). 
Thus through examination of multiple genomes for correlations in the presence and 
absence of proteins potential functional linkages can be detected. A phylogenetic profile is 
typically a binary string representing the presence or absence of a homolog of a given 
gene/protein. Predictions are made through examination of levels of similarity between these 
strings. These suggestions are suggestive in their nature rather than specific as it is unclear 
what the nature of a functional linkage between two proteins with similar profiles might be. 
The relationship could be a direct physical interaction such as subunits involved in 
heterodimerisation or more indirect such as the link between a transcription factor and the 
product of its associate gene.  
The first use of phylogenetic profiles to predict functional linkages used Hamming 
distance as a metric in order to cluster similar profiles (Pellegrini et al. 1999). The Hamming 
distance of two strings can be defined as the number of points at which they differ (Hamming 
1950). There have been various extensions and reinterpretations of the method since then 
(Ranea et al. 2007). Some of these involved examination of profiles using higher logical 
operations to carry out more complex comparisons of profiles (Bowers et al. 2004; Antonov 
and Mewes 2008). The method was also applied to protein domains rather then whole 
sequences (Pagel et al. 2004b). Work by Ranea utilised domain information from the Gene3D 
database to create phylogenetic profiles of the presence and absence of structural domains 
within genomes (Ranea et al. 2007). This method thus bypasses the problem of identification 
of genes that are functionally homologous by focussing on the presence and absence of 
predefined domains within proteins. Chen and Vitkup used examination of correlation 
coefficients to measure similarity in phylogenetic profiles (Chen and Vitkup 2006). They 
observed that the method was successful in identifying genes that were members of the same 
metabolic pathways (Chen and Vitkup 2006). 
 As a tool phylogenetic profiling could be used to detect errors in genome annotation 
through the detection and displays of gene absences, which are not plausible in closely 
related species. A similar approach has in fact been used by Pinney to detect and annotate 
enzyme-coding genes in the protist E. tenella (Pinney et al. 2005).   
Other extensions to the method involved the utilisation of the phylogenetic 
relationships of the organisms include work by Barker and Pagel (Barker and Pagel 2005). 




This method made use of an explicit phylogeny and ancestral reconstruction over the 
phylogeny based on a continuous-time Markov model. The likelihood of a model of 
dependent or contingent evolution was compared with the likelihood of a model of 
independent evolution over the phylogeny.  This method was then further extended by 
investigating the effects of constraining the rate at which genes could be acquired over the 
phylogeny (Barker et al. 2007). 
Other methods of incorporating phylogenetic information included the work by Vert 
(Vert 2002), which utilised support vector machines, as well as the work by Cokus (Cokus et 
al. 2007), which utilised phylogeny as a heuristic by ordering profiles by the phylogenetic 
closeness of the organisms involved. 
1.5.4.2.2.5 Comparative methods  
Comparing phylogenetic profiles over a phylogenetic tree can be considered to be an 
application of the comparative method to traits at the molecular level. The comparative 
method is a well-established method in biology (Harvey and Pagel 1991). The fundamental 
idea of underpinning the comparative method is how the state of one factor (which can be a 
trait or environmental condition) influences the state of another over the context of a 
topology of a phylogenetic tree (Maddison 1990). Testing for correlations without 
considering the phylogeny will detect correlations in gene content based on phylogenetic 
relationships rather than functional linkage. For example the set of all genes that are intrinsic 
to the class Mammalia will share similar phylogenetic profiles. This does not however 
suggest that they are all functionally linked. 
There are a number of tests that have been developed in order to test the correlations 
in the states of traits over a phylogeny. Ridley (Ridley 1983) developed one of the earliest of 
these tests. This test involved the construction of a 2x2 contingency table where the state of 
each trait was considered as a categorical variable defined at each node in the tree. The 
method assumed that the construction of an accurate phylogeny and accurate reconstruction 
of ancestral context for each node within the phylogeny. Ridley’s method did not however 
differentiate between dependant and independent variables in measuring the significance of a 
given set of changes (Maddison 1990).  The method did not take into account the sequence of 
changes in the states of traits (i.e. was a change in state A followed by a change in state B or 
vice versa). This makes the results of the method difficult to interpret (Maddison 1990).   
Joe Felsenstein (Felsenstein 1985b) developed another test for correlations in traits 
over a phylogeny. This test was developed to measure continuous data and modelled changes 




over a tree as a Brownian process. Another test for detection of correlations in traits and/or 
external environmental conditions was devised by Grafen. This test was a phylogenetically 
corrected regression, which did not rely on any form of ancestral reconstruction (Grafen 
1989). 
 Maddison developed a similar test to Ridleys in 1990 (Maddison 1990). It however 
did distinguish between dependant and independent variable by defining areas of a phylogeny 
to be in state A or state B depending on the state of one of the traits under consideration. The 
test then measured how many of the changes in the other trait occurred in the area of the tree 
that was in state A compared to how many changes were possible over the whole tree. 
One of the issues with the tests described above was the fact that none of them 
integrated information on branch lengths of the phylogeny. This meant that the probability of 
a change in the state of a given trait was equally likely over a branch of a phylogenetic tree 
regardless of its length. However clearly a change on a short branch is less likely than a 
longer branch. Work by Pagel took this into account by integrating branch lengths into a test 
for correlated evolution (Pagel 1994). The parameters defined by this work were utilised by 
Barker and Pagel in their approach to phylogenetic profile analysis (Barker and Pagel 2005). 
1.5.4.2.2.6 Mirror trees 
Another method of detection potential protein interactions is known as mirror trees. This 
method involves the detection of protein interactions through the construction and 
comparison of phylogenetic trees of proteins with a single genome (Pazos and Valencia 
2001). The rationale behind this method is similar to that of phylogenetic profiling. However 
correlation is sought not in the presence and absence of homologous genes but in the pattern 
of sequence evolution of interacting proteins. Trees are examined by examining distance 
matrices of homologous sequences for correlations. These matrices are the inputs used in the 
formation of the trees in question. The phylogenetic tree of any given protein in a genome 
will however carry signal from the speciation events, which shaped the genome of the 
organism in question. An upgrade of the method has been developed to take into account this 
background similarity (Pazos et al. 2005). Hakes and others have however pointed out that 
the evolutionary pressures as well as the functional constraints on duplicated genes differ 
depending whether the mechanism of duplication was whole genome duplication or small-
scale duplication (Hakes et al. 2007). This indicates that sequence divergence and functional 
evolution are not necessarily correlated (Robertson and Lovell 2009). Thus any similarity in 




the phylogenetic trees of functionally linked genes is more likely to be due to chance or as 
mentioned above due to background similarity. 
1.5.5 Storage of functional information 
With the exponential increase in sequence data that has been generated through the 2000s 
there have been a number of attempts with which to organise and contextualise function 
information surrounding genomic entities.   
1.5.5.1 GO 
A notable attempt to do this has been the establishment of a controlled vocabulary with which 
to describe the functional role of a gene as well as its physical location within the cell. The 
vocabulary is known as the Gene Ontology (GO) (Ashburner et al. 2000). GO associates a set 
of terms with gene products. These terms are known as GO terms and fall into three general 
domains. These are 
• Cellular component: This is the physical location within the cell where the gene 
product is generally to be found. 
• Biological process: This is the biological pathway or process that the gene product has 
been localised in. 
• Molecular function: This is a lower level to the biological process domain and 
includes the specific molecular capabilities of the molecule in question. An example 
of molecular function could be the ability to bind a particular metal. 
Terms are organised as a network starting from the root terms defined above. As the 
network is traversed starting from a root term, terms become more specific, i.e. if term B 
is directly below term A in the ontology then term B is a subclass of term A. 
1.5.5.1 KEGG 
Another database that localises gene products within functional pathways is KEGG (Kyoto 
Encylopedia of Genes and Genomics) (Kanehisa 1997; Kanehisa et al. 2006).  KEGG 
maintains a list of functional pathways of processes that occur within the cell. These 
processes are arranged in a similar manner to GO in that they start from general categories 
and become more specific.  





The transcriptome of a cell can be considered to be the sum total of its genome that is 
transcribed into RNA. Studying the transcriptome can also yield insights into the 
functionality of gene products.  
1.6.1 Microarrays 
At the transcriptomic level the putative function of a gene can be at least partially determined 
through establishing the association of the expression of a particular gene with a particular 
external condition or treatment. This can be achieved through the use of glass slides known 
as microarrays (Mount 2004). These slides have oligonucleotides, which are subsections of a 
set of genes attached to them. Cells of the organism under study are subjected to variable 
experimental conditions. mRNA is then extracted from these cells, converted to cDNA and 
fused with a unique florescent dye. By examining the relative degrees of florescence for the 
colours associated with the two versions of the cDNA of the gene of interest it is possible to 
measure levels of gene expression in response to a given experimental condition. A variant of 
this involves using full cDNA molecules as the contents of the chip. 
1.6.2 Other methods for transcriptome examination 
Expression levels for a given environmental condition can also be measured through direct 
sequencing and counting through use of the SAGE (Serial analysis of gene expression). In 
this method mRNA is extracted from the cells of interest. A small section is excised from 
each mRNA molecule. A tag is then connected to each separate subsection. These 
subsections are then amplified and the tags counted thus providing a measure of gene 
expression levels (Velculescu et al. 1997).  Another protocol for sequencing mRNA to detect 
gene expression levels has also been developed. This protocol is known as RNA-Seq and is 
made feasible through the utilisation of the high throughput nature of next generation 
sequencing (Wang et al. 2009b). 
1.7 Proteomics 
Proteomics in a similar way to genomics and transcriptomics is the study of the full protein 
complement produced by a cell. The proteomic level is the point where the connection 
between macromolecules and measurable phenotypes is first bridged. Proteins can be 
considered as making up close to the totality of both structural (e.g. microtubules) and active 
(e.g. enzymes) components of a cell.  The function of a protein can be determined by the 
determination of its structure and/or the determination of its interaction partners. 




1.7.1 Protein Structure 
There are two main methods utilised to determine the three dimensional structure of a protein 
molecule (Brown 2006). These are: 
• X-Ray crystallography: This procedure involves the production of a crystal from the 
protein of interest. X-rays are then fired through this crystal to acquire a backscatter 
diffraction pattern. This diffraction pattern can then be used to reconstruct the 
structure of the protein. X-ray crystallography is limited by the fact that it requires the 
protein to be able to crystallise (Brown 2006). 
• NMR spectroscopy: NMR or nuclear magnetic resonance is electro-magnetic 
radiation produced by the absorption and re-emition of electro-magnetic radiation by 
the nuclei of atoms. By bombarding a protein with electro-magnetic radiation, these 
patterns of resonance can be used to work out the structure of the protein (Brown 
2006). 
1.7.2 Protein interactions  
In terms of protein interactions there are two primary modes of protein interaction. The first 
is a direct physical interaction. Direct physical interactions between distinct proteins can 
occur in two contexts (Orengo et al. 2003). These are: 
• Formation of a stable complex: A protein complex is a stable structure formed by two 
or more proteins to carry out a specific function. In order to maintain the structural 
integrity of a complex proteins within the complex have to maintain relatively long 
term direct physical interactions. The subunits of the ribosome are an example of a 
stable protein complex as well as the histone octamer and RNA polymerases (Orengo 
et al. 2003).  Not all interactions within a protein complex are direct as members of a 
complex with more then two interacting partners do not necessarily have to be 
physically connected to every other protein within that complex. 
• Transient interaction: These are functional interactions where proteins physically 
interact but also exist independently in their own right (Orengo et al. 2003). An 
example of a transient interaction is the interaction between the human proteins Rho 
and RhoGap, which triggers a signalling cascade, involved in cytoskeleton formation 
and cell proliferation (Nooren and Thornton 2003).   




The other form of interaction between proteins is indirect interactions. Examples of these 
could be two proteins that have a role in a given metabolic pathway but whose production is 
temporally and spatially separated. Examples of indirect interactions include the interaction 
between SHC-transforming protein and mitogen-activated protein kinase 1 over several steps 
of the insulin-signalling pathway (Sasaoka and Kobayashi 2000). 
The full collection of all protein interactions within a cell has been labelled the interactome. 
1.7.2.1 Experimental detection of protein interactions 
Protein interactions can be detected using a variety of techniques. The main techniques 
include: 
• Yeast two-hybrid: In order to detect protein interactions one widely used (Marcotte et 
al. 1999) method is the yeast two-hybrid technique. This technique exploits the S. 
cerevisiae GAL4 transcription factor. This transcription factor has two domains that 
require physical proximity in order to operate. One of these domains binds DNA and 
the other domain is an activator for the transcription factor. A protein interaction can 
be detected by fusing two genes of interest to both of these domains respectively on 
separate plasmids and insertion of these plasmids into a yeast cell with a reporter gene 
upstream of the GAL4 transcription factor-binding site. Reporter gene transcription is 
only possible if the protein products of the two genes of interest were able to maintain 
a physical interaction (Griffiths 2002). The primary drawbacks to this method are the 
facts that all interactions must take place in the nucleus removing a large number of 
proteins from their native cell compartment and that only binary protein interactions 
can be tested for (von Mering et al. 2002). The yeast two-hybrid method does have a 
high rate of false positives. One reason for this is that pairs of proteins that stick 
together are not necessarily ever expressed at the same time or in the same tissue 
(Vidalain et al. 2004). Also some proteins such as heat shock proteins are inherently 
promiscuous in their binding affinities (Vidalain et al. 2004).   
• Proteome chips: In a manner similar to the use of microarrays described above for the 
measurement of gene expression levels microarrays can also be used with proteins. 
By printing translations of 5800 ORFs from S. cerevisiae on to a microarray chip Zhu 
and others (Zhu et al. 2001) were able to detect 33 novel interactions for the multi 
functional calcium binding protein calmodulin. The drawbacks to this method are that 
it is low throughput and again is restricted to binary interactions. 




• Mass spectrometry of purified complexes: In order to detect interactions that are not 
binary, complexes of proteins can be isolated using techniques such as tandem affinity 
purification. This technique entails the tagging of a protein of interest with a tag that 
allows the purification of the main protein and any complex partners that it might 
have. These complexes can be characterised through the use of mass spectrometry 
(von Mering et al. 2002). 
1.8 Description of project. 
This work details the development and application of a novel heuristic which combines 
application of the Barker and Pagel approach to phylogenetic profiling (Barker et al. 2007; 
Barker and Pagel 2005) in conjunction with a novel data filter. The Barker and Pagel 
approach to phylogenetic profiling will subsequently be referred to as constrained ML 
(maximum likelihood). It was observed over the course of this project that this method could 
be useful in elucidating novel protein interactions. Novel protein interactions will allow 
further elucidation and annotation of protein function through the principle of guilt by 
association as articulated above.  The proteome of Homo sapiens is still filled with known 
unknowns in terms of protein-protein interactions. The HPRD (Prasad et al. 2009) currently 
contains 38,788 binary protein interactions and data on 998 protein complexes. Current 
estimates of the interactome size such as work by Stumpf (Stumpf et al. 2008), which 
estimates the size of the interactome as 650,000, intimate that the majority of protein-protein 
interactions have not yet been elucidated. The potential of phylogenetic profiling to detect 
novel interactions has been demonstrated in work by Ramazzina (Ramazzina et al. 2006) 
where two novel genes involved in the degradation of uric acid were detected. The 
phylogenetic profiling method has also been successful in identifying enzymes of the 
MEP/DOXP pathway (Cunningham et al. 2000).  
 Chapter 2 details the construction of a eukaryotic phylogeny over 54 taxa as well as 
the phylogenetic profiles of known proteins within the human genome relative to the other 53 
species which was one of the essential precursor steps to this study.  
 Chapter 3 contains the results of the application of the method in context and 
compares it to a comparable high throughput experimental technique. Specifically the method 
is compared to detection of protein-protein interactions as well as indirect functional linkages 
through co-expression of genes as measured by microarrays. The method is also compared to 
PIPs which is the protein interaction prediction system maintained by Barton (McDowall et 




al. 2009; Scott and Barton 2007). This system makes novel predictions through the 
combination of different informative features. 
 Chapter 4 describes the construction of the data filter, which is based on Dollo 
parsimony. The filter reduces the size of the overall search space facilitating the use of the 
method for whole genome comparisons. This is achieved through the elimination of pairs of 
proteins, whose function cannot be detected via examination of patterns of presence and 
absence. 
 Chapter 5 presents a network of predictions generated as a putative human 
interactome of proteins, which are susceptible to this line of enquiry. This network is 
analysed for consistency with known data. A set of novel predictions is presented.  
 Finally Chapter 6 will sum up this work and present details on potential future 
directions. 
 




Chapter 2  
Reconstruction of eukaryotic phylogeny as precursor to comparative 
analysis 
2.1 Introduction 
Examination of the evolutionary histories of organisms is a fundamental step for any form of 
study of biological function as adaptation can only be examined within an historical context 
(Harvey and Pagel 1991). As a phylogeny is by definition an evolutionary history of species 
(Harrison and Langdale 2006) it is a necessary step within the process of a comparative 
study. In terms of examination of changes in gene content within a probabilistic framework it 
provides the necessary topology over which such changes occur. This is a fundamental 
parameter in any such model.  
2.1.1 Homology 
The fundamental object of any phylogenetic study, whether molecular or morphological, is 
the comparison of homologous structures within the organisms under consideration. When 
genomic data is under consideration homologous structures within organisms correspond to 
those genomic elements, which were present in the last common ancestor of the set of 
organisms under consideration. These elements can provide a measure of divergence (Fitch 
1970). These elements if functional (which is implied by conservation) can either maintain 
their ancestral function or if sufficiently diverged have a new (or no) function. In discussions 
of elements of genomes (genes) there are a number of subclasses of homologous 
relationships. These are:  
• Orthology: Genetic elements are orthologous if they are the direct product of 
divergence from a common ancestral species (speciation) (Fitch 1970). 
• Paralogy: Genetic elements are paralogous if they are the product of a duplication 
event within a given species. Mechanisms of duplication include retrotransposition 
(insertion of reverse transcribed RNA back into a genome) and unequal crossover 
leading to tandem duplication of a portion of a chromosome (Hurles 2004). It is 
thought that these duplication events are a major force in creating and broadening 
genetic repertoires (Zhang 2003).  
• Xenology: Genetic elements are xenologous if they are the product of a direct 
exchange of DNA between organisms (Fitch 2000). These exchanges are known to be 
far more prevalent in prokaryotes given their lack of a true nucleus and the existence 




of plasmids (free floating segments of DNA) in some prokaryotes. Genes have also 
been observed as xenologous in eukaryotes. Xenologous genes in eukaryotes can be 
acquired via organelles, which are the product of endosymbiosis such as the 
mitochondrion and chloroplasts (Blanchard and Lynch 2000).  
It is important for purposes of phylogenetic reconstruction to be able to draw a distinction 
between genes which are paralogous and which are orthologous. If paralogous genes are 
compared between species the distance between them does not necessarily reflect the overall 
genetic divergence between the species under consideration. Genetic elements that are 
orthologous provide information on levels of divergence between speciation events whereas 
those that are paralogous provide data on duplication events. 
A converse relationship to homology is that of analogy where through convergent 
evolution genes that share no common ancestry develop and maintain sequence similarity due 
to similar demands placed on the organisms in question by their environment. A classic 
example of this at the molecular level is that of the convergent evolution of the enzyme 
lysozyme in both the langur monkeys of the Indian subcontinent (Semnopithecus entellus) 
and ruminants due to the similar requirements imposed by a herbivorous diet (Swanson et al. 
1991). 
2.1.2 Molecular evolution 
The fundamental idea at the heart of modern biology is that of random mutations guided by 
natural selection producing adaptation, which allow an organism to thrive in a given 
ecological niche.  The large-scale study of evolution at a molecular level has only recently 
become possible due to advance in DNA sequencing technologies. This has been extremely 
useful as random mutations occur at the molecular level and also DNA/ amino acids are the 
fundamental comparable common denominator across morphologically and physiological 
diverse species (Nei and Kumar 2000).  
At the DNA level there are four basic types of mutation (Nei and Kumar 2000). These are:  
• Insertions: These mutations are insertions of additional nucleotides into a sequence of 
nucleotides. These can be caused by replication errors (Brown 2006). If an insertion 
occurs within an open reading frame it can cause the frame to be shifted hence 
insertions in coding regions can also be referred to as frameshift mutations. 
• Deletions: Deletions are the opposite of insertions. Deletions within an ORF can also 
cause a frame shift (Brown 2006). 




• Substitutions: These mutations are also referred to as point mutations and involve the 
substitution of a nucleotide with any other nucleotide. Substitutions do not necessarily 
have to involve a single nucleotide (Brown 2006). There are two types of 
substitutions transitions which entail the replacement of a purine with another purine, 
e.g. A to G or a pyrimidine with another pyrimidine, e.g. C to T. The other form of 
substitution is a transversion, which involves the replacement of a purine with a 
pyrimidine or vice versa (Nei and Kumar 2000). 
• Inversions: An inversion mutation involves the reversing of the sequence of a strand 
of DNA, e.g. the sequence TGA being replaced with AGT (Nei and Kumar 2000). 
2.1.2.1 Synonymous and non-synonymous mutations 
Recalling the genetic code where nucleotide triplets known as codons specify amino acids, 
mutations within coding regions can also be classified by the effect that they have on the 
potential protein product. Thus mutations where the amino acid specified is altered are 
known as non-synonymous mutations, while mutations where there is no effect on the amino 
acid specified are referred to as synonymous mutations (Nei and Kumar 2000). Most 
synonymous mutations occur in the third position of codons. Measuring the relative rate of 
synonymous vs. non-synonymous mutations is technique for the detecting of positive 
Darwinian selection (Nei and Kumar 2000). 
2.1.3 Phylogenetic trees 
The evolutionary relationship between organisms has traditionally been presented as a tree 
like structure starting first presented in 1801 by French botanist Augustin Augier (Stevens 
and Augier 1983).  Intuitively it is fairly clear what an evolutionary tree represents. 
Mathematically a tree can be defined as an acyclic graph. A graph is an abstraction, which 
can be used to model binary relations between objects (Parida 2008). A graph G can be 
defined as G(V,E) where V is a set of vertices or nodes and E is a subset defined as E ! (V " 
V)(Parida 2008). E is thus a subset of the set of all ordered pairs that can be created from 
elements of V. The elements of E are referred to as the edges of the graph (Parida 2008). A 
tree is a graph where all vertices are connected possessing the property that any two vertices 
v1, v2 # V are connected by a unique path (Parida 2008). A vertex in a tree that has one 
incoming edge is known as a leaf node (Parida 2008). All other vertices by contrast are 
known as internal nodes (Parida 2008). 




In the case of a phylogenetic tree leaf nodes are extant taxonomic units or taxa and 
internal nodes are proposed hypothetical common ancestors as illustrated in Figure 2.1.  A 
subsection of a phylogenetic tree can be referred to as a clade (Nei and Kumar 2000). 
 
Figure 2.1: Sample phylogenetic tree. In this tree the extant taxa are nodes A, B and C 
while node E is an ancestral node for A and C.  
2.1.3.1 Species trees and gene trees 
There are two main types of phylogenetic tree that are commonly investigated. These are: 
• Species trees: The topology of these phylogenetic trees represents the branching order 
of species. Thus internal nodes are hypothetical common ancestors for the nodes that 
succeed them. The split at these ancestral nodes represent speciation events. A 




speciation event is considered to be the moment in time when two species were 
reproductively isolated from each other (Nei and Kumar 2000).   
• Gene trees: Gene trees measure the degree of divergence between homologous genes 
within and/or across species. Thus internal nodes in a gene tree represent a 
hypothetical gene that existed prior to a mutation event that created its two immediate 
descendants (Nei and Kumar 2000). 







Figure 2.2: A species tree. Adapted from (Brown 2006). 
 





Figure 2.3: A gene tree. Adapted from (Brown 2006). 
2.1.3.2 Topologies and branch lengths 
The branching pattern of a phylogenetic tree is known as its topology.  The topologies of 
phylogenetic trees can be rooted as above in Figure 2.1 or unrooted as present below in 
Figure 2.4. 
 





Figure 2.4: Sample of an unrooted phylogenetic tree representing four taxa. 
 
Theoretically the topologies of most phylogenetic trees are bifurcating, as ancestral 
nodes will split into two descendant nodes at a given point in time. Multifurcation is possible 
in phylogenetic trees. A node with more than two descendents is referred to as a polytomy. 
There are two types of polytomy. Soft polytomies where the multifurcation is attributable to a 
lack of information and hard polytomies where species genuinely split into multiple 
descendants simultaneously (Page and Holmes 1998). Most polytomies are treated as soft as 
simultaneous speciation is considered unlikely (Page and Holmes 1998).  
The number of possible unrooted bifurcating tree topologies B(t) can be calculated 
using the formula given below (Salemi and Vandamme 2003) where t is the number of taxa 
under consideration.  




      (1) 
 
The number of possible rooted bifurcating topologies B(t) can be counted using the following 
formula: 
               
! 
B(t) = (2t " 3)!2 t"2 (t " 2)!       (2) 
                   
Thus estimation of a phylogenetic tree is a problem that quickly becomes computationally 
intractable as the number of taxa rises. 
Another attribute that can be added to a phylogenetic tree is the length of its 
individual branches. As the nodes within a tree represent taxa, the lengths of the braches 
between them represent the degree of evolutionary change between the taxa over time. A 
phylogenetic tree with branch length information is also known as an additive tree, a metric 
tree or a phylogram (Page and Holmes 1998).  
2.1.3.3 Bootstrap support values 
Another attribute commonly associated with internal nodes in phylogenetic tree is the 
bootstrap support value. This value reflects the amount of times a particular internal node or 
split is selected if a phylogenetic analysis is repeated on a random set of re-samples (with 
replacement) from the original dataset (Page and Holmes 1998).  
2.1.3.4 Evolutionary models in tree estimation 
In order to estimate the amount of evolutionary change between taxa, methods considered to 
be effective tree estimators, utilise models of evolution that specify information on the 
evolutionary rate of substitution between homologous stretches of nucleotide or amino acid 
data.  These models are framed as m  m matrices where m is the number of entities in the 
data type, i.e. 4 in the case of nucleotides and 20 in the case of amino acids.  To illustrate, an 
example of the simplest substitution model possible for DNA is the Jukes-Cantor model, 
which assumes that nucleotide substitution occurs with equal frequency (Nei and Kumar 
2000). Thus the substitution matrix for the Jukes-Cantor model is presented below where ! 















 A T C G 
A - ! ! ! 
T ! - ! ! 
C ! ! - ! 
G ! ! ! - 
Table 2.1: Rates of nucleotide substitution for the Jukes-Cantor model (Nei and Kumar 
2000). 
 
The methods of tree estimation that utilise these models of evolution include the 
distance method, tree estimation by Bayesian methods, and tree estimation by maximum 
likelihood (Felsenstein 2004).  
In distance methods an evolutionary model provides a measure of evolutionary 
distance between taxa, whereas in probabilistic methodologies such as maximum likelihood 
and Bayesian methods they provide a measure of probability for a given set of substitutions 
between taxa. Evolutionary models can be calculated via a priori assumptions about the 
evolutionary process or can be constructed empirically by examining the rate of observed 
substitutions in homologous sequences.  Examples of empirically calculated substitution 
matrices for amino acids include the PAM matrices created in the seminal work by Margaret 
Dayhoff (Dayhoff et al. 1978) and more recently the WAG (Whelan and Goldman 2001) and 
LG matrices (Le and Gascuel 2008).  
2.1.4 Detection of homology in molecular data 
In order to construct a phylogenetic tree, which represents the evolutionary history of a set of 
taxa using molecular data, it is necessary to compare homologous sequences. More 
specifically it is necessary to detect orthologous genes/proteins. These genes/proteins are the 
most appropriate measure of genetic divergence between species, as an equal level of genetic 
divergence will have occurred since the speciation event causing the split.  
There are a number of algorithms, which are utilised in the selection of homologous 
genes/proteins and their subsequent classification as orthologous or paralogous.  These 
include: 




• Reciprocal Best Hits (RBH): This procedure is implemented by the COGs (Tatusov et 
al. 2003) database hosted by the NCBI. The underlying rationale of the algorithm is 
that orthologous genes between two species will possess more similarity with each 
other then with any other gene. This similarity is generally established using pairwise 
sequence alignment algorithms such as BLAST (Altschul et al. 1990) or the Smith-
Waterman algorithm (Smith and Waterman 1981). 
• InParanoid: This algorithm extends the idea behind RBHs by using them to seed 
orthologous clusters, and then by an application of an iterative inclusion process 
constructs a set of gene/protein families (Remm et al. 2001).  
• OrthoMCL: This process also utilises RBHs as seed pairs for clusters. Similarity 
relations between gene/proteins are then established as a graph and additional 
paralogous sequences are determined through a process of graph clustering (Li et al. 
2003).  
• Reciprocal smallest distance (RSD):  This procedure does not utilise RBHs and 
instead, for a set of hits for a given query protein, over a given E-value (Expect 
value), conducts pairwise alignments between each of the hits and the original query. 
Hits that are alignable to a given threshold are then subjected to further analysis to 
calculate the number of amino acid substitutions or distance between them and the 
original query. The hit with the shortest distance is then used to reverse the process. If 
the reversal yields the original query then the two sequences are declared orthologous 
(Wall et al. 2003).  
• EnsemblCompara GeneTrees:  This is an algorithm utilised by the Ensembl Compara 
database (Vilella et al. 2009). The process involves RBHs. Two species are subjected 
to an all against all pairwise alignment.  Like OrthoMCL the resulting data is then 
converted into a graph. This graph is then clustered. Gene trees are then constructed 
using these clusters and reconciled against a gold-standard species tree. 
In comparative studies the Inparanoid algorithm (Remm et al. 2001) was shown to 
perform better than its rivals (Hulsen et al. 2006). This work showed the Inparanoid 
algorithm tied as the best performer with simple reciprocal best hits at identification of 
orthologs. However reciprocal best hits in practise only yield one to one orthologous 
relationships (Hulsen et al. 2006). This reduces the coverage of the method (Hulsen et al. 




2006). OrthoMCL was shown to perform a close second to the Inparanoid algorithm in 
benchmarking tests (Hulsen et al. 2006). Subsequent benchmarking work (Altenhoff and 
Dessimoz 2009) showed that OrthoMCL outperformed Inparanoid to an extent at lower 
levels of specificity but higher coverage. However at points benchmarking was applied to 
data and organisms common to both reviews the results were seen as broadly congruent 
(Altenhoff and Dessimoz 2009). 
2.1.5 Multiple sequence alignment 
Given a set of orthologous sequences further processing is required in order to convert them 
into a suitable input for a phylogenetic tree estimation procedure.  This input is known as a 
multiple sequence alignment (MSA) (Edgar and Batzoglou 2006).  The process involves 
creating an optimal alignment between three or more protein sequences. Insertions and 
deletions between orthologous proteins are represented by introducing gaps into the 
alignment. Alignments are scored through the use of substitution matrices. The process 
converts orthologous sequences into a rectangular array where each column of the array 
corresponds to a homologous attribute between the taxa under consideration (Edgar and 
Batzoglou 2006).  
Forms of multiple sequence alignment include. 
• Progressive: This form of alignment involves the construction of initial pairwise 
alignments between all the sequences under consideration. The distances thus 
established between the sequences are used to create a guide tree. The multiple 
sequence alignment is then built up progressively in the order suggested by the guide 
tree (Mount 2004). The main flaw with this method is that errors made any stage of 
constructing the MSA remain in the final alignment (Wheeler and Kececioglu 2007). 
A very prominent example of a progressive MSA tool is the Clustal suite (Higgins 
and Sharp 1988).  
• Iterative: In order to reduce the errors introduced by the progressive approach to MSA 
the iterative approach realigns sub-groups of the sequences repeatedly (Mount 2004). 
Examples of iterative MSA programs include MUSCLE (Edgar 2004) and DIALIGN 
(Morgenstern et al. 1998). The performance of the iterative approach can be improved 
by the inclusion of consistency information between the growing MSA and the pre-




computed pairwise alignments used by some of algorithms within the MAFFT 
(Multiple alignment by fast Fourier transform) program (Katoh et al. 2002).  
The quality of a multiple alignment is crucial to the accuracy of the phylogenetic tree 
created via its analysis (Blair and Murphy 2011). This is especially true when there are gaps 
in the alignment (Talavera and Castresana 2007). Thus benchmarking tests have been carried 
out to examine the performance of various algorithms currently available. The results of these 
have found that MAFFT (running in its iterative, consistency enhanced mode) using the 
Smith-Waterman algorithm (Smith and Waterman 1981) for its initial pairwise alignment 
outperformed its nearest rivals (Ahola et al. 2006; Nuin et al. 2006). This mode of MAFFT is 
known as MAFFT-L-INS-i. 
2.1.5.1 Multiple sequence alignment quality filtration 
Given the effects of MSA quality on phylogenetic analysis it is argued that filtration of 
areas, which are problematic to align, will improve the outcome of subsequent phylogenetic 
analyses (Talavera and Castresana 2007). It is common practise to edit MSAs by hand before 
analysing them further though it is considered that this makes all results thus gained 
irreproducible through the subjectivity of the overall process (Blair and Murphy 2011).  Thus 
this process has been semi automated by programs such as Gblocks (Talavera and Castresana 
2007) and Trimal (Capella-Gutierrez et al. 2009). These programs will retain sections of 
MSAs, which are highly conserved and remove gaps in the alignment. 
 Gblocks will either remove all gaps in its stringent mode or only remove gaps if they are 
present in more than half the sequences in the alignment in its relaxed mode (Talavera and 
Castresana 2007). Trimal will remove columns from an alignment based on a conservation 
threshold defined by the user, i.e. how much of the original alignment does the user wish to 
conserve (Capella-Gutierrez et al. 2009). In benchmarking tests optimum performance for 
Gblocks in enhancing tree estimation was observed using its relaxed mode (Capella-Gutierrez 
et al. 2009). 
2.1.6 Methods to estimate phylogenetic trees 
The focus of this section as mentioned above shall be on the analysis of molecular data 
though the methods described are applicable to any form of measurable polymorphic trait. 
These data provide a measure of distance between the species under consideration.  




The first subdivision in types of methods of phylogenetic analyses is between discrete 
character state and distance matrix methods (Salemi and Vandamme 2003). Discrete 
character state methods examine the differences in state of a set of discrete characters or 
traits. Distance matrix methods utilise the distance between sets of data through the creation 
of a matrix of pairwise distances and application of clustering techniques. Subtypes of the 
character state method include the maximum parsimony method that does not utilise an 
explicit model of evolution and maximum likelihood, which conversely does (Salemi and 
Vandamme 2003). 
2.1.6.1 Distance methods 
Distance methods were originally developed to construct phenograms, i.e. (diagrams which 
reflect the similarity between a given group of taxa without consideration of 
ancestor/descendant relationships (Salemi and Vandamme 2003; Sneath and Sokal 1973) as 
opposed to phylogenies. Distance methods however can also be applied to elucidating 
phylogeny under the assumption of equal rates of mutation in cases where a quick initial 
result is required. 
Distance methods of phylogeny depend on the construction of a matrix of pairwise 
distances for the trait data of the organisms under consideration. This data is generally 
nucleotide and or amino acid sequence data though the method is also applicable to any other 
form of discrete descriptive data.  In the case of amino acid or nucleotide data distances are 
estimated according to evolutionary models, which allow a meaningful calculation of the 
evolutionary distance between two species. 
The simplest form of evolutionary distance measure is the proportion of differing sites 
between two sequences p. This is calculated through a simple count of differing sites nd and 
division by the total number of sites n as shown in Equation 3 (Nei and Kumar 2000). 
 
! 
p = ndn          (3) 
p is an underestimate of evolutionary distance over extended periods of time as multiple 
substitutions accumulate per site.  Thus in order to represent this information substitutions 
can be modelled as a Poisson process over time and then the probability of k mutations over t 
time can be can be calculated by the standard Poisson distribution function where # = the rate 
of mutations / unit time and e = the base of the natural logarithm (Nei and Kumar 2000). 
 








k!         (4) 
                        
 
 This probability can then be used to calculate a distance between two sequences. This 
distance is referred to as the Poisson corrected distance (Nei and Kumar 2000). 
The Poisson corrected distance assumes a homogenous rate of mutations / 
substitutions over a molecular sequence.  This assumption however is not true as different 
areas of a sequence (coding or not coding in the case of nucleotides, for example) will be 
subject to differing selective pressure hence differing mutation rates (Nei and Kumar 2000). 
This information is integrated into calculations of distance via the observation that 
variation in rates of substitution over a sequence follows a gamma distribution (Nei and 
Kumar 2000). 
Having created a matrix of pairwise distances between the sequences under 
comparison this matrix can then used to generate a phylogenetic tree via clustering. 
A commonly used form of clustering in the generation of distance-based trees is 
neighbour joining. This algorithm follows the following steps (Brown 2006): 
• Construction of a fully multifurcating star shaped tree including all taxa under 
consideration. 
• The selection of a random pair of taxa and removing them from the star to 
form a tree consisting of a clade containing that pair and a clade containing the 
rest of the star. 
• Evaluation of the total branch lengths of the new tree. 
• Iteration of this process for all possible pairs storing the results of the branch 
length calculation. 
• Identification of the pair, which yields the first interim tree with the shortest 
branch length. 
• This pair is now placed on their own branch and the process is iterated until a 
fully bifurcating tree is retrieved. 
 
Another method of tree estimation involving distance matrices is least squares fitting 
in which for each tree the residual sum of squares is calculated between pairs of taxa.  This 
method is known as the Fitch-Margoliash method. This involves applying the following 
equation (Nei and Kumar 2000). 






Rs = (dij " eij )2#                                                             (5) 
       
Where dij is the observed distance in the matrix between taxa i and taxa j and eij is the 
patristic distance between the taxa. The patristic distance between two taxa is the sum of the 
branch lengths that make up the shortest path between the two taxa. The tree with the lowest 
Rs is selected by the method.  Generally tree space is searched using a heuristic search 
method as described below in Section 2.1.6.3. 
Other standard techniques for this process are clustering methods such as UPGMA 
(unweighted pair group methods with arithmetic means), which group organisms by degree 
of closeness in the matrix. The underlying assumption of UPGMA is that the evolutionary 
process occurs at a consistent pace, i.e. follows a molecular clock (Felsenstein 2004). Thus in 
cases where data does not follow a molecular clock, UPGMA will deliver misleading results 
as it will cluster species on short branches with each other (Felsenstein 2004).  
Another commonly applied method is minimum evolution, which creates a tree where 
the overall amount of evolution (measured by the total branch lengths of the tree from root to 
tip) is minimised (Salemi and Vandamme 2003). Again tree space is traversed by heuristic 
search as described below. 
Distance methods are comparatively fast compared to character based methods and 
given a dataset with relatively constant rates of evolution and closely related taxonomic units 
fairly accurate (Felsenstein 2004). However they suffer from a systemic issue where if the 
taxa under consideration display variability of rates of evolution along a sequence at different 
points in a tree this cannot be detected as all distances between the sequence are calculated 
locally, i.e. between adjacent species (Felsenstein 2004). 
2.1.6.2 Discrete character state methods 
Discrete state character methods operate on matrices populated with assigned attributes or 
characters to each taxon under consideration. Possible trees are then evaluated against this 
matrix in an attempt to satisfy an optimality criterion (Salemi and Vandamme 2003). One of 
the two most popular optimality criterions is parsimony, which entails minimisation of the 
amount of change required over a given tree to produce the data observed in the matrix. The 
other widely used criterion for selection of trees is likelihood. This method frames the tree as 
a hypothesis for the matrix of observed data and evaluates its likelihood given the matrix of 




observed data (Felsenstein 2004). Maximisation of the likelihood function yields the 
optimum tree. 
2.1.6.2.1 Maximum Parsimony  
 Using parsimony, as a criterion for judging potential trees was first introduced by Camin and 
Sokal in 1965 (Camin and Sokal 1965). The rationale behind considering a tree that is more 
parsimonious is based on the principle of Ockham’s razor, which can be stated, as a simpler 
explanation for an observed phenomenon is to be preferred to a more complex ad hoc 
explanation (Steel and Penny 2000).  
Specific variants of parsimony that can be utilised are (Felsenstein 2004): 
• Fitch parsimony: this form of parsimony is also known as Wagner parsimony 
(Felsenstein 2004). This form of parsimony allows all possible changes in any 
direction and counts them all equally. 
• Camin-Sokal parsimony: this form of parsimony only allows evolutionary 
change in one direction (Camin and Sokal 1965). For example if a two state 
character which can take on states 0 and 1 is considered Camin-Sokal 
parsimony will only allow changes in the 0 to 1 direction (assuming that is the 
direction selected as permissible) (Felsenstein 2004).  
• Dollo parsimony: this form of parsimony is based on the principle of 
phylogenetic irreversibility (Lequesne 1974). The acquisition of a complex 
character is allowed once and then all subsequent changes over the tree can 
only be reversions (Felsenstein 2004).  
• Parsimony on an ordinal scale: this deals with the case where changes in a 
multi state character are considered on an ordinal scale. Thus only changes 
that are adjacent are allowed (Felsenstein 2004).  
• Polymorphism parsimony: this form of parsimony allows an intermediate state 
of polymorphism to be acquired at a point within the tree. All changes 
subsequent to the polymorphic areas in the tree are counted as a loss of one of 
the composite characters that make up the polymorphic state (Farris 1978; 
Felsenstein 1979; Felsenstein 2004).  
Evaluating the number of character changes required over a particular tree for a given 
character matrix is computationally easy and can be calculated rapidly through applications 
of dynamic programming algorithms such as:  




• The Fitch algorithm (Fitch 1971): operates by carrying out a post order 
traversal of the phylogenetic tree (Felsenstein 2004). At each internal node the 
set of potential ancestral states is set to either the intersection of the states of 
its immediate descendant nodes if such an intersection exists. If no such 
intersection exists then the state of the nodes is set to the union of the states of 
the two descendant nodes. 
• The Sankoff algorithm (Sankoff 1975): is similar but not identical to the Fitch 
algorithm (Felsenstein 2004). A cost matrix is created which stores the cost of 
all possible changes of state within the context of the data under consideration. 
Ancestral node states are then assigned by selecting the state with the minimal 
cost. 
The complexity of both these algorithms is linear as the number of operations 
required increases linearly with the number of taxa, the number of characters under 
consideration and the number of states that those characters can take on. 
Parsimony based methods have been popular due to their computational as well as 
conceptual simplicity. Parsimony methods were recently utilised to construct the largest 
phylogenetic tree ever reconstructed consisting 73,060 eukaryotic taxa with a combination of 
morphological and molecular data (Goloboff et al. 2009). However in general over the last 
two decades there has been a swing toward the use of likelihood-based methods (Steel and 
Penny 2000). This is due in part to the demonstration (Felsenstein 1978) that under given 
conditions maximum parsimony will converge on the wrong tree. These conditions have 
come to be known as the Felsenstein zone.  
2.1.6.2.2 Maximum likelihood  
Maximising the likelihood of a given tree as a hypothesis to explain observed data was first 
applied to phylogenetic inference by Edwards and Cavali-Sforza (Cavalli-Sforza 1964).  The 
likelihood function assigns a value to the ability of a hypothesis to explain an observed set of 
results. Assume a statistical model M that associates a probability with a set of possible 
outcomes and a set of observed outcomes (or results) R.  Thus P(R|M) is the probability of 
observing R assuming M is a correct description of the process under study (Edwards 1992). 
The likelihood L of M is defined as:  
L(M)=P(R|M)  k      (6)  
! 
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Where k is an arbitrary constant. Use of this constant allows relative comparison of 
likelihoods (Edwards 1992). To paraphrase an example from (Durbin 1998) in the case of a 
die if our hypothesis is that the die is fair then the probability of any outcome is equal to 0.16. 
If we go on to roll 5 sixes then this forms our observed data. The likelihood of the hypothesis 
is then proportional to 0.165 or 0.000104. Hypotheses can thus be judged on their relative 
abilities to explain observed results. A hypothesis with a higher estimate of the probability of 
rolling a 6 would be better fit to the observed data in the case of the die. Thus likelihood 
provides a framework with which to select a hypothesis or model appropriate to the observed 
data. 
In the case of phylogeny each tree is a hypothesis explaining the distribution of the 
traits under consideration. The phylogeny with the maximum likelihood is selected as the 
optimal tree. The likelihood of a tree can be measured through the application of a 
substitution model of evolution, which models the probability of individual evolutionary 
events over the tree. Empirically calculated substitution models can be used as a substitute for 
the calculation of a set of probabilities, which permits the application of more generalised 
rules of evolution to each individual phylogenetic study. Empirical models of evolutionary 
events can be created through the examination of homologous sequences in different species. 
Models currently in use for amino acid based phylogenies include the WAG (Whelan and 
Goldman 2001) and LG (Le and Gascuel 2008) substitution models. 
If a model is badly specified and a poor fit for the data then likelihood methods can 
return an inaccurate tree with high statistical support (Keane et al. 2006). There are a limited 
number of cases where parsimony methods can outperform likelihood-based methods, which 
has been called the inverse Felsenstein zone, or Farris zone (Siddall 1998). It has been shown 
however that these cases are extremely rare in real data (Swofford et al. 2001) and in cases 
where it is computationally feasible maximum likelihood has become the one of the dominant 
paradigms in phylogeny reconstruction.  
2.1.6.2.3 Bayesian Methods 
Another criterion related to likelihood is the posterior probability of a tree given a matrix of 
observations and a prior probability for the tree. The posterior probability of a hypothesis is 
the probability of the hypothesis being true given some observed data. The posterior 
probability of a tree given a multiple alignment is calculated through the application of Bayes 
theorem, which is defined as: 






P(X |Y ) = P(Y | X)P(X)P(Y )        (7) 
 
Where X and Y are separate events and P(Y|X) is the conditional probability of event Y given 
event X has occurred. P(X) is known as the prior probability of event X. P(X|Y) is the 
posterior probability of event X given event Y has occurred. P(X) represents a subjective prior 
belief in the probability of X occurring.  
In the case of phylogenetic analysis X is a phylogenetic tree and Y is a given multiple 
alignment. It is however non-trivial to evaluate the posterior probabilities over all possible 
tree topologies exhaustively (Huelsenbeck et al. 2001). This process had been made feasible 
by sampling the distribution of posterior probabilities of trees. The posterior probability of a 
particular tree is measured as the amount of times it is visited over traversal of tree space.  
Tree space traversal is facilitated by the use of Metropolis-coupled MCMC (Markov chain 
Monte Carlo) methods first introduced by the doctoral work of Li and Mau (Pickett and 
Randle 2005).  
The algorithm returns a set of trees sampled from the posterior distribution. An 
individual phylogeny is then generally assembled from the returned sample through using 
majority rule consensus methods (Cranston and Rannala 2007).  
Bayesian methods suffer from the potential source of bias of prior probabilities 
(Holder and Lewis 2003). This issue can be ameliorated through the use of flat or 
uninformative priors. Flat priors can however still bias a Bayesian phylogenetic study 
towards trees with particular configurations of clades (Pickett and Randle 2005). 
2.1.6.3 Heuristic search methods  
Given the large number of possible topologies possible for even a small number of taxa the 
estimation of phylogenetic trees is a problem that is intractable by brute force searching. Thus 
the space of all possible trees is usually searched heuristically (Felsenstein 2004).  What this 
entails is the selection of a random first tree. This tree is then evaluated on the basis for 
whatever measure that has been defined to evaluate the “quality” of the tree. Examples of 
possible quality measures for a phylogeny include as previously discussed parsimony, 
likelihood and distance. The tree is then altered thus moving to a new point in tree space. 
This new tree is then evaluated. This process is then iterated until a local optimum point has 




been reached within the space. This point is not guaranteed to be a global optimum within the 
space (Felsenstein 2004).   
Examples of alterations/moves that are used to traverse tree space include (Felsenstein 2004): 
• Nearest neighbour interchange (NNI): This process involves the swapping of adjacent 
branches within a tree. This is a local rearrangement of the tree.  
• Subtree pruning and regrafting (SPR): This process involves the removal or pruning 
of a subtree from an overall tree and reattaching it at another point. As opposed to 
NNI this is a global rearrangement of the tree.  
• Tree bisection and reconnection (TBR): This involves the deletion of an interior 
branch to split a tree into separate trees and then all possible connections are made 
between the branch set of the first tree and the second. This is also a global 
rearrangement of the tree. 
Global rearrangements are more radical moves within the tree space and thus are less 
likely to stabilise in local optima.  Modern phylogeny estimation programs generally 
provide the options to carry out either form of rearrangement. The advantage of using 
local rearrangements is greater speed in arriving at the optimum tree. Examples of 
programs, which offer this choice, are a number of programs within the PHYLIP suite  
(Felsenstein 1989) and PhyML (Guindon and Gascuel 2003). PhyML is generally as 
accurate as other phylogeny estimation programs while being considerably faster 
(Dereeper et al. 2008). Programs within PHYLIP can carry out multiple searches through 
the space jumbling the order of the taxonomic data to widen space coverage. The 




















Short descriptions of these programs can be found on the PHYLIP webpage 
(http://evolution.genetics.washington.edu/phylip/). 
 2.1.7 Bootstrapping 
Bootstrapping was first proposed as a method for evaluating confidence limits in 
phylogenetic trees by Felsenstein in 1985 (Felsenstein 1985a). The procedure evaluates how 
well supported a particular tree topology is by a given dataset. This entails constructing a 
dataset created by random resampling from the original dataset. This new dataset should be 
of the same size as the original dataset.  This procedure is repeated to produce the appropriate 
number of replicates. The original tree estimation procedure is then repeated on this subset 
producing a set of trees. 
 The original tree is then evaluated in the light of these new trees. Each interior branch 
of the original tree is compared to the bootstrap trees, and for every bootstrap tree, which 
contains a branch, which creates an identical partition of the data the branch is marked as 
present. Thus each internal branch gets a score or bootstrap confidence value calculated by 
dividing the number of times it was found to be present in one of the bootstrap trees with the 
total number of bootstraps (Nei and Kumar 2000). 
In the PHYLIP package presented by Felsenstein bootstrapping is carried out through 
the use of two of its internal programs SEQBOOT and CONSENSE (Felsenstein 1989). This 
procedure calculates confidence values for a consensus tree created from the bootstrap trees 
as opposed to the original tree (Nei and Kumar 2000). The procedure for obtaining these 
bootstrap support values is: 
• Run SEQBOOT on original dataset. This produces the number of required 
resamples/replicates of the dataset. SEQBOOT requires a random odd number 
as a seed. 




• Repeat original estimation procedure on each replicate. This produces a set of 
trees all of which represent the original data. 
• CONSENSE is then used to merge these trees together. CONSENSE is a 
program, which is designed to produce a consensus tree from a set of trees. 
CONSENSE will add internal values /branch which represent the confidence 
values in those branches. 
2.1.8 Model selection in phylogenetic tree estimation 
As mentioned above, three of the main methods of phylogenetic tree estimation utilise 
evolutionary models as described in section 2.1.3.4 with which to convert homologous data 
matrices into trees.  The use of an inappropriate model has been shown to adversely affect all 
aspects of tree reconstruction including branch lengths and topology (Bruno and Halpern 
1999).  A poorly specified model will return an incorrect tree with high statistical confidence 
(Posada and Buckley 2004).    
Thus procedures have been developed with which to estimate how well a given 
evolutionary model fits a dataset. A standard probabilistic measure that is used to measure the 
fit of a model to a given dataset is likelihood. As a model can be fitted (over fit) perfectly to a 
dataset by adding parameters, the likelihood of any given model is evaluated in the context of 
how many parameters the model has.  Two standard measures for integrating this information 
(the likelihood of the model with respect to the dataset and the number of parameters) for 
doing this are the Akaike Information Criterion (AIC) and the Bayesian Information Criterion 
(BIC).  Both of these measures penalise parameter rich models over simpler models thus 
selecting the simplest model that explains the observed data adequately (Felsenstein 2004).   
 The AIC is calculated by the following equation (Felsenstein 2004). 
 
! 
AICi = "2 ln Li + 2pi         (8) 
 
Where Li is the likelihood of model i and pi is the number of parameters in model i. The BIC 
has a higher penalty for parameter richness than the AIC and is calculated via the following 
equation (Felsenstein 2004). 
! 
BICi = "2 ln Li + pi ln(n)       (9) 




Where Li is the likelihood of model i and pi is the number of parameters in model i and n is 
the number of data points in the dataset. 
 An example of a model selection procedure involving likelihood, utilised by a model 
selection tool ModelGenerator is as follows (Keane et al. 2006). 
• The construction of a simple guide tree using neighbour joining on the dataset.  
• Each model to be evaluated is then examined over this guide tree and the dataset to 
calculate the likelihood of that model. 
• The AIC/BIC are calculated for the model. 
• The model with lowest AIC/BIC is presented as the best model for the given dataset.  
 
2.1.9 Comparing phylogenetic trees 
Given sets of two or more phylogenetic trees produced by disparate estimation procedures it 
can sometimes be necessary to compare trees for congruence with each other as well as with 
the datasets underlying them. 
There are a number of procedures that can be followed to compare trees. The simplest 
of these is attempting to visualise the parts of trees that are topologically similar. A method 
for doing do is presented in work by Nye (Nye et al. 2006). 
Other measures have been designed to define the difference between two trees. These 
include: 
• The Robinson-Foulds distance: This is a distance that counts how many 
branches differ between two trees. This is done by ignoring branch lengths and 
considering each tree as a set of branches. Each branch splits the tree into two 
partitions. The Robinson-Foulds distance is a count of the partitions present in 
one tree and not in the other (Felsenstein 2004). 
• The NNI distance: This distance can be considered an edit distance, analogous 
to the Levenshtein distance used to compare strings of text. It is the number of 
NNI operations it would take to transform one of the trees into the other 
(Felsenstein 2004). 
• The Branch Score distance: This measure uses branch lengths as well as 
topology to calculate the distance between two trees (Felsenstein 2004).  




Another way to measure the quality of a pair of estimated tree relative to a given dataset is 
use of the Kishino-Hasegawa (KH) test. This is a test of how well individual homologous 
sites within a dataset support a given tree in contrast to another tree (Goldman et al. 2000).  
Both trees are selected a priori as the possible best hypotheses for an observed dataset. The 
test was first introduced in the work (Hasegawa and Kishino 1989). The underlying rationale 
is that if the trees are equally well supported by the dataset. Thus using the notation provided 
in  (Goldman et al. 2000) the test can be carried out via the following procedure. 
• Given two trees T1 and T2 calculated by a given quality criterion, e.g. parsimony or 
likelihood. 
• Assuming for the purposes of explanation that the quality criterion is likelihood, the 
likelihoods of T1 and T2 (with respect to a given dataset D) are L1 and L2 respectively. 
• Calculate $ as the difference between the two likelihoods, i.e. $ = L1 - L2. 
• The underlying hypothesis of the test is that T1 and T2 do not explain D equally well or 
$ %0.   
• Thus the hypotheses for the test are: 
H0: E[$]=0 
H1: E[$] % 0 
Where E[x] corresponds to the expected value of the random variable x.   
• In order to test these hypotheses it is necessary to calculate how extreme the observed 
value of $ is with respect to the distribution of $. 
• In order to calculate this distribution a bootstrapping procedure is followed to 
calculate multiple replicated datasets from D. 
• The likelihoods of the trees T1 and T2 are then recalculated for each bootstrapped 
dataset. 
• For each of these likelihoods a corresponding $ is calculated. 




• This provides a distribution for $ against which the position of the initial $ can be 
compared via a two-tailed test. A two tailed test is used as there is no a priori 
expectation of which tree is to be preferred (Goldman et al. 2000). 
The test assumes that all columns within the dataset are independent and identically 
distributed according the evolutionary history of the taxa under consideration. 
The KH test is used to compare trees, which are selected a priori as possible best 
explanations for a given dataset. To examine how well a given best estimated tree matches an 
underlying dataset relative to another tree the SOWH (Swofford-Olsen-Wadell-Hillis) test 
can be used in conjunction with the KH test. This test is an example of parametric 
bootstrapping (Goldman et al. 2000). Essentially the test involves the construction of a tree 
with a given quality criterion over a given dataset. Then this initial tree is used to create 
multiple datasets, simulated using the parameters that define the tree. Each of these datasets 
is then used to create a new tree. The likelihoods of these new trees can then be compared to 
the likelihood of the initial tree relative to the simulated datasets. This creates a set of 
likelihood differences, the distribution of which can be compared to the difference between 
the initial tree and other trees of interest. This test is not widely used due the computational 
demands of the construction of multiple trees and the construction of simulated datasets. 
2.1.10 Phylogenetic analysis using gene presence 
Leaving aside sequence data there are other aspects to the genomes of a set of organisms that 
also provide signal indicating their evolutionary divergence. One of these aspects is proteome 
content, i.e. which genomic features are present in a genome and which are absent (Snel et al. 
1999). This aspect is essentially the phylogenetic profile of the genomic feature. The 
presence and absence of the genomic feature can be treated as a binary trait and then used as 
an input to apply standard phylogenetic tree estimation procedures.  Methods for the 
estimation of trees from discrete traits precede the methods described above for the analysis 
of molecular sequence data. The issues and criteria for estimation procedures surrounding the 
tree estimation from this form of data remain the same, as the underlying process for the 
generation of the data is the same. 
As an illustrative example consider 5 species with six genes. Any of these genes can either be 
present or absent. An absence of a gene is coded as 0 and the presence of a gene is coded as 
1. 




Thus given the following distribution of the genes over the 5 species named [A-E]. 
A         111010 
B         111111 
G         000001 
D         111100 
E         000000 
A phylogenetic tree can be estimated from this data clustering these species.  An example 
tree reconstructed using Dollo parsimony as implemented in the PHYLIP package in the 
program DOLLOP (Felsenstein 1989) is shown in the figure below. 
 
Figure 2.5: Dollo parsimonious estimation of a phylogenetic tree from example data. 
As species E is devoid of all six genes it is placed as an outgroup relative to the other 5. 
2.2 Methods 
In order to carry out a comparative study on human protein function a phylogeny was 
constructed to provide a framework on which to evaluate the distribution of human proteins 
over the eukaryotic kingdom. Sets of phylogenetic profiles, which detail this distribution, 
were also generated. 




2.2.1 Data Selection  
Given the computational nature of this project as well as the abundance of molecular data it 
was clear that its use was to be preferred over morphological data. Also given the wide 
morphological divergence of eukaryotes isolating individual features to be compared was not 
considered a plausible option.  
The next point of consideration was whether to utilise nucleotide or amino acid 
molecular data. It is known that over long periods of evolution it is more likely for nucleotide 
data to become saturated with multiple back substitutions as nucleotide data has four 
potential changes of state at any given site as opposed to 20 potential changes in amino acid 
data. This can lead to an underestimate of genetic distance (Harrison and Langdale 2006; 
Salemi and Vandamme 2003). Thus despite nucleotide data outperforming amino acid data 
over smaller time frames such as the period of time covering the divergence of the division 
Angiospermae (Simmons et al. 2002) and of the sub phylum Vertebrata (Townsend et al. 
2008) it was felt that amino acid data was a more appropriate choice as a measure of genetic 
distance over all eukaryotes.  
2.2.2 Data Acquisition  
Having decided to utilise amino acid data the next step was to acquire usable data. The 
protein sets of 54 eukaryotic genomes were downloaded on the 16th and 17th of August 2007 
of which 41 organisms were accessed from the NCBI RefSeq database (using the Entrez data 
retrieval interface at http://www.ncbi.nlm.nih.gov/sites/gquery) (Pruitt et al. 2005) and the 
remainder from the Sanger Centre (ftp://ftp.sanger.ac.uk), Genoscope 
(http://www.genoscope.cns.fr/spip/spip.php?lang=en), TIGR ((now the JCVI ) 
http://www.jcvi.org/), the Broad Institute (http://www.broadinstitute.org), Ensembl (using 
BioMart at http://www.ensembl.org/biomart) and lastly SilkDb 
(http://silkworm.genomics.org.cn) (Wang et al. 2005b).  These databases were employed, as 
they were (at the time of access) the sources utilised by the KEGG database (Kanehisa et al. 
2006). An additional archeon Methanosarcina acetivorans was downloaded from the NCBI 
RefSeq database (Pruitt et al. 2005) in order to root the phylogeny using the outgroup 
criterion. This method entails using an organism that falls outside the known taxonomy of the 
group under consideration to provide a point of reference for the overall topology of the tree 
(Felsenstein 2004). It is widely accepted after work by Carl Woese (Woese et al. 1990) that 
the archea form a sister group to the Eucarya. Thus it was felt that an archeon was an 




appropriate choice for an outgroup species. Full details of all data sources and species can be 
seen in the table below. 




Organism                   Database   Common Name 
Methanosarcina acetivorans (Outgroup) RefSeq NA 
Anopheles gambiae Ensembl Mosquito 
Arabidopsis thaliana RefSeq Thale Cress 
Ashbya gossypii RefSeq NA 
Aspergillus fumigatus RefSeq NA 
Aspergillus niger RefSeq NA 
Bombyx mori SilkDB Silkworm 
Bos Taurus RefSeq Cow 
Caenorhabditis briggsae Ensembl NA 
Caenorhabditis elegans RefSeq NA 
Candida albicans RefSeq NA 
Candida glabrata RefSeq NA 
Canis familiaris RefSeq Dog 
Ciona intestinalis RefSeq Sea squirt 
Cryptococcus neoformans RefSeq NA 
Cryptosporidium hominis RefSeq NA 
Cryptosporidium parvum RefSeq NA 
Danio rerio RefSeq Zebrafish 
Debaryomyces hansenii RefSeq NA 
Dictyostelium discoideum RefSeq NA 
Drosophila melanogaster RefSeq Fruitfly 
Drosophila pseudoobscura RefSeq NA 
Encephalitozoon cuniculi RefSeq NA 
Entamoeba histolytica RefSeq NA 
Gallus gallus RefSeq Chicken 
Homo sapiens RefSeq Human 
Kluyveromyces lactis RefSeq NA 
Leishmania major Sanger NA 
Macaca mulatta RefSeq Rhesus macaque 
Magnaporthe grisea RefSeq NA 
Table 2.1: Organisms in study. 





Monodelphis domestica RefSeq Grey short-tailed oppossum 
Mus musculus RefSeq Mouse 
Neurospora crassa Broad Institute  NA 
Oryza sativa RefSeq Rice 
Ostreococcus lucimarinus RefSeq NA 
Pan troglodytes RefSeq Chimpanzee 
Paramecium tetraurelia Genoscope NA 
Pichia stipitis RefSeq NA 
Plasmodium falciparum RefSeq NA 
Plasmodium knowlesi Sanger NA 
Plasmodium yoelii TIGR NA 
Populus trichocarpa JGI Black cottonwood tree 
Rattus norvegicus RefSeq Rat 
Saccharomyces cerevisiae RefSeq Brewers yeast 
Schizosaccharomyces pombe RefSeq Fission yeast 
Strongylocentrotus purpuratus RefSeq NA 
Takifugu rubripes Ensembl Pufferfish 
Tetrahymena thermophila RefSeq NA 
Theileria annulata RefSeq NA 
Theileria parva RefSeq NA 
Trichomonas vaginalis RefSeq NA 
Trypanosoma brucei RefSeq NA 
Trypanosoma cruzi RefSeq NA 
Ustilago maydis RefSeq NA 
Yarrowia lipolytica RefSeq NA 
Table 2.1: Organisms in study (cont). 




2.2.3 Pairwise Alignment  
In order to gauge the relatedness of individual proteins in the organisms it was necessary to 
use a pairwise alignment algorithm, which would deliver a measure of similarity between any 
two given sequences. The Smith-Waterman algorithm (Smith and Waterman 1981) was 
selected as it is guaranteed to locate optimal regions of local similarity. Speed is an issue with 
use of the Smith-Waterman algorithm however an accelerated implementation developed by 
Michael Farrar provided within the Fasta package made its use feasible (Farrar 2007; Pearson 
and Lipman 1988).  
A necessary pre-processing step was to subject all sequences to low complexity 
filtering to remove regions of the sequence which are non random but not biologically 
significant such as regions of compositional bias. Thus all sequences were fed into the SEG 
program (Wootton and Federhen 1993) with the parameter –x, which masks out regions of 
low complexity sequence and replaces them with the character lower case x. 
Each protein set was then split into its individual proteins and each protein compared 
against every other organism in the dataset in order to locate sequences that were 
significantly similar. Each comparison was run with a gap-opening penalty of -12 and a gap 
extension penalty of -2. The substitution matrix BLOSUM62 (Henikoff and Henikoff 1992) 
was used to score the alignments. The results of these searches were then parsed and 
pertinent data, i.e. raw Smith-Waterman score, E value, bit score and the coordinates of the 
alignments along the sequences were stored in a relational database structure in MySQL to 
facilitate further analysis.  
2.2.4 Orthology Determination 
In order to select data which would allow the measurement of evolutionary divergence over 
the species it was necessary to cluster the proteins into orthologous clusters. As the 
Inparanoid procedure (Remm et al. 2001) had been observed to perform well in this function 
it was decided to utilise this procedure. The Inparanoid procedure as described in work 
published by Remm (Remm et al. 2001) is detailed below. 
2.2.4.1 Inparanoid 
Given a set of n pairwise alignments between organism A and organism B the Inparanoid 
algorithm returns a set of clusters s using sequence similarity as an inverse distance. A 
pairwise alignment of two proteins protein a and protein b in this case is a composite input 
consisting of  




• Bit score aSb: This is the result of the normalisation of a raw pairwise alignment with 
respect to the scoring system (Karlin and Altschul 1990). Normalisation places all 
scores on the same scale, which is a fundamental prerequisite for use as a distance 
metric. 
• Sequence Lengths ax and bx.  
• Alignment lengths: The length of the alignments along both proteins alength and 
blength. 
 
 The latter two length inputs are used to eliminate short hits using a minimum length 
cut-off. These short hits may reflect functionally homologous (potentially orthologous) 
domains as opposed to whole proteins, which are inherited intact as a discrete unit from the 
last common ancestor of the two species under consideration. The bit score is employed as a 
cut-off to limit the radius of the clustering step. The Inparanoid algorithm runs the following 
steps in a pairwise comparison (Remm et al. 2001). 
• Sort all bit scores in ascending order. 
• Read in all hits excluding those that fall below score and length cutoffs. 
• Select the best scores between organism A and B. 
• For each best-hit protein from A-B examine the reciprocal relationship B-A. 
• All reciprocal best hits are stored as a set of seed pairs for orthologous clusters. 
• For each seed pair paralogous genes are grouped around them if the largest score that 
the putative paralog has in the set of all scores is against the putative ortholog in the 
seed cluster of the organism under consideration. 
• Overlapping clusters are then resolved through either deletion or subsumption 
depending on the degree and topology of the overlap.  
2.2.4.2 Implementation 
An implementation of the Inparanoid algorithm in the Perl language (Remm et al. 2001) was 
acquired from the Inparanoid website (http://inparanoid.sbc.su.se). However as this 
implementation provided by proved to not be amenable to the analysis of bespoke output, it 
was decided to re-implement the procedure described above.  
The Inparanoid algorithm was implemented through the application of object 
orientated (OO) software design principles. OO principles involve the characterisation of a 
problem domain as a collection of interacting objects where functionality inherent to each 




object is implemented as internal to that particular object (Pressman 2001). Objects within a 
problem domain are generally identified through the identification of nouns within a problem 
statement (Pressman 2001). Perusal of the algorithm specification provided in (Remm et al. 
2001) led to the above design. 
2.2.4.2.1 Design 
The main object that the procedure required in order to operate was identified as a Cluster 
object, which was implemented with the following attributes and operations. 
 
Figure 2.6: Class diagram of the main entity. 
The box that represents the object above is split into three segments. The first segment 
contains the name of the object. The second segment contains the attributes that the object 
contains. In the case of the Cluster object it has two attributes. One of these attributes 
theAGenes is a list of genes/proteins clustered together from species A. Conversely   
theBGenes is a list of genes/proteins clustered together from species B. 
 The third segment of the boxes represents the operations that it is possible for the 
object to carry out. In the case of the Cluster object the main operations necessary are the 
ability to add and delete members as well as to detect whether two Clusters overlap. Finally 
the ability to merge two Clusters is an essential operation.  




It was decided to use the programming language Java to implement the above design 
as the language provides functionality, which facilitates the OO paradigm. The 
implementation was then tested against the author provided Perl implementation to ensure 
correctness.  
The Java implementation deviated slightly from the author provided Perl 
implementation in two respects. The first deviation from the author provided Perl 
implementation was the use of higher precision double values to represent the bit scores of 
alignments as opposed to the use of integers by Perl. This led to cases where scores that had 
been rounded in the Perl implementation and (thus marked as reciprocal best hits) were not 
marked as reciprocal best hits (examples in Appendix A). 
The second deviation was to cluster orthologous genes with two equal reciprocal best 
hits between the species at the stage of sorting. This change in the order of steps has no effect 
overall on the groups produced by the implementation. The implementation was run using a 
bit score cut-off of 50 and an alignment length cut-off, which was 50% of the length of the 
longer protein.  
2.2.4.3 Application 
The data generated from the similarity searches was then clustered to identify orthologous 
genes using the constructed Inparanoid implementation. The study was carried out using H. 
sapiens as a reference species. Orthologous groups are sought in each organism for every 
protein within the human proteome. This study can be considered unbalanced as no 
information was collected on proteins that are absent in H. sapiens (Davey et al. 2007).  
 As the dataset under consideration was amino acid sequence data there was a choice 
as to how to deal with alternatively spliced isoforms of the same protein.  As the goal of this 
project was to examine the presence and absence of the proteins under consideration it was 
decided that the retention of all isoforms in the dataset and clustering them as inparalogs was 
appropriate. This would allow an examination of correlations in gain and loss of the protein 
as an independent phenotypic entity.   
2.2.5 Phylogenetic profiles 
The output from the clustering step was then used to generate phylogenetic profiles, which as 
mentioned previously are binary strings of presence and absence of an orthologous group for 
a given gene in the reference species.   




In order to establish create phylogenetic profiles of each protein within the human 
proteome the following steps were undertaken. 
• A list of each GI identifier for the set of human proteins was generated. 
• For each entry in this list the relevant identifier was scanned against all files 
containing orthology predictions in alphabetical order. 
•  If the entry was present within the orthology prediction file for a given organism that 
position within the profile string was marked as 1. Otherwise that position was 
marked as 0. The order of the profiles is alphabetical. Therefore for example the 
profile 100000000000000000000000100000000000000000000000000000 indicates a 
protein with an orthologous group present in Anopheles gambiae and Homo sapiens 
but absent in all other species under consideration. 
• Two sets of profiles were generated, one including the outgroup for use in ortholog 
selection and the other excluding the outgroup for use in prediction of functional 
linkage. 
 
Table 2.2 lists the organisms under study along with their proteome sizes and number of 
orthologous groups with reference to H. sapiens. Figure 2.7 shows the distribution of 
proteome sizes in the organisms under consideration. Figure 2.8 shows the number of 
proteins clustered in each organism. 





Organism                                                      No. of Proteins    No. of Clusters     No. of Proteins Clustered 
Methanosarcina acetivorans 
(Outgroup) 
4544 408 822 
Anopheles gambiae 13465 4889 5030 
Arabidopsis thaliana 31915 2849 3389 
Ashbya gossypii 4292 1590 1599 
Aspergillus fumigatus 9630 2167 2175 
Aspergillus niger 14102 2197 2210 
Bombyx mori 21302 4060 4104 
Bos Taurus 25379 15508 16567 
Caenorhabditis briggsae 19553 4009 4212 
Caenorhabditis elegans 23220 4149 4404 
Candida albicans 14107 1909 3367 
Candida glabrata  5192 1737 1784 
Canis familiaris  33527 16372 17681 
Ciona intestinalis 15852 6097 6117 
Cryptococcus neoformans 6594 1985 2045 
Cryptosporidium hominis 3886 953 957 
Cryptosporidium parvum 3805 1080 1086 
Danio rerio 36083 11598 13007 
Debaryomyces hansenii 6317 1861 1887 
Dictyostelium discoideum 13377 2551 2650 
Drosophila melanogaster  20071 5037 6847 
Drosophila pseudoobscura 9871 4230 4240 
Encephalitozoon cuniculi 1996 711 725 
Entamoeba histolytica 9772 1282 1572 
Gallus gallus 18710 11489 11769 
Homo sapiens  33473 26634 33473 
Kluyveromyces lactis 5339 1745 1751 
Leishmania major  8302 1494 1706 
Macaca mulatta 37856 17025 22774 
Magnaporthe grisea 14010 2099 4420 
Monodelphis domestica  20194 13633 13880 
Mus musculus 35048 16607 18448 
Neurospora crassa 10082 1998 2002 
Oryza sativa 26887 2699 2753 
Ostreococcus lucimarinus 7603 2152 2241 
Pan troglodytes  51517 18916 28944 
Paramecium tetraurelia 39642 2147 2740 
Pichia stipitis  5816 1883 3826 
Plasmodium falciparum 5270 1090 2198 
Plasmodium knowlesi 4958 1125 2254 
Plasmodium yoelii 7861 1058 2140 
Populus trichocarpa 45555 3037 3363 
Rattus norvegicus  35903 16414 21279 
Saccharomyces cerevisiae  5883 1803 3706 
Schizosaccharomyces pombe  5045 2066 4272 
Table 2.2: List of organisms used in study along with data source and proteome size as well 
as number of orthologous groups in alphabetical order. The outgroup is placed at the top. 
 









42373 6638 13387 
Takifugu rubripes 22428 10891 11046 
Tetrahymena thermophila 26235 2014 2051 
Theileria annulata 3795 1000 1016 
Theileria parva 4079 1005 2044 
Trichomonas vaginalis 59681 1823 2567 
Trypanosoma brucei 8772 1531 3596 
Trypanosoma cruzi 19606 1737 2079 
Ustilago maydis 6548 3756 3762 
Yarrowia lipolytica 6545 4092 4132 
Table 2.2: List of organisms used in study along with data source and proteome size as well 




Figure 2.7: Distribution of proteome sizes in organisms under consideration. N=55.  
 
 





Figure 2.8: Distribution of number of proteins placed within clusters in each organism. N=55.  
 
Table 2.3 shows the top ten profiles within the human genome and provides an interpretation. 






Profile                                           Count             Interpretation 
000000000000000000000000100000000000000000000000000000 
 
5150 Present in species 
Homo sapiens. 
000000000000000000000000100000000010000000000000000000 2281 Present in Tribe 
Hominini. 
000000100001000000000001100101100010000001000000000000 1089 Present in Phylum 
Chordata. 
000000000000000000000000100100000010000000000000000000 622 Present in Order 
Primate. 




466 Present in species 




378 Present in Class 
Mammalia and 
Class Aves 




281 Present in the 
Phylum Chordata 
with the exception 
of the Species 
Takifugu rubripes 





Table 2.3: Top ten occurring phylogenetic profiles ranked by counts. 





2.2.5.1 Single copy proteins 
In order to select orthologous proteins, which most accurately reflected the evolutionary 
histories of the species under consideration, it was decided to focus on orthologous groups 
that were present in a single copy across all 55 taxa.  This focus on single copy proteins 
excluded potential comparisons between paralogous proteins.   
A set of proteins with ubiquitous profiles was extracted from the data and these were 
sifted for proteins that were present in single copy in each organism in the dataset. 10 
proteins were present in single copy over all the organisms under study. Table 2.4 shows 
details of these proteins. 
 
NCBI RefSeq GI Number                 Description in NCBI annotation.    Entrez Gene Name 
116805340 glycyl-tRNA synthetase  GARS 
32307132 NFS1 nitrogen fixation 1 precursor  NFS1 
4506605 ribosomal protein L23  RPL23 
4506743 ribosomal protein S8  RPS8 
4507215 
signal recognition particle 54kDa 













5803092 Methioine aminopeptidase 2 METAP2 
  24430151 26s protease regulatory subunit 4 PSMC1 
 
Table 2.4: Single copy ubiquitous genes extracted via analysis of profiles. 




2.2.5.2 Proteome content data/tree 
The phylogenetic profiles as developed provided a matrix of presence and absence of every 
human protein in the dataset across the remaining 53 eukaryotes and 1 outgroup archeon. As 
this form of data also contains phylogenetic signal, i.e. shows the divergence in the 
proteomes of the given species over time, it was decided to subject this data to a phylogenetic 
analysis as well as the main phylogenetic analysis to be carried out on the multiple sequence 
alignments of the homologous proteins. The tree was reconstructed using Dollo parsimony 
(Farris 1977) via the program DOLLOP (Felsenstein 1989). This tree can be seen in Figure 
2.17. 
In order to carry this out the profiles were transposed, so that rather than showing the 
distribution of human proteins over a set of species they showed the pattern of presence and 
absence of human proteins over a single species. Thus instead of a matrix of 33,473 proteins 
by 55 species the end product was a matrix of 55 species by 33,473 proteins. In other words 
each species was assigned a binary string of length 34,373 where 1 indicated the presence of 
a particular human protein and 0 its absence.   
This matrix was converted into PHYLIP format through the truncation of species 
names to 10 characters and the addition of header information about the size of the matrix. 
Finally this formatted file was input to the DOLLOP program (Felsenstein 1989). The 
program was run with its default settings.  
In order to examine the level of support for the initial outputted tree 100 bootstrap 
replicates were created with SEQBOOT (Felsenstein 1989). These 100 replicates were 
resubmitted to DOLLOP to produce 100 bootstrap trees. These trees were unified using 
CONSENSE (Felsenstein 1989). 
2.2.6 Multiple alignment 
As an initial step to generate a phylogenetic tree using the orthologous proteins selected a 
multiple alignment of each of the 10 proteins was constructed utilising Mafft (Katoh et al. 
2002) (Multiple Alignment By Fast Fourier Transform) using the L-INS-i algorithm for 1000 
iterations. Each alignment was then subjected to Gblocks filtration (Talavera and Castresana 
2007) to remove columns that were poorly aligned. Gblocks was run in its relaxed mode. 
These alignments were then concatenated to form a super matrix measure of divergence in 




order to generate a measure of divergence across the genomes as opposed to at a single locus, 
as has been suggested by (Rokas et al. 2003). The full alignment can be seen in Appendix D. 
2.2.7 Model selection 
In order to select an evolutionary model which provided a statistically accurate measure of 
genetic divergence ModelGenerator (Keane et al. 2006) was used to select the model that best 
fitted the concatenated multiple alignment. It requires as an argument a number for gamma 
categories, to account for heterogeneity in substitution rates. The argument was given a value 
of 4 gamma categories as this has been observed to be sufficient number to create a “near-
optimum fit” of a model (Yang 1994). 
It has been observed that individual gene trees can be highly incongruent with species 
trees (Cranston et al. 2009). Thus it is possible for the inference of a species tree to be misled 
by “non-phylogenetic signal” from the individual genes (Cranston et al. 2009). In order to 
examine potential incongruence between gene alignments each individual alignment was first 
analysed separately. The model selected for the complete supermatrix was the LG 
substitution matrix (Le and Gascuel 2008). The LG matrix was predicted with the additional 
parameter $ that allows different rates of evolution across the sequence. Each gene alignment 
was also matched by the LG matrix along with different variations as shown in Table 2.5. 
The LG matrix is generated by a model of evolution that takes into account mutation rate 
heterogeneity over sites, thus yielding better results then its predecessors WAG and JTT (Le 
and Gascuel 2008). The models selected were a best fit judged by both the Aikake 
Information Criterion (AIC) as well as the Bayesian Information Criterion (BIC) in all but 
two cases (GARS and ERCC3). Where they disagreed the BIC was selected over the AIC 
(Yang 2008) thus lowering the possibility of overfitting a more complex model to the data.  
The models selected for the individual orthologs were exactly the same as the model 
for the concatenated alignment except in the case of SRP54 where the additional parameter I 



























Table 2.5: Substitution model selected by ModelGenerator for each ortholog. 
 
2.2.8 Phylogeny reconstruction  
After selection of the model each alignment was individually input to PhyML (Guindon and 
Gascuel 2003) with its individual substitution model as well as the concatenated alignment. A 
total of 11 trees were generated one per orthologous gene and one for the concatenated 
alignment as a whole. For the concatenated alignment 1000 replicates were also generated 
using SEQBOOT (Felsenstein 1989) and rerun using PhyML (Guindon and Gascuel 2003). 
These 1000 replicated trees were input to CONSENSE (Felsenstein 1989) in order to acquire 
an estimate of the overall bootstrap support for the tree from within the data. The topology of 
the bootstrapped trees was identical to the topology of the primary ML tree.  
 




2.2.9 Comparison of protein content tree with super matrix tree 
In order to place a measure on whether the protein content tree was a significantly worse 
hypothesis of the evolutionary relationships of the species under study the PHYLIP program 
PROML (Felsenstein 1989) was utilised. PROML was given the supermatrix alignment as a 
dataset and the two trees as user inputted trees to evaluate against the dataset. PROML then 
ran the KH test against the two trees to examine the differences in the likelihood of the trees 
relative to the dataset.  
2.3 Results 
The individual gene trees can be seen in Appendix B. In order to examine potential 
differences in phylogenetic signal between the individual genes trees TREEDIST 
(Felsenstein 1989) was used to generate a distance matrix between the 10 gene trees. 
TREEDIST uses the Branch Score distance (Kuhner and Felsenstein 1994) to calculate the 
distance between two trees. This distance takes into account the branch lengths of the trees 
input as well as the overall topology. This matrix was then used to generate a dendogram 
using UPGMA (Unweighted Pair Group Method with Arithmetic mean) clustering as shown 
in Figure 2.9. 
 
 
Fig 2.9: Cluster diagram of tree distances of individual gene phylogenies. 
 




The gene trees fell into three main clusters. In order to examine the degree of incongruence of 
each cluster from the super matrix species tree the trees contained with each cluster were then 
submitted to CONSENSE (Felsenstein 1989) in order to view the consensus trees. 
CONSENSE was run with the majority rule setting where a group has to appear more than 
50% of the time in the input trees in order to be conserved in the consensus tree. Figures 2.10 
shows the outlier tree estimated from ERCC3 and Figures 2.11 and 2.12 show the consensus 
trees.  





Figure 2.10: Gene tree for gene ERCC3. 





Figure 2.11: Consensus Tree for Cluster 2 containing genes: RSP8 ATP6V1D PSMC1 and 
METAP2. 





Figure 2.12: Consensus Tree 2 for Cluster 3 containing genes: GARS, NFS1, RPL23, SRP54 
and KARS.  






Both consensus trees preserve the kingdoms of Plantae, Animalia and Fungi though 
the order of branching is lost. However both clusters demonstrate a broad congruence with 
the fully concatenated ML tree, which can be seen in Figure 2.13. This is a useful measure of 
the degree of overlap of phylogenetic signal contributed from each of the individual genes. 
Figure 2.13 is an illustration of the topology of the tree with the animals, fungi and plants 
highlighted. Figure 2.14 also overlays the bootstrap support values for each proposed clade. 
Figure 2.15 presents the reconstructed phylogeny with a measure of support, which is the 
proportion of the individual gene trees that supported a clade (Bratke 2009). Figure 2.16 
shows the topology of the tree in combination with branch lengths. 





Figure 2.13: ML tree of 54 eukaryotes without branch lengths created from a super matrix of 
the concatenated alignments of all genes listed in Table 2.5. The clades containing animals, 
fungi and plants are coloured blue, red and green respectively. 
 





Figure 2.14: ML tree of 54 eukaryotes without branch lengths created from a super matrix of 
the concatenated alignments of all genes listed in Table 2.5. Bootstrap support values are 
only shown at each node where support was less than 1000 (not universally supported across 
1000 bootstrap replicates). 





Figure 2.15: ML tree of 54 eukaryotes created from the concatenated alignments of genes 
listed in Table 2.5. Support Values are proportion of individual gene trees, which show a 
given clade (Bratke 2009).  







Fig 2.16: ML tree of 54 eukaryotes with proportional branch lengths. 





Figure 2.17: Proteome content phylogeny with bootstrap support only shown at each node 
which was not 100% supported out of 100 bootstraps.  
 





The results of the KH test carried out using PROML (Felsenstein 1989) showed that the 
proteome content tree is a significantly worse hypothesis of the evolutionary relationships 
between the organisms as shown in the table below. 
 
Tree          Log likelihood 
Protein alignment supermatrix ML tree -131725.8 
Proteome content parsimony tree -133941.0 
 
PROML (Felsenstein 1989) reported that the log likelihood of the proteome content tree was 
significantly worse than that of the protein supermatrix tree. 
2.4 Discussion 
2.4.1.ML tree 
In terms of current thought about super groups within eukaryotes the phylogeny 
reconstructed as seen in Figure 2.13 is incongruent. However given that it is based on a 
concatenation of nuclear genes this is not surprising (Parfrey et al. 2006). This work showed 
that there is generally weak support for most putative eukaryotic super groups in phylogenies 
built using proteins coded by nuclear genes. The super group Opisthokonta is however 
supported as would be expected from the work (Parfrey et al. 2006) though it does subsume 
the Amoebozoa. The ML tree is consistent with known eukaryotic trees (Baldauf et al. 2000) 
in placing plantae as an outgroup to fungi and metazoans. The base of the tree is inconsistent 
with known trees in its placement of E. histolytica as an early braching eukaryote with T. 
vaginalis when it is thought that E. histolytica branches higher up in the tree as a member of 
the Amoebozoa super group (Parfrey et al. 2006). However there is no clear synapomorphy 
(shared derived character) which defines the group Amoebozoa. There is also a lack of 
unambiguous support for the existence of the group as a whole within the nuclear genome 
(Parfrey et al. 2006). This placement is also not novel as both organisms lack mitochondria 
and have been grouped together at the base of eukaryota by phylogenetic analyses of small 
subunit (SSU) RNA genes though their ultimate placement is not certain (Vanacova et al. 
2003).  




Within the animals the tree is consistent with the Coelomata hypothesis which places 
the nematoda as an outgroup to both arthropods and vertebrates. This grouping is fairly 
common in phylogenies derived using molecular data (Wolf et al. 2004) despite being held to 
be false (Aguinaldo et al. 1997). This is thought to be an artefact of long branch attraction 
due to rapid evolution along the C. elegans line (Telford 2004). The classes Mammalia (H. 
sapiens, P. troglodytes, B .taurus, M. domestica, C. familiaris, M. musculus and  R. 
norvegicus), Aves (G. gallus), Osteichthyes (T. rubripes, D. rerio) are all maintained in the 
order that they are generally found in most broad vertebrate phylogenies, e.g. work by Stuart 
(Stuart et al. 2002). 
The tree also arranges its four plant species as expected (Rodriguez-Ezpeleta et al. 
2005) with the algae O. lucimarinus forming an outgroup to the monocot O. sativa and the 
two dicots A. thaliana and P. trichocarpa. 
Within the fungi the tree is consistent with known fungal phylogenies (Fitzpatrick et 
al. 2006). The kingdom Dikarya is a separate clade. Within Dikarya in the phylum 
Ascomycota the subphyla Saccharomycotina (S. cerevisiae, C. albicans, C. glabrata, P 
.stipitis, D. hanseii, Y. lipolytica, K. lactis , A. gossypii), Taphrinomycotina (S. pombe) and 
Pezizomycotina (A. fumigatus, A. niger, N. crassa, M. grisea) are grouped as separate clades. 
Another phylum in Dikarya Basidiomycota (U. maydis, C. neoformans) is a separate clade 
within the tree. The microsporidium E. cuniculi branches out as an outgroup to the Dikarya. 
Within Saccharomycotina the WGD (fungi which have undergone whole genome 
duplication) (C. glabrata, S. cerivisae) are presented as a clade. Also the CTG group (fungi 
which utilise the codon CTG to encode serine instead of leucine) (P. stipitis, D. hanseii, C. 
albicans) (Fitzpatrick et al. 2006) is proposed as a separate clade within the tree. Within the 
CTG group the tree shows disagreement with some published trees (Wang et al. 2009a) by 
placing P. stipitis and C. albicans together with D. hanseii as an outgroup. Figure 2.6 shows 
that this fungal topology was highly supported by the bootstrap analysis.  
The Chromoalveolates are grouped together in one clade. Within this clade the 
Apicomplexa form a monophyletic group within that clade with the Ciliates as an outgroup. 
These groupings are congruent with published trees (Burki et al. 2008; Rodriguez-Ezpeleta et 
al. 2007).  
2.4.2 Proteome content phylogeny 
The proteome content phylogenetic tree as presented in Figure 2.17 shows a degree of 
topological congruence with the tree based on concatenated protein sequences shown in 




Figure 2.13 in that it preserves the animals as a monophyletic group. The branching order of 
the taxa is however different. It also shows the fungi as a clustered group (though not 
monophyletic). However given that PROML reports that it is a significantly worse fit to the 
alignment of homologous proteins it is clearly a worse representation of the dataset then the 
ML supermatrix tree. 
2.4.3 Conclusion 
The reconstructed phylogeny via an application of maximum likelihood to the concatenated 
supermatrix of 10 eukaryotic proteins appeared to be a plausibly accurate reflection of the 
relationships between the taxa. This plausibility was assessed by both by inspection by eye 
and comparisons to previously published eukaryotic phylogenies. 
  The proteome content phylogeny reconstructed by Dollo parsimony on the other hand 
was shown to be a significantly worse representation of the evolutionary relationships 
between the species. As such it was the ML supermatrix tree that was utilised as the 
framework for comparative analysis of protein function within the species. 
The work described in this chapter also produced phylogenetic profiles for each human 
protein across 54 other eukaryotes. 




Chapter 3  
Comparison of methods of prediction of functional linkage in proteins 
3.1 Introduction 
This chapter presents the comparison of four systems of inferring functional links between 
proteins using phylogenetic profiles. These systems were: 
1) Hamming distance:  Phylogenetic profiling was initially used without taking into 
account species phylogeny and treating the state of each point in the profile as 
independent (Pellegrini et al. 1999). Using profiling in this way entailed comparison 
of profiles using the string comparison algorithm Hamming distance (Hamming 
1950), which is a count of the points at which two strings differ.  
2) Use of the comparative method (Barker and Pagel 2005; Pagel 1994) in the context of 
phylogenetic profiling (Pellegrini et al. 1999) with constrained rates of gene gain 
(Barker et al. 2007) over the phylogeny developed in Chapter 2 to detect protein 
interactions. An implementation of the method, BayesTraits (Pagel et al. 2004a) was 
used in order to calculate the relevant likelihoods.  
3) Co-expression of mRNAs corresponding to given proteins: Proteins that physically 
interact or are required to be produced in some of form of spatio-temporal order tend 
to show correlations (positive or negative) in the expression of their underlying 
mRNA molecules. This method has been shown to be effective in detecting 
interactions in Saccharomyces cerevisiae (von Mering et al. 2002) as well as in 
Arabidopsis thaliana in combination with examination of other genomic features (De 
Bodt et al. 2009). Use of this system presents a comparison of an un-curated high-
throughput physical experimental system with an equivalently un-curated 
computational system. 
4) Use of a Bayesian classifier to combine disparate sources of evidence comprising 
gene co-expression, orthology, post translational modification, co-localisation, 
intrinsic disorder, domain co-occurrence and network analysis data in order to predict 
protein interactions (McDowall et al. 2009).  
3.1.1 Hamming distance 
The distance measure Hamming distance is named after its creator Richard Hamming who 
introduced it in his work (Hamming 1950). As mentioned above and in previous chapters, it 
is the distance between two strings of equal length calculated as a count of the points where 




they differ. A string can be represented as a vector of characters.  As an illustrative example 
given the two strings x and y as defined below: 
         
The hamming distance between the two strings is 1 as they vary by 1 character.  
In the context of phylogenetic profile analysis, a hamming distance of 1 between two 
profiles would indicate that the gene/protein under consideration differed by only one species 
in its pattern of distribution. 
3.1.2 Comparative method 
As mentioned in the introductory chapter the comparative method involves the examination 
of the association of a given trait in an organism with another variable in the context of a 
phylogenetic tree (Harvey and Pagel 1991). This variable can be another trait or potentially 
an environmental factor. A prerequisite for this form of analysis is reconstructing putative 
ancestral states at each hypothetical ancestral node within the tree (Pagel 1994).  Using this 
method in the context of phylogenetic profile analysis involves testing whether the presence 
or absence of a given gene is associated with the presence or absence of a second gene or 
protein.  
The implementation of the comparative method used in this chapter is based on the 
approach introduced by Mark Pagel (Pagel 1994) and utilised in the context of phylogenetic 
profiling by Barker and Pagel (Barker and Pagel 2005). This approach is preferred to other 
applications of the comparative method (e.g. work by Wayne Maddison (Maddison 1990) 
and work by Mark Ridley (Ridley 1983)) due to the fact that it does not depend on a single 
set of reconstructed ancestral states over a tree but instead calculates test statistics based on 
all possible ancestral states (Barker and Pagel 2005; Pagel 1994).  An explanation of how 
Barker and Pagel (Barker and Pagel 2005) utilised the framework established in previous 
work by Pagel (Pagel 1994) in order to analyse phylogenetic profiles follows. 
3.1.2.1 Phylogenetic profile analysis using the comparative method 
Imagine a gene or protein G1, which exists in a group of species and a phylogenetic tree 
representing the evolutionary relationships between the members of the group.  At any given 
internal node (hypothetical ancestor) within the tree G1 can either be present or absent.  This 








Over a given branch if the state of G1 at the ancestral node is 0 then there is a 
probability of a gain, i.e. moving to state 1 at the descendant node over the time period 
represented by the branch. Conversely if the ancestral state is 1 then there is a corresponding 
probability of a loss. These probabilities are represented as P01(t) and P10(t) where t  is equal 
to the time interval represented by the branch.  There are also the probabilities of no 
transitions which are represented by P00(t) and P11(t). The probabilities P01(t) and P10(t) can 
also be considered the rate of transitions. 
The comparative method as applied to phylogenetic profiling is an examination of 
whether the state of a second gene/protein has an effect on the state of the first.  Thus 
introducing a second gene / protein G2 there is a corresponding set of probabilities for G2. In 
order to examine whether the state of G2 has an effect on the state of G1 the probabilities or 
transition rates P01(t), P10(t), P00(t) and P11(t)  for G1 can be split in order to factor in the state 
of G2. Thus for example P01(t) can be split into two probabilities one corresponding to the rate 
of gain of G1 if G2 is present and the other corresponding to the rate of gain of G1 if G2 is 
absent. These transition rates were the basic parameters used by Barker and Pagel (Barker 
and Pagel 2005) as represented in the following figure.  
 
Figure 3.1: Parameters for modelling state transitions for pairs of genes as used by 
Barker and Pagel (Barker and Pagel 2005) (Figure is directly reproduced).  
 




Assuming the numbers at the corners of the above figure represent the states of G1 and G2, 
The parameters as presented above represent the following rates of transitions. 
Parameter  Description 
q13 Rate of gain for G1 given the absence of G2. 
q31 Rate of loss for G1 given the absence of G2. 
q12 Rate of gain for G2 given the absence of G1. 
q21 Rate of loss for G2 given the absence of G1. 
q34 Rate of gain for G2 given the presence of G1. 
q43 Rate of loss for G2 given the presence of G1. 
q24 Rate of gain for G1 given the presence of G2. 
q42 Rate of loss for G1 given the presence of G2. 
Table 3.1: Description of rate parameters used by Barker and Pagel (Barker and Pagel 2005). 
  Given these rates it is possible to investigate whether the state of G2 has an effect on the 
transition rates for G1. In order to carry out this investigation two competing models / 
hypotheses were constructed using these parameters (Barker and Pagel 2005). One was a 
dependant model where the presence of G1 is somehow contingent on the presence of the 
absence of G2 or an independent model where there was no connection (Barker and Pagel 
2005).  The dependent model makes an assumption that the rate of gain/loss of G1 is 
somehow affected by the state of G2.  Thus for example the rate of gain of G1 in the presence 
of G2 (q24) will be different from the rate of gain of G1 in the absence of G2 (q13). Conversely 
the dependant model makes the assumption that there is no effect on the transition rates of G1 
by the state of G2. To detect gains and losses over a phylogenetic tree Barker and Pagel 
reconstructed the likelihood of these two competing hypothesis about the distribution of pairs 
of proteins in the constituent species (Barker and Pagel 2005). The premise of the work was 
that the dependent model would prove a better fit to observed data if the transition rate for a 
given protein were affected by the state of the other. In order to detect correlated evolution 
the two competing models were thus defined as follows  




• The independent model of evolution where the probabilities of gain and loss of A 
were independent of the state of B. In order to create this model the parameters 
involving gain and loss of A were constrained to be equal irrespective of the state B 
and vice versa. Using the symbols to define the rates shown in Figure 3.1 this entailed 
setting the transition rates as q13=q24, q42=q31, q31=q43 and q12=q34. This reduced the 
number of parameters for the independent model to four. 
•  A dependant or correlated model of evolution that utilised all eight-transition rate 
parameters.  
 
 Thus given a set of phylogenetic profiles and a phylogenetic tree, the values of the 
parameters that maximised the likelihood of each of the two models was calculated in turn 
between pairs of profiles. These likelihoods were calculated summing the likelihoods of all 
possible ancestral reconstructions at each internal node of the tree thus removing the need for 
the reliance on a single set. Having calculated the likelihoods of both models, the goodness of 
fit of the models to the observed data was compared using the likelihood ratio statistic, LR. 
This can be calculated using the following equation (Yang 2006): 
  
                                            (1) 
 
As applied to detection of correlated evolution H0 was the likelihood of the 
independent model of evolution and H1 was the model of dependent evolution (Barker et al. 
2007; Barker and Pagel 2005).   
Further work showed that constraining the rate of gain of a gene to a preset low level 
as a more potentially realistic representation of actual biological reality improved on the 
ability of the method to detect functional linkages in Saccharomyces cerevisiae (Barker et al. 
2007). This entailed specifying values for the parameters connected to gene gain specifically 
q31, q24, q34 and q12. Rate of gene gain is specifically low in eukaryotes where horizontal gene 
transfer is relatively rare (Whitaker et al. 2009). The rate of de novo generation of genes over 
a relatively short time scale has also been observed to be extremely low. A study detected 
three potential genes in the human genome, which were generated de novo since the split 
with P. troglodytes (Knowles and McLysaght 2009) (estimated at around 4 million years 
(Hobolth et al. 2007)).  
! 
LR = "2(ln(H0) " ln(H1))




This method of fitting models of correlated and uncorrelated models of evolution for 
pairs of proteins using maximum likelihood (ML) (Barker and Pagel 2005) while 
constraining the rate of protein gain (Barker et al. 2007) shall from here on be referred to as 
constrained ML. 
3.1.3 Co-expression as measured by microarray 
As mentioned in Chapter 1 a microarray is a chip usually made of glass, with fluorescently 
labelled oligonucleotide probes representing subsections of genes. The degree of florescence 
from these probes corresponds to the abundance of a given mRNA in a sample and therefore 
the level of expression (Quackenbush 2002; Wodicka et al. 1997).  In a typical microarray 
experiment cells are subjected to different treatments, or harvested from organisms with 
differing phenotypic or disease states (e.g. cancerous tissue vs. normal in human cancer 
patients). The probes on a given microarray chip are generally designed to map to a within a 
coding region on a given gene (Brown 2006).   
To establish whether a given experimental condition corresponds with differential 
expression of a given gene, a descriptive statistic illustrating the central tendency of 
expression (usually the median) is calculated for the entire set of samples. If a given gene is 
found to be expressed at a statistically significant higher level than the central value, this 
gene is interpreted as up-regulated.  Similarly if a gene is expressed at a significantly lower 
level then that gene is interpreted as down-regulated. Probes on a microarray chip can map to 
a single gene, or members of a gene family depending on the specificity of the probe design 
(Heyer et al. 1999). 
3.1.4 Bayesian classifier 
The fourth system of prediction of functional linkage to be considered was that utilised by the 
PIPs server (http://www.compbio.dundee.ac.uk/www-pips)(McDowall et al. 2009). This 
system (Scott and Barton 2007) utilised a combination of sources of evidence for protein 
interactions. These sources were: 
• Gene co-expression: As described and used above a correlated shift in gene 
expression patterns in response to a given environmental stimulus can be used to 
detect given protein interactions. 
• Orthology: If a given pair of proteins is orthologous to a pair of proteins in another 
species that are known to interact then this interaction annotation can be ported from 
one species to the other (Yu et al. 2004a). 




• Subcellular localisation, domain co-occurrence, and posttranslational modification co-
occurrence: These features of a protein can also be informative as to its interaction 
partners. The PIPs system (Scott and Barton 2007) combines these as a joint source of 
evidence.  
• Protein disorder: This measure is based on the observation that the unstructured 
regions within protein molecules are often involved in transient protein interactions. 
(Singh et al. 2007) showed that intrinsic disorder is enriched in “date hubs”, proteins 
that maintain multiple interactions but at different times. 
• Network topology similarity: This measure utilises the principle that proteins that 
interact will share other interacting partners.  
 
These five predictors are combined using a naïve Bayesian classifier to generate a single 
score based on the posterior odds ratio of interaction after calculation of likelihood ratios 
over each of the individual predictor modules (Scott and Barton 2007).   
In order to explain what an odds ratio is it is necessary first to define odds.  Odds are a 
method of presenting the probability of an event by relating this probability to the probability 
of the event not occurring.  Thus the odds of an event are simply the probability of an event 
occurring divided by the probability of the event not occurring (Sokal and Rohlf 1995).  The 
odds of a given event can be calculated by the equation: 
! 
odds(e) = p(e)1" p(e)         (2) 
 
An odds ratio is thus is the ratio of multiple odds. It can be used to measure the effect size 
of a given factor on the probability of an event. Thus if for example the probability of heart 
disease in people who consume a high fat diet is calculated as 
! 
1
4  and the converse probability 
of heart disease in individuals who do not consume a high fat diet is calculated as 
! 
1
8 , the 
odds of having heart disease with a high fat diet are thus via Equation 2 equal to 0.3 and the 




0.14  which is roughly equal to 2. Thus in this example a high fat diet roughly 
doubles the probability of heart disease. 




The posterior odds ratio utilised by PIPs (Scott and Barton 2007) was calculated by 
utilising a prior odds ratio calculated by using a prior probability of interaction estimated as 
! 
1
400 . This prior odds ratio was then multiplied by the likelihood ratios yielded by each of the 
individual predictor modules. The product of this calculation is the posterior odds ratio.  
As in the example, the posterior odds ratio corresponds to the posterior probability of 
interacting, e.g. a score of 2 translates to the probability of interacting being twice as high as 
the probability of not interacting (McDowall et al. 2009; Scott and Barton 2007). 
3.2 Methods 
3.2.1 Assessing quality 
In terms of classification of the accuracy of a binary classification system a common method 
of measurement is the use of sensitivity and precision. Sensitivity can be defined as the 
probability of predicting a true positive and precision as the probability of that prediction 
being correct (Baldi and Brunak 2001). In order to calculate these measures some 
terminology must be introduced. 
True positives (TP): The number of positive predictions made by a binary classifier that 
lie within the positive training set. 
False positives (FP): The number of positive predictions made by a binary classifier that 
lie within the known negative training set. 
False negatives (FN): The number of items in the known positive set, which were not 
predicted by a binary classifier. 
Given these values precision and sensitivity can be calculated as follows (Baldi and 
Brunak 2001; Barker et al. 2007; von Mering et al. 2003): 
 
! 
precision = (TP)(TP+FP)      (3) 
 
! 
sensitivity = (TP)(TP+FN )      (4) 
       
       
 
       





      
3.2.2 Training and test data. 
In order to calculate these values it was necessary to acquire data on known positive 
interactions. Thus the data used by Scott in her development of PIPs (Scott and Barton 2007) 
which was in turn derived from the HPRD (Human Protein Reference Database) (Mishra et 
al. 2006) was acquired. This dataset contained 25,013 predicted protein interactions. The 
dataset was then compared with the set of human proteins contained in the version of RefSeq 
(Pruitt et al. 2005) downloaded in Chapter 2 and the overlap was kept leaving a positive 
dataset of 6,106 proteins and 18,322 protein pairs. 
A negative dataset was generated by creating a set of all possible pairs of proteins 
from the full set of human proteins. In order to filter out proteins which could potentially 
interact the full set of GO (Gene Ontology)(Ashburner et al. 2000) terms associated with each 
protein was downloaded. All pairs with any overlaps in associated GO terms were then 
excluded. As with the positive set the negative dataset was compared to the set of human 
proteins contained in the locally held version of RefSeq (Pruitt et al. 2005) and the overlap 
preserved. As a final check the negative set was compared to the positive set in order to 
examine whether there was any overlap. There was an overlap of 9,568 proteins pairs 
between the positive and negative datasets or 52% of the positive set. This suggests that the 
use of specific GO terms is not better than the selection of random pairs as a procedure for 
the generation of a negative set. However as previous work such as the PIPs procedure (Scott 
and Barton 2007) considered in this chapter, utilised solely random pairs, it was decided that 
this procedure of GO + HPRD filtration was an improvement on this process. The process 
resulted in a negative dataset of 3,216 proteins and 207,952 protein pairs. 
To use the datasets effectively as an objective measure of quality as well as a training 
tool for the evaluation of optimal rates at which to constrain levels of gene gain (Barker et al. 
2007) for BayesTraits (Pagel et al. 2004a) the datasets were randomly split into two halves. 
This was done in order to cross validate the predictive power of any proposed optimal rate of 
gain. This process yielded a positive training set of 4,868 proteins / 9,161 protein pairs and a 
negative training set of 3,216 proteins / 103,971 protein pairs. The second half of the dataset 
was marked as testing data and contained a positive testing set of 4,796 proteins / 9,161 
protein pairs and a negative testing set of 3,215 proteins / 103,974 protein pairs. The sizes of 
the two negative sets are uneven as 5 pairs of proteins had to be removed from the negative 




training set, as they were present in a B-A orientation in the positive set. Similarly two pairs 
of proteins had to be removed from the negative testing set. 
The ratio of the size of negative to positive datasets in this case was roughly 11 to 
1.This is biologically unrealistic as current estimates of the size of the full human interactome 
range from 154,000-369,000 (Hart et al. 2006) to 650,000 (Stumpf et al. 2008). Stumpf 
estimated the potential size of the interactome by treating known experimentally verified data 
as a sub-network of the true network and extrapolating from the sub-network to the full 
network (Stumpf et al. 2008). Hart on the other hand employed the idea that two independent 
samples (experiments) from the complete interactome or subspace of the interactome of size 
N would be expected to share k interactions by random chance under the hypergeometric 
distribution (Hart et al. 2006). Thus Hart estimated the size of N using actually observed 
intersections between experiments (Hart et al. 2006). 
If these numbers are subtracted from the size of all potential interactions 
112,044,172,9 (calculated as all possible pairs from version of RefSeq held) the remaining 
ratios of negative to positive range from 1722:1 to 8 617:1. For any full genome-wise survey 
it would be necessary to scale all the precision and sensitivity scores from the training set 
ratios to ratios constructed from estimates of the interactome size. This issue is addressed 
more fully in Chapter 5. 
3.2.3 Hamming distance 
The ability of Hamming distance to differentiate between the positive and negative training 
set was measured with a lower distance corresponding to a higher score.  Precision/sensitivity 
were evaluated at every integer within a range of Hamming distance cut-offs ranging from 0 
to 54.  
3.2.4 Constrained ML 
To use phylogenetic profiling in a phylogenetically aware manner to detect correlations in 
gain and loss the software package BayesTraits was utilised (Pagel et al. 2004a). This has 
been used in previous work (Barker and Pagel 2005) to demonstrate that detection of 
correlations in gain and loss of particular genes can be used as a tool with which to detect 
functional interactions.  
The script bms_runner (Barker et al. 2007) was used to examine the performance of 
different rates of gain in predicting functional interactions amongst the training sets in order 
to select an optimal rate. The script utilised the phylogenetic profiles and phylogeny 




described in Chapter 2 as well the positive and negative training sets to evaluate the 
performance of different rates of gain. bms_runner (Barker et al. 2007) creates input for the 
program BayesTraits (Pagel et al. 2004a) to evaluate the relative likelihood of correlated 
evolution at a range of rates of gain. bms_runner creates a non-redundant set of profiles 
(Barker et al. 2007)  before passing them on to BayesTraits for comparisons. Thus 113,132 
protein pairs in the training set were reduced to a set of 54,906 non-redundant pairs of 
profiles.  
A number of rates of gain were evaluated for precision and sensitivity over the 
training data ranging from 1  10-6 up to placing no restriction on gain. An LR score was 
calculated for each profile pair at rate of gain and assigned to each protein pair corresponding 
with that profile pair. bms_runner then evaluates precision and sensitivity at a range of cut-
offs commencing at the minimum LR encountered and moving up by a decreasing interval 
until a value close to  the maximum LR is reached (Barker et al. 2007). The program then 
provides a table that includes the following information for this range of cut-offs.  
 
LR cutoff No of predictions Precision Sensitivity 
Table 3.2: Column headings for data matrix returned by bms_runner (Barker et al. 2007). 
3.2.5 Co-expression of mRNA 
The co-expression of two genes in association with a given environmental condition can be 
considered a potential indictor of functional linkage. In order to examine the performance of 
the ML reconstruction method in predicting protein functional interactions against the co-
expression of mRNA the results of all microarray experiments held in the EBIs ArrayExpress 
database were downloaded.  
This data was pre-processed and thus contained expression data at the gene level 
rather than at the probe level. As oligonucleotide probes only map to small subsections of a 
gene and also can hybridise with multiple targets the relationship between probe to gene is 
many-to-many. This many-to-many relationship was collapsed by data processing carried out 
by ArrayExpress on each individual experiment. 
Thus a total of 377 experiments were downloaded. Each experiment record contained 
information on genes whose expression level varied significantly in response to the 
experimental treatment/tissue state. The size of individual experiments ranged in size from 1 
! 
"




gene to a maximum of 15,987. The mean number of genes showing significant variation per 
experiment was approximately 3,143. 
A sample line from the downloaded data is shown below for illustrative purposes: 
 
Gene Symbol    Ensembl ID                Species             Factor                    Value           Accession             Expression        p Value 









Table 3.3: Sample processed data from ArrayExpress for experiment E-GEOD-3790 (Hodges 
et al. 2006). 
 
E-GEOD-3790 is a study on gene expression in brain tissue afflicted with Huntington’s 
disease (Hodges et al. 2006).  The factor column has a number of potential values 
corresponding to the annotation of the individual samples. In this case it corresponds to 
whether the tissue comes from a patient diagnosed with Huntington’s disease as opposed to 
normal tissue. The value column shows the value of the factor (in this case normal). The p 
value column shows the significance of the identified differential expression. Thus the data 
presented above shows that the gene STAT1 is significantly (p<0.05) down-regulated in 
tissue annotated as normal.  
To use the training datasets to measure the ability of gene co-expression to predict 
protein interactions it was necessary to convert the training data from protein pairs to gene 
pairs. Using a translation key provided by the International Protein Index (IPI) (Kersey et al. 
2004) each RefSeq Gi number was mapped to the associated gene name. As individual genes 
can produce multiple proteins via the process of alternative splicing there isn’t a one to one 
correspondence between the number of genes and the number of protein in both training sets. 
With some Gi entries missing in the translation key this created a positive gene training set of 
4319 genes /8057 gene pairs and a negative set of 2833 genes /89549 pairs of genes. 
In order to predict functional linkage the following procedure was followed.  
• The data in each microarray experiment was split according to experimental 
condition. 
• For each experimental condition pairs of genes were marked as functionally linked if 
their expression level went up or down in response to the given experimental 
condition.  
• True positives were counted if the genes existed as a pair in the positive set. 




• False positives were counted if the genes existed as a pair in the negative set. 
• False negatives were counted as the complement of the set of predictions and the 
positive set. 
This data was processed using a program implemented in Java, which followed the steps 
presented below. The input to the program was a file containing a set of lines as shown above 
for a single experiment. 
 
• Create a non-redundant set of factors present in the experiment. 
• Create a non-redundant set of values for each factor. 
• Create an empty set L to hold functionally linked pairs 
• For each factor F: 
For each factor value FV: 
For each expression value E (UP or DOWN) 
Create a set S of all genes possessing the attributes {F,FV,E}where the associated p 
value for E is less than 0.05 
All genes within  S  are declared functionally linked. 
All possible pairs of genes within S are added to L 
• L is now evaluated against the training data for precision/sensitivity. 
3.2.6 Bayesian classifier 
The PIPs server offers its data split into six score cut-offs: 0.25, 1, 2.5, 25, 250 and 2500 
(McDowall et al. 2009). These datasets were downloaded and evaluated for precision and 
sensitivity at each of these cut-offs. For each cut-off the server provides a file with pairs of 
proteins and the associated posterior odds ratio score. Each pair of proteins within each file 
was declared to be functionally linked and then evaluated against the training data. This 
provided associated precision/sensitivity scores for each cut-off. 
 





3.3.1 Hamming distance 
Figure 3.2 shows the performance of phylogenetic profiling over the training sets using 
Hamming distance. 
 
Figure 3.2: Performance of phylogenetic profiling using Hamming distance over the training 
data. 
 
Hamming distance as a measure does not perform well over the training data 
achieving a maximum precision of 0.08796. 
 




3.3.2 Constrained ML 
The ability of constrained ML (Barker et al. 2007; Barker and Pagel 2005) to distinguish 
between the training data was tested at a number of rates of gain. The results of this can be 
seen in Figure 3.3. 
 
Figure 3.3: Performance of constrained ML (Barker et al. 2007; Barker and Pagel 2005) over 
training data at different rates of gain. 
 
Figure 3.3 shows points at a range of sensitivity between 0-1. Sensitivity over the 
whole training set ranges between 1 at LR cut-offs of 0 where all pairs of proteins are 




predicted to be functionally linked to 0 at the points where no pairs from the positive set are 
predicted to be functionally linked.  
Precision ranges from 0.0809 (a base level that is derived from the ratio of the size of 
the positive set to the size of the negative set) up to 1 which is the point at which all 
predictions made at a given LR cut-off lie in the positive set, i.e. are true positives.  
Of the two metrics (precision/sensitivity) it is precision, which appears to be the 
strong suit of constrained ML. This is probably due to the fact that correlated evolution will 
not occur in all cases of protein interactions. A large number of protein interactions will 
contain members that are phylogenetically ubiquitous. In some of these cases the interaction 
will be essential to maintenance of normal eukaryotic cellular function. In other cases even if 
an interaction is being lost or gained in an organism, its individual members might still be 
present (the interaction being lost due to some form of temporal/spatial separation of the 
members).  Thus as low sensitivity is inevitable with this method; it was decided to focus on 
rates of gain that achieve 100% precision. Figure 3.4 places all rates of gain on a single plot 
and zooms into a range of sensitivities between 0 and 0.001. 






Figure 3.4: Performance of constrained ML (Barker et al. 2007; Barker and Pagel 2005) over 
training data magnified to a scale of sensitivity ranging from 0 to 0.001. For clarity some of 
the worse performing rates of gain are removed. 
 
Figure 3.4 shows that the rate 0.025 is the clear best performer as it delivers 
predictions with a precision of 1 at the highest sensitivity. The LR cut-off at this point is 
58.54. The sensitivity at this cut-off for the rate 0.025 is 0.000545. This rate is thus chosen as 
the exemplar rate to represent the method in comparisons and to utilise for further analysis. 
The findings of (Barker et al. 2007) were borne out in this investigation as lower rates of gain 
were generally seen as the best performers.  




 Over the training data constrained ML (Barker et al. 2007; Barker and Pagel 2005) 
with the rate of gain constrained to 0.025 makes five predictions from the positive set shown 
in Table 3.1 




Cell division protein 
kinase 2  
 
Origin recognition 
complex subunit 1 
 


















Cell division protein 













Exportin 1 Direct In-vivo/in-vitro 
experimentation 









2B catalytic subunit 
alpha 
 
Direct Yeast 2-hybrid 
(Stelzl et al. 2005) 
Table 3.1: True positive proteins predicted by constrained ML (Barker et al. 2007; Barker 
and Pagel 2005) from the training data with rate of gain constrained to 0.025 at an LR cutoff 
of 58.54. 
 
 The examination of the training datasets yielded a similar result to (Barker et al. 2007) in so 
much as lower rates of gain tended to perform better.  




As 0.025 was selected as the optimum rate of gene gain over the training data it was 
also tested on the testing data to cross validate this selection. Figure 3.5 shows the results of 
this cross validation check. 
 
 
Figure 3.5: Performance of constrained ML (Barker et al. 2007; Barker and Pagel 2005) over 
test data with rate of gain constrained to 0.025. 
 
Figure 3.5 shows that constraining the rate of gain to 0.025 also achieves a precision 
of 1 over the testing data. This precision occurs at an LR cutoff of 53.3.  The sensitivity at 
this point is 0.00054. At this cutoff constrained ML (Barker et al. 2007; Barker and Pagel 


















DDX3X isoform 1 
Direct In-vitro 
experimentation 





protein complex 1 
beta 1 subunit 
isoform a  
 AP-1 complex 
subunit gamma-1 
isoform b 
Direct Yeast 2-hybrid 













(Coin et al. 1998) 
 
NP_005517     
NP_004497        
heat shock factor 
protein 1 
heat shock factor 
protein 2 isoform a 
Direct In-vivo/in-vitro 
experimentation 
(He et al. 2003) 
NP_066953        
NP_000936  
peptidyl-prolyl cis-
trans isomerase A 
calcineurin subunit 
B type 1 
Complex In-vitro  
experimentation 
(Huai et al. 2002) 
Table 3.2: True positive proteins predicted by constrained ML (Barker et al. 2007; Barker 
and Pagel 2005) from the testing data with rate of gain constrained to 0.025 at an LR cutoff 
of 50.217. 
3.3.2.1 Likelihood ratio statistic 
The likelihood ratio statistic (LR) derived from the comparison of the independent and 
dependant models of evolution is asymptotically distributed as a %2 variate with degrees of 
freedom equal to the difference of numbers in parameters between the two models which in 
this case equals 4 under assumptions about the size of the phylogeny and the speed of 
evolution of the character under consideration (Barker and Pagel 2005; Pagel 1997).  Thus if 
the LR falls within the critical region of the distribution it is considered significant. A 
histogram showing the theoretical %2 distributions with 4 degrees of freedom is shown below 
in Figure 3.6. 






Figure 3.6: Theoretical %2 distribution with 4 degrees of freedom. 
 
 
The distribution of LRs in the positive and negative set as well as over the combined 
training data differs from this theoretical distribution as can be seen in Figures 3.7, 3.8, 3.9 
and 3.10.  
 





Figure 3.7: Distribution of likelihood ratio statistic for constrained ML within the rate 
of gain 0.025 over the positive training set. 





Figure 3.8: Distribution of likelihood ratio statistic for constrained ML within the rate 
of gain 0.025 over the negative training set. 
 






Figure 3.9: Distribution of likelihood ratio statistics for constrained ML (Barker et al. 
2007; Barker and Pagel 2005) within the rate of gain 0.025 over the complete training 
dataset. 
 
Minimum      1st Quartile           Median                  Mean              3rd Quartile   Maximum    
0.08932  7.85 10.51 11.14 13.79 74.80 
Table 3.3: Descriptive statistics for the distribution of likelihood ratios for the rate of gain 
0.025 over the complete training data. 





Figure 3.10: Distribution of likelihood ratio statistics for constrained ML within the 
rate of gain 0.025 over the complete training dataset, the positive training dataset and the 
negative training dataset compared with the theoretical %2 distribution with 4 degrees of 
freedom. 
 
The distribution of LR statistics over the training data seems to differ from the 
theoretical %2 distributions with 4 degrees of freedom.  
This distribution was also tested via a two-sample Kolmogorov-Smirnov test for 
goodness of fit between a generated theoretical %2 distribution with 4 degrees of freedom and 
the LR statistic score distribution over the training data using R (R Development Core Team 
2011). This also showed a difference between the two distributions (D=0.9993, p-value<2.2e-
16). 




This may be due to a violation of assumptions of the model with regards to the speed 
of character transition.  
The overall frequency of higher LR statistics does appear to be higher in the positive 
set which is further validation for the constrained ML method. 
3.3.3 Co-expression of mRNA 
The results for each microarray experiment measured over the training data are given below 




Figure 3.11: Precision/ sensitivity results for 377 microarray experiments over the 
training datasets.  
 




As before the area of interest in Figure 3.11 is the point at which precision equals 1.  
This is because the average correlation between transcript abundance and peptide abundance 
has been observed to be fairly low in primates at around 0.33 (Fu et al. 2007). Thus mRNA 
co-expression is unlikely to be capable of high sensitivities in protein-protein interaction 
detection. Figure 3.12 is a magnification of this area. 
  
Figure 3.12: precision/ sensitivity results for microarray experiments over the training 
datasets magnified to a scale of sensitivity ranging from 0 to 0.01. 
 
Mean precision over all 377 microarray experiments was 0.2141 and mean sensitivity 
was 0.1195. Out of the 377 total 18 experiments achieved a precision of 1. Details of these 














Accession              Size                 Description of experiment                           Sensitivity  
E-GEOD-4567  166 Transcription profiling of human pulmonary artery endothelial 




168 Transcription profiling of oral cavity samples from human 
squamous cell carcinoma patients (O'donnell et al. 2005). 
0.0003274752 
E-GEOD-3183  255 Transcription profiling of human bronchial cell line treated 
with IL-13 to better understand early cytokine-mediated 
mechanisms that lead to asthma. 
0.0002183168 
E-GEOD-994  266 Transcription profiling of human intra-pulmonary airways and 
buccal mucosa to identify the effects of cigarette smoke on the 
human airway epithelial cell transcriptome (Spira et al. 2004). 
0.0002183168 
E-GEOD-2152  474 Transcription profiling of human uterine fibroids mith mutated 
or wild type fumarate hydratase gene (Vanharanta et al. 2006). 
0.0008728860 
E-GEOD-2504   28 Transcription profiling of untreated, HIV-1 vector-infected 
and TNFalpha-treated human Jurkat T cells (Lewinski et al. 
2005). 
0.0002182929 
E-GEOD-4748  191 Transcription profiling of human dendritic monocytes treated 
with LPS (lipopolysaccharide) or CyP (Cyanobacterial 
Product) (Macagno et al. 2006). 
0.0004366336 
E-MEXP-1224 538 Transcription profiling of human colon samples from patients 
who have colorectal cancer recurrence or are recurrence-free 
(Garman et al. 2009). 
0.0030511060 
E-GEOD-7664  254 Transcription profiling of human PBMC response to benzene 
metabolites (Gillis et al. 2007). 
0.0008728860 
E-GEOD-2361  87 Transcription profiling of 36 normal human tissue types to 
identify tissue-specific genes (Ge et al. 2005). 
0.0003274752 
E-GEOD-1739  212 Transcription profiling of blood samples from human patients 
with severe acute respiratory syndrome (SARS) (Reghunathan 
et al. 2005). 
0.0002182929 
 
Table 3.4: Microarray experiments achieving a precision of 1. 
 




E-TABM-577  95 Transcription profiling of human placenta from women 
presenting at term with villitis of unknown etiology (Kim et 
al. 2009). 
0.0001091584 
E-GEOD-2018  129 Transcription profiling of human bronchoalveolar lavage 
samples collected from lung transplant recipients with 
rejection states determined at the time of sample collection 
(Lande et al. 2003). 
0.0001091584 
E-GEOD-1786  126 Transcription profiling of human male vastus lateralis muscle 
samples from healthy and COPD subjects before and after 3 
months of training (Radom-Aizik et al. 2005). 
0.0008728860 
E-GEOD-2624  293 Transcription profiling of human tetracycline-regulated cell 
line expressing an NF-kB inhibitor to systematically identify 
NF-kB dependent genes (Tian et al. 2005). 
0.0014181302 
E-MEXP-714   55 Transcription profiling of human hepatitis C virus replicon 
cell line treated with interferon-alpha 2a in a time series. 
0.0002182929 
E-GEOD-9770  1225 Transcription profiling of human neurons from different brain 
regions derived from individuals with mild cognitive 
impairment. 
0.0008731718 
E-GEOD-403  333 Transcription profiling time series of the cAMP-induced 
decidualization of human endometrial stromal cells (Tierney 
et al. 2003). 
0.0007641087 
 
Table 3.4: Microarray experiments achieving a precision of 1 (cont). 
 
The highest scoring microarray experiment was E-MEXP-1224, an investigation into 
whether there was a difference in expression profiles between the colorectal tissue of patients 
who has recurrent cancer and those who remained clear (Garman et al. 2009). The sensitivity 
of this experiment was  with a precision of 1. 
3.3.4 Bayesian classifier  
The ability of the PIPs (McDowall et al. 2009) server to predict functional interaction over 
the training set was evaluated at 6 cutoffs. The results can be seen in Figure 3.13  
! 
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Figure 3.13: Precision/ sensitivity results for predictions from the PIPs server over six 









Figure 3.14: precision/ sensitivity results for predictions from the PIPs server over six cutoffs 
over the training dataset zoomed in to a maximum sensitivity of 0.15.  
 
None of the score cut-offs over the predictions from the PIPs server achieved a full 
precision of 1. However none of them fell under 0.9 either as seen in Table 3.5. 






Cutoff                         Predictions                       Precision               Sensitivity 
0.25  79441 0.9135546  0.14366504 
 
1.00  37606 0.9395973  0.11068444 
 
2.50  25598 0.9533333  0.09825928 
 
25.00  5394 0.9949239  0.04742318 
 
250.00  1232 0.9865772  0.01832689 
 
2500.00    498  0.9883721  0.01067973  
 
 
Table 3.5: precision/ sensitivity results for predictions from the PIPs server over six cutoffs.  
 
3.3.5 Method Comparison 
 Three out of the four methods evaluated are able to discriminate between the negative and 
positive examples in the training data with varying degrees of success. Figure 3.12 shows all 
three methods charted in on the same plot. Examination of phylogenetic profiles via detection 
of correlated evolution using maximum likelihood is represented by the single optimum rate 
of gene gain of 0.025 as the object of the ML correlated evolution training step was the 
selection of this optimum rate of gain. 





Figure 3.12: All methods compared over training dataset. Legend explanation (PIPs=PIPs 
server, MA= microarray experiment and PP= phylogenetic profiling measuring correlation in 
gain and loss over a phylogeny with constrained rate of gain). 
3.4 Discussion 
Arguably the best performing method out of all three methods is the PIPs server (McDowall 
et al. 2009) as it achieves the highest rates of combined precision and sensitivity over the 
training data. The success of the PIPs server in terms of accuracy and coverage is attributable 
to its use of multiple, disparate sources of evidence. The other two methods both focus on 
particular types of interactions.  
Phylogenetic profiling measured with constrained ML over a phylogeny is limited to 
proteins that have been gained and lost in a correlated fashion over a phylogeny. Thus protein 
interactions between phylogenetically ubiquitous partners cannot be detected. Similarly it 
cannot detect interactions between interactors with potentially redundant partners.  




Microarrays are more flexible in the types of interaction they are capable of detecting. 
However individual experiments are limited in the types of interactions that they can uncover 
by the experimental conditions under which their constituent mRNAs were extracted.  They 
are also biased toward stable complexes (von Mering et al. 2002). Another limitation in the 
use of microarray experiments in the prediction of protein interactions is the fact that 
expression levels of a gene at the transcription level do not correlate strongly with overall 
levels of protein production at the translational level (Gygi et al. 1999). This is due to 
regulation at the posttranscriptional level by factors such as mRNA half-life, codon usage and 
ribosome occupancy and density (Wu et al. 2008). The best performing microarray 
experiments outperformed constrained ML in terms of sensitivity. 
However given the difference in cost and labour intensiveness between a microarray 
experiment and a computational analysis employing phylogenetic profiling, the latter can 
clearly be a useful tool in the functional annotation of identified genes within a newly 
sequenced genome. 
3.4.1 Low Sensitivities  
None of the methods as described and utilised above can are particularly sensitive in 
detecting protein-protein interactions. Constrained ML and gene co-expression are insensitive 
to protein-protein interactions for the reasons described above.  
 The PIPs server as the best performer achieves a sensitivity of 0.14 at a high level of 
precision. However this still corresponds to a 14% chance of detecting a possible protein 
interaction despite its integration of various forms of supporting evidence. It is possible that it 
is this integration of evidence that renders PIPs insensitive. If for example the likelihood ratio 
returned by one of its predictor modules was high with the rest all being low, the overall 
posterior odds ratio score would be low. Thus the individual sensitivities of the module 
predictors are averaged out.  
 It seems that maximising coverage of the interactome is beyond the scope of each of 
the predictive methods considered in this chapter. To use the analogy of the interactome as a 
dark room, none of these methods are equivalent to an overhead light that illuminates every 
corner of the room. Rather each method is more like a lamp that casts a pool of light on its 
immediate surroundings. It is only by lighting a number of these lamps that the entire room 
can be illuminated.  




Chapter 4  
Design and implementation of data filter 
4.1. Introduction 
The constrained maximum likelihood (ML) method used to detect proteins which share 
correlated evolutionary histories as described in Chapter 3 and in work by Barker et al. 
(Barker et al. 2007; Barker and Pagel 2005) estimates values for parameters which model the 
transition rates of the gain and loss of discrete characters (Pagel 1994) by integrating over all 
possible ancestral states at each node within the phylogenetic tree.  
As pointed out by Barker (Barker et al. 2007) placing a constraint on the rate of 
acquisition of new proteins increases the ability of the likelihood method to discriminate 
between proteins that interact and those that do not.  The determination of an optimum rate of 
gain reduces the scale of the problem of parameter estimation (Barker and Pagel 2005) as it 
reduces the numbers of parameters to be fitted to 2 for the independent model and 4 for the 
dependent model.  
The detection of potential functional interactors for a single given protein using this 
method is possible, however given the low sensitivity of the method (see Chapter 3) the 
probability of detecting a functional interaction for any given single protein or even a set of 
proteins is low. A complete genome-wide survey however would detect all protein pairs that 
displayed evidence of correlated evolution. 
The procedure is however prohibitively slow for a complete genome-wide survey 
without access to a significant amount of computing power. A timed training run over the 
training dataset for a single rate of gain took approximately 110 CPU-hours to conclude 
54,906 comparisons of non redundant phylogenetic profile pairs on a single core of a 3 GHz 
dual-core Intel Xeon processor (see Section 4.5). As there are 60,615,555 possible non-
redundant pairs of phylogenetic profiles in the version of the human proteome currently held; 
a full genome comparison would take 121,825.05 CPU-hours or 13.9 CPU-years on the 
single core of a dual-core 3 GHz Intel Xeon processor.  The speed of constrained ML (Barker 
et al. 2007; Barker and Pagel 2005) was also measured in work presenting a genome order 
based approach to phylogenetic profiling (Cokus et al. 2007). In this case it was found to 
range between 5-15 seconds per pair of proteins (Cokus et al. 2007). This caused the authors 
to utilise a subset of their data in their benchmarking study of constrained ML (Cokus et al. 
2007). 




Potentially access to multi-core CPUs and/or computing clusters could ameliorate this 
to a certain extent.  As application of constrained ML (Barker et al. 2007; Barker and Pagel 
2005) involves sequential comparison of pairs of phylogenetic profiles, it is a process that is 
easily amenable to parallelisation via splitting the task into a smaller set of tasks, which can 
be launched in parallel. Task farming is applied in computational biology to tasks that are 
potentially intractable if tackled serially, e.g. analysis of gel electrophoresis data (Dowsey et 
al. 2003) or analysis of microarray data (Hill et al. 2008). However even with the application 
of task farming it is clear that a full genome-wide survey is not feasible for this method on 
any averaged sized eukaryotic genome.  
This chapter details the development of a data filter to remove protein pairs that 
display little or no evidence of correlated evolution.  There are two main types of filter 
evaluated. The first type is a simple distance based test (Hamming distance) as shown in 
Chapter 3 and utilised in early work on phylogenetic profiling (Pellegrini et al. 1999).  
Potentially proteins that display evidence of correlated evolution will have phylogenetic 
profiles that have a lower Hamming distance from each other. Thus even though Hamming 
distance applied in isolation performs poorly as seen in Chapter 3, it may serve as a filter for 
proteins which do not display evidence of correlated evolution in combination with the 
second type of filter.  
The second type of filter will utilise a single set of reconstructed ancestral states. By 
using a single set of reconstructed states and a simpler method for the detection of evidence 
of correlated evolution proteins that do not display any such evidence may be filtered out. 
This chapter describes the implementation and comparison of five filters, which utilise a 
single set of reconstructed ancestral states to detect signs of correlated evolution. As a large 
amount of the computations performed by constrained ML (Barker et al. 2007; Barker and 
Pagel 2005) involve estimation of the transition rate parameters by integrating over all 
possible ancestral states, use of a single set of reconstructed ancestral states reduces the scope 
of the problem. Through the use of an effective and accurate data filter a genome-wide 
survey for an average eukaryotic organism could be rendered feasible.  
The end product of this research described in this chapter is just such a filter based on 
logistic regression of a set of empirically evaluated predictors/parameters, which reflect 
correlated evolution between a pair of proteins.  The filter is approximately 2208 times faster 
then constrained ML and achieves a reasonable degree of precision/sensitivity over the 
training data in its own right.  Thus application of this filter can facilitate a heuristic search 




for genes/proteins displaying evidence of correlated evolution over an entire 
genome/proteome. 
In order to describe the process of filter development/evaluation it will firstly be 
necessary to present an overview of ancestral state reconstruction. 
4.1.1 Ancestral state reconstruction 
The procedures involved in the reconstruction of the states of characters and traits in extinct 
ancestral species are similar to those involved in phylogeny reconstruction. This is due to the 
similarity of the issues involved.  The reconstruction procedures for character states thus 
utilise similar criteria with which to judge putative reconstructions. Ancestral reconstruction 
is a useful tool for investigating hypothetical evolutionary scenarios having been used to 
investigate many biological questions such as for example the demonstration of homoplasy in 
the evolution of lysozyme (Malcolm et al. 1990; Messler and Stewart 1997; Stewart et al. 
1987). It is also a prerequisite step for a number of comparative method tests (Maddison 
1990; Ridley 1983).  
4.1.1.1 Parsimony 
A parsimonious reconstruction of ancestral states over a phylogenetic tree would 
entail the selection of the internal state that minimised change. Thus if for example two 
terminal nodes within a given clade had the same internal state the same state would be 
assigned to the node immediately preceding them. 
  Algorithms such as the Fitch (Fitch 1971) and Sankoff (Sankoff 1975) algorithms as 
described in Chapter 2 are used employed as a step within phylogeny reconstruction (Albert 
2006). However given a particular already constructed phylogenetic tree they can be 
employed to reconstruct a set of ancestral node values which minimises evolutionary change 
over that particular tree (Felsenstein 2004). The algorithms themselves do not reconstruct 
individual states at each internal node but instead construct sets of potential states at each 
node. These potential states can be resolved into a singular state reconstruction through the 
application of algorithms such as ACCTRAN (Accelerated transformation) (Swofford and 
Maddison 1987), which reconstructs ancestral states by placing points of change as close to 
the root of the tree as possible (Agnarsson and Miller 2008). The converse approach to 
ACCTRAN is DELTRAN (delayed transformation)(Swofford and Maddison 1987), which 
reconstructs ancestral states by placing points of change as close to the tips of the tree as 
possible (Agnarsson and Miller 2008). ACCTRAN and DELTRAN are the most commonly 




used methods for collapsing node state sets into individual node states though of the two 
ACCTRAN is the more widely employed (Agnarsson and Miller 2008). 
Parsimony methods fail to consider different branch lengths in different parts of the 
tree (Yang et al. 1995). Parsimony based methods have also been criticised for their lack of 
statistical soundness (Elias and Tuller 2007). Parsimony methods are also unable to 
distinguish between reconstructions that are equally parsimonious (Koshi and Goldstein 
1996).  
4.1.1.2 Likelihood  
In a similar fashion as likelihood is employed as an optimality criterion for phylogeny 
generation, it can also be used in the context of ancestral state reconstruction. Maximum 
likelihood techniques are used to estimate the parameters of the specified model of evolution 
(Yang 2006). Once these parameters are estimated they can be utilised to calculate the 
posterior probability of ancestral states using Bayes theorem (Yang 2006). The state with the 
highest posterior probability is then assigned to the node under consideration. This procedure 
has been defined as empirical Bayes (Yang 2006). Empirical Bayes can be used to either 
assign a character state to a set of nodes in a tree via a process known as marginal 
reconstruction or it can be used to assign a set of possible characters to each node (Yang 
2006). This latter process is known as joint reconstruction (Yang 2006). 
Empirical Bayes can be contrasted with hierarchical Bayes where rather than estimating a 
single value for the parameters of a model of evolution a prior probability distribution is 
assigned for each unknown parameter (Yang 2006). The posterior probability for a given 
ancestral state is then calculated by integrating over all possible values of parameters 
(Huelsenbeck and Bollback 2001).  Again the putative state with the highest posterior 
probability is then assigned to each ancestral node. 
  Work by Koshi and Goldstein used the empirical Bayes method to reconstruct the 
sequence of ancestral ribonuclease (Koshi and Goldstein 1996). The performance of 
parsimony and the empirical Bayes method was also compared in a reconstruction of 
lysozyme c by Yang et al. (Yang et al. 1995). This work found that empirical Bayes 
outperformed parsimony but both methods suffered when the sites within the multiple 
alignments being reconstructed were highly variable and the distance from the ancestral 
nodes to the extant species was high (Yang et al. 1995).  
An interesting application of empirical Bayes reconstruction was carried out by 
Gashen (Gaschen et al. 2002). This work entailed reconstruction of the reconstruction of the 




sequence of the ancestor to various regional variants of the HIV-1 virus in order to contribute 
to the creation of a potential vaccine (Gaschen et al. 2002). 
4.2 Filters 
4.2.1 Hamming distance filter 
The original work which introduced the methodology of phylogenetic profiling as a means of 
detection of functional interaction between genes (Pellegrini et al. 1999) utilised Hamming 
distance (Hamming 1950) as a measure of similarity of profiles. Phillip Kensche also 
examined this method in a review of phylogenetic profiling methods, and found it to perform 
reasonably well over a dataset composed of the proteins sequences of 25 fungi (Kensche et 
al. 2008). Hamming distance did not perform well over the training data as seen in Chapter 3 
however it was possible that it could reduce the possible search space for an application of 
constrained ML. As a potential heuristic it offers speed, as Hamming distance is one of the 
simplest comparisons that can be carried out between two strings. Hamming distance 
therefore was investigated as a potential filter to be used possibly in conjunction with a filter 
based on a single set of reconstructed states.  
4.2.2 Ancestral state reconstruction filter 
The first consideration in the development of a heuristic/filter based on a single set of 
reconstructed characters was which criterion to use to reconstruct that set.  Likelihood as a 
criterion yields more accurate results as discussed above. However as the aim of this heuristic 
approach was to develop a method that reduced the search space for an application of the 
computationally intensive constrained ML (Barker et al. 2007; Barker and Pagel 2005) to 
phylogenetic profiling, it was decided to use the simpler though less accurate criterion of 
parsimony.  
4.2.2.1 Dollo parsimony 
Dollo parsimony operates under the assumption that once a complex trait has been lost it 
cannot be re-acquired (Albert 2006). Given that the character under investigation is the 
presence and absence of genes/proteins in eukaryotic organisms it was decided that Dollo 
parsimony was the appropriate variant to use. Dollo parsimony has been previously used to 
investigate the propensity of particular genes to be lost over the course of evolutionary time 
in eukaryotes (Krylov et al. 2003). It was chosen by the authors due to the relative rarity of 
lateral gene transfer events in eukaryotes (Krylov et al. 2003).  




Dollo parsimony has also been utilised to investigate gene gain in poxviruses 
(McLysaght et al. 2003). The results of this use however may have been affected by the fact 
that poxviruses were later observed to acquire genetic material from infected hosts (Hughes 
and Friedman 2005). Kensche also evaluated the efficacy of Dollo reconstructions of profiles 
as a method of phylogenetic profiling (Kensche et al. 2008). Kensche utilised a distance 
measure d(A,B) between the Dollo parsimonious reconstructions of the phylogenetic profiles 
of two (orthologous groups of ) proteins A and B calculated as: 
 
! 
d(A,B) = | (anc(ai )" desc(ai ))" (anc(bi )" desc(bi )) |
i#branches
$    (1) 
 
where branches denoted the set of branches in the phylogenetic tree, anc(ai) was defined as 
the state of orthologous group A at the ancestral node of branch i, desc(ai) was defined as the 
state of orthologous group A at the descendant node of branch i, anc(bi) was defined as the 
state of orthologous group B at the ancestral node of branch I and desc(bi) was defined as the 
state of orthologous group B at the descendant node of branch i (Kensche et al. 2008). The 
distance d(A,B) was a count of branches where either orthologous group was gained or lost 
independently. The method performed as well as more sophisticated techniques on the data 
analysed by Kensche (Kensche et al. 2008).  
One of the methods evaluated by Barker as a potential source of signal for correlated 
evolution was also examination of Dollo parsimony based reconstructions of phylogenetic 
profiles over a phylogeny (Barker et al. 2007). Dollo parsimony was utilised as it reflected 
the idea of setting the rate of acquisition of a complex trait (in this case a protein) to a preset 
low level (Barker et al. 2007). Pairs of proteins were scored on branches of the tree where 
they were jointly lost and jointly gained to form a score referred to as Dollo-pos (Barker et al. 
2007). Branches where proteins were not gained or lost together were also counted and 
subtracted from Dollo-pos to form a score referred to as Dollo-overall (Barker et al. 2007). 
Both these scores however did not perform particularly well over the data examined (Barker 
et al. 2007). Dollo-overall however performed significantly better than Dollo-pos (Barker et 
al. 2007). 
Thus given the fact that Dollo parsimony based tests had been moderately successful 
at detecting correlated evolution, a series of potential data filters /heuristics for examination 
of phylogenetic profiles using constrained ML (Barker et al. 2007; Barker and Pagel 2005) 




based on a single set of reconstructed ancestral states over the phylogeny using Dollo 
parsimony were investigated.  
4.2.2.2 Maddison Test for correlated evolution 
To use the reconstructed ancestral state data a test to detect correlated evolution using the 
comparative method that utilised a set of reconstructed ancestral states over a given 
phylogenetic tree was needed. One candidate test was a contingency table based test 
presented by Ridley where a gain or loss of a character was considered in the light of whether 
it occurred in the presence or absence of another character over a phylogenetic tree (Ridley 
1983). This test however does not separate which character is dependent and which is 
independent.  
A second candidate test considered was a procedure described by Wayne Maddison 
(Maddison 1990) for the comparison of the association of changes in one binary character 
with the given state of another. This test was designed to carry out this analysis assuming a 
given phylogenetic tree and a set of reconstructed characters (Maddison 1990).  This test has 
been referred to as a test for concentrated changes (Felsenstein 2004). 
The fundamental idea behind the Maddison test is to test whether changes in one trait 
or character are concentrated in an area of a tree where a second trait or character in a given 
state. As an illustrative example consider a fictional monophyletic group of related cow-like 
animals.  These animals do not possess horns.  The phylogenetic relationships of these 
animals are fully resolved and understood as well as the ancestral states for all morphological 
and molecular traits. Now imagine that this group overall has no ability to metabolise valine. 
Finally imagine the ability to metabolise valine is independently acquired by a sub-clade of 
our fictional group and this leads to the development of horns in this sub-clade.  
If we wished to test whether the ability to metabolise valine leads to horn 
development, the Maddison test would return the probability of the observed configuration of 
valine metabolism / horn presence. This probability would be calculated by firstly calculating 
the total number of ways to acquire horns in the presence of the ability to metabolise valine 
over the phylogenetic tree. Secondly the number of ways to acquire horns over the entire tree 
irrespective of the state of the ability to metabolise valine are calculated. By dividing the first 
value by the second a probability can be calculated. If horns are concentrated in parts of the 
tree where valine metabolism is also present this probability will be lower.  
 
 







Figure 4.1: Illustrative example tree. 
 
Thus imagine in the above figure only Cow1 has the ability to metabolise valine and 
also possesses horns.  Thus a reasonable hypothesis/reconstruction could be that both abilities 
were gained in the branch leading to Cow1. There is 1 gain of horns. Over the entire tree 
there are 6 branches (not counting the root branch) and thus 6 ways to have 1 gain of horns. 
However there is only one way of having a gain of horns in the presence of valine 









  To reiterate the test works through counting all possible ways of having a set of 
observed changes in a character over a phylogeny and then counting how many ways there 
are of having the same number of changes in parts of the tree where a second character is in a 
given state. Thus if correlated evolution is occurring changes in the first character will be 
concentrated in areas of the tree where the second character is in the causative state. Consider 
as a second example two proteins, which carried out the same function. If the presence of the 
first protein made the second protein redundant then losses in the second protein could be 
concentrated in areas where the first protein was present.  
  The drawbacks of the test are the fact that it treats all forms of evolutionary change as 
equally likely and its inability to take into account branch lengths (Pagel 1994).  However as 
the motivation behind the implementation of the test was its use as a simple data filter to 
remove protein pairs that showed little or no evidence of correlated evolution it was decided 
that the Maddison test (Maddison 1990) was an appropriate test. 
4.3 Methods 
 To create Dollo parsimony based reconstructions over each phylogenetic profile over the 
phylogeney presented in Chapter 2, the program DOLLOP from the PHYLIP package 
(Felsenstein 1989) was used. The program implements the Dollo parsimony reconstruction 
algorithm described in work by Farris (Farris 1977). 
Given a binary trait T that can take on 2 possible values coded as [0,1], DOLLOP 
implements Dollo parsimony by seeking to explain a given observed configuration of 
presence and absence for T over a set of taxa over a phylogenetic tree by allowing one gain 
(transition from 0 to 1) and multiple reversions (transition from 1 to 0) (Felsenstein 1989). 
As an illustrative example consider the tree below and a trait with the distribution 
010101. 
 





Figure 4.2: Example tree. 
 
DOLLOP will reconstruct the trait as initially gained at the root of the tree and lost at 
the braches leading to A, B and E. This is as opposed to allowing multiple gains on the 
branches leading to D and G. 
The process followed was similar to the process followed to generate the genome 
content tree produced in Chapter 2. The main difference in this case was that DOLLOP was 
run with the –U option, which instructed it to produce Dollo parsimonious reconstructions 
over a user-supplied tree. The program was supplied with the phylogeny generated in Chapter 
2 as well as the phylogenetic profile for each protein under consideration.  
Apart from the –U option the program was run with its default settings. The output 
from DOLLOP contained data on the state of the protein at every node in the phylogeny as 
well the branches within the phylogeny at which transitions occurred. In order to record this 
data DOLLOP assigns an identifying number to each internal node of the phylogeny. 
An example of the outputted data from DOLLOP is given below. For a human protein 
with the profile 000000000000000000000000100000000000000000000000000000 (Only 
present in Homo sapiens) over the species used for the phylogeny produced in Chapter 2, the 
following reconstruction was provided for species close to the root of the tree.  
 
 




From                              To                                   Changed                          State 








2 3 No Absent 
3 4 No Absent 
Table 4.1: Sample output from DOLLOP. 
 
Clearly the parsimonious reconstruction for this protein would only contain one gain. This 
gain occurs between the ancestral node immediately preceding Homo sapiens.  
The output files from DOLLOP were stored for further use.  
In order to process this data and utilise it as input for various tests of correlated 
evolution two Java objects were defined and implemented. 
 
Figure 4.3: Class diagram illustrating classes underpinning Dollo analyses. 
 




The main object in the preceding figure is the Transition Matrix object. This object has 2 
main attributes. 
• The States: This is a list of Transition objects. Transition objects contain the same 4 
attributes as shown in Table 4.1 
• The Position Map: This is a Tree Map, which contains a position within the tree as a 
key and the state of a given trait at that position as a value. Thus this attribute can be 
queried for the state (present or absent) of a given trait at any point in the tree. 
The Transition Matrix object also has 2 main operations. 
• Calculate clade:  This function returns all parts of a tree descended from a given node. 
Thus if a trait is gained or lost at Node n, the function will return the monophyletic 
group consisting of n and all its descendants. 
• Create Position Map: This function traverses the States list and utilises the Calculate 
clade function to populate the Position map.  
These objects underpin all further analyses described in this chapter. 
 4.3.1 Maddison test for correlated evolution 
Given the set of the ancestral reconstructed state the Maddison test as described above and in 
the original work by Wayne Maddison (Maddison 1990) was implemented. The following 
description of the algorithm utilised is based entirely upon the work presented by Maddison 
(Maddison 1990).  A modification to the test for correlated evolution defined by Maddison 
(Maddison 1990) to fit the constraints imposed by Dollo parsimony is presented in Section 
4.3.2 
4.3.1.1 Algorithm 
Assume two discrete binary characters A and B and a phylogenetic tree T and a set of 
reconstructed states for A and B for each node N within T. Possible states for characters A and 
B lie within the closed interval [0,1]. A gain is defined as a transition from 0 to 1 and 
conversely a loss is defined as a transition from 1 to 0.  
Define character B as reference trait.  Define state s as the relevant state of character 
B.  Define subset k ( ) as the area(s) of the tree where B is in state s. 
! 
k " T






Wroot (x,y |b) as the total number of ways to have x gains and y losses of 
character A over the tree starting at the root node given that state of character A is b at the 
root of the tree. 
Define 
! 
Broot (p,q | x,y,b) as the total number of ways to have p gains and q losses of 
character A in subset k given x gains and y losses over the entire tree starting at the root node 
given that state of character A is b at the root of the tree. 
The test for correlated evolution is thus calculated by  
 
! 
p(obs) = Broot (p,q | x,y,0) + Broot (p,q | x,y,1)Wroot (x,y | 0) +Wroot (x,y |1)
    (2) 
 
Solving Equation 2 provides the probability p(obs) of having p gains and q losses of 
character A in subset k given a total of  x gains and y losses occur over the whole tree under 
the null hypothesis of no correlated evolution. If gains and losses of character A are in some 
way dependent on whether character B is in state s then we could expect those gains and 
losses to be concentrated in subset k. 
! 
Wroot (x,y |b) and 
! 
Broot (p,q | x,y,b)  are calculated 
through the use of a dynamic programming approach starting at the tips of the tree and 
proceeding in a post order fashion (Maddison 1990).  
4.3.1.2 Calculation of total number of ways of having x gains and y losses over the tree 
In order to calculate 
! 
Wroot (x,y |b) over the entire tree for a character A, a matrix containing 
the number of ways of having 0 to x gains, 0 to y losses for either potential values of b (0 or 
1) has to be calculated for each node in the tree. 
For a leaf node there are 0 ways of having x gains and y losses at the node for all 
values of x and y which are greater than 0. There is one way of having 0 gains and 0 losses at 
a leaf node.  
For a non-leaf node K there are four calculations to make. Firstly assume all gains and 
losses occur post the node’s immediate descendants L and M and that the state of character A 
is 0. A non-leaf node is only processed after both its descendants have been visited. The 
number of ways of having x gains and y losses at node K given a state of 0 can be calculated 
by the expression
! 






# (x $ i,y $ j | 0). This counting system operates on the 
principle that for every way of having i gains and j losses on node L there are (x-i) gains and 
(y-j) gains on node M. Thus if for example there was 1 gain and 1 loss to distribute over node 




K then if both of them occurred post descendent L then no changes would occur post 
descendent M. If only the gain occurred post L then the loss would occur post node M. 
The second part of this calculation is based on the assumption that one of the changes 
occurs between K and one of its child nodes for example M. Thus as one of the changes has 
occurred (the change is a gain as the state of the character is of character A at node K is 0) the 
state of character A at node M is now 1 and one of x gains has already occurred. Thus the 
number of ways to have the remaining number of gains and losses can be calculated by the 
expression. 
! 






$ . The third part of the calculation covers the 
eventuality that the change happens between K and its other child L. Thus the number of 
ways remaining to have x gains and y losses are calculated by the expression 
! 






$ .  Finally assume changes occur between K and both of its 
child nodes L and M. The states of both nodes will be 1 and there will be two fewer gains to 
distribute over the remainder of the tree. Thus the fourth part of the calculation is: 
! 






$ .     
Summing up the results of these four expressions will provide the number of ways of 
having x gains and y losses at non-leaf node K given that the state of character A is 0. The 
calculation of the number of ways of having x gains and y losses if the state of character A is 
1 at node K is a mirror image of the process described above (Maddison 1990). 
4.3.1.3 Calculation of total number of ways of having p gains and q losses in subset k 
given x gains and y losses over the entire tree 
This calculation of 
! 
Broot (p,q | x,y,b) is very similar to the one described above. As above a 
matrix containing the number of ways of having 0 to p gains in subset k, 0 to q losses in 
subset k given 0 to x gains and 0 to y losses over the whole tree for either potential values of b 
(0 or 1) has to be calculated for each node in the tree. 
For a leaf node there are 0 ways of having p gains and q losses in subset k given x 
gains and y losses overall for all values of p, q, x and y which are greater than 0. There is one 
way of having 0 gains and 0 losses in subset k given 0 gains and 0 losses overall. 
As above a non-leaf node is only processed when both its children have been visited. 
For a non-leaf node K with character A having state 0 with children L and M there are again 




four calculations to be made. The first calculation counts the possibilities where both changes 













" BL ( f ,g | i, j,0) # BM (p $ f ,q $ g | x $1,y $ j,0). The second calculation counts 
the possibilities where one of the changes occurs between node K and node M.  Whether this 
change is counted as within subset k depends on whether node M lies within subset k. To 
facilitate calculation (Maddison 1990) defined a number ZM as set to 1 if M lies within k. 
Thus the second calculation is evaluated by the expression 
! 












$ . The third calculation 
counts the possibility of one of the changes occurring between node K and node L. This is 
evaluated via the expression
! 












$ . The fourth calculation 
counts the possibilities where changes occur between K and L as well as K and M. This is 
evaluated with the expression: 
! 














  The summation of the solutions of the four expressions yields the total number of 
ways to have p gains and q losses of character A within subset k given x gains and y losses of 
character A overall under node K given the state of character A is 0. As above this process is 
mirrored when the state of character A is 1 (Maddison 1990). 
4.3.1.4 Permutation effects 
The Maddison test for correlated evolution (Maddison 1990) is potentially susceptible to two 
effects in the context of examination of protein phylogenetic profiles. Maddison’s test was 
designed to test specific hypotheses about correlated evolution. For example one of the first 
applications of the test was on data testing the association of gregariousness in butterflies 
with unpalatable larvae (Sillentullberg 1988; Maddison 1990). Thus in a pairwise comparison 
of characters one character is held static as a reference while the location of changes in the 
other dynamic character are examined over the tree. The terms static and dynamic shall be 
used in this context in all subsequent references. 




 In the case of examinations of correlated evolution in phylogenetic profiles however 
it is not possible to state whether we are testing for the dependence of the distribution of 
protein A with the state of protein B or vice versa. The first effect is thus permutation. 
The second effect is based on how subset k is defined. As phylogenetic profiles 
compare patterns of presence and absence of genes subset k can either be defined as the 
presence of protein B or the absence of protein B. 
This second effect is however precluded as defining subset k as the absence of protein 
B shifts position of the number of changes sought. Consider the tree shown in Figure 4.4. If 
for example protein A was gained once within the clade containing Species 1 and Species 2 
and protein B was present in that clade but no where else within the tree. Thus the ancestral 
state of B would be reconstructed parsimoniously as shown in Figure 4.5.  
If k is defined as the presence of B then the test is investigating the probability of 1 
gain within k with 1 gain over the entire tree. If k was defined as the absence of B then the 
test is investigating the probability of 0 gains within k with 1 gain over the entire tree.  
Thus over the sample tree if k is defined as the presence of B, then there are 3 ways to 
have 1 gain of A within k. That is 1 on the branch leading to Species 1, 1 on the branch 
leading to Species 2 and 1 on the branch leading to the clade. There are 9 ways of having 1 
gain over the entire tree. Thus the probability of 1 gain in k is 
! 
3
9  or 0.33. If on the other hand 
k is defined as the absence of B then there are 0 gains within k with 1 gain overall. As there is 
one gain to be accounted for and this gain can only occur within the clade containing Species 
1 and Species 2. Thus as before there are 3 ways of having one gain within that clade and 9 
ways of having one gain over the whole tree thus the associated probability remains the same, 
i.e. 0.33. 
 





Figure 4.4: Sample phylogeny of 5 hypothetical species. The numbers on the tree 
represent presence and absence of protein B. The arrow points out the point post which 
protein A was acquired. 








Figure 4.5: Sample phylogeny of 5 hypothetical species. The black area of the tree 
corresponds to a Fitch parsimonious reconstruction (Fitch 1971) carried out by Mesquite 
(Maddison and Maddison 2010) of protein B if protein B has the phylogenetic profile 11000 
(where the order of species in the profile is the same as the numerical order of the species). It 
is also the Dollo parsimonious reconstruction. This black area corresponds to subset k if it is 
defined as the presence of B. Conversely the white area of the tree corresponds to k if it is 
defined as the absence of B. 
 
A further example of this concept can be considered by using the initial example 
provided in 4.2.2.2 involving our fictional cow like species. In that case the probability of 
acquiring horns in the presence of valine was calculated as 
! 
1
6 . If we were to examine the 
probability of acquiring horns in the absence of valine then the denominator remains the 
same and there are 0 gains of horns in k (the area of the tree where the ability to metabolise 
valine is absent). There is 1 way of having 0 gains of horns. Thus the probability of the 
observed configuration remains the same.  
Thus the results shown in by the Maddison-Dollo test over the training data as 
described in Chapter 3 were identical with respect to the choice of how subset k is defined. 




4.3.1.5 Evaluation of Maddison test as heuristic for constrained ML 
The Maddison test (Maddison 1990) as described above modified to accommodate the 
assumptions of Dollo parsimony (Section 4.3.2) was implemented using Java. This entailed 
writing 3,563 lines of code. The implementation was supplied with the set of reconstructed 
states for each protein pair and the phylogenetic tree on which they are reconstructed.  
In order to remove permutation based effects from the analysis the training dataset as 
described in Chapter 3 was doubled so it included proteins pairs in both the A-B and the B-A 
orientations. The Maddison test was run on this expanded training set. Thus each protein pair 
in the training set had two associated probability scores.  The lower of these two scores was 
selected as the lower the probability of the observed distribution of gains and losses the 
stronger the evidence for correlated evolution. In order to use this probability as an ascending 
score the score was defined as 1-p. The test was run with subset k defined as the absence of 
trait B. 
The ability of the test to detect protein interactions was then judged according to the 
criterion of precision/sensitivity as defined in Chapter 3.  
This process was then repeated with k defined as the presence of trait B in order to 
verify the observation that there was no effect on whether k was defined as the absence or the 
presence of trait B. 
4.3.2 Modification of test to match Dollo constraints 
The calculation of the null distribution under the standard Maddison approach (Maddison 
1990) allows for all sequences and permutations of gains and losses as allowed by Fitch 
parsimony (Fitch 1971). In order to reconcile the test to the assumptions of Dollo parsimony 
the test was modified to remove all possibility of a gain following a loss. This was achieved 
by examining the state of the character under consideration at the root node. If the root node 
was 0 then the standard test as described in Equation 2 was utilised. However if the state was 
1 then the following test was used. 
 
! 
p(obs) = Broot (p,q | x,y,0) + Broot (0,q | 0,y,1)Wroot (x,y | 0) +Wroot (0,y |1)
    (3) 
 
If a character is acquired at the root of the tree then no gains can be allowed to occur 
post a loss thus a is calculated for 0 gains and y losses from the root. 
 




To illustrate this difference consider the following tree. 
 
 
Figure 4.6: Example tree to illustrate the imposition of Dollo parsimonious constraints 
on the Maddison test for correlated evolution.   
 
Assume the state of a character C was reconstructed as 1 at the root node of the tree 
and there was one gain and one loss to be distributed over the tree. If gains were allowed to 
follow losses then there are 4 ways of having one gain and one loss over the tree. These are: 
 
• A loss between node 2 and node 6 followed by a gain between node 6 and 
node 7. 
• A loss between node 2 and node 6 followed by a gain between node 6 and 
node 8. 
• A loss between node 2 and node 3 followed by a gain between node 3 and 
node 4. 
• A loss between node 2 and node 3 followed by a gain between node 3 and 
node 5. 




However with the added Dollo parsimony constraint there are no ways having one 
gain and one loss over the tree in Figure 4.6 if the state at the root node is 1. 
4.3.3 Differential parsimony 
The distance as defined in work by Phillip Kensche (Kensche et al. 2008) and reiterated in 
Section 4.3.1 was implemented and its performance examined over the training data. 
4.3.4 Dollo-pos/ Dollo-overall 
Both measures as described by Barker et al. (Barker et al. 2007) were implemented and 
examined in the light of the testing data. 
4.3.5 Test based on logistic regression 
In order to test for correlated evolution the reconstructed ancestral states allowed the 
calculation of potential predictor variables, which bore a correspondence to the transition rate 
parameters, used by Barker and Pagel (Barker and Pagel 2005; Pagel 1994) as described in 
Chapter 3. These parameters represent the rates of transition in state for a discrete binary 
character given a particular state for a second discrete binary character.  
Given a single set of reconstructed ancestral states these transitions can be empirically 
counted over the reconstructed states. For example a protein is lost on a given branch of the 
phylogeny and a second protein is present on that branch according to the reconstructed states 
this can be counted as a loss of one protein in the presence of the other. 
The Dollo parsimony based reconstructions of each phylogenetic profile contain 
within them the state of the associated protein at every given point in the tree. It was thus 
possible to compare the state of any given ancestral branch within the tree for any two given 
proteins. The Dollo reconstruction data is framed in terms of transitions between two nodes. 
This meant that it was possible to compare a transition in the state of a given protein with the 
state of the other protein at the same point in the tree. 
In order to use the Dollo reconstructions of each phylogenetic profile as potential 
predictors of functional interaction using logistic regression the reconstructions had to be 
framed in terms of being potential predictors of correlated evolution. The possible states that 
a protein could be in at any given transition in the tree were coded as: 
 
• 0: Absent 
• 1: Present 
• 2: Lost 






Each profile was associated with a matrix of transitions, which was constructed using 
the reconstruction of the ancestral states of the profile over the tree. Pairwise comparisons 
were then carried out. Thus at each transition point the state of protein A was compared to 
that of protein B.  
 In order to avoid permutation effects the order in which protein pairs were considered 
was made redundant. This was performed by framing transitions in terms of changes in 
proteins as opposed to changes in a particular protein.  If for example protein A was lost in 
the presence of protein B this would be counted as the loss of a protein in the presence of 
another, not the loss of A in the presence of B. Pairwise comparisons were thus carried out at 
each node of the tree to create the predictors shown in Table 4.2. The lower case s stands for 
scenario. 





Predictor      Description 
s00 A point in the tree where both proteins are absent. 
s01 A point in the tree where one protein is present and the 
other is absent. 
s02 A point in the tree where one protein is absent and the 
other is lost. 
s03 A point in the tree where one protein is present and the 
other is gained. 
s11 A point in the tree where both proteins are present. 
s12 A point in the tree where one protein is present and the 
other is lost. 
s13 A point in the tree where one protein is present and the 
other is gained. 
s22 A point in the tree where both proteins are lost. 
s23 A point in the tree where one protein is lost and the 
other is gained. 
s33 A point in the tree where both proteins are gained. 
Table 4.2: Description of predictor parameters to be utilised in regression model. 
 
Whether or not two proteins interact is a binomially distributed variable. Models for 
the calculation of the probability of a dichotomous outcome include: 
• Two group discriminant function analysis: given two predictors X1 and X2 
discriminant functional analysis constructs a variable Z which is a linear function of 
X1 and X2. This function is the equation of a line that separates the data under 
consideration into two groups. One of these groups will have high values for Z and 
the other will have low values (Sokal and Rohlf 1995). Novel data with measured 
values for X1 and X2 can thus be classified by solving the equation for Z (Sokal and 
Rohlf 1995).  




• Logistic regression: logistic regression relates the probability of a successful outcome 
in this case that of an interaction with estimated coefficients for a set of predictors via 
the following application of the logistic function (Sokal and Rohlf 1995). 
 
Preliminary trials were carried out on the training data, which found the results of logistic 
regression and a linear discriminant function to be broadly similar. However the values of 
predictors associated with gains are not distributed normally as the number of gains is 
restricted to 1. In such cases logistic regression is the recommended technique (Lei and 
Koehly 2003) as it makes no assumptions of normality regarding the distribution of the 
predictor variables. Thus logistic regression was selected as an appropriate method of testing 
whether the predictor variables contribute to the outcome of interaction as well as 
determining the degree to which they contribute. Logistic regression is carried out via an 





1+ ea+bX       (4) 
 
Where a is the y-intercept of a regression line, e is the base of the natural logarithm 
and b is the coefficient of a predictor variable X for a set of predictors (X0,X1,X2…….…Xi) . 
The logistic function, which is also known as the sigmoid function returns a value within the 
closed interval [0,1] for values in the range of real numbers from  to .  




(1" p)  where p is equal to the probability of an interaction (Sokal and Rohlf 
1995). 
Solving the expression substituting Equation 4 as a value for p yields the following 
equation (Sokal and Rohlf 1995).   
! 
p
(1" p) = e
a+bX          (5) 
Finally the odds of an interaction are converted into the log odds or logit of an 
interaction via Equation 6  (Sokal and Rohlf 1995): 
 
! 










The optimal values for the coefficients and intercept of an optimal regression line are 
estimated by maximum likelihood (Sokal and Rohlf 1995). The full positive training set of 
9,161 protein pairs was used as examples of proteins, which interact. A random subsample of 
9,161 proteins was then selected from the negative training set as examples of proteins, 
which do not interact. The size of negative and positive sets were set to be equal to allow the 
linear model to create a regression line which matched the distribution of the predictors in 
both sets rather than being biased by a larger negative set. 
Counts were then calculated for each parameter for each pair of profiles within the new 
training dataset. The statistical package R (R Development Core Team 2011) was then used 
to fit a generalised linear model between the two binary variables using a binomial (logit) 
link function. The predictor variables were considered to be continuous. 
Predictor variables s13, s22, s23 and s33 were found to cause singularities within the model. 
s13 was found to be perfectly correlated with s03 and s33  as Dollo parsimony only allows one 
acquisition of a complex trait. s22 and s33 only occur rarely as seen below. 
 
 
Minimum          1st Quartile         Median               Mean             3rd Quartile      Maximum.   
0 0 0 0.5259 1 14 
Table 4.3: Descriptive statistics for counts of predictor s22. 
 
 
Minimum          1st Quartile         Median               Mean             3rd Quartile      Maximum.   
0 0 0 0.1 0 1 
Table 4.4: Descriptive statistics for counts of predictor s33. 
 
The predictor s23 never occurs at all within the data. The results of the initial 













Predictor                           Coefficient                      p value  <0.05       
s00 0.02179 0.1278 (Not 
significant) 
s01 0.02607 0.0845 (Not 
significant) 
s02 0.03775 0.0244 
s03 -0.24041 2.66 & 10-05 
s11 0.06446 5.46 & 10-5 
s12 0.04350 0.0189 
Table 4.5: Coefficients of the initial logistic regression equation.  
 
After removing all predictors that caused singularities as well as all insignificant 
predictors the analysis was repeated. This led to the following coefficients as shown in Table 
4.6.  
 
Predictor                             Coefficient                                       p value  <0.05       
s02 0.019429 2.05 & 10-7 
s03 -0.177835 0.00115 
s11 0.043359 < 2 
! 
"  10-16  
s12 0.018787 0.00107 
Table 4.6: Coefficients of the logistic regression equation derived via examination of 
the reduced set of predictors. 
 
The full equation of the regression line is shown below as Equation 7.  
 





y = 0.019429s02 " 0.177835s03 + 0.043359s11 + 0.018787s12 " 0.791849    (7) 
 
y is equal to the logit score of the probability of two proteins interacting versus the 
probability of them not interacting. The logit scores were then transformed into a probability 
of interaction via an application of the logistic function. This probability was used as the 
score. 
The predictor, which contributes the most to the probability of an interaction, is s03. 
This would suggest that a protein being gained in the absence of the other is indicative of the 
two proteins not being functionally linked (as the coefficient is negative). The other 
significant terms, which contribute positively to the probability of an interaction, are s02, s11 
and s12. Losses appear to be a defining event for correlated evolution whether a loss in the 
presence of a protein or a loss in the absence of a protein. This could potentially be 
confirmation of work postulating that gene loss is relatively the most important event shaping 
gene content and determining phenotype. However this may be attributable to the use of 
Dollo parsimony for ancestral state reconstruction. A loss of a protein in the presence of 
another might suggest some form of redundancy-based loss. A loss of a protein in the 
absence of another on the other hand might suggest a cascade of losses of a group of proteins 
that carry out a particular function that is no longer needed in a particular lineage. 
s11 is the final significant predictor which implies that two proteins coexisting for 
periods of time at different points in the phylogeny are also more likely to be functionally 
linked. This predictor can be thought of as similar to the method used by Cokus (Cokus et al. 
2007) except whereas while that work carried out a horizontal comparison of the distribution 
of presence and absences of proteins across a set of genomes clustered by similarity, the 
predictor s11 measures co-occurrence both horizontally across species and vertically over a 
set of putative ancestors as reflected by the phylogenetic tree.  
 
4.3.5.1 Evaluation of logistic regression as a heuristic for constrained ML 
In order to examine the efficacy of the derived regression equation it was applied to the full 
training dataset. The performance of the method was then evaluated using through the 
calculation of precision/sensitivity. 





The results for the five tests carried out were measured in terms of precision and sensitivity 
over the training data.  The intersection of the predictions made by the tests with the 6 
predictions made by constrained ML method (Barker et al. 2007; Barker and Pagel 2005) at 
its optimum rate of gain 0.025 and its optimum likelihood ratio cut-off of 58.54 over the 
training dataset was also examined. As pointed out in Chapter 3 this combination of rate of 
gain and likelihood ratio cut-off yielded 5 predictions all of which were true positives. 
Maintenance of this intersection is judged to be a key criterion for any data filter to form part 
of a heuristic approach. Thus in order to use a test as a data filter for constrained ML (Barker 
et al. 2007; Barker and Pagel 2005) the highest acceptable cut-off for the test was considered 


















4.4.1 Maddison test for correlated evolution 
 
Figure 4.7: Performance of the Maddison test for correlated evolution on the training data with k as the absence 
of trait B. The figure shows the performance between cut-offs of 0.9999 and 1 rising by increments of 1 x 10-7.  





Figure 4.8: Performance of the Maddison test for correlated evolution on the training data with k defined as the 
presence of trait B. The figure shows the performance between cut-offs of 0.9999 and 1 rising by increments of 
1 x 10-7. 
 
The Maddison test for correlated evolution (Maddison 1990) performs reasonably 
well on the training data as can be seen in Figure 4.7. There is a maximum intersection of 1 in 
this range of cut-offs with the 5 predictions made by constrained ML (Barker et al. 2007; 
Barker and Pagel 2005) at its optimum rate of gain and optimum LR cut-off. It is however a 
computationally intensive process with each node in the tree being evaluated for all 
combinations of states, gains and losses respectively firstly for the calculation of the null 
distribution and secondly for all combinations of gains within subset k, losses within subset k, 
gains over the whole tree, losses over the whole tree and states. Binary tree traversal is 
carried out in linear time (Felsenst.J 1973). The amount of time taken as the number of gains 
and losses to be accounted for increase however rises at a much steeper rate (Maddison 
1990).   




The mirror property of the algorithm, i.e. that the calculations mirror each other for 
any given combination of states (Maddison 1990) cannot be utilised in this particular case as 
gains are restricted to 1 by the use of Dollo parsimony. 
 
4.4.2 Differential parsimony 
 
 
Figure 4.9: Precision and sensitivity measure of differential parsimony over training data. 
 
Differential parsimony (Kensche et al. 2008) was not very successful on the training 
data as shown in Figure 4.9. It reached a maximum precision of 0.22547 with a sensitivity of 
0.023. There was an intersection of 3 at this point with the predictions made by ML 















Figure 4.10: Precision and sensitivity measure of Dollo-pos over training data. Range of cut-
offs at which predictions are made: 0 to14.  
 
 Dollo-pos (Barker et al. 2007) was fairly successful over the training data with a 
maximum precision of 0.57 at a cut-off of 13 as shown in Figure 4.10. The sensitivity at this 
point was 0.00043. There was an intersection of 2 with the 6 predictions made by constrained 
ML (at its optimum rate of gain and LR cut-off) at this cut-off. In order to use Dollo-pos as a 
potential data filter the lowest acceptable cut-off that maintained an intersection with all 6 
predictions made by constrained ML was 1. At this cut-off the precision of Dollo-pos was 














Figure 4.11: Precision and sensitivity measure of Dollo-overall over training data. Range of 
cut-offs at which predictions are made: -23 to 14.  
 
The results for Dollo-overall (Barker et al. 2007) were found to be broadly similar to 
Dollo-pos (Barker et al. 2007) as seen in Figure 4.11. However the effective range of cut-offs 
for Dollo-overall is shifted down. The maximum precision achieved was 0.5 at a cut-off of 
11. The sensitivity at this point was 0.00002. The lowest cut-off at which the intersection 
with the 6 predictions made by constrained ML (at its optimum rate of gain and LR cut-off) 
was maintained was -21. At this cut-off the precision of Dollo-overall was 0.08074 and the 
sensitivity was 0.99.  
4.4.5 Logistic regression 
Logistic regression performed well on the training data as can be seen below in Figure 4.11. 
 
 






Figure 4.12: Precision and sensitivity measure of logistic regression over training data. Range 
of probability cut-offs at which predictions are made: 0 to 1. Cut-offs were incremented by 
0.001. 
 
The maximum precision achieved by logistic regression was 0.736 at a sensitivity of 
0.01.  This was achieved at a probability cut-off of 0.967. The lowest probability cut-off at 
which the intersection with predictions made by constrained ML was maintained was 0.85. 
The precision achieved at this point was 0.479 and the sensitivity was 0.0598. The method 
that achieved the highest precision while maintaining a full intersection with the predictions 
made by constrained ML was thus logistic regression.  




In order to cross validate the ability of the logistic regression based filter to 
discriminate between proteins that interact and those that do not, the filter was run on the 
testing data. Figure 4.13 shows the performance of the filter over the testing data. 
 
 
Figure 4.13: Precision and sensitivity measure of logistic regression over testing data. Range 
of probability cut-offs at which predictions are made: 0 to 1. Cut-offs were incremented by 
0.001. 
 
As the s predictors used to determine the logit score used in the logistic regression 
filter are based on the transition rate parameters used to detect correlated evolution by the 
constrained ML technique (Barker et al. 2007; Barker and Pagel 2005; Pagel 1994) it was 
expected that there is a correlation between a high logit score for a protein pair and a high LR 




(likelihood ratio statistic) score using the exemplar rate of gain elucidated in Chapter 3 
(0.025). The distribution of LR scores is extremely skewed towards the lower end as can be 
seen in Chapter 3. All true positive protein pairs detected by constrained ML (Barker et al. 
2007; Barker and Pagel 2005) at the optimum rate of gain lie within the 99th percentile of LR 
scores. This is due to the fact that many protein pairs within the training dataset do not 
display little or no evidence of correlated evolution, i.e. the low sensitivity of the method as 
shown in Chapter 3.   
It is only in the upper ranges of the LR scores that protein pairs that interact are 
distinguished from those that do not interact. This phenomenon was also observed by Barker 
as well as by Kensche (Barker et al. 2007; Kensche et al. 2008). Thus in order to display the 
relationship between the two prediction systems the logit derived probability scores of 
protein pairs with corresponding LR scores that lay in the 95th percentile of the distribution of 
LR scores were selected. This came to a set of 5,658 protein pairs. 
The logit derived probability scores of these pairs were plotted against their 
corresponding LR score. Figure 4.14 shows the logit derived probability scores of these 5,658 
proteins pairs plotted against their LR scores. The relationship between the values is 
displayed via an overlaid regression line. There is a large amount of scatter around the 
regression line however the relationship between the two variables is found to be significant 
(p value < 0.001). 





Figure 4.14: Linear regression line (Adjusted R2=0.1049) drawn over a plot of logit 
derived probability scores against likelihood ratio statistics over the training data. Vertical 
dotted line shows optimum cut-off for likelihood ratio statistic. Horizontal dotted line shows 
optimum cut-off for the logit derived probability score.  
 
Figure 4.14 shows that there is a positive relationship between the LR score generated 
by constrained ML (Barker et al. 2007; Barker and Pagel 2005) and the logit derived 
probability scores generated by application of Equation 6 to the set of reconstructed ancestral 
states.  
Figure 4.15 shows that a similar relationship is observed over the testing data set (p 
value < 0.001). 







 Figure 4.15: Linear regression line (Adjusted R2=0.0995) drawn over a plot of logit derived 
probability scores against likelihood ratio statistics over the testing data. Vertical dotted line 
shows optimum cut-off for likelihood ratio statistic determined by the training data. 
Horizontal dotted line shows optimum cut-off for the logit derived probability score 









4.4.6 Hamming distance 
In order to further improve the quality of the heuristic hamming distance was applied to the 
set of predictions generated at each logit score cut-off. The goal of the additional filter was to 
reduce the size of the search space while still preserving the 6 true positive predictions made 
by constrained ML. 
This yielded an unexpected result. The expectation with the application of Hamming 
distance was that as the Hamming distance increased the number of true positives predicted 
actually went up. This would suggest that as evidence of correlated evolution goes down, the 
probability of predicting a protein-protein interaction goes up. This anomalous result is 
probably due to the fact that Hamming distance does not take in the phylogenetic 
relationships between the organisms in the study as pointed out by Barker (Barker and Pagel 
2005).  
4.5 Discussion 
The Maddison-Dollo test proved not to be an effective filter as evidenced by its speed. The 
method achieved a high level of accuracy however it did not maintain an intersection with 
constrained ML (Barker et al. 2007; Barker and Pagel 2005) at its higher cut-offs. 
Differential parsimony (Kensche et al. 2008) was unable to differentiate between the 
negative and positive training data to an adequate degree. 
Dollo-pos and Dollo-overall (Barker et al. 2007) were both able to differentiate 
between the negative and positive data however they did not preserve the intersection with 
constrained ML (Barker et al. 2007; Barker and Pagel 2005) at a reasonable level of 
precision/sensitivity. 
The application of logistic regression on the other hand is a viable filter for 
constrained ML analysis (Barker et al. 2007; Barker and Pagel 2005) as evidenced by both its 
relative speed as well as its relationship with the LR scores provided by constrained ML 
(Barker et al. 2007; Barker and Pagel 2005).  
The filter utilising logistic regression on a single set of reconstructed ancestral states 
as implemented above is quick as compared to both constrained ML (Barker et al. 2007; 
Barker and Pagel 2005) as well as the Maddison test for correlated evolution (Maddison 
1990). The comparative CPU time taken by each method over the training data as measured 
by the Mac OS X utility time is given in Table 4.7. 






Process                                       Duration: Minutes/Hours                 
Maddison Dollo test (Farris 
1977; Felsenstein 1989; 
Maddison 1990) 
3988 minutes and 20 
seconds/ 66 hours and 28 
minutes (approximately). 
Logistic regression using 
Dollo parsimony 
reconstructions (Farris 1977; 
Felsenstein 1989) 
3 minutes and 48 seconds. 
Constrained ML (Barker and 
Pagel 2005;Barker et al. 
2007) 
6624 minutes and 37 
seconds/ 110 hours and 24 
minutes. 
Table 4.7: Times taken by each of the three methods on the training data. The time given for 
the Maddison Dollo test is an extrapolation from a run on 12.5% of the training data. This 
12.5% was selected randomly. Times given in minutes are rounded to the nearest second. 
Times given in hours are rounded to the nearest minute. All tests were run on an Intel Xeon 
3.0 GHz processor. 
 
The reduction in potential protein pairs to be investigated via an application of the 
logistic regression filter using the probability score cut-off of 0.85 is 111,902 (113,132-
1132). This is a reduction of 98.9%. As the filter discriminates between proteins, which show 
evidence of correlated evolution, the remaining 1.1% should be enriched for proteins 
amenable to investigation via phylogenetic profiling using ML reconstructions with 
constrained rates of gain (Barker et al. 2007; Barker and Pagel 2005). Thus an application of 
the filter to the full human genome followed by an application of phylogenetic profiling using 
constrained ML (Barker et al. 2007; Barker and Pagel 2005) will potentially yield a large set 
of interactions from within the human genome some of which may be novel. 
All code implementing the procedures described in this chapter is available on request from 
the author.





Genome-wide prediction of protein functional interactions in humans using 
a heuristic approach 
5.1 Introduction 
The interactome of an organism can be defined as the complete set of molecular interactions 
that occur within its full complement of cell types (Yu et al. 2008). This study focuses on the 
elucidation of interactions between proteins (both direct and indirect) in the human proteome 
(PPIs). PPIs have been defined as physical interactions between proteins (De Las Rivas and 
Fontanillo).  PPIs are detected by methods such as the yeast 2-hybrid and tandem affinity 
purification coupled to mass spectrometry (TAP-MS) (De Las Rivas and Fontanillo 2010) as 
well as co-immunoprecipitation (De Las Rivas and Fontanillo 2010). Interactions between 
proteins that are indirect can be detected by gene co-expression as investigated in Chapter 3 
or techniques like double mutant synthetic lethality (De Las Rivas and Fontanillo 2010). 
Indirect protein interactions are also detected by TAP-MS as proteins that share membership 
of a complex do not necessarily maintain a direct physical interaction. Computational 
interaction detection methods as described in Chapter 1 can contribute to this effort by 
pointing out putative interactions, which can then be further verified. This chapter describes 
the application of the logistic regression-based data filter developed in Chapter 4 in 
combination with constrained ML (Barker et al. 2007; Barker and Pagel 2005) phylogenetic 
profile analysis to detect potential novel protein-protein interactions as well as novel indirect 
interactions between proteins. 
5.1.1 PPI databases 
As experimental data has accumulated on protein-protein interactions there have been a 
number of attempts to organise and annotate accumulated data on PPIs. There are thus a 
number of databases, which contain data on human protein-protein interactions. As any 
attempt to examine the quality of predicted PPIs comparison with known data, a brief 
overview of the major PPI databases is presented below. 
5.1.1.1 MIPS 
MIPs (Mammalian Protein-Protein Interaction Database)(Pagel et al. 2005), is a PPI database 
which contains 1,812 experimentally verified human protein-protein interactions (PPIs). It 




only includes published data from individual experiments as opposed to large scale high-
throughput surveys (Pagel et al. 2005). 
 
5.1.1.2 BIND 
BIND (Biomolecular Interaction Network Database) contains data on three main interactions 
types (Bader et al. 2001). These are binary interactions, molecular complexes and pathway 
data (Bader et al. 2001).  
5.1.1.3 MINT 
MINT (Molecular INTeraction) in contrast to MIPS contains data from large scale high-
throughput experiments (Chatr-aryamontri et al. 2007). As of 2009 it contains data derived 
from more than 19,000 experiments and 25,105 curated human PPIs (Ceol et al. 2010). 
5.1.1.4 INTACT 
IntAct is one of the larger PPI databases containing over 200,000 curated binary protein 
interactions (Aranda et al. 2010).  IntAct follows an extremely specific curation process with 
information from experiments being recorded in high detail using a number of controlled 
vocabularies to facilitate further data analysis (Aranda et al. 2010). 
5.1.1.5 HPRD 
The HPRD (Human Protein Reference Database) is a human specific PPI database. There are 
currently 45,207 interactions held in the HPRD (Prasad et al. 2009). It contains manually 
curated data on protein interactions derived from both high throughput surveys as well as 
single experiments (Prasad et al. 2009).  
5.1.1.6 DIP 
The DIP (Database of Interacting Proteins) is one of the earlier PPI databases. It contains data 
derived from manual curation of the literature as well as from structural information on 
complexes derived from the PDB (Protein Data Bank) (Salwinski et al. 2004). 
5.1.1.7 REACTOME 
The REACTOME database holds data on PPIs in the context of the biological pathways that 
underpin cellular processes and is also manually curated (Haw et al. 2011). 





The STRING database holds data on PPIs that are experimentally verified and also adds a set 
of computationally predicted PPIs (von Mering et al. 2005). It contains PPI information on 
630 organisms (Jensen et al. 2009). The total number of interactions held by STRING 
exceeds 50,000,000 (Jensen et al. 2009).  
5.1.1.9 I2D 
The I2D (Interologous Interaction) database contains the full literature derived predictions 
from the databases HPRD, BIOGRID, InTact, BIND and MINT as well as computationally 
predicted interactions (Brown and Jurisica 2005). The sources of evidence utilised for 
computational predictions include domain co-occurrence, gene co-expression and intersection 
of GO terms.  I2D contains 133,250 unique entries for detected protein interactions between 
13,490 proteins. 
5.1.1.10 KEGG 
KEGG as mentioned in Chapter 1 localises gene products within functional pathways 
(Kanehisa 1997; Kanehisa et al. 2006).  This is similar to REACTOME. 
5.1.1.11 BIOGRID 
The BIOGRID database also contains curated data. It has 49,378 interactions involving 
human proteins (Stark et al. 2006). 
5.1.1.12 Discussion 
There is an overlap between these databases as they are all based on examination of similar 
experimental data (De Las Rivas and Fontanillo 2010). Given that current estimates of the 
human interactome size are around 650,000 including non-direct functional interactions 
(Stumpf et al. 2008) there are still a large number of interactions still to be characterised.   
5.1.2 Power law 
In order to examine the statistical properties of PPI networks, these networks are usually 
analysed as graphs (Jeong et al. 2001). An interesting observation of the degree distribution 
within some of these graphs (the degree of a vertice within a graph is the number of edges 
connected to that given vertice) appear to follow a power law (Jeong et al. 2001).  That is the 
number of vertices within a graph with degree k is approximately 
! 
k"x  where x is a constant 
(Alon 2007). What this entails is that for any given protein within the PPI network the 
probability of having a large degree (many interactions) is low. There will however be 




proteins within the network that will have a large number of interacting partners. These 
proteins have been referred to as “hubs” (Han et al. 2004).  It has been hypothesised that 
there are two forms of protein hub (Han et al. 2004). These are  “date” hubs, which interact 
with different partners at different times, and “party” hubs, which interact with multiple 
partners simultaneously (Han et al. 2004). 
Networks with similar degree distributions have been observed in both natural and 
man-made networks such as the neural arrangements of C. elegans and the power grid of the 
western United States (Watts and Strogatz 1998).  
In the case of PPI networks however as there is a clear physical limit to the number of 
interacting partners that a given molecule can interact with, the power law distribution over a 
PPI network will sharply decay at the upper ends of the distribution, as hub proteins reach 
saturation point with a given number of interaction partners. Similarly the lower end of the 
distribution may not match a power law, as the cellular environment and other physio-
chemical factors will affect the probability of being an entirely monogamous interacting 
partner in a binary interaction. Examples of PPI networks that do not exhibit a power law in 
degree distribution have been pointed out in the literature, e.g. in work by Tanaka (Tanaka et 
al. 2005).  
5.2 Methods 
The first step in carrying out a full genome-wide survey was to develop a list of all possible 
ordered pairs of proteins within the version of RefSeq (Pruitt et al. 2005) used. This came a 
total of to 560,237,601 pairs. The logistic regression-based filter implemented in Chapter 4 
was applied to the ordered pairs of profiles at its optimum probability cut-off of 0.85. 
Removing all pairs that scored beneath this threshold resulted in a total of 5,312,880 pairs of 
proteins. This was a reduction of approximately 90 % of the total search space. This set of 
reduced profile pairs was then analysed by constrained ML (Barker et al. 2007; Barker and 
Pagel 2005) with the rate of gain parameters restricted to the optimum rate of 0.025. This 
analysis was carried out using a cluster consisting of 260 2 GHz dual core Opteron 270 
processors.  
The results of the constrained ML analysis were then filtered for pairs with a 
likelihood ratio (LR) statistic score of higher than 58.54 (this was the optimum LR score 
determined in Chapter 3). This led to a set of 20,605 predicted interactions between protein 




pairs, consisting of 2,188 individual proteins. In order to examine predicted interactions 
between members of the same orthologous group predictions were then converted to 
predictions between orthologous groups. These orthologous groups were identified as the 
groups clustered by the Inparanoid (Remm et al. 2001) implementation described in Chapter 
2 resulting in a predicted set of 7,150 interactions between orthologous group pairs, 
consisting of 1,417 individual orthologous groups. 
5.2.1 Short Branch filtration 
Examination of the distribution of interactions amongst the individual proteins showed that 
some of the individual proteins were predicted to have an extremely large number of 
interacting partners. The maximum number of interactions partners was predicted for the 
protein with RefSeq GI number 148613856 (described as “probable ATP-dependent RNA 
helicase DDX17 isoform 3” on the NCBI website). This was predicted to have 1,503 
interactions. However given the overall distribution of interaction partners within the set of 
predictions as shown below in Figure 5.1 these extreme numbers seem to be implausible.  
 
Figure 5.1: Distribution of number of predicted interaction partners/protein in constrained 
ML predictions. 
 
Thus the profiles of these highly connected proteins were investigated.  




Another protein with the RefSeq GI numbers 29029591 (labelled “putative ribosomal RNA 
methyltransferase 1 isoform b” on the NCBI website) was predicted to take part in 1,430 
interactions. The phylogenetic profile of this protein was: 
001101001001010001111010100010000001001000010001111010 
This translates to these proteins being present in Ashbya gossypii, Aspergillus fumigatus, 
Bombyx mori, Caenorhabditis elegans, Canis familiaris, Cryptococcus neoformans, 
Debaryomyces hansenii, Dictyostelium discoideum, Drosophila melanogaster, Drosophila 
pseudoobscura, Entamoeba histolytica, Homo sapiens, Magnaporthe grisea, Paramecium 
tetraurelia, Plasmodium knowlesi, Schizosaccharomyces pombe, Theileria annulata, 
Theileria parva, Trichomonas vaginalis, Trypanosoma brucei and Ustilago maydis. This is 
an extremely unbalanced distribution over the tree as illustrated in Figure 5.2. 





Figure 5.2: Distribution of protein labelled  “putative ribosomal RNA methyltransferase 1 
isoform b”. The character 1 indicates presence of the orthologous group.  
 
 It was hypothesised that this unbalanced distribution of this profile contributed to its 
display of a high likelihood ratio statistic (LR) score with a large number of proteins. In 
particular it was hypothesised that the profiles of prediction heavy proteins might contain 
losses on the branches leading to P. troglodytes and M. mulatta.  As the branches leading to 
these taxa are short (see Chapter 2) this may contribute to spuriously high LR scores.  In 
order to investigate this hypothesis a list of RefSeq Gis for proteins lost on either the branch 
leading to P. troglodytes or the branch leading to M. mulatta was sifted from the overall set 
of phylogenetic profiles.   




The following procedure was then applied iteratively. 
• Set cut-off to 0. 
• Select all protein Gis from predicted interactions where no. of predicted interactions 
for  > cut-off. 
• Examine intersection of Gis in selected list with set of Gis of proteins lost on short 
branches. 
• Increment cut-off by 1. 
 
At the point where the cut-off was equal to 298, the intersection between the two sets was 
100% as shown in the Venn diagram below. 
 
Figure 5.3: Intersection of proteins lost on in P. troglodytes and M. mulatta with proteins 
with > 298 predicted interaction partners.  
 




The 16 proteins in this intersection alone accounted for 13,082 of the total predicted protein 
interactions or 63%. It is impossible to tell whether these proteins are genuinely evolving in a 
correlated fashion or merely an artefact of the loss on a short branch.  
Thus a post-processing step was applied which removed any prediction involving 
proteins with profiles that matched this pattern. Thus 16,301 proteins with profiles that 
contained a 0 at either the position representing P. troglodytes or the position representing M. 
mulatta were removed from the set of predicted interactions.  This led to the removal of 
19,463 predicted interactions between proteins. This left a reduced set of 1,142 predictions.  
An examination of the training data showed that 2 of the 5 predicted interactions by 
constrained ML (Barker et al. 2007; Barker and Pagel 2005) at its selected optimum rate of 
gain (0.025) during the training step (see Chapter 3) involved the protein 
(16936528/NP_001789) which would have been removed by this post processing step. This 
reduces the sensitivity of the method by 40%.  
5.2.2 GO term enrichment 
A plausible method to examine the potential accuracy of the predicted interaction is to test 
whether the GO terms associated with the predicted interaction partners are enriched for 
particular terms. 
In order to subject the data to GO (Gene ontology) term analysis (Ashburner et al. 
2000) the set of 1,142 predicted interactions between protein pairs was converted to 
predictions between gene pairs. This was carried out using IDconverter (Alibes et al. 2007).  
This produced a set of 273 interactions between pairs of genes and 183 individual genes. 
 In order to investigate the validity of predicted interactions the set of interactions 
between genes was converted into a network of interactions.  The network can be represented 
as an undirected graph. The graph in this case would be undirected as there is no way of 
inferring any form of directional relationship between putative predictions. 
The predicted interactions were converted into a graph through insertion of the 
characters ‘xx’ between each predicted pair. This converted the predicted interactions into a 
format known as the simple interaction format, which is usable by a platform known as 
Cytoscape (Shannon et al. 2003). Cytoscape is a program that allows visualisation and 
analysis of network data (Shannon et al. 2003) and is widely used for such analyses. The 
broad structure of the resultant graph is shown in Figure 5.4. 
 
 






Figure 5.4: Graph of 273 interactions between genes as predicted by the application of 
constrained ML post data filtering. Each vertex in the graph is one gene. The edges in the 
graph represent a predicted functional interaction between two vertices. 
 
In order to examine the quality of the predictions the graph was subjected to clique 
analysis to break up the network into sub-graphs, which are densely connected. The 
Cytoscape plugin ClusterViz (Cai 2010) was utilised to deconstruct the network into sub 
clusters.  The plugin was used with the FAG-EC agglomerative hierarchical algorithm (Li et 
al. 2008), which builds up sub-clusters through analysis of the clustering coefficient of each 
edge in the graph. The clustering coefficient measures the density of connections between a 
given edge and its neighbours. It does this by calculating the number of triangles that a given 
edge is part of and dividing this number by the number of triangles that might potentially 
include it given the degree (number of incoming edges) of its adjacent nodes (Radicchi et al. 
2004). FAG-EC was run with a specified cut-off of sub-cliques of at least size 3. This was 
because GO terms can be found to be significantly enriched in pairs of proteins even if an 
annotation is attached to just one protein in the pair. 




  FAG-EC was also run with a “weak” module definition. This identifies modules as 
sub-cliques within graphs where the sum of in-degree of each node within a module is higher 
than the sum of out-degree (Li et al. 2008). The in-degree of a node within an undirected 
graph is defined as defined as the number of edges connecting it to other nodes in the same 
subgraph (Li et al. 2008). The out-degree of a node is defined as the number of edges 
connecting it to the rest of the graph excluding its subgraph (Li et al. 2008). 
The application of this algorithm yielded 10 connected sub-cliques. GO term 
enrichment was examined through the use of the Cytoscape plugin Bingo (Maere et al. 2005). 
Bingo operates through examination of all GO terms associated with a given network. There 
are a number of sources of evidence by which a term may be associated with a gene 
(Ashburner et al. 2000). These are: 
 
• IMP: inferred from mutant phenotype 
• IGI: inferred from genetic interaction 
• IPI: inferred from physical interaction 
• ISS: inferred from sequence similarity 
• IDA: inferred from direct assay 
• IEP: inferred from expression pattern 
• IEA: inferred from electronic annotation 
• TAS: traceable author statement 
• NAS: non-traceable author statement 
• ND: no biological data available 
• IC: inferred by curator 
 
In order to utilise reliable sources of evidence terms that were determined using the evidence 
codes ISS, IEA, NAS and ND were excluded.  
Bingo operates by calculating the probability of the association of a given set of terms 
with a cluster of genes given a background distribution of terms associated with a reference 
set of genes. This is calculated using the hypergeometric test (Maere et al. 2005). The 
probability of a given set of genes being associated with a given GO term follows the 
hypergeometric distribution, which is equivalent to the binomial distribution but utilising 
sampling without replacement (Sokal and Rohlf 1995). The probability of a cluster C of r 
genes being associated with a given GO term g (if evaluated against a background set of N 




genes and assuming the total number of genes associated with g is t) can be calculated. The 
background probability of any given gene being associated with g is t/N and the probability 
of g not being associated with a gene is (1-t/N). Thus the probability of x genes inside C 










































'  is the number of combinations of k items taken Y at a time (Sokal and Rohlf 1995). 
The effects of multiple testing are reduced through application of the Bonferroni 
correction. This correction scales the point at which p values are found to be significant down 
by dividing by n the number of tests performed (Sokal and Rohlf 1995). A procedure 
involving the hypergeometric test is common in GO enrichment tools and is also utilised by 
ClueGO (Bindea et al. 2009), Gorilla  (Eden et al. 2009) and GOEAST (Zheng and Wang 
2008) amongst others. 
Bingo was run against a background set of genes, which consisted of the full set of 
human genes held in Entrez Gene. 
5.2.3 Intersection with other data sources  
To examine the extent to which the predictions made by the filter in combination with 
constrained ML (Barker et al. 2007; Barker and Pagel 2005) intersected with known data it 
was decided to compare the predictions to a known set of PPIs. It was decided to utilise the 
I2D database (Brown and Jurisica 2005) as it contained data from all the other major PPI 
databases. Thus the Interologous Interaction Database (I2D) version 1.95 was downloaded.  
Predictions were converted from RefSeq GI numbers to their corresponding Uniprot 
(Apweiler et al. 2010) primary accession. Only Swiss-Prot accessions were used, as these are 
high confidence protein molecules that have been manually annotated (Apweiler et al. 2010). 
As mentioned above there were 1,142 predictions made between RefSeq GI pairs. 
This conversion reduced the set of predictions to 278 predictions as a complete mapping of 










5.3.1 GO Enrichment 
Table 5.1 shows details of the sub-clusters generated by ClusterViz (Cai 2010) ordered in 
descending order by size. 
Cluster No.  No. of genes  No. of interactions    Genes 
1 97 188 PRPF31 RRP9 SNRPE SUPT4H1 TNPO1 
COPB1 FASN GLRX5 RPS25 WWOX 
DHDDS EXO1 H2AFY ATP5C1 RPS29 
RER1 PHF5A PIGL RPS21 POLR2G PSMD8 
TP53RK ABT1 ANAPC10 TCEA2 NOP10 
POLR2L SF3B5 LZTR1 TUBGCP2 CDS1 
MAK16 CTDSPL RBM34 KIFC1 GFPT1 
PPP1CC UBE2D4 BYSL PSMA6 FDX1L 
TFB1M C20orf118 KIAA1609 UBE2V1 
NAPNAPB RLBP1 RPF1 PSMC4 
TRAPPC6B RBMX2 RHOC TOP2B UBE2I 
CDK5 FKBP4 CCT6A CDK7 CKS2 CTDSP1 
DIMT1L FAM96B FKBP5 GNB1 GUK1 
HSPE1 KIF19LSM7 POLE2 PSMB1 
RIOK2RPL13 RPL19 RPL30 RPL37A 
RPS23 SEC11C SLC2A6 
SMARCAL1TRAPPC1 TRAPPC4 
TRAPPC6ATXNL4B UBE2V2 VBP1 VPS45 
ZDHHC21 ERCC2 SPO11 TRIT1 SHMT2 
GDPD1 DOLK DUSP5 LIG1 TRMT112 
 
 
Table 5.1: Sub-cliques of predicted interactions generated through analysis of clustering 
coefficients.  
 




Cluster No.  No. of genes  No. of interactions    Genes 
2 4 6 MTMR2 MTM1 
MTMR9 MTMR1 
3 8 10 VAPB ZNF516 STK17A 
ZNF225 
MAZ ZNF286A ZNF304 
DNM1L 
4 4 4 NLE1 CDC6 TEP1 GEMIN5 
5 3 2 ZRSR2 PPP1CB 
RPL31 
6 3 2 DERL1 DERL2 
DNAJC12 
7 3 2 H2AFV ATG4A 
UNG 
 
Table 5.1: Sub-cliques of predicted interactions generated through analysis of clustering 
coefficients (cont).  
 
To investigate whether GO terms were enriched in the predicted sub-clusters; clusters were 
subjected to analysis for GO term enrichment using Bingo (Maere et al. 2005). All terms 
were judged significant at p < 0.05 after application of the Bonferroni correction.  Table 5.2 
presents the clusters and the GO terms enriched in each cluster.  
 




Cluster No.        Enriched GO terms 
1 44238 primary metabolic process 
44237 cellular metabolic process  
8152 metabolic process 
44260 cellular macromolecule metabolic process 
43170 macromolecule metabolic process 
6414 translational elongation 
6412 translation 
44267 cellular protein metabolic process 
6368 RNA elongation from RNA polymerase II 
promoter 
6354 RNA elongation 
10467 gene expression 
19538 protein metabolic process 
44265 cellular macromolecule catabolic process  
 
2 No significant enrichment  
3 19224 termination of RNA polymerase II 
transcription  
43653 mitochondrial fragmentation during apoptosis   
4 79 regulation of cyclin-dependent protein kinase 
activity  
31981 nuclear lumen  
5 No significant enrichment 
6 30970 retrograde protein transport, ER to cytosol 
30433 ER-associated protein catabolic process 
6515 misfolded or incompletely synthesized protein 
catabolic process 
6984 ER-nuclear signaling pathway 
30176 integral to endoplasmic reticulum membrane 
31227 intrinsic to endoplasmic reticulum membrane 
51789 response to protein stimulus 
 
Table 5.2: GO enrichment in sub-cliques within predicted interaction network. 




Cluster No.        Enriched GO terms 
6 31301 integral to organelle membrane 
31300 intrinsic to organelle membrane 
43161 proteasomal ubiquitin-dependent protein catabolic 
process 
10498 proteasomal protein catabolic process 
5789 endoplasmic reticulum membrane 
42175 nuclear envelope-endoplasmic reticulum network 
44432 endoplasmic reticulum part 
43632 modification-dependent macromolecule catabolic 
process 
51603 proteolysis involved in cellular protein catabolic 
process 
19941 modification-dependent protein catabolic process 
6511 ubiquitin-dependent protein catabolic process 
44257 cellular protein catabolic process 
30163 protein catabolic process 
9607 response to biotic stimulus 
6886 intracellular protein transport 
19060 intracellular transport of viral proteins in host cell 
30581 intracellular protein transport in host 
51708 intracellular protein transport in other organism 
during symbiotic interaction 
15031 protein transport 
44265 cellular macromolecule catabolic process 
45184 establishment of protein localization 
43285 biopolymer catabolic process 
8104 protein localization 
9057 macromolecule catabolic process 
46719 regulation of viral protein levels in host cell 
33036 macromolecule localization 
12505 endomembrane system 
6508 proteolysis 
46907 intracellular transport 
5783 endoplasmic reticulum 
 
Table 5.2: GO enrichment in sub-cliques within predicted interaction network (cont). 
 
 





Cluster No.        Enriched GO terms 
6 44248 cellular catabolic process 
31090 organelle membrane 
9056 catabolic process 
51649 establishment of localization in cell 
42288 MHC class I protein binding 
51641 cellular localization 
42287 MHC protein binding 
30307 positive regulation of cell growth 
42221 response to chemical stimulus 
45793 positive regulation of cell size 
65008 regulation of biological quality 
19048 virus-host interaction 
45927 positive regulation of growth 
51701 interaction with host 
7242 intracellular signaling cascade 
44419 interspecies interaction between organisms 
44404 symbiosis, encompassing mutualism through 
parasitism 
6950 response to stress 
6810 transport 
51234 establishment of localization 
22415 viral reproductive process 
16032 viral reproduction 
1558 regulation of cell growth 
51179 localization 
8361 regulation of cell size 
44267 cellular protein metabolic process 
19538 protein metabolic process 
40008 regulation of growth 
44260 cellular macromolecule metabolic process 
51869 response to stimulus 
16021 integral to membrane 
7154 cell communication 
43170 macromolecule metabolic process 
30968 endoplasmic reticulum unfolded protein response 
 
Table 5.2: GO enrichment in sub-cliques within predicted interaction network (cont). 





Cluster No.        Enriched GO terms 
6 31224 intrinsic to membrane 
44446 intracellular organelle part 
44422 organelle part 
43283 biopolymer metabolic process 
7165 signal transduction 
44425 membrane part 
51706 multi-organism process 
22414 reproductive process 
8284 positive regulation of cell proliferation 
6986 response to unfolded protein 
7 No Significant enrichment. 
Table 5.2: GO enrichment in sub-cliques within predicted interaction network (cont). 
 
5.3.2 Intersection with known data 
The comparison of the set of protein interactions predicted by constrained ML (Barker et al. 
2007; Barker and Pagel 2005) with the I2D database (Brown and Jurisica 2005) was carried 
out by determining the intersection between the two sets of interactions. There were 2 
predictions in common between the two datasets, which were not self-interactions (there were 
9 self interactions in the intersection). These were: 
 
Protein Pair (RefSeq GI numbers)                            Evidence of interaction 
118600991 13129120 (Kummel et al. 2008) 
21361657 4758304 (Jessop et al. 2007) 
 
Table 5.2: Intersection between I2D (Brown and Jurisica 2005) and predictions by logistic 
regression/constrained ML (Barker et al. 2007; Barker and Pagel 2005). 
  
There are thus 1,131 predictions made by logistic regression/constrained ML (Barker 
et al. 2007; Barker and Pagel 2005), which are potentially novel. All predictions made can be 
seen in Appendix C. 




5.3.3 Network statistics 
The degree distribution of nodes within the graph appears to follow a power law. This could 
potentially also be indicative of the correctness of the predictions made by constrained ML. 




Figure 5.5:  Degree distribution for full graph of protein interactions. Line is fitted power law 
of the form y=axb. Line is fitted by least squares regression R2=0.694. 








Figure 5.6:  Degree distribution for graph of protein interactions post short branch filtration. 




A full genome wide investigation of human protein interactions by constrained ML (Barker et 
al. 2007; Barker and Pagel 2005) in combination with the logistic regression-based data filter 
seems to be a potentially fruitful source of new protein interactions. The enrichment of GO 
terms in some sub-cliques of the resultant network suggests that the system has an ability to 
make predictions with some basis in reality and thus a proportion of the set of predictions 
made are both novel and accurate.  
 
5.4.1 GO enrichment 
GO enrichment was investigated conservatively by excluding the GO evidence code IEA. 
This evidence code is associated with 90% of GO annotations (Buza et al. 2008).  However 




despite removing terms associated with this code as well as terms associated with the codes 
ISS, ND and NAS, a reasonable degree of enrichment was still observed.  
The terms enriched appear to be associated with processes, which are divergent across 
eukaryotes such as transcription (enriched in sub-clique 1) (Coulson and Ouzounis 2003). 
This is a demonstration of the fact that it is only proteins that show a degree of variability in 
their distribution pattern that are susceptible to this line of investigation. 
 
5.4.2 Intersection with known data 
The level of intersection with the I2D database is fairly low. Using the estimate of 
interactome size provided by (Stumpf et al. 2008) and assuming every prediction in I2D 
(Brown and Jurisica 2005) is correct. This would correspond to a coverage level of  
133,250/ 650,000 or 20%. Thus the probability of any given accurate prediction being within 
this database would be 0.2.  Thus the converse probability of an accurate prediction not being 
in the database would be 1-0.2 or 0.8. 
If every prediction made by the heuristic approach were accurate, then the observed 
result of an intersection of 11 and a complement of 1,131 would be highly improbable 0.81131 
or ~0).   The lack of intersection between the two datasets could be due to the bias in PPI 
databases to particular physical detection systems such as yeast 2 hybrid. Approximately 37 
% of the binary interactions held in HPRD (Mishra et al. 2006) were detected using yeast 2 
hybrid. 
The issue of RefSeq to Uniprot mapping is also pertinent in contributing to this lack 
of intersection as over 75% of the predictions were lost post mapping. 
Finally it is also unlikely that there is 100% accuracy in all PPIs held in I2D. 
 
5.4.3 Weaknesses 
Clearly the result of a precision of 1 as achieved on the training and testing data cannot be 
extended to a full genome wide survey.  The fact that predictions are made through 
comparisons of the phylogenetic distribution of proteins suggests that one weakness of the 
method could be an inability to distinguish between paralogs/isoforms and proteins showing 
evidence of correlated evolution. However this issue is far from clear-cut as there is evidence 
to show that homologous proteins are more likely to interact (Ispolatov et al. 2005; Orlowski 
et al. 2007). Thus it is possible that the success of the phylogenetic profile method is partly 
based on this observation. This is a potentially confounding issue for the method.  However 




examination of interactions between predicted orthologous groups can ameliorate this. In the 
case of this study of the 1,142 pairs of proteins predicted to be functionally linked by this 
study 221 lie within the same orthologous group as identified by the Inparanoid 
implementation (Remm et al. 2001).  
Thus predictions between members of orthologous groups are not particularly 
widespread over the data examined.  
The other weakness of phylogenetic profiling in general that applies to this set of 
predictions is potentially inaccurate profiles. Profiles can be inaccurate for a number of 
reasons including low coverage sequencing, poor annotation or incorrect assumptions in 
homolog identification. The short branch filtration step undertaken before further analysis is 
potentially attributable to this phenomenon.  
 
5.4.3.1 Scaling 
The precision and sensitivity results observed over the training data were based on a 
biologically unrealistic ratio of 10:1 of negative to positive examples of interacting proteins.  
The results observed can be adjusted for the whole genome by scaling to a more realistic 
ratio. A possibly more realistic ratio can be calculated using estimates of interactome size. 
These range from 154,000-369,000 (Hart et al. 2006) to 650,000 (Stumpf et al. 2008). If these 
numbers are subtracted from the size of all potential interactions 560,237,601 (calculated as 
all possible pairs from version of RefSeq held) estimated ratios of negative to positive range 
from approximately 860:1 to 3636 :1. Assume for the sake of argument the ratio of 860:1 is 
adopted (via an assumption of an interactome size of 650,000). Recall that the size of the 
positive set in the training data is 9,161 pairs of known interactions. Thus as an illustrative 
example if a given predictive method yielded a precision of 0.5 and a sensitivity of 0.1 over 
the training data this would correspond to making 916 predictions of which 50% were correct 
(TP=458, FP=458 and FN=8703). In order to scale the data the following numbers need to be 
calculated: 
 
• P(TP)= Probability of predicting a true positive. 
• P(FP)= Probability of predicting a  false positive. 
• P(FN)= Probability of predicting a false negative.  
 
These numbers can be calculated by the following equations: 






P(TP) = (TP)(PS)       (1) 
! 
P(FP) = (FP)(NS)      (2) 
! 
P(FN) = (FN)(PS)      (3) 
 
        
Where PS= size of the positive set and NS= size of the negative set.  
 
For the example above P(TP)=458/9161=0.049, P(FP)=458/103971=0.004 and  
P(FN)=8703/9161=0.95. Thus by multiplying these probabilities by the estimated full 
interactome size (in this case) 650,000 the sizes of TP and FN can be calculated over the full 
interactome. In order to calculate the size of FP the size of a potential negatome (proteins that 
do no interact) must be calculated. This can be calculated as the estimated size of the 
interactome subtracted from the number of all possible interactions (in this case 560,237,601-
650,000=559,587,601). Given these numbers the values of TP, FP, and FN over the full 
interactome for this example would be 31,850, 2,238,216.5 and 617,500 respectively leading 
to a scaled precision of 0.014 and a scaled sensitivity of 0.049 over the whole interactome. In 
cases where precision =1 scaling will not affect this value as there are no false positives 
predicted.  
Probabilities of predicted interactions being genuine can also be calculated via an 
alternate route applying Bayes theorem with the prior probability of an interaction being 
derived from an estimate of interactome size. Thus applying Bayes theorem the posterior 
probability of an interaction can be calculated using the following parameters (Yang 2006): 
• P(I)=prior probability of interaction. Calculated by division of interactome size 
estimate by total number of potential interactions.  
• P(Pos)=  Probability of  making any positive prediction. Calculated as   
! 
P(Pos) = P(Pos | I )(P(I ))+P(Pos |~ I )(P(~ I )) 
In cases where precision is = 1 
! 
P(Pos |~ I ) = 0. Note 
! 
P(Pos |~ I ) = P(FP) 
• Thirdly the probability of making a positive prediction given an interaction is 
calculated as: P(Pos|I)= Sensitivity of the method. 




Thus the posterior probability of a predicted interaction being genuine can be calculated 
using Bayes theorem as presented in Equation 4: 
 
! 
P(I |Pos) = P(I) " P(Pos | I)P(Pos)      (4) 
         
Bayes theorem however is only applicable in cases where precision < 1 as the posterior 
probability is 1 when precision =1. 
This can be simply demonstrated using basic algebra and recasting the terms. 
 
! 




P(FP)(1"Pr ior)  = 0 the posterior probability is 1. 
5.4.4 Conclusions 
Given results observed on the training data and testing data and the GO term enrichment 
observed in the sub-clusters, as well as the results of previous work on the phylogenetic 
profile method (Barker et al. 2007; Barker and Pagel 2005; Bowers et al. 2004; Cokus et al. 
2007; Kensche et al. 2008; Pagel et al. 2004b; Pellegrini et al. 1999; Vert 2002) amongst 
others, it appears that the method is capable of discerning between proteins that are 
functionally linked and proteins that are not. Thus the novel predictions made could 
potentially be genuine interactions, which are of yet uncharacterised.  




Chapter 6  
Conclusions and further work 
6.1 Summary of Project 
The goal of this project has been an investigation into detection of human protein interactions 
using the comparative method.  More specifically the development of a novel heuristic 
approach to allow application of the effective but computationally intensive constrained ML 
(Barker et al. 2007; Barker and Pagel 2005) approach to phylogenetic profile analysis on a 
genome-wide scale. This application was intended to allow the generation of novel 
predictions of protein interactions. 
A database of all against all comparisons of the proteomes of 54 eukaryotic organisms 
plus 1 archaeon was created.  This was used to as input to an implementation of the 
Inparanoid (Remm et al. 2001) procedure to cluster the contents of the proteomes into 
orthologous groups. Using the human proteome as a reference point phylogenetic profiles 
were then constructed for each protein within the human proteome. 
10 proteins that were universally present in single copies in all organisms under 
consideration were then selected through analysis of the phylogenetic profiles and 
orthologous groups.  The versions of these single copy proteins from each species were then 
aligned to create a multiple sequence alignment. Each multiple sequence alignment was then 
concatenated to create one single combined alignment. This combined alignment provides a 
measure of divergence between the 55 organisms under consideration. The concatenated 
multiple sequence alignment was then used to reconstruct a phylogenetic tree of the 54 
eukaryotes under consideration using the archaeon as an outgroup with which to root the tree. 
This phylogeny was broadly congruent with current thought on eukaryotic evolution (see 
Chapter 2) .  





Figure 6.1:  Process flow for research carried out in Chapter 2. 
 
In order to use constrained ML (Barker et al. 2007; Barker and Pagel 2005) to analyse 
the training data it was necessary to ascertain the optimum rates at which a character could be 
gained in order to constrain the models of evolution used by the method (Barker et al. 2007). 
In order to do this it was necessary to obtain training data, i.e. examples of protein pairs that  
interact and examples of protein pairs that are unlikely to interact. Positive data was acquired 
which was based protein interactions held with the HPRD database. Negative data was 
generated by creating a set of all possible pairs of human proteins. These pairs were filtered 
by removing all pairs that possessed any Gene Ontology (GO) (Ashburner et al. 2000) terms 
in common. Once these training sets were obtained different rates of protein gain were 
evaluated in terms of precision and sensitivity and an optimum rate of gain of 0.025 was 
selected. The highest sensitivity reached by constrained ML at this rate was 1 at a cut-off of 
56.37. The sensitivity of the method at this cut-off was 0.000654.  
The efficacy of constrained ML (Barker et al. 2007; Barker and Pagel 2005) in 
detecting protein-protein interactions was then compared to a comparable high throughput 
laboratory based method for detecting interactions using the training data. This method was 
examination of gene co-expression in response to given experimental stimuli as measured by 




microarrays. The highest performing microarray experiments also achieved a precision of 1. 
The highest performing microarray experiment E-MEXP-1224 (Garman et al. 2009) achieved 
a sensitivity of 0.003.  
Constrained ML (Barker et al. 2007; Barker and Pagel 2005) was also compared to 
the PIPs server (McDowall et al. 2009) which uses a semi-naive Bayesian classifier (Scott 
and Barton 2007) in order to evaluate multiple sources of evidence for potential protein 
interactions.  At its highest cut-off the Bayesian classifier achieved a precision of 0.9883721 
and a sensitivity of 0.01. 
 
Figure 6.2: Process flow for research described in Chapter 3. 
 
These comparisons showed that constrained ML (Barker et al. 2007; Barker and Pagel 
2005) showed comparable levels of precision to gene co-expression at an optimal level of 
constraint for rate of gain and outperformed the method that integrated multiple sources of 
evidence. In terms of sensitivity however constrained ML (Barker et al. 2007; Barker and 
Pagel 2005) was clearly the worst performer. However given that constrained ML (Barker et 




al. 2007; Barker and Pagel 2005) achieved a precision of 1 over the training data it was 
utilised for further analysis.   
 The application of constrained ML (Barker et al. 2007; Barker and Pagel 2005) to a 
full genome-wide survey was found to be impractical due to time considerations. Thus a 
heuristic was developed which approximated the ability of constrained ML (Barker et al. 
2007; Barker and Pagel 2005) to distinguish between proteins that interact and those that do 
not. This heuristic was based on the reconstruction of ancestral states using Dollo parsimony 
(Farris 1977) over the phylogenetic tree. Two novel potential heuristics were developed, 
implemented and tested using the Dollo parsimonious reconstruction. The first was an 
implementation of a test for correlated evolution which calculates the probability of the 
concentration of a set of gains and losses of a protein in the areas of a phylogenetic tree 
where a second protein was either present or absent (Maddison 1990).  The second potential 
heuristic was based on logistic regression using empirical counts of the presence, absence, 
gain or loss of one protein given the presence, absence, gain or loss of the other as predictor 
variables.  
The Maddison test (Maddison 1990) based heuristic performed reasonably well in its 
own right as a method of detecting functional interactions. It achieved a maximum precision 
of 0.857 with a sensitivity of 6.54 
! 
" 10-4 over the training data at a score cut-off of 
0.9999997999999475. However it proved not to be efficient enough in terms of speed to be 
justified for use as a heuristic. It also did not maintain an intersection with the 5 predictions 
made by constrained ML (Barker et al. 2007; Barker and Pagel 2005) at its optimum rate of 
gain (0.025) and at its optimum likelihood ratio (LR) statistic score cut-off (58.3). 
Maintenance of an intersection with these predictions was considered a necessary property of 
an effective heuristic. 
The heuristic that utilised logistic regression achieved a precision of 0.736 with a 
sensitivity of 0.01 at its optimum cut-off of 0.967.  It also maintained an intersection with the 
predictions made by constrained ML (Barker et al. 2007; Barker and Pagel 2005) (at its 
optimum rate of gain and LR cut-off) up to a cut-off of 0.85. At a cut-off of 0.85 the heuristic 
made 1,230 predictions, which amounted to a reduction of the search space of potential 
proteins by 98.9%.  
The heuristic based on logistic regression was then applied to the full human genome 
in order to filter out protein pairs that displayed little or no evidence of correlated evolution. 
The heuristic reduced the size of the search space by 90% over the whole genome.  








Figure 6.3: Process flow for research carried out in Chapter 4. Note: Validation sets 
were used to validate all methods. The connectors have been left out for clarity.  
 
Having applied the heuristic to the method a full genome-wide survey was launched. 
The results of the genome-wide survey found that a large majority of predicted protein 
interactions involved proteins, which had been lost on short branches in the phylogeny. These 
predictions were removed from the overall set of predictions. The prediction set was then 
recast as a network of interactions. 
 The results of the genome-wide survey were then examined by generating sub-
networks from the complete network generated and examining these sub networks for 
enrichment in Gene Ontology (GO) (Ashburner et al. 2000) terms.  GO term enrichment was 
found in 57% of the clusters generated. The intersection of the predictions made by 
constrained ML (Barker et al. 2007; Barker and Pagel 2005) with the I2D database (Brown 
and Jurisica 2005) was also examined. The intersection with the I2D (Brown and Jurisica 
2005) database was low suggesting that any correct predictions generated by this project are 




also novel predictions of protein interaction. The genome-wide survey yielded a final set of 
1,131 predictions of protein interaction.  
 
Figure 6.4: Procedure for research carried out in Chapter 5. 
 
6.1.1 Repeat Analysis 
To apply this procedure to a new dataset, the following procedure would have to be followed. 
Prerequisites needed: 
• Phylogenetic tree for species of interest. 
• Phylogenetic profiles for proteins of interest. 
• Positive and negative examples of protein interaction data. An automated procedure 
for the acquisition of training/testing data is found in (Chen et al. 2011). 
Having acquired these, the programs BayesTraits (Pagel et al. 2004a) and bms_runner 
(Barker et al. 2007) should be downloaded.  
To determine the optimum rate of protein gain for use in the constrained ML procedure 
bms_runner should be used to evaluate multiple rates of gain. The LR scores for all 
proteins for the optimum rate of gain should be kept. 




Once this rate is determined, the next step is the ancestral state reconstructions. In order 
to carry out these reconstructions it will be necessary to download the program 
DOLLOP held in the PHYLIP package (Felsenstein 1989). 
DOLLOP should be run with the –U option, which will allow it to utilise the 
phylogenetic tree. (Note bms_runner uses a NEXUS formatted tree while DOLLOP will 
need a PHYLIP format tree). DOLLOP should be run on every profile in the dataset. 
Thus the end product of this step is a set of ancestral reconstructions over the tree for 
each profile. 
At this point code written by the author (available on request) can be used to process 
these reconstructions.  This code will take in the reconstructions and return a dataset 
consisting of the s parameters described in Chapter 4 calculated for each protein. 
This data can then be processed using standard statistical package R (R Development 
Core Team 2011) in order to carry out logistic regression. Once regression has been 
carried out, this should yield a linear equation for calculating a logit based score for the 
probability of interacting. 
Again code available from the author can now be utilised. This code will take in the 
specified coefficients for the s parameters calculated in R, the Dollo reconstructions of 
the proteins, the LR scores of the proteins at the optimum rate of gain and the validation 
data and return the optimum logit cut-off for the data for preserving the performance of 
constrained ML (Barker et al. 2007; Barker and Pagel 2005). 
At this point a dataset of all possible pairs of profiles should be prepared. Code from the 
author can be used to apply the linear equation to each of these pairs to calculate the logit 
score. These pairs can now be filtered by the optimum cut-off. 
Once a reduced set has been created, constrained ML can be applied to this set (Barker 
et al. 2007; Barker and Pagel 2005). 
6.2 Conclusion 
This project has investigated use of the comparative method specifically constrained ML 
(Barker et al. 2007; Barker and Pagel 2005) as a means to detect protein-protein interactions.  
It has generated a set of predictions that if validated by further laboratory based investigation 
could contribute to knowledge about the human interactome. It has also developed a method 




that allows the application of the computationally intensive constrained ML (Barker et al. 
2007; Barker and Pagel 2005) approach to phylogenetic profiling on a genome-wide scale. 
 The ability of the comparative method to unearth protein interactions can only be 
enhanced by the current rate of data generation given the rapid uptake of next generation 
sequencing technologies such as the Roche 454 GS FLX sequencer, the Illumina Genome 
Analyser and the Applied Biosystems SOLID sequencer, which can generate gigabases of 
sequence data in a matter of days (Mardis 2008). As more organisms are sequenced the 
quality of reconstructed phylogenies and consequently the efficacy of the comparative 
method in detecting associations between traits should improve due to increased taxon 
sampling (Heath et al. 2008). 
  Given this increased pace of data generation it is also necessary to develop fast and 
effective computational techniques for functional annotation of proteins. Detection of protein 
interactions can be used to functionally annotate proteins via the principle of “guilt by 
association” (Aravind 2000).  Thus the combination of the developed heuristic with 
constrained ML (Barker et al. 2007; Barker and Pagel 2005) can contribute to annotation 
efforts. It has been seen that this method is not very sensitive thus the probability of it making 
any predictions at all for a given protein are low. But used in a high throughput unsupervised 
context the method is potentially capable of detecting novel interactions as one tool amongst 
many.   
Among the methods of detecting protein interactions examined over the course of this 
study was the PIPs server (McDowall et al. 2009), which as mentioned above combines 
multiple sources of evidence in order to detect potential protein interactions (Scott and Barton 
2007) utilising a Bayesian classifier. A similar approach of using combined evidence in a 
Bayesian framework was previously taken by (Jansen et al. 2003). This combination of 
diverse sources of evidence as a means to elucidate protein interactions has also been applied 
by Mohamed (Mohamed et al. 2010) utilising a classifier based on a majority vote from a 
collection of decision trees. Other approaches such as support vector machines and singular 
decision trees have also been investigated by (Qi et al. 2006). 
Potentially the application of constrained ML (Barker et al. 2007; Barker and Pagel 
2005) in combination with the heuristic in a genome-wide manner could be utilised as a 
source of contributory evidence in a similar framework. 




6.3 Future directions  
Constrained ML (Barker et al. 2007; Barker and Pagel 2005) has been seen to be capable of 
detecting protein-protein interactions at a reasonable level of accuracy. With the data 
accumulated over the course of this project there are a number of further avenues of 
investigation and areas of extension. 
6.3.1 Computational extensions 
The procedure followed in order to utilise constrained ML (Barker et al. 2007; Barker and 
Pagel 2005) for a genome-wide survey of H. sapiens involved the use of bespoke scripts and 
various programs provided by a plethora of authors as cited throughout this text. To facilitate 
the application of this tool by other users it will be necessary to create an interface and 
combine the functionality of the programs utilised into one computational procedure. 
 The construction of phylogenetic profiles for all proteins in all species held in the 
current dataset and the provision of these profiles online via a web interface would also 
facilitate this process. The data generated by this project as presented in Appendix D could 
also be presented via an online database either an extant protein interaction database such as 
String or I2D or a bespoke database, which would have to be constructed.  
6.3.2 Consensus profiles 
The application of constrained ML (Barker et al. 2007; Barker and Pagel 2005) to detection 
of protein interactions is carried out in a pairwise fashion. Work by Bowers extended the idea 
of pairwise comparisons to three way comparisons using Boolean logic operators (Bowers et 
al. 2004). This method attempted to detect dependencies in the presence and absence of a 
given gene on the presence and absence of two other genes. A similar technique could be 
utilised to integrate matching profiles into consensus profiles. By classifying mismatches as 
missing information consensus phylogenetic profiles could be constructed to represent groups 
of proteins. The program BayesTraits (Pagel et al. 2004a), which is utilised to apply the 
constrained ML approach, handles missing data by reconstruction of the missing data as an 
extension of ancestral state reconstruction. Thus when a plausible reconstruction is reached at 
the immediate ancestral node of the taxon with the missing data the state of the taxa can be 
estimated using rate transition parameters (Pagel 1994). Consensus profiles will utilise a 
mismatch character X to represent missing information. Thus if for example we compare the 
following four species profiles: 
1010 





The consensus profile of the above two profiles would be: 
1X10 
In comparisons of consensus profiles the X character will remain unchanged if matched 
against another X, shift to 0 if matched against a 0 and shift to 1 if matched against a 1.  Thus 
a 1 or a 0 in a consensus profile will always be present in more than 50% of its constituent 
profiles. 
Some of these groups will represent clade specific distributions of proteins. Others 
will represent distributions of proteins correlated with the distribution a given function over 
the species under consideration. Comparison of a protein with an as yet unascertained 
function using consensus profiles would connect a protein to either a clade-specific group or 
a group, which possessed a function connected to the presence of the protein. Thus a protein 
that showed correlated evolution with a consensus profile could potentially be functionally 
linked to all constituent members of that profile. At a higher-level if two consensus profiles 
show evidence of correlated evolution with each other this could suggest functional linkage 
between two groups of proteins, e.g. the functional interaction of one pathway with another. 
6.3.3 Correlated evolution of proteins with the presence or absence of phenotypes 
Given the data currently generated an interesting avenue of investigation would be the 
comparison of the presence and absence of given phenotypes with the presence and absence 
of given proteins.  This process can detect proteins that underlie the phenotype of interest. 
This method was developed by Levesque (Levesque et al. 2003) and used to detect genes 
associated with cell motility. It was also applied to associating a number of phenotypes with 
given proteins (Jim et al. 2004; Slonim et al. 2006). The method was found to be to be 
reasonably effective with traits that were evenly distributed among the organisms under 
consideration (Jim et al. 2004). A further application of the method by Gonzalez and Zimmer 
examined the association of optimal growth pH with given genotypes (Gonzalez and Zimmer 
2008). Gonzalez and Zimmer utilised a threshold with which to discretise continuous 
phenotypes (Gonzalez and Zimmer 2008). If the measured value of a measured phenotype 
was over a given value then the phenotype was declared present. Applications of this method 
have so far utilised measures like string distance measures (Jim et al. 2004; Levesque et al. 
2003) and mutual information (Gonzalez and Zimmer 2008; Slonim et al. 2006) to compare 
the phylogenetic profiles of genes and given phenotypes. Use of a phylogenetically aware 
method such as constrained ML (Barker et al. 2007; Barker and Pagel 2005) would enhance 




the method and potentially yield more accurate results. Given the range of eukaryotic 
organisms currently held potential traits to be investigated could include multi-cellularity, 
aerobic respiration and parasitism.  
6.3.4 Drug Targets 
Keeping with the theme of parasitism there are a number of disease causing parasitic 
organisms in the dataset currently held.  These are 
• Plasmodium falciparum 
• Plasmodium knowlesi 
• Plasmodium yoelii 
• Trypanosoma brucei 
• Trypanosoma cruzi 
• Leishmania major 
• Trichomonas vaginalis 
• Theileria annulata 
• Theileria parva 
• Encephalitozoon cuniculi  
These include T. cruzi and T. brucei, which cause Chagas disease (Lescure et al. 
2010) and sleeping sickness (Ralston et al. 2009) respectively. Also included in the dataset 
are three members of the malaria-causing genus Plasmodium. Take for example P. 
falciparum. There is currently resistance to all five groups of anti-malarial drugs (Hayton and 
Su 2004).  The detection of protein interactions in P. falciparum could potentially aid in the 
development of new anti-malarial drugs. Using this species as a reference point, phylogenetic 
profiles for its proteome could be constructed.  An application of the logistic regression based 
heuristic would make all against all comparisons using constrained ML (Barker et al. 2007; 
Barker and Pagel 2005) feasible. These studies could potentially detect novel protein 
interactions within P. falciparum.  Disruption of protein-protein interactions is potentially 
one avenue for drug development.  This could potentially be carried out via procedures such 
as peptidomimetics (Hruby 1997), which involves the construction of a molecule that mimics 
the properties of one of the interacting partners. The construction of phylogenetic profiles 
could also reveal proteins and protein interactions that are unique to P. falciparum. These 
molecules could potentially be targeted with a lower risk of side effects in the host organism. 
A similar procedure could be followed with all other parasitic organisms in the dataset.
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Appendix A Description of divergence of Java implementation of Inparanoid algorithm 
from Perl implementation. 
 
In order to examine the differences in output between the novel Java implementation of the 
Inparanoid algorithm and the version (2.0) distributed by Remm et al. (Remm et al. 2001) the 
following test was run. 
 
Organism A: Saccharomyces cerevisiae. 
Organism B: Encephalitozoon cuniculi. 
 
The algorithm BLASTP (version 2.2.18) was run on with the Fasta formatted file 
containing all proteins for Saccharomyces cerevisiae as the query and the Fasta formatted file 
containing all proteins for Encephalitozoon cuniculi as the database.  The program formatdb 
was used to create parsable input for BLASTP. 
The substitution matrix BLOSUM62 was used to score alignments. The converse 
command was also run with Encephalitozoon cuniculi as the query and Saccharomyces 
cerevisiae as the database. The two organisms were also run against themselves as query and 
database. The parameters v and b were set to the number of proteins in the database files and 
the parameter z is set to a theoretical maximum database size by (Remm et al. 2001) to 
maintain consistent values for relevant statistics such as K and 
! 
"  described below. 
The exact syntax of the commands is given below: 
 
blastall -i Saccharomyces_cerevisiae -d Saccharomyces_cerevisiae -p blastp -v 5883 -b 5883 
-F "m S" -M BLOSUM62 -z 5000000 -V  
blastall -i Saccharomyces_cerevisiae -d Encephalitozoon_cuniculi -p blastp -v 1996 -b 1996 -
F "m S" -M BLOSUM62 -z 5000000 -V  
blastall -i Encephalitozoon_cuniculi -d Saccharomyces_cerevisiae -p blastp -v 5883 -b 5883 -
F "m S" -M BLOSUM62 -z 5000000 -V  
blastall -i Encephalitozoon_cuniculi -d Encephalitozoon_cuniculi -p blastp -v 1996 -b 1996 -
F "m S" -M BLOSUM62 -z 5000000 -V   
 
The output from these commands was fed to the Perl script blast_parser.pl provided in the 
Inparanoid package, which produces formatted output in the following order: 





• Protein Id1.   
• Protein Id2.  
• Bit Score.   
• E value.   
• Protein A Length.   
• Protein B Length.     
• Alignment Length on query sequence. 
• Identity percentage. 
• Similarity percentage. 
• Coordinates of alignment on query sequence. 
 
 Blast bit scores are calculated using the formula 
 
! 




S '= bit score, S= raw score, K = constant associated with search space size and 
! 
"  =constant 
associated  with scoring system(Mount 2004).    
Blast bit scores can be affected by composition based score adjustments which were 
introduced in order to deal with comparisons of proteins with highly biased amino acid 
compositions (Altschul et al. 2005). 
This and variable database sizes (depending on whether the order of database and 
query is reversed due to search space size variation) can lead to an asymmetry in bit scores 
for the same pair of sequences. In order to deal with this artefact scores are normalised by 
both implementations by averaging the A-B and B-A orientations.  
Results were filtered for hits containing only single high scoring pairs as the Java 
implementation was constructed to deal with SSEARCH output, which only returns a single 










Reciprocal best hits as marked by Perl implementation but not by Java implementation. 
 
Protein pair 1 
Protein A: NP_015092 (Saccharomyces cerevisiae ) 
Protein B: NP_586462 (Encephalitozoon cuniculi) 
A-B bit score = 56.2  (Rounded down to 56 by Perl). This is the best score in the A-B 
direction. 
B-A bit score = 55.5 (Rounded up to 56 by Perl).  
Mean bit score = 55.85 (Rounded to 56 by Perl). 
NP_586462 however has another significant score against Saccharomyces cerevisiae, which 
is NP_013908 with a mean bit score of 56.2 (Rounded down to 56 by Perl). 
The Java implementation does not recognise NP_015092 and NP_586462 as reciprocal best 
hits as 56.2 > 55.85. 
 
Protein pair 2 
Protein A: NP_014520 (Saccharomyces cerevisiae ). 
Protein B: NP_586468  (Encephalitozoon cuniculi). 
A-B Bit score = 61.6  (Rounded up to 62 by Perl).  
B-A Bit score = 61.6 (Rounded up to 62 by Perl).  
Mean bit score = 61.6 (Rounded up to 62 by Perl).  
NP_586468 has another significant score against Saccharomyces cerevisiae, which is 
NP_014097 with a mean bit score of 62.0. 
The Java implementation does not recognise NP_014520 and NP_586468 as reciprocal best 
hits as 62.0 > 61.6. 
 
Protein pair 3 
Protein A: NP_013648 (Saccharomyces cerevisiae ). 
Protein B: NP_597364  (Encephalitozoon cuniculi). 
A-B Bit score = 111.0   
B-A Bit score = 112.0  
Mean bit score = 111.5 (Rounded up to 112 by Perl). 
NP_597364 has another significant score against Saccharomyces cerevisiae, which is 
NP_013546 with a mean bit score of 112.0 




The Java implementation does not recognise NP_013648 and NP_597364 as reciprocal best 
hits as 112.0  > 111.5. 
 
Protein pair 4 
Protein A: NP_013182 (Saccharomyces cerevisiae ). 
Protein B: NP_586039 (Encephalitozoon cuniculi). 
A-B Bit score = 60.5 
B-A Bit score = 60.5 
Mean bit score= 60.5 (Rounded up to 61 by Perl).  
NP_586039 has two other significant scores against Saccharomyces cerevisiae, which are 
NP_010629 and NP_010630, which both have mean bit scores of 60.85. 
The Java implementation does not recognise NP_013648 and NP_597364 as reciprocal best 
hits as 60.85 > 60.5.  
 
Protein pair 5 
Protein A: NP_010407 (Saccharomyces cerevisiae). 
Protein B: NP_597607 (Encephalitozoon cuniculi). 
A-B Bit score = 246.0 
B-A Bit score = 245.0 
Mean bit score = 245.5(Rounded up to 246 by Perl). 
NP_597607 has another significant score against Saccharomyces cerevisiae, which is 
NP_013197, which has a mean bit score of 246. 
The Java implementation does not recognise NP_013648 and NP_597364 as reciprocal best 
hits as 246> 245.5. 
 
Differences in Cluster Output 
There are a number of groups which differ between the two implementations on this test data. 
This is due to different scores being stored for various values affecting the criterion for 
reciprocal bests as well as the criteria for merging and deleting clusters. However the primary 
purpose for ortholog selection in this project, which is detection of presence and absence of 
proteins, is achieved, as the number of Saccharomyces cerevisiae proteins found to be present 
in Encephalitozoon cuniculi was identical.  
 




Groups, which differ between implementations. 
 
There are 16 groups, which differ between the two implementations. The Java 
implementation produces 616 groups while the Perl implementation produces 619. 
 
Orthologous Group 1 
Perl Inparanoid implementation 
NP_009501 NP_586181  
NP_014887 
 
Java implementation clusters NP_009501 and NP_014887 with a separate protein 
XP_955683. 
 
Orthologous Group 2 
Perl Inparanoid implementation 
NP_011424 NP_586425 
 
Orthologous Group 3 
Perl Inparanoid implementation 
NP_012263 NP_597203 
 
Groups 2 and 3 are merged into one group by the Java implementation. 
 
Orthologous Group 4 
Perl Inparanoid implementation 
NP_012610.   XP_955636  
NP_010056.                               
NP_009928.                               
NP_010504.  
 
Group 4 does not contain NP_009928 in output from the Java implementation. 
 
Orthologous group 5 
Perl Inparanoid implementation 




NP_012710.   NP_597625  
NP_014074.  
 
Orthologous group 6 
Perl Inparanoid implementation 
NP_014293.   NP_597270  
NP_014752.                                
NP_012264.  
  
Groups 5 and 6 are merged into one group by the Java implementation. 
 
Orthologous group 7 
Perl Inparanoid implementation 
NP_011573.   XP_965975  
NP_011975.                               
NP_013418.   
 
Orthologous group 7 has an additional paralog added in Saccharomyces cerevisiae by the 
Java implementation NP_009928. 
 
Orthologous group 8 
Perl Inparanoid implementation 
NP_011651.   NP_597477  
  
Orthologous group 8 has an additional paralog added in Saccharomyces cerevisiae by the 
Java implementation NP_014604. 
 
Orthologous Group 9 
Perl Inparanoid implementation 
NP_013618.   NP_597286  
NP_014604.                                
 




Orthologous group 9 has an additional paralog added in Saccharomyces cerevisiae by the 
Java implementation NP_015007. This paralog replaces NP_014604. 
 
Orthologous Group 10 
Perl Inparanoid implementation 
NP_014045.   NP_586473  
NP_015007.     
 
Java implementation clusters NP_014045. and NP_015007. with a separate protein 
NP_597286. 
 
Orthologous Group 11 
Perl Inparanoid implementation 
 
NP_012603. NP_584802                                                         
NP_597429  
 
Group 11 does not contain NP_597429 in output from the Java implementation. 
 
Orthologous Group 12  
Perl Inparanoid implementation 
NP_010144.   NP_597320  
NP_010089.   NP_586125  
NP_014737.  
 
Orthologous Group 13 
Perl Inparanoid implementation 
NP_009723.   NP_597558  
NP_015274.  
 
Orthologous groups 12 and 13 are merged into one group by the Java implementation. 
 
 





Orthologous Group 14 
Perl Inparanoid implementation 
NP_009800   NP_584705  
NP_010629   NP_586039  
NP_010630                                
NP_013182                                
NP_011960                                
NP_012316                                
NP_014486                                
NP_010632                                
NP_011962                                
NP_012321                                
NP_011964                                
NP_013724                                
NP_116644                                
NP_010845                                
NP_014470                                
NP_010036                                
NP_012692                                
NP_011411                                
NP_014081                                
NP_010087                                
NP_010143                                
NP_010825                                
NP_014538                                
NP_010785                               
NP_010675                               
NP_116613                                
NP_011805                               
NP_010034                               
NP_012694                               
NP_009857                                






Orthologous group 14 has an additional paralog added in Saccharomyces cerevisiae by the 
Perl implementation NP_010082. 
 
Orthologous Group 15 
Perl Inparanoid implementation 
NP_012710.   NP_597625  
NP_014074.  
 
Orthologous Group 16 
Perl Inparanoid implementation 
NP_014293.   NP_597270  
NP_014752.                                
NP_012264.   
 
Orthologous groups 15 and 16 are merged into one group by the Java implementation.




Appendix B Individual Gene trees for genes in super matrix utilised in construction of 
Phylogeny
 
Gene RPL23: 60S ribosomal protein L23.




Gene RPS8: 40S ribosomal protein S8. 
 





Gene SRP54:signal recognition particle 54 kDa protein. 




Gene  ERCC3: TFIIH basal transcription factor complex helicase XPB. 





Gene KARS: lysyl-tRNA synthetase. 






Gene METAP2: methionine aminopeptidase 2 




Gene ATP6V1D: V-type proton ATPase subunit D. 
 





Gene PSMC1: 26S protease regulatory subunit 4.




Gene NFS1:cysteine desulfurase, mitochondrial precursor. 




Gene GARS: glycyl-tRNA syntheta




Appendix C: Predictions made by constrained ML 
 
Protein 1          Description                                                         
Protein 2        Description 
91984773 
apolipoprotein A-I binding protein 
precursor 89042891 
PREDICTED: 
similar to adaptor-related protein complex 1 
sigma 2 subunit 
23110944 proteasome alpha 6 subunit 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
23110944 proteasome alpha 6 subunit 38201680 
meiotic recombination protein SPO11 
isoform b 
23110944 proteasome alpha 6 subunit 113414586 PREDICTED: similar to CG17293-PA 
11024714 ubiquitin B precursor 113423966 
PREDICTED: similar to Ubiquitin-63E 
CG11624-PA, isoform A 
11024714 ubiquitin B precursor 5454144 ubiquitin D 
7705785 transcription factor B1, mitochondrial 113414586 PREDICTED: similar to CG17293-PA 
7705785 transcription factor B1, mitochondrial 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7705785 transcription factor B1, mitochondrial 38201680 
meiotic recombination protein SPO11 
isoform b 
4557896 myotubularin 41350318 myotubularin-related protein 2 isoform 2 
4507385 
transcription elongation factor A protein 
2 isoform a 51467029 
PREDICTED: similar to 40S ribosomal 
protein S26 
4507385 
transcription elongation factor A protein 
2 isoform a 7705477 hypothetical protein LOC51504 
4557896 myotubularin 28872761 myotubularin-related protein 1 
4507385 
transcription elongation factor A protein 
2 isoform a 113418682 
PREDICTED: similar to postmeiotic 
segregation increased 2-like 2 
4507385 
transcription elongation factor A protein 
2 isoform a 38201710 DEAD box polypeptide 17 isoform 1 





transcription elongation factor A protein 
2 isoform a 113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
4557896 myotubularin 44680154 myotubularin-related protein 2 isoform 1 
4507385 
transcription elongation factor A protein 
2 isoform a 4507129 
small nuclear ribonucleoprotein polypeptide 
E 
4507385 
transcription elongation factor A protein 
2 isoform a 4759276 
RNA, U3 small nucleolar interacting protein 
2 
4507385 
transcription elongation factor A protein 
2 isoform a 116812591 RER1 retention in endoplasmic reticulum 1 
4507385 
transcription elongation factor A protein 
2 isoform a 4557719 DNA ligase I 
4507385 
transcription elongation factor A protein 
2 isoform a 56549681 small CTD phosphatase 3 isoform 2 
4557896 myotubularin 18491016 exonuclease 1 isoform b 
4507385 
transcription elongation factor A protein 
2 isoform a 4758922 
phosphatidylinositol glycan anchor 
biosynthesis, class L 
4507385 
transcription elongation factor A protein 
2 isoform a 4506233 proteasome 26S non-ATPase subunit 8 
4507385 
transcription elongation factor A protein 
2 isoform a 7019319 activator of basal transcription 1 
4507385 
transcription elongation factor A protein 
2 isoform a 10863925 
DNA directed RNA polymerase II 
polypeptide L 
4507385 
transcription elongation factor A protein 
2 isoform a 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
4507385 
transcription elongation factor A protein 
2 isoform a 150170706 anaphase promoting complex subunit 10 
4557896 myotubularin 19923424 myotubularin-related protein 9 
4507385 
transcription elongation factor A protein 
2 isoform a 8923942 nucleolar protein family A, member 3 
4507385 
transcription elongation factor A protein 
40254869 pre-mRNA processing factor 31 homolog 




2 isoform a 
4507385 
transcription elongation factor A protein 
2 isoform a 41327715 p53-related protein kinase 
4507385 
transcription elongation factor A protein 
2 isoform a 4507311 suppressor of Ty 4 homolog 1 
4507385 
transcription elongation factor A protein 
2 isoform a 113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
4507385 
transcription elongation factor A protein 
2 isoform a 4506651 ribosomal protein L36a-like protein 
4557896 myotubularin 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4557896 myotubularin 113414586 PREDICTED: similar to CG17293-PA 
4507385 
transcription elongation factor A protein 
2 isoform a 4505947 




synthetase 1 28557709 
phosphoribosyl pyrophosphate synthetase 1-
like 1 
153791910 hypothetical protein LOC79868 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4506541 retinaldehyde binding protein 1 4557719 DNA ligase I 
38348232 dual specificity phosphatase 7 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
40254869 
pre-mRNA processing factor 31 
homolog 113414586 PREDICTED: similar to CG17293-PA 
40254869 
pre-mRNA processing factor 31 
homolog 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
40254869 
pre-mRNA processing factor 31 
homolog 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
40254869 
pre-mRNA processing factor 31 
113429091 
PREDICTED: similar to peptidylprolyl 




homolog isomerase A isoform 1 
38348232 dual specificity phosphatase 7 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
40254869 
pre-mRNA processing factor 31 
homolog 38201680 
meiotic recombination protein SPO11 
isoform b 
13775200 SF3b10 62909985 hypothetical protein LOC140711 
13775200 SF3b10 4505331 
N-ethylmaleimide-sensitive factor 
attachment protein, gamma 
13775200 SF3b10 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
13775200 SF3b10 38201680 
meiotic recombination protein SPO11 
isoform b 
13775200 SF3b10 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
13775200 SF3b10 4502743 cyclin-dependent kinase 7 
13775200 SF3b10 111494251 
ras homolog gene family, member C 
precursor 
13775200 SF3b10 111494248 
ras homolog gene family, member C 
precursor 
13775200 SF3b10 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
13775200 SF3b10 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
13775200 SF3b10 113414586 PREDICTED: similar to CG17293-PA 
7706367 
DNA replication complex GINS protein 
PSF2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7705433 
eukaryotic translation initiation factor 3 
subunit 6 interacting protein 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




7662482 transmembrane protein 15 4557719 DNA ligase I 
4826675 cyclin-dependent kinase 5 38201680 
meiotic recombination protein SPO11 
isoform b 
4826675 cyclin-dependent kinase 5 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4826675 cyclin-dependent kinase 5 4557719 DNA ligase I 
4507213 signal recognition particle 19kDa 113414586 PREDICTED: similar to CG17293-PA 
5453954 
delta isoform of regulatory subunit B56, 
protein phosphatase 2A isoform 1 113414586 PREDICTED: similar to CG17293-PA 
4826675 cyclin-dependent kinase 5 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4826675 cyclin-dependent kinase 5 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
35493987 ubiquitin-conjugating enzyme E2I 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
44917606 
N-ethylmaleimide-sensitive factor 
attachment protein, beta 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
44917606 
N-ethylmaleimide-sensitive factor 
attachment protein, beta 4557719 DNA ligase I 
16945972 kelch domain containing 3 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
44917606 
N-ethylmaleimide-sensitive factor 
attachment protein, beta 4505331 
N-ethylmaleimide-sensitive factor 
attachment protein, gamma 
35493987 ubiquitin-conjugating enzyme E2I 113414586 PREDICTED: similar to CG17293-PA 
44917606 
N-ethylmaleimide-sensitive factor 
attachment protein, beta 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
16945972 kelch domain containing 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
35493987 ubiquitin-conjugating enzyme E2I 38201680 
meiotic recombination protein SPO11 
isoform b 




16945972 kelch domain containing 3 7019405 host cell factor C2 
133925811 transportin 1 isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
133925811 transportin 1 isoform 1 23510381 transportin 1 isoform 2 
111494248 
ras homolog gene family, member C 
precursor 38201680 
meiotic recombination protein SPO11 
isoform b 
111494251 
ras homolog gene family, member C 
precursor 38201680 
meiotic recombination protein SPO11 
isoform b 
111494251 
ras homolog gene family, member C 
precursor 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
111494251 
ras homolog gene family, member C 
precursor 4557719 DNA ligase I 
111494251 
ras homolog gene family, member C 
precursor 118600973 RNA binding motif protein, X-linked 2 
111494248 
ras homolog gene family, member C 
precursor 118600973 RNA binding motif protein, X-linked 2 
111494251 
ras homolog gene family, member C 
precursor 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
119943098 dihydropyrimidine dehydrogenase 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
111494251 
ras homolog gene family, member C 
precursor 111494248 
ras homolog gene family, member C 
precursor 
111494251 
ras homolog gene family, member C 
precursor 4506717 ribosomal protein S29 isoform 1 
111494248 
ras homolog gene family, member C 
precursor 71772583 ribosomal protein S29 isoform 2 
111494251 
ras homolog gene family, member C 
precursor 71772583 ribosomal protein S29 isoform 2 
111494251 
ras homolog gene family, member C 
precursor 47717139 leucine-zipper-like transcription regulator 1 





ras homolog gene family, member C 
precursor 47717139 leucine-zipper-like transcription regulator 1 
111494248 
ras homolog gene family, member C 
precursor 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
111494251 
ras homolog gene family, member C 
precursor 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
111494251 
ras homolog gene family, member C 
precursor 38201710 DEAD box polypeptide 17 isoform 1 
111494248 
ras homolog gene family, member C 
precursor 38201710 DEAD box polypeptide 17 isoform 1 
111494248 
ras homolog gene family, member C 
precursor 56549681 small CTD phosphatase 3 isoform 2 
111494251 
ras homolog gene family, member C 
precursor 56549681 small CTD phosphatase 3 isoform 2 
111494248 
ras homolog gene family, member C 
precursor 14249398 PHD-finger 5A 
111494251 
ras homolog gene family, member C 
precursor 14249398 PHD-finger 5A 
111494251 
ras homolog gene family, member C 
precursor 10863925 
DNA directed RNA polymerase II 
polypeptide L 
111494248 
ras homolog gene family, member C 
precursor 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
111494248 
ras homolog gene family, member C 
precursor 4557719 DNA ligase I 
111494248 
ras homolog gene family, member C 
precursor 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
111494248 
ras homolog gene family, member C 
precursor 4502859 CDC28 protein kinase 2 
111494248 
ras homolog gene family, member C 
precursor 4506717 ribosomal protein S29 isoform 1 






isoform a 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
109389365 
glucose-6-phosphate dehydrogenase 
isoform a 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
111494248 
ras homolog gene family, member C 
precursor 10863925 
DNA directed RNA polymerase II 
polypeptide L 
51173724 bystin 38201680 
meiotic recombination protein SPO11 
isoform b 
51173724 bystin 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
51173724 bystin 113414586 PREDICTED: similar to CG17293-PA 
41406094 J domain containing protein 1 isoform b 13236516 Der1-like domain family, member 1 
41281768 cytochrome b-5 isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
41349495 DNA primase polypeptide 2 38201680 
meiotic recombination protein SPO11 
isoform b 
41406094 J domain containing protein 1 isoform b 11141871 J domain containing protein 1 isoform a 
41349495 DNA primase polypeptide 2 113414586 PREDICTED: similar to CG17293-PA 
41281768 cytochrome b-5 isoform 1 4503183 cytochrome b-5 isoform 2 
41349495 DNA primase polypeptide 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
41281768 cytochrome b-5 isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
41406094 J domain containing protein 1 isoform b 31455614 Der1-like domain family, member 2 
41406094 J domain containing protein 1 isoform b 4557719 DNA ligase I 
35493996 ubiquitin-conjugating enzyme E2I 113414586 PREDICTED: similar to CG17293-PA 
35494003 ubiquitin-conjugating enzyme E2I 113414586 PREDICTED: similar to CG17293-PA 
35494003 ubiquitin-conjugating enzyme E2I 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 




35493996 ubiquitin-conjugating enzyme E2I 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
35493996 ubiquitin-conjugating enzyme E2I 38201680 
meiotic recombination protein SPO11 
isoform b 
35494003 ubiquitin-conjugating enzyme E2I 38201680 
meiotic recombination protein SPO11 
isoform b 
31581534 tRNA isopentenyltransferase 1 38201680 
meiotic recombination protein SPO11 
isoform b 
30581111 
minor histocompatibility antigen 13 
isoform 3 4557719 DNA ligase I 
31543831 tubulin, gamma 1 6996005 dynamin 1-like protein isoform 1 
30581111 
minor histocompatibility antigen 13 
isoform 3 6996005 dynamin 1-like protein isoform 1 
31543831 tubulin, gamma 1 4557719 DNA ligase I 
31581534 tRNA isopentenyltransferase 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
29826282 protein phosphatase 1G 4505999 protein phosphatase 1G 
31581534 tRNA isopentenyltransferase 1 113414586 PREDICTED: similar to CG17293-PA 
30581111 
minor histocompatibility antigen 13 
isoform 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
30581111 
minor histocompatibility antigen 13 
isoform 3 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
19913408 DNA topoisomerase II, beta isozyme 113414586 PREDICTED: similar to CG17293-PA 
19913408 DNA topoisomerase II, beta isozyme 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
19913408 DNA topoisomerase II, beta isozyme 38201680 
meiotic recombination protein SPO11 
isoform b 
13236516 Der1-like domain family, member 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




13236516 Der1-like domain family, member 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
13236516 Der1-like domain family, member 1 113414586 PREDICTED: similar to CG17293-PA 
13236516 Der1-like domain family, member 1 38201680 
meiotic recombination protein SPO11 
isoform b 
13236516 Der1-like domain family, member 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
10835049 ras homolog gene family, member A 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
9955970 
ATP-binding cassette, sub-family C, 
member 3 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
10092619 
nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, alpha 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5729877 heat shock 70kDa protein 8 isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 4557719 DNA ligase I 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 71772583 ribosomal protein S29 isoform 2 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 4506717 ribosomal protein S29 isoform 1 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 10863925 
DNA directed RNA polymerase II 
polypeptide L 
5729877 heat shock 70kDa protein 8 isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5729991 
proteasome 26S ATPase subunit 4 
8923942 nucleolar protein family A, member 3 





6005764 GABA(A) receptor-associated protein 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
5729991 
proteasome 26S ATPase subunit 4 
isoform 1 56549681 small CTD phosphatase 3 isoform 2 
4557481 
ATP-binding cassette, sub-family C 
(CFTR/MRP), member 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4507785 ubiquitin-conjugating enzyme E2I 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4507785 ubiquitin-conjugating enzyme E2I 113414586 PREDICTED: similar to CG17293-PA 
4507785 ubiquitin-conjugating enzyme E2I 38201680 
meiotic recombination protein SPO11 
isoform b 
4506025 
protein phosphatase 3, regulatory 
subunit B, alpha isoform 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4503659 
ubiquitin-like protein fubi and 
ribosomal protein S30 precursor 113422449 
PREDICTED: similar to Ubiquitin-like 
protein FUBI 
4504277 H2B histone family, member Q 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4503183 cytochrome b-5 isoform 2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4503183 cytochrome b-5 isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
153252132 ribosomal protein L31 isoform 3 4506005 
protein phosphatase 1, catalytic subunit, beta 
isoform 1 
153251916 
hypothetical protein LOC57604 isoform 
2 153251913 hypothetical protein LOC57604 isoform 1 




153252132 ribosomal protein L31 isoform 3 113414586 PREDICTED: similar to CG17293-PA 
33286434 p47 protein isoform c 116256336 SEC31 homolog A isoform 4 
33286434 p47 protein isoform c 6996005 dynamin 1-like protein isoform 1 
30520314 hypothetical protein LOC118812 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7657339 molybdenum cofactor synthesis 3 113414586 PREDICTED: similar to CG17293-PA 
151101386 coenzyme Q10 homolog A isoform b 151101384 coenzyme Q10 homolog A isoform a 
73622130 BolA-like protein 2 85797673 bolA-like protein 2B 
7662010 zinc finger protein 516 10190686 zinc finger protein 286 
41406067 
H2A histone family, member V isoform 
3 19718751 uracil-DNA glycosylase isoform UNG2 
149944735 hypothetical protein LOC728937 89041601 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 1 
149944735 hypothetical protein LOC728937 15011936 ribosomal protein S26 
149944735 hypothetical protein LOC728937 88980535 
PREDICTED: similar to 40S ribosomal 
protein S26 
149944735 hypothetical protein LOC728937 88982349 
PREDICTED: similar to 40S ribosomal 
protein S26 
149944735 hypothetical protein LOC728937 113420084 
PREDICTED: similar to 40S ribosomal 
protein S26 
149944735 hypothetical protein LOC728937 89025350 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 2 
149944735 hypothetical protein LOC728937 113430282 
PREDICTED: similar to 40S ribosomal 
protein S26 
149944735 hypothetical protein LOC728937 88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 
149944735 hypothetical protein LOC728937 113429703 
PREDICTED: similar to 40S ribosomal 
protein S26 
150010661 SEC14-like 5 89042891 
PREDICTED: similar to adaptor-related 




protein complex 1 sigma 2 subunit 
150170706 anaphase promoting complex subunit 10 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
38201710 DEAD box polypeptide 17 isoform 1 38201680 
meiotic recombination protein SPO11 
isoform b 
28626498 kinesin family member C1 4557719 DNA ligase I 
47778943 syntaxin 16 isoform a 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
38201710 DEAD box polypeptide 17 isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
38201710 DEAD box polypeptide 17 isoform 1 4758496 H2A histone family, member Y isoform 2 
38201710 DEAD box polypeptide 17 isoform 1 113414586 PREDICTED: similar to CG17293-PA 
38201710 DEAD box polypeptide 17 isoform 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
38201710 DEAD box polypeptide 17 isoform 1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
38201710 DEAD box polypeptide 17 isoform 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 2 protein 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 2 protein 8923942 nucleolar protein family A, member 3 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 2 protein 47717139 leucine-zipper-like transcription regulator 1 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
4557719 DNA ligase I 




complementation group 2 protein 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 2 protein 10863925 
DNA directed RNA polymerase II 
polypeptide L 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 2 protein 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 2 protein 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 2 protein 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
15834617 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 2 protein 38201680 
meiotic recombination protein SPO11 
isoform b 
5031645 
COX17 homolog, cytochrome c oxidase 
assembly protein 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5031645 
COX17 homolog, cytochrome c oxidase 
assembly protein 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4503719 fragile histidine triad gene 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
148727247 ubiquitin specific peptidase 5 isoform 2 8923942 nucleolar protein family A, member 3 
148727247 ubiquitin specific peptidase 5 isoform 2 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
148536853 
coatomer protein complex, subunit 
alpha isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
148596961 stearoyl-CoA desaturase 4 isoform a 148596938 stearoyl-CoA desaturase 4 isoform b 
148536853 
coatomer protein complex, subunit 
alpha isoform 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
145275210 RNA processing factor 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 





145275210 RNA processing factor 1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
145275210 RNA processing factor 1 113414586 PREDICTED: similar to CG17293-PA 
145275187 tRNA-(N1G37) methyltransferase 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
145275210 RNA processing factor 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
145275210 RNA processing factor 1 38201680 
meiotic recombination protein SPO11 
isoform b 
126723390 ankyrin repeat domain 24 121582655 ankyrin repeat domain 35 
124256496 heat shock 70kDa protein 1-like 34419635 heat shock 70kDa protein 6 (HSP70B') 
126723390 ankyrin repeat domain 24 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
122937243 
dual specificity phosphatase 27 
(putative) 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
121582655 ankyrin repeat domain 35 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
118600973 RNA binding motif protein, X-linked 2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
118600973 RNA binding motif protein, X-linked 2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
118600991 
trafficking protein particle complex 6B 
isoform 1 13129120 trafficking protein particle complex 6A 
118600991 
trafficking protein particle complex 6B 
isoform 1 38201680 
meiotic recombination protein SPO11 
isoform b 
118498359 ribosomal L1 domain containing 1 113414586 PREDICTED: similar to CG17293-PA 




118600973 RNA binding motif protein, X-linked 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
118600991 
trafficking protein particle complex 6B 
isoform 1 113414586 PREDICTED: similar to CG17293-PA 
116812591 
RER1 retention in endoplasmic 
reticulum 1 62909985 hypothetical protein LOC140711 
116812591 
RER1 retention in endoplasmic 
reticulum 1 113414586 PREDICTED: similar to CG17293-PA 
116812591 
RER1 retention in endoplasmic 
reticulum 1 38201680 
meiotic recombination protein SPO11 
isoform b 
116812591 
RER1 retention in endoplasmic 
reticulum 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
116812591 
RER1 retention in endoplasmic 
reticulum 1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
116812591 
RER1 retention in endoplasmic 
reticulum 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
116734710 
ATP-binding cassette, sub-family A 
member 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
116734710 
ATP-binding cassette, sub-family A 
member 3 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
116256336 SEC31 homolog A isoform 4 110347439 zinc finger protein 225 
116256336 SEC31 homolog A isoform 4 4506005 
protein phosphatase 1, catalytic subunit, beta 
isoform 1 
115387112 ubiquitin-like 5 13236510 ubiquitin-like 5 
115387112 ubiquitin-like 5 113414586 PREDICTED: similar to CG17293-PA 
112382244 
proto-oncogene tyrosine-protein kinase 
FGR 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
112382241 
proto-oncogene tyrosine-protein kinase 
89042891 
PREDICTED: similar to adaptor-related 




FGR protein complex 1 sigma 2 subunit 
112382377 ubiquitin-conjugating enzyme E2S 113430896 
PREDICTED: similar to Ubiquitin-
conjugating enzyme E2S (Ubiquitin-
conjugating enzyme E2-24 kDa) (Ubiquitin-
protein ligase) (Ubiquitin carrier protein) 
(E2-EPF5) 
112382212 
SEC24 (S. cerevisiae) homolog B 
isoform a 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
112382212 
SEC24 (S. cerevisiae) homolog B 
isoform a 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
112382244 
proto-oncogene tyrosine-protein kinase 
FGR 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
112382241 
proto-oncogene tyrosine-protein kinase 
FGR 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
110815813 
ankyrin repeat and FYVE domain 
containing 1 isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
110815813 
ankyrin repeat and FYVE domain 
containing 1 isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
110349738 
serine/threonine kinase 24 (STE20 
homolog, yeast) isoform b 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
110347439 zinc finger protein 225 6996005 dynamin 1-like protein isoform 1 
110347439 zinc finger protein 225 10190696 zinc finger protein 304 
110347459 
MYC-associated zinc finger protein 
isoform 2 110347439 zinc finger protein 225 
110349799 testis-specific protein kinase 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
110347439 zinc finger protein 225 113413881 
PREDICTED: similar to zinc finger protein 
114 
110347439 zinc finger protein 225 10190686 zinc finger protein 286 
110349799 testis-specific protein kinase 2 89041736 
PREDICTED: similar to adaptor-related 




protein complex 1 sigma 2 subunit 
109452595 zinc finger protein 205 109452593 zinc finger protein 205 
109255245 serine/threonine kinase 17a 113414586 PREDICTED: similar to CG17293-PA 
109255245 serine/threonine kinase 17a 6996005 dynamin 1-like protein isoform 1 
108773782 
ATP-binding cassette, sub-family E, 
member 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
108773784 
ATP-binding cassette, sub-family E, 
member 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
95147356 mitogen-activated protein kinase 15 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
95147356 mitogen-activated protein kinase 15 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
94721250 
vesicle-associated membrane protein-
associated protein A isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
93004102 
nuclear LIM interactor-interacting factor 
2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
93004102 
nuclear LIM interactor-interacting factor 
2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
93141204 methyltransferase like 2B 113414586 PREDICTED: similar to CG17293-PA 
89145417 methyltransferase like 7A 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
84043963 
eukaryotic translation initiation factor 
5B 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
77812674 
nucleolar protein family A, member 2 
isoform b 8923444 
nucleolar protein family A, member 2 
isoform a 
77812670 exosome component 9 isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
77812670 exosome component 9 isoform 2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 





myosin head domain containing 1 
isoform 3 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
75812980 
myosin head domain containing 1 
isoform 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
75677335 
digestive-organ expansion factor 
homolog 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
72534754 
hypothetical protein LOC112812 
isoform 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
72534754 
hypothetical protein LOC112812 
isoform 1 38201680 
meiotic recombination protein SPO11 
isoform b 
72534754 
hypothetical protein LOC112812 
isoform 1 113414586 PREDICTED: similar to CG17293-PA 
71772583 ribosomal protein S29 isoform 2 4758496 H2A histone family, member Y isoform 2 
71772583 ribosomal protein S29 isoform 2 32130516 serologically defined colon cancer antigen 1 
71772583 ribosomal protein S29 isoform 2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
71772583 ribosomal protein S29 isoform 2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
71772583 ribosomal protein S29 isoform 2 62909985 hypothetical protein LOC140711 
71772583 ribosomal protein S29 isoform 2 113414586 PREDICTED: similar to CG17293-PA 
71772583 ribosomal protein S29 isoform 2 19718751 uracil-DNA glycosylase isoform UNG2 
71772583 ribosomal protein S29 isoform 2 8393719 
ubiquitin-conjugating enzyme E2D 4 
(putative) 
70995211 
peroxisomal enoyl-coenzyme A 
hydratase-like protein 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
71772583 ribosomal protein S29 isoform 2 4506717 ribosomal protein S29 isoform 1 
71772583 ribosomal protein S29 isoform 2 38016127 RNA binding motif protein 34 




71772583 ribosomal protein S29 isoform 2 4502743 cyclin-dependent kinase 7 
71772583 ribosomal protein S29 isoform 2 4557719 DNA ligase I 
71772583 ribosomal protein S29 isoform 2 38201680 
meiotic recombination protein SPO11 
isoform b 
71772583 ribosomal protein S29 isoform 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
68509270 transcriptional adaptor 2-like isoform a 113414586 PREDICTED: similar to CG17293-PA 
68303635 mutS homolog 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
68226422 Yip1 domain family, member 5 32401427 Yip1 domain family, member 5 
62955833 DNA-damage inducible protein 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
64276486 
serologically defined colon cancer 
antigen 10 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
64276486 
serologically defined colon cancer 
antigen 10 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
62955833 DNA-damage inducible protein 2 48717485 DDI1, DNA-damage inducible 1, homolog 1 
62865890 dual specificity phosphatase 5 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
62460637 importin 4 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
62865890 dual specificity phosphatase 5 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
62865890 dual specificity phosphatase 5 4557719 DNA ligase I 
62865890 dual specificity phosphatase 5 8393719 
ubiquitin-conjugating enzyme E2D 4 
(putative) 
62865890 dual specificity phosphatase 5 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
62865890 dual specificity phosphatase 5 8923942 nucleolar protein family A, member 3 




62865890 dual specificity phosphatase 5 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
62865890 dual specificity phosphatase 5 56549681 small CTD phosphatase 3 isoform 2 
62240994 cysteinyl-tRNA synthetase isoform d 62240992 cysteinyl-tRNA synthetase isoform c 
62234438 Notchless gene homolog isoform b 41350318 myotubularin-related protein 2 isoform 2 
62234438 Notchless gene homolog isoform b 44680154 myotubularin-related protein 2 isoform 1 
62234461 Notchless gene homolog isoform a 41350318 myotubularin-related protein 2 isoform 2 
62234461 Notchless gene homolog isoform a 62234438 Notchless gene homolog isoform b 
62234438 Notchless gene homolog isoform b 4502703 cell division cycle 6 protein 
62234438 Notchless gene homolog isoform b 21536371 telomerase-associated protein 1 
62234461 Notchless gene homolog isoform a 44680154 myotubularin-related protein 2 isoform 1 
58533179 trafficking protein particle complex 2 7657548 trafficking protein particle complex 2 
60279265 Sec61 gamma subunit 38201680 
meiotic recombination protein SPO11 
isoform b 
58533179 trafficking protein particle complex 2 38201680 
meiotic recombination protein SPO11 
isoform b 
60279265 Sec61 gamma subunit 7657546 Sec61 gamma subunit 
60279265 Sec61 gamma subunit 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
58533179 trafficking protein particle complex 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
58533179 trafficking protein particle complex 2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
58533179 trafficking protein particle complex 2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
58533179 trafficking protein particle complex 2 113414586 PREDICTED: similar to CG17293-PA 




57165436 serine/threonine kinase 16 57165434 serine/threonine kinase 16 
56549681 small CTD phosphatase 3 isoform 2 88943062 
PREDICTED: similar to peptidylprolyl 
isomerase A (cyclophilin A)-like 4 
56549681 small CTD phosphatase 3 isoform 2 113423887 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
56549681 small CTD phosphatase 3 isoform 2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
56549681 small CTD phosphatase 3 isoform 2 31543091 RNA binding motif protein 13 
56549681 small CTD phosphatase 3 isoform 2 22035624 phosphatidate cytidylyltransferase 1 
56549683 small CTD phosphatase 3 isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
56549681 small CTD phosphatase 3 isoform 2 4502743 cyclin-dependent kinase 7 
56549681 small CTD phosphatase 3 isoform 2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
56549681 small CTD phosphatase 3 isoform 2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
56549681 small CTD phosphatase 3 isoform 2 113422777 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
56549681 small CTD phosphatase 3 isoform 2 89042897 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
56549681 small CTD phosphatase 3 isoform 2 38016127 RNA binding motif protein 34 
56549681 small CTD phosphatase 3 isoform 2 38201680 
meiotic recombination protein SPO11 
isoform b 
56549681 small CTD phosphatase 3 isoform 2 5729840 tubulin, gamma complex associated protein 2 
56549681 small CTD phosphatase 3 isoform 2 8393719 
ubiquitin-conjugating enzyme E2D 4 
(putative) 
56549681 small CTD phosphatase 3 isoform 2 88943041 
PREDICTED: similar to peptidylprolyl 
isomerase A (cyclophilin A)-like 4 




56549681 small CTD phosphatase 3 isoform 2 88953813 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
56549681 small CTD phosphatase 3 isoform 2 113426831 
PREDICTED: similar to TBC1 domain 
family member 3 (Rab GTPase-activating 
protein PRC17) (Prostate cancer gene 17 
protein) (TRE17 alpha protein) isoform 1 
56549681 small CTD phosphatase 3 isoform 2 4557719 DNA ligase I 
56550059 
CCR4-NOT transcription complex, 
subunit 4 isoform b 56550057 
CCR4-NOT transcription complex, subunit 4 
isoform a 
56699411 solute carrier family 35, member E2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
56549683 small CTD phosphatase 3 isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
56549681 small CTD phosphatase 3 isoform 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
56549681 small CTD phosphatase 3 isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
56549681 small CTD phosphatase 3 isoform 2 4758496 H2A histone family, member Y isoform 2 
56549681 small CTD phosphatase 3 isoform 2 6912680 
meiotic recombination protein SPO11 
isoform a 
56699411 solute carrier family 35, member E2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
56549681 small CTD phosphatase 3 isoform 2 62909985 hypothetical protein LOC140711 
55956895 CGI-01 protein isoform 3 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
56549113 debranching enzyme homolog 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
56118223 choline/ethanolaminephosphotransferase 5174415 choline/ethanolaminephosphotransferase 
56549113 debranching enzyme homolog 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 





SMT3 suppressor of mif two 3 homolog 
2 isoform b precursor 54792069 
SMT3 suppressor of mif two 3 homolog 2 
isoform a precursor 
51873036 
oxoglutarate (alpha-ketoglutarate) 
dehydrogenase (lipoamide) isoform 1 
precursor 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
51944950 phosducin-like 2 113414586 PREDICTED: similar to CG17293-PA 
50593537 
DnaJ (Hsp40) homolog, subfamily B, 
member 12 41054844 
DnaJ (Hsp40) homolog, subfamily B, 
member 12 
50726960 
phosphatidylinositol (4,5) bisphosphate 
5-phosphatase, A isoform 2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
50658065 
SMC4 structural maintenance of 
chromosomes 4-like 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
50658063 
SMC4 structural maintenance of 
chromosomes 4-like 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
50726960 
phosphatidylinositol (4,5) bisphosphate 
5-phosphatase, A isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
50726960 
phosphatidylinositol (4,5) bisphosphate 
5-phosphatase, A isoform 2 18765707 
skeletal muscle and kidney enriched inositol 
phosphatase isoform 2 
50658063 
SMC4 structural maintenance of 
chromosomes 4-like 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
50658065 
SMC4 structural maintenance of 
chromosomes 4-like 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
50409789 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409781 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409796 
APC11 anaphase promoting complex 
subunit 11 isoform 2 18777675 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409789 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409750 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409796 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409750 
APC11 anaphase promoting complex subunit 
11 isoform 2 





APC11 anaphase promoting complex 
subunit 11 isoform 2 50409789 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409804 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409750 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409804 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409789 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409804 
APC11 anaphase promoting complex 
subunit 11 isoform 2 18777675 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409804 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409781 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409804 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409796 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409789 
APC11 anaphase promoting complex 
subunit 11 isoform 2 18777675 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409796 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409781 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50593002 
small nuclear ribonucleoprotein 
polypeptide A' 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
49574502 
NAD(P)H:quinone oxidoreductase type 
3, polypeptide A2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
50083277 ATPase class I type 8B member 4 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
50409781 
APC11 anaphase promoting complex 
subunit 11 isoform 2 50409750 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409781 
APC11 anaphase promoting complex 
subunit 11 isoform 2 18777675 
APC11 anaphase promoting complex subunit 
11 isoform 2 
50409750 
APC11 anaphase promoting complex 
subunit 11 isoform 2 18777675 
APC11 anaphase promoting complex subunit 
11 isoform 2 
49574502 
NAD(P)H:quinone oxidoreductase type 
3, polypeptide A2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 





DDI1, DNA-damage inducible 1, 
homolog 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
48717485 
DDI1, DNA-damage inducible 1, 
homolog 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
47717139 
leucine-zipper-like transcription 
regulator 1 6996005 dynamin 1-like protein isoform 1 
47717139 
leucine-zipper-like transcription 
regulator 1 38201680 




regulator 1 4758496 H2A histone family, member Y isoform 2 
47717139 
leucine-zipper-like transcription 
regulator 1 4557719 DNA ligase I 
47132595 
solute carrier family 25 member 3 
isoform b precursor 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 113414586 PREDICTED: similar to CG17293-PA 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 21536371 telomerase-associated protein 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 23397458 kinesin family member 19 
45580742 
dehydrodolichyl diphosphate synthase 
isoform a 45580738 
dehydrodolichyl diphosphate synthase 
isoform b 
45580742 
dehydrodolichyl diphosphate synthase 
isoform a 113414586 PREDICTED: similar to CG17293-PA 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 113423887 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 88943062 
PREDICTED: similar to peptidylprolyl 
isomerase A (cyclophilin A)-like 4 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 89042897 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 





dehydrodolichyl diphosphate synthase 
isoform b 113422777 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 5729840 tubulin, gamma complex associated protein 2 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 38201680 
meiotic recombination protein SPO11 
isoform b 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 4506707 ribosomal protein S25 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 41872631 fatty acid synthase 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 38016127 RNA binding motif protein 34 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 4505775 
solute carrier family 25 member 3 isoform b 
precursor 
45580742 
dehydrodolichyl diphosphate synthase 
isoform a 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 32130516 serologically defined colon cancer antigen 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 62909985 hypothetical protein LOC140711 
45580738 
dehydrodolichyl diphosphate synthase 
113426831 
PREDICTED: similar to TBC1 domain 
family member 3 (Rab GTPase-activating 




isoform b protein PRC17) (Prostate cancer gene 17 
protein) (TRE17 alpha protein) isoform 1 
46249376 
protein phosphatase 1, catalytic subunit, 
beta isoform 1 4506005 
protein phosphatase 1, catalytic subunit, beta 
isoform 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 17978477 vacuolar protein sorting 11 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 4557719 DNA ligase I 
45580742 
dehydrodolichyl diphosphate synthase 
isoform a 38201680 
meiotic recombination protein SPO11 
isoform b 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 4758496 H2A histone family, member Y isoform 2 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 4502743 cyclin-dependent kinase 7 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 42516576 glutaredoxin 5 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 7706523 
WW domain-containing oxidoreductase 
isoform 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 18860884 
WW domain-containing oxidoreductase 
isoform 2 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 7705369 coatomer protein complex, subunit beta 
45580742 
dehydrodolichyl diphosphate synthase 
isoform a 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
45580742 
dehydrodolichyl diphosphate synthase 
isoform a 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 31455614 Der1-like domain family, member 2 
45580738 
dehydrodolichyl diphosphate synthase 
23510381 transportin 1 isoform 2 






dehydrodolichyl diphosphate synthase 
isoform b 88953813 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
45580738 
dehydrodolichyl diphosphate synthase 
isoform b 88943041 
PREDICTED: similar to peptidylprolyl 
isomerase A (cyclophilin A)-like 4 
45238849 poly(A) binding protein, cytoplasmic 3 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
44680154 
myotubularin-related protein 2 isoform 
1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
44680154 
myotubularin-related protein 2 isoform 
1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
44680154 
myotubularin-related protein 2 isoform 
1 113414586 PREDICTED: similar to CG17293-PA 
44680154 
myotubularin-related protein 2 isoform 
1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
44680154 
myotubularin-related protein 2 isoform 
1 41350318 myotubularin-related protein 2 isoform 2 
44680154 
myotubularin-related protein 2 isoform 
1 19923424 myotubularin-related protein 9 
44680154 
myotubularin-related protein 2 isoform 
1 21536371 telomerase-associated protein 1 
45439355 
transcription elongation factor A 1 
isoform 2 113414586 PREDICTED: similar to CG17293-PA 
45238849 poly(A) binding protein, cytoplasmic 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
44680154 
myotubularin-related protein 2 isoform 
1 28872761 myotubularin-related protein 1 
42794754 
acyl-CoA synthetase long-chain family 
member 3 42794752 
acyl-CoA synthetase long-chain family 
member 3 




42516563 UDP-glucuronate decarboxylase 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
41872631 fatty acid synthase 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
42516563 UDP-glucuronate decarboxylase 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
42516576 glutaredoxin 5 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
41872631 fatty acid synthase 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
41350318 
myotubularin-related protein 2 isoform 
2 19923424 myotubularin-related protein 9 
41350316 
myotubularin-related protein 2 isoform 
2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
41350318 
myotubularin-related protein 2 isoform 
2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
41350318 
myotubularin-related protein 2 isoform 
2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
41350318 
myotubularin-related protein 2 isoform 
2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
41350318 
myotubularin-related protein 2 isoform 
2 21536371 telomerase-associated protein 1 
41350318 
myotubularin-related protein 2 isoform 
2 28872761 myotubularin-related protein 1 
41350318 
myotubularin-related protein 2 isoform 
2 113414586 PREDICTED: similar to CG17293-PA 
41327715 p53-related protein kinase 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
41327715 p53-related protein kinase 89042891 
PREDICTED: similar to adaptor-related 




protein complex 1 sigma 2 subunit 
41349441 SEC31 homolog A isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
41327715 p53-related protein kinase 113414586 PREDICTED: similar to CG17293-PA 
41349441 SEC31 homolog A isoform 2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
40806167 
ubiquitin-conjugating enzyme E2 
variant 1 isoform a 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
40806167 
ubiquitin-conjugating enzyme E2 
variant 1 isoform a 113414586 PREDICTED: similar to CG17293-PA 
40806167 
ubiquitin-conjugating enzyme E2 
variant 1 isoform a 38201680 
meiotic recombination protein SPO11 
isoform b 
39725636 
transmembrane emp24 protein transport 
domain containing 9 113414586 PREDICTED: similar to CG17293-PA 
39725636 
transmembrane emp24 protein transport 
domain containing 9 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
39725636 
transmembrane emp24 protein transport 
domain containing 9 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
39725636 
transmembrane emp24 protein transport 
domain containing 9 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
38708309 hypothetical protein LOC51029 113428755 PREDICTED: similar to CG7222-PA 
38327644 hypothetical protein LOC57707 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
38327644 hypothetical protein LOC57707 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
38327644 hypothetical protein LOC57707 62909985 hypothetical protein LOC140711 
38201680 
meiotic recombination protein SPO11 
isoform b 29742309 
PREDICTED: similar to ribosomal protein 
L31 





meiotic recombination protein SPO11 
isoform b 113427093 
PREDICTED: similar to ribosomal protein 
L31 
38201680 
meiotic recombination protein SPO11 
isoform b 7706343 hypothetical protein LOC51647 
38201680 
meiotic recombination protein SPO11 
isoform b 4504221 guanylate kinase 1 
38201680 
meiotic recombination protein SPO11 
isoform b 4506193 proteasome beta 1 subunit 
38201680 
meiotic recombination protein SPO11 
isoform b 7657198 dimethyladenosine transferase 
38201680 
meiotic recombination protein SPO11 
isoform b 4507797 ubiquitin-conjugating enzyme E2 variant 2 
38201680 
meiotic recombination protein SPO11 
isoform b 4506699 ribosomal protein S21 
38201680 
meiotic recombination protein SPO11 
isoform b 4506643 ribosomal protein L37a 
38201680 
meiotic recombination protein SPO11 
isoform b 13129120 trafficking protein particle complex 6A 
38201680 
meiotic recombination protein SPO11 
isoform b 7706423 U6 snRNA-associated Sm-like protein LSm7 
38201680 
meiotic recombination protein SPO11 
isoform b 4557719 DNA ligase I 
38201680 
meiotic recombination protein SPO11 
isoform b 10863925 
DNA directed RNA polymerase II 
polypeptide L 
38201680 
meiotic recombination protein SPO11 
isoform b 14249398 PHD-finger 5A 
38201680 
meiotic recombination protein SPO11 
isoform b 62909985 hypothetical protein LOC140711 
38201680 
meiotic recombination protein SPO11 
isoform b 7705477 hypothetical protein LOC51504 





meiotic recombination protein SPO11 
isoform b 11321585 
guanine nucleotide-binding protein, beta-1 
subunit 
38201680 
meiotic recombination protein SPO11 
isoform b 21071060 
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin a-like 1 
38201680 
meiotic recombination protein SPO11 
isoform b 4506631 ribosomal protein L30 
38201680 
meiotic recombination protein SPO11 
isoform b 15150809 SEC11-like 3 
38201680 
meiotic recombination protein SPO11 
isoform b 7657546 Sec61 gamma subunit 
38201680 
meiotic recombination protein SPO11 
isoform b 8923475 thioredoxin-like 4B 
38201680 
meiotic recombination protein SPO11 
isoform b 113418682 
PREDICTED: similar to postmeiotic 
segregation increased 2-like 2 
38201680 
meiotic recombination protein SPO11 
isoform b 4758384 FK506 binding protein 5 
38201680 
meiotic recombination protein SPO11 
isoform b 8922905 RIO kinase 2 
38201680 
meiotic recombination protein SPO11 
isoform b 4506701 ribosomal protein S23 
38201680 
meiotic recombination protein SPO11 
isoform b 18105063 vacuolar protein sorting 45A 
38201680 
meiotic recombination protein SPO11 
isoform b 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
38201680 
meiotic recombination protein SPO11 
isoform b 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
38201680 
meiotic recombination protein SPO11 
isoform b 8923942 nucleolar protein family A, member 3 
38201680 
meiotic recombination protein SPO11 
4502643 
chaperonin containing TCP1, subunit 6A 




isoform b isoform a 
38201680 
meiotic recombination protein SPO11 
isoform b 4758922 
phosphatidylinositol glycan anchor 
biosynthesis, class L 
38201680 
meiotic recombination protein SPO11 
isoform b 15431295 ribosomal protein L13 
38201680 
meiotic recombination protein SPO11 
isoform b 15431297 ribosomal protein L13 
38201680 
meiotic recombination protein SPO11 
isoform b 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
38201680 
meiotic recombination protein SPO11 
isoform b 7706667 trafficking protein particle complex 4 
38201680 
meiotic recombination protein SPO11 
isoform b 4507311 suppressor of Ty 4 homolog 1 
38201680 
meiotic recombination protein SPO11 
isoform b 113428574 
PREDICTED: similar to 60S ribosomal 
protein L29 (Cell surface heparin-binding 
protein HIP) 
38201680 
meiotic recombination protein SPO11 
isoform b 32189369 DNA polymerase epsilon subunit 2 
38201680 
meiotic recombination protein SPO11 
isoform b 4503729 FK506-binding protein 4 
38201680 
meiotic recombination protein SPO11 
isoform b 89035017 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 2 
38201680 
meiotic recombination protein SPO11 
isoform b 4507873 von Hippel-Lindau binding protein 1 
38201680 
meiotic recombination protein SPO11 
isoform b 4507129 
small nuclear ribonucleoprotein polypeptide 
E 
38201680 
meiotic recombination protein SPO11 
isoform b 8923733 
solute carrier family 2 (facilitated glucose 
transporter), member 6 
38201680 
meiotic recombination protein SPO11 
isoform b 113414586 PREDICTED: similar to CG17293-PA 





meiotic recombination protein SPO11 
isoform b 4502859 CDC28 protein kinase 2 
38201680 
meiotic recombination protein SPO11 
isoform b 4506609 ribosomal protein L19 
38201680 
meiotic recombination protein SPO11 
isoform b 32813443 
CTD (carboxy-terminal domain, RNA 
polymerase II, polypeptide A) small 
phosphatase 1 isoform 2 
38201680 
meiotic recombination protein SPO11 
isoform b 113427613 
PREDICTED: similar to ribosomal protein 
L31 
38201680 
meiotic recombination protein SPO11 
isoform b 6912680 
meiotic recombination protein SPO11 
isoform a 
38201680 
meiotic recombination protein SPO11 
isoform b 7657548 trafficking protein particle complex 2 
38201680 
meiotic recombination protein SPO11 
isoform b 113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
38201680 
meiotic recombination protein SPO11 
isoform b 51467029 
PREDICTED: similar to 40S ribosomal 
protein S26 
38201680 
meiotic recombination protein SPO11 
isoform b 10864021 trafficking protein particle complex 1 
38201680 
meiotic recombination protein SPO11 
isoform b 113418084 
PREDICTED: similar to DNA primase large 
subunit, 58kDa 
38201680 
meiotic recombination protein SPO11 
isoform b 113418086 
PREDICTED: similar to DNA primase large 
subunit, 58kDa 
38201680 
meiotic recombination protein SPO11 
isoform b 4506717 ribosomal protein S29 isoform 1 
38149981 
small nuclear ribonucleoprotein 
polypeptide B'' 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
38201680 
meiotic recombination protein SPO11 
isoform b 4502743 cyclin-dependent kinase 7 
38201680 
meiotic recombination protein SPO11 
isoform b 5729840 tubulin, gamma complex associated protein 2 





meiotic recombination protein SPO11 
isoform b 4504523 heat shock 10kDa protein 1 (chaperonin 10) 
38201680 
meiotic recombination protein SPO11 
isoform b 113419590 
PREDICTED: similar to 40S ribosomal 
protein S28 
38201680 
meiotic recombination protein SPO11 
isoform b 4506651 ribosomal protein L36a-like protein 
38201680 
meiotic recombination protein SPO11 
isoform b 113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
38201680 
meiotic recombination protein SPO11 
isoform b 23397458 kinesin family member 19 
38201680 
meiotic recombination protein SPO11 
isoform b 4759276 
RNA, U3 small nucleolar interacting protein 
2 
34147522 
chaperone, ABC1 activity of bc1 
complex like precursor 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
34147513 RAB7, member RAS oncogene family 113414586 PREDICTED: similar to CG17293-PA 
34147522 
chaperone, ABC1 activity of bc1 
complex like precursor 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
32698962 
glycerophosphodiester 
phosphodiesterase domain containing 1 4557719 DNA ligase I 
32967278 
ubiquitin-conjugating enzyme E2A 
isoform 3 32967276 ubiquitin-conjugating enzyme E2A isoform 2 
32967278 
ubiquitin-conjugating enzyme E2A 
isoform 3 32967280 ubiquitin-conjugating enzyme E2A isoform 1 
32130516 
serologically defined colon cancer 
antigen 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
31542547 dullard homolog 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
31542507 HORMA domain containing 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
32130516 
serologically defined colon cancer 
10863925 
DNA directed RNA polymerase II 




antigen 1 polypeptide L 
32130516 
serologically defined colon cancer 
antigen 1 18765707 
skeletal muscle and kidney enriched inositol 
phosphatase isoform 2 
31542547 dullard homolog 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
32130516 
serologically defined colon cancer 
antigen 1 4506717 ribosomal protein S29 isoform 1 
29553970 H2A histone family, member J 63029935 H2A histone family, member B3 
30425538 zinc finger, DHHC-type containing 21 4557719 DNA ligase I 
31455614 Der1-like domain family, member 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
31455614 Der1-like domain family, member 2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
30410779 huntingtin interacting protein B 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
29553970 H2A histone family, member J 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
29553970 H2A histone family, member J 63029943 H2A histone family, member B2 
28872761 myotubularin-related protein 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
28872761 myotubularin-related protein 1 19923424 myotubularin-related protein 9 
28872761 myotubularin-related protein 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
28872761 myotubularin-related protein 1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
29553970 H2A histone family, member J 89042891 
PREDICTED: similar to adaptor-related 




PREDICTED: similar to adaptor-related 




phosphorylation regulated kinase 4 protein complex 1 sigma 2 subunit 
28872761 myotubularin-related protein 1 113414586 PREDICTED: similar to CG17293-PA 
24762236 
PRP38 pre-mRNA processing factor 38 
(yeast) domain containing A 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
24371272 
zinc finger, DHHC-type containing 14 
isoform 2 24371241 
zinc finger, DHHC-type containing 14 
isoform 1 
24430186 phosphatidylinositol glycan, class C 4505795 phosphatidylinositol glycan, class C 
24430186 phosphatidylinositol glycan, class C 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
23510381 transportin 1 isoform 2 8923942 nucleolar protein family A, member 3 
23397458 kinesin family member 19 8923942 nucleolar protein family A, member 3 
23397458 kinesin family member 19 10863925 
DNA directed RNA polymerase II 
polypeptide L 
23510381 transportin 1 isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
23397458 kinesin family member 19 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
23199991 casein kinase 1 epsilon 4503093 casein kinase 1 epsilon 
22202633 prefoldin subunit 5 isoform alpha 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
22035624 phosphatidate cytidylyltransferase 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
21624654 spermatogenesis associated 5 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
21362110 thiamin pyrophosphokinase 1 isoform a 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
21624654 spermatogenesis associated 5 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
21362110 thiamin pyrophosphokinase 1 isoform a 89042891 
PREDICTED: similar to adaptor-related 




protein complex 1 sigma 2 subunit 
21450653 zinc finger, DHHC-type containing 15 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
21361144 proteasome 26S ATPase subunit 3 113414586 PREDICTED: similar to CG17293-PA 
21361376 splicing factor 3a, subunit 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
21361144 proteasome 26S ATPase subunit 3 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
21361657 
protein disulfide isomerase-associated 3 
precursor 4758304 protein disulfide isomerase-associated 4 
20270343 ADP-ribosylation factor-like 10B 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
21071060 
SWI/SNF-related matrix-associated 
actin-dependent regulator of chromatin 
a-like 1 4502743 cyclin-dependent kinase 7 
21071060 
SWI/SNF-related matrix-associated 
actin-dependent regulator of chromatin 
a-like 1 113414586 PREDICTED: similar to CG17293-PA 
21071060 
SWI/SNF-related matrix-associated 
actin-dependent regulator of chromatin 
a-like 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
19718751 uracil-DNA glycosylase isoform UNG2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
19718751 uracil-DNA glycosylase isoform UNG2 10863925 
DNA directed RNA polymerase II 
polypeptide L 
19718751 uracil-DNA glycosylase isoform UNG2 18765707 
skeletal muscle and kidney enriched inositol 
phosphatase isoform 2 
19718751 uracil-DNA glycosylase isoform UNG2 4506717 ribosomal protein S29 isoform 1 
18860916 5'-3' exoribonuclease 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




19913428 vacuolar H+ATPase B2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
19718751 uracil-DNA glycosylase isoform UNG2 30795252 
autophagy-related cysteine endopeptidase 2 
isoform a 
19718751 uracil-DNA glycosylase isoform UNG2 30795248 
autophagy-related cysteine endopeptidase 2 
isoform b 
19923424 myotubularin-related protein 9 113414586 PREDICTED: similar to CG17293-PA 
19718751 uracil-DNA glycosylase isoform UNG2 8923942 nucleolar protein family A, member 3 
18105063 vacuolar protein sorting 45A 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
18105063 vacuolar protein sorting 45A 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
18491016 exonuclease 1 isoform b 4557719 DNA ligase I 
18105063 vacuolar protein sorting 45A 113414586 PREDICTED: similar to CG17293-PA 
18105063 vacuolar protein sorting 45A 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
18087815 
ATPase, H+ transporting, lysosomal 
31kDa, V1 subunit E isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
17978519 vacuolar protein sorting 26 A isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
17978477 vacuolar protein sorting 11 4502859 CDC28 protein kinase 2 
17978519 vacuolar protein sorting 26 A isoform 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
15011936 ribosomal protein S26 88980535 
PREDICTED: similar to 40S ribosomal 
protein S26 
15011936 ribosomal protein S26 89041601 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 1 
15150809 SEC11-like 3 113414586 PREDICTED: similar to CG17293-PA 




15011936 ribosomal protein S26 88982349 
PREDICTED: similar to 40S ribosomal 
protein S26 
15011936 ribosomal protein S26 113420084 
PREDICTED: similar to 40S ribosomal 
protein S26 
15150809 SEC11-like 3 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
15011936 ribosomal protein S26 89025350 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 2 
15011936 ribosomal protein S26 113430282 
PREDICTED: similar to 40S ribosomal 
protein S26 
15011936 ribosomal protein S26 88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 
15011936 ribosomal protein S26 113429703 
PREDICTED: similar to 40S ribosomal 
protein S26 
14249398 PHD-finger 5A 4758496 H2A histone family, member Y isoform 2 
14249398 PHD-finger 5A 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
14249398 PHD-finger 5A 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
14249398 PHD-finger 5A 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
14211845 
IMP2 inner mitochondrial membrane 
protease-like 113414586 PREDICTED: similar to CG17293-PA 
14249398 PHD-finger 5A 113414586 PREDICTED: similar to CG17293-PA 
14149696 SEC31 homolog B 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
13236510 ubiquitin-like 5 113414586 PREDICTED: similar to CG17293-PA 
11863130 
phosphatidylinositol N-
acetylglucosaminyltransferase subunit A 
113429091 
PREDICTED: similar to peptidylprolyl 




isoform 1 isomerase A isoform 1 
10863925 
DNA directed RNA polymerase II 
polypeptide L 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
10864021 trafficking protein particle complex 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
10863925 
DNA directed RNA polymerase II 
polypeptide L 8393719 
ubiquitin-conjugating enzyme E2D 4 
(putative) 
10863925 
DNA directed RNA polymerase II 
polypeptide L 4502743 cyclin-dependent kinase 7 
10863925 
DNA directed RNA polymerase II 
polypeptide L 4557719 DNA ligase I 
10863925 
DNA directed RNA polymerase II 
polypeptide L 38016127 RNA binding motif protein 34 
10863925 
DNA directed RNA polymerase II 
polypeptide L 62909985 hypothetical protein LOC140711 
10863925 
DNA directed RNA polymerase II 
polypeptide L 6912680 
meiotic recombination protein SPO11 
isoform a 
10863925 
DNA directed RNA polymerase II 
polypeptide L 4758496 H2A histone family, member Y isoform 2 
10863925 
DNA directed RNA polymerase II 
polypeptide L 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
10863925 
DNA directed RNA polymerase II 
polypeptide L 5729840 tubulin, gamma complex associated protein 2 
10863925 
DNA directed RNA polymerase II 
polypeptide L 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
10864021 trafficking protein particle complex 1 113414586 PREDICTED: similar to CG17293-PA 
10863925 
DNA directed RNA polymerase II 
polypeptide L 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
10863925 
DNA directed RNA polymerase II 
113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 




polypeptide L (SIG-20) 
10863925 
DNA directed RNA polymerase II 
polypeptide L 113414586 PREDICTED: similar to CG17293-PA 
8923942 nucleolar protein family A, member 3 4506005 
protein phosphatase 1, catalytic subunit, beta 
isoform 1 
8923942 nucleolar protein family A, member 3 4502743 cyclin-dependent kinase 7 
8923942 nucleolar protein family A, member 3 4557719 DNA ligase I 
8923942 nucleolar protein family A, member 3 4758496 H2A histone family, member Y isoform 2 
8923942 nucleolar protein family A, member 3 38016127 RNA binding motif protein 34 
8923942 nucleolar protein family A, member 3 113426831 
PREDICTED: similar to TBC1 domain 
family member 3 (Rab GTPase-activating 
protein PRC17) (Prostate cancer gene 17 
protein) (TRE17 alpha protein) isoform 1 
8923942 nucleolar protein family A, member 3 113414586 PREDICTED: similar to CG17293-PA 
8923942 nucleolar protein family A, member 3 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
8923942 nucleolar protein family A, member 3 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
8923942 nucleolar protein family A, member 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
8923942 nucleolar protein family A, member 3 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
8923712 
uncharacterized hypothalamus protein 
HARP11 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
8923942 nucleolar protein family A, member 3 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
8923712 
uncharacterized hypothalamus protein 
HARP11 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




7706326 splicing factor 3B, 14 kDa subunit 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706753 ubiquitin C-terminal hydrolase UCH37 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706667 trafficking protein particle complex 4 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706657 cell division cycle 40 homolog 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706667 trafficking protein particle complex 4 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7706326 splicing factor 3B, 14 kDa subunit 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706495 
DnaJ (Hsp40) homolog, subfamily B, 
member 11 precursor 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706657 cell division cycle 40 homolog 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706667 trafficking protein particle complex 4 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7705483 hypothetical protein LOC51507 113414586 PREDICTED: similar to CG17293-PA 
7705483 hypothetical protein LOC51507 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7705483 hypothetical protein LOC51507 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7657198 dimethyladenosine transferase 113414586 PREDICTED: similar to CG17293-PA 
7657522 ring finger protein 7 isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7657198 dimethyladenosine transferase 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7657548 trafficking protein particle complex 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 




7657546 Sec61 gamma subunit 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7657548 trafficking protein particle complex 2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
7657548 trafficking protein particle complex 2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
7657548 trafficking protein particle complex 2 113414586 PREDICTED: similar to CG17293-PA 
6912680 
meiotic recombination protein SPO11 
isoform a 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
6912680 
meiotic recombination protein SPO11 
isoform a 4557719 DNA ligase I 
6912680 
meiotic recombination protein SPO11 
isoform a 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
6005701 
ATP-binding cassette, sub-family A 
member 8 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5902002 dual specificity phosphatase 14 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
6006001 
plasma glutathione peroxidase 3 
precursor 31542539 
DnaJ (Hsp40) homolog, subfamily A, 
member 3 
6005701 
ATP-binding cassette, sub-family A 
member 8 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5729840 
tubulin, gamma complex associated 
protein 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
5729840 
tubulin, gamma complex associated 
protein 2 113414586 PREDICTED: similar to CG17293-PA 
5729840 
tubulin, gamma complex associated 
protein 2 6996005 dynamin 1-like protein isoform 1 
5454144 ubiquitin D 113423966 
PREDICTED: similar to Ubiquitin-63E 
CG11624-PA, isoform A 





tubulin, gamma complex associated 
protein 2 4557719 DNA ligase I 
5729840 
tubulin, gamma complex associated 
protein 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5729840 
tubulin, gamma complex associated 
protein 2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5453660 
tubulin, gamma complex associated 
protein 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5032133 eukaryotic translation initiation factor 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5031635 cofilin 1 (non-muscle) 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4827046 
U2 small nuclear RNA auxiliary factor 
1-like 2 4506005 
protein phosphatase 1, catalytic subunit, beta 
isoform 1 
4885079 
ATP synthase, H+ transporting, 
mitochondrial F1 complex, gamma 
subunit isoform H (heart) precursor 4758496 H2A histone family, member Y isoform 2 
4759302 VAMP-associated protein B/C 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4759302 VAMP-associated protein B/C 6996005 dynamin 1-like protein isoform 1 
4759302 VAMP-associated protein B/C 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4826924 
DNA directed RNA polymerase II 
polypeptide K 113414586 PREDICTED: similar to CG17293-PA 
4826924 
DNA directed RNA polymerase II 
polypeptide K 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4758922 
phosphatidylinositol glycan anchor 
biosynthesis, class L 113414586 PREDICTED: similar to CG17293-PA 
4758922 
phosphatidylinositol glycan anchor 
biosynthesis, class L 4502743 cyclin-dependent kinase 7 





phosphatidylinositol glycan anchor 
biosynthesis, class L 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4758922 
phosphatidylinositol glycan anchor 
biosynthesis, class L 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4758922 
phosphatidylinositol glycan anchor 
biosynthesis, class L 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4507873 von Hippel-Lindau binding protein 1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4507873 von Hippel-Lindau binding protein 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4557563 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 3 9910180 ACN9 homolog 
4507947 tyrosyl-tRNA synthetase 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4507873 von Hippel-Lindau binding protein 1 113414586 PREDICTED: similar to CG17293-PA 
4507797 
ubiquitin-conjugating enzyme E2 
variant 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4507873 von Hippel-Lindau binding protein 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4507797 
ubiquitin-conjugating enzyme E2 
variant 2 113414586 PREDICTED: similar to CG17293-PA 
4506701 ribosomal protein S23 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506699 ribosomal protein S21 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506699 ribosomal protein S21 113431146 
PREDICTED: similar to 60S ribosomal 




protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506717 ribosomal protein S29 isoform 1 4758496 H2A histone family, member Y isoform 2 
4507047 
solute carrier family 7 (cationic amino 
acid transporter, y+ system), member 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4506717 ribosomal protein S29 isoform 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506717 ribosomal protein S29 isoform 1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506699 ribosomal protein S21 4758496 H2A histone family, member Y isoform 2 
4506717 ribosomal protein S29 isoform 1 62909985 hypothetical protein LOC140711 
4506717 ribosomal protein S29 isoform 1 113414586 PREDICTED: similar to CG17293-PA 
4506699 ribosomal protein S21 4502743 cyclin-dependent kinase 7 
4506717 ribosomal protein S29 isoform 1 8393719 
ubiquitin-conjugating enzyme E2D 4 
(putative) 
4506699 ribosomal protein S21 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4507047 
solute carrier family 7 (cationic amino 
acid transporter, y+ system), member 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4506717 ribosomal protein S29 isoform 1 38016127 RNA binding motif protein 34 
4506717 ribosomal protein S29 isoform 1 4502743 cyclin-dependent kinase 7 
4506701 ribosomal protein S23 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506701 ribosomal protein S23 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506701 ribosomal protein S23 113414586 PREDICTED: similar to CG17293-PA 




4506699 ribosomal protein S21 113414586 PREDICTED: similar to CG17293-PA 
4507123 
small nuclear ribonucleoprotein 
polypeptide B'' 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4506717 ribosomal protein S29 isoform 1 4557719 DNA ligase I 
4506715 ribosomal protein S28 113422526 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 
4506715 ribosomal protein S28 113423050 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 
4506715 ribosomal protein S28 89034184 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 2 
4506715 ribosomal protein S28 88959151 
PREDICTED: similar to 40S ribosomal 
protein S28 
4506715 ribosomal protein S28 88953906 
PREDICTED: similar to 40S ribosomal 
protein S28 
4506717 ribosomal protein S29 isoform 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506643 ribosomal protein L37a 113414586 PREDICTED: similar to CG17293-PA 
4506617 ribosomal protein L17 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4506643 ribosomal protein L37a 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506609 ribosomal protein L19 113414586 PREDICTED: similar to CG17293-PA 
4506609 ribosomal protein L19 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506193 proteasome beta 1 subunit 113414586 PREDICTED: similar to CG17293-PA 
4506193 proteasome beta 1 subunit 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506303 
protein tyrosine phosphatase, receptor 
type, A isoform 1 precursor 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 





protein phosphatase 1, catalytic subunit, 
beta isoform 1 4557719 DNA ligase I 
4506233 proteasome 26S non-ATPase subunit 8 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4505621 prostatic binding protein 22165364 mitochondrial ribosomal protein L38 
4505795 phosphatidylinositol glycan, class C 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504511 
DnaJ (Hsp40) homolog, subfamily A, 
member 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504511 
DnaJ (Hsp40) homolog, subfamily A, 
member 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4504221 guanylate kinase 1 113414586 PREDICTED: similar to CG17293-PA 
4504007 glycerol kinase isoform b 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504007 glycerol kinase isoform b 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504221 guanylate kinase 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4502703 cell division cycle 6 protein 21536371 telomerase-associated protein 1 
4503301 2,4-dienoyl CoA reductase 1 precursor 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4502643 
chaperonin containing TCP1, subunit 
6A isoform a 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
63029935 H2A histone family, member B3 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
28557709 
phosphoribosyl pyrophosphate 
synthetase 1-like 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
63029935 H2A histone family, member B3 63029943 H2A histone family, member B2 
28557709 
phosphoribosyl pyrophosphate 
synthetase 1-like 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




66912162 histone 2, H2bf 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
148747574 hypothetical protein LOC51030 21945058 hypothetical protein LOC201158 
63029935 H2A histone family, member B3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
118402582 cell division cycle 20 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
38016127 RNA binding motif protein 34 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
38016127 RNA binding motif protein 34 51467029 
PREDICTED: similar to 40S ribosomal 
protein S26 
38016127 RNA binding motif protein 34 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
38016127 RNA binding motif protein 34 4557719 DNA ligase I 
37595752 lamin B receptor 37595750 lamin B receptor 
38016127 RNA binding motif protein 34 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
38348260 ankyrin repeat domain 47 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
38016127 RNA binding motif protein 34 6996005 dynamin 1-like protein isoform 1 
32189369 DNA polymerase epsilon subunit 2 113414586 PREDICTED: similar to CG17293-PA 
32189369 DNA polymerase epsilon subunit 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
32189369 DNA polymerase epsilon subunit 2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
32189369 DNA polymerase epsilon subunit 2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
32484973 adenosine kinase isoform a 113429091 
PREDICTED: similar to peptidylprolyl 




isomerase A isoform 1 
32528306 replication factor C large subunit 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
32483374 nucleolar protein 5A 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
31795544 origin recognition complex, subunit 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
31543091 RNA binding motif protein 13 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
31795544 origin recognition complex, subunit 1 113414586 PREDICTED: similar to CG17293-PA 
31543091 RNA binding motif protein 13 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
30795252 
autophagy-related cysteine 
endopeptidase 2 isoform a 30795248 
autophagy-related cysteine endopeptidase 2 
isoform b 
31542315 
CCR4-NOT transcription complex, 
subunit 8 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
31543091 RNA binding motif protein 13 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
31795544 origin recognition complex, subunit 1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
31795544 origin recognition complex, subunit 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
28376621 SEC14p-like protein TAP3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
28376621 SEC14p-like protein TAP3 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
28173554 histone H2B 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




28559085 cytidine triphosphate synthase II 28559083 cytidine triphosphate synthase II 
30795252 
autophagy-related cysteine 
endopeptidase 2 isoform a 113414586 PREDICTED: similar to CG17293-PA 
30795248 
autophagy-related cysteine 
endopeptidase 2 isoform b 113414586 PREDICTED: similar to CG17293-PA 
30795248 
autophagy-related cysteine 
endopeptidase 2 isoform b 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
30795252 
autophagy-related cysteine 
endopeptidase 2 isoform a 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
24586679 testis-specific histone H2B 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
24586675 slingshot homolog 3 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
24586679 testis-specific histone H2B 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
27436969 
potassium voltage-gated channel, 
shaker-related subfamily, beta member 
2 isoform 2 4504825 
potassium voltage-gated channel, shaker-
related subfamily, beta member 2 isoform 1 
22538446 tumor protein p53 inducible protein 3 22538444 tumor protein p53 inducible protein 3 
22001417 gemin 5 21536371 telomerase-associated protein 1 
22027655 
adaptor-related protein complex 1 sigma 
2 subunit 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
22027655 
adaptor-related protein complex 1 sigma 
2 subunit 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
21362084 TBC1 domain family, member 15 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
21362084 TBC1 domain family, member 15 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
21450679 
IMP1 inner mitochondrial membrane 
peptidase-like 113414586 PREDICTED: similar to CG17293-PA 




21314720 Smad nuclear interacting protein 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
20911035 peptidylprolyl isomerase-like 4 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
19923315 
serine hydroxymethyltransferase 2 
(mitochondrial) 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
18860884 
WW domain-containing oxidoreductase 
isoform 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
18860884 
WW domain-containing oxidoreductase 
isoform 2 7706523 
WW domain-containing oxidoreductase 
isoform 1 
19923315 
serine hydroxymethyltransferase 2 
(mitochondrial) 4557719 DNA ligase I 
18860884 
WW domain-containing oxidoreductase 
isoform 2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
15431297 ribosomal protein L13 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
15431297 ribosomal protein L13 113414586 PREDICTED: similar to CG17293-PA 
16306568 poly(A) polymerase gamma 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
16306566 histone H2B 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
15431297 ribosomal protein L13 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
15431297 ribosomal protein L13 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
14251212 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 20 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
13376747 nucleotide binding protein-like 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




14043026 vesicle-associated membrane protein 8 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
14043026 vesicle-associated membrane protein 8 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
13430872 nucleolar protein 10 113414586 PREDICTED: similar to CG17293-PA 
13430872 nucleolar protein 10 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
13129120 trafficking protein particle complex 6A 113414586 PREDICTED: similar to CG17293-PA 
11321585 
guanine nucleotide-binding protein, 
beta-1 subunit 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
11321585 
guanine nucleotide-binding protein, 
beta-1 subunit 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
11056006 kelch-like 12 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
11056006 kelch-like 12 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
12758125 hypothetical protein LOC23378 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
12758125 hypothetical protein LOC23378 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
12758125 hypothetical protein LOC23378 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
11386163 ELAV-like 4 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
8922905 RIO kinase 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
8923733 
solute carrier family 2 (facilitated 
glucose transporter), member 6 113414586 PREDICTED: similar to CG17293-PA 
10190686 zinc finger protein 286 10190696 zinc finger protein 304 
10190686 zinc finger protein 286 18765707 
skeletal muscle and kidney enriched inositol 




phosphatase isoform 2 
8923733 
solute carrier family 2 (facilitated 
glucose transporter), member 6 62909985 hypothetical protein LOC140711 
10190686 zinc finger protein 286 113413881 
PREDICTED: similar to zinc finger protein 
114 
8923733 
solute carrier family 2 (facilitated 
glucose transporter), member 6 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
8923733 
solute carrier family 2 (facilitated 
glucose transporter), member 6 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
8923733 
solute carrier family 2 (facilitated 
glucose transporter), member 6 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
8922905 RIO kinase 2 113414586 PREDICTED: similar to CG17293-PA 
10190686 zinc finger protein 286 6996005 dynamin 1-like protein isoform 1 
7706343 hypothetical protein LOC51647 113414586 PREDICTED: similar to CG17293-PA 
7705477 hypothetical protein LOC51504 113414586 PREDICTED: similar to CG17293-PA 
7705748 TNNI3 interacting kinase 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7706423 
U6 snRNA-associated Sm-like protein 
LSm7 113414586 PREDICTED: similar to CG17293-PA 
7705748 TNNI3 interacting kinase 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706497 cytidylate kinase 113414586 PREDICTED: similar to CG17293-PA 
7705369 coatomer protein complex, subunit beta 113414586 PREDICTED: similar to CG17293-PA 
7705369 coatomer protein complex, subunit beta 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7706523 
WW domain-containing oxidoreductase 
isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




7706343 hypothetical protein LOC51647 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7705477 hypothetical protein LOC51504 4557719 DNA ligase I 
7706497 cytidylate kinase 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
8922388 RNA binding motif protein 28 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7657508 ring-box 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7705477 hypothetical protein LOC51504 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
7705477 hypothetical protein LOC51504 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
7706523 
WW domain-containing oxidoreductase 
isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7705477 hypothetical protein LOC51504 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7706423 
U6 snRNA-associated Sm-like protein 
LSm7 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7705748 TNNI3 interacting kinase 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7019405 host cell factor C2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
7019405 host cell factor C2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
6912280 
AHA1, activator of heat shock 90kDa 
protein ATPase homolog 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
7019319 activator of basal transcription 1 113414586 PREDICTED: similar to CG17293-PA 




7657315 Lsm3 protein 113414586 PREDICTED: similar to CG17293-PA 
6996005 dynamin 1-like protein isoform 1 10190696 zinc finger protein 304 
6912280 
AHA1, activator of heat shock 90kDa 
protein ATPase homolog 1 113414586 PREDICTED: similar to CG17293-PA 
7019319 activator of basal transcription 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
5729953 nuclear distribution gene C homolog 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
5902034 periodic tryptophan protein 1 113414586 PREDICTED: similar to CG17293-PA 
4557719 DNA ligase I 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4758496 
H2A histone family, member Y isoform 
2 4503729 FK506-binding protein 4 
4759156 
small nuclear ribonucleoprotein 
polypeptide A 113414586 PREDICTED: similar to CG17293-PA 
4759224 programmed cell death 5 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4758384 FK506 binding protein 5 4503729 FK506-binding protein 4 
4759276 
RNA, U3 small nucleolar interacting 
protein 2 113414586 PREDICTED: similar to CG17293-PA 
4759224 programmed cell death 5 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4759156 
small nuclear ribonucleoprotein 
polypeptide A 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4758384 FK506 binding protein 5 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4758496 
H2A histone family, member Y isoform 
2 4557719 DNA ligase I 
4557719 DNA ligase I 62909985 hypothetical protein LOC140711 





H2A histone family, member Y isoform 
2 113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
4758496 
H2A histone family, member Y isoform 
2 4506651 ribosomal protein L36a-like protein 
4557719 DNA ligase I 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4758496 
H2A histone family, member Y isoform 
2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4557719 DNA ligase I 18765707 
skeletal muscle and kidney enriched inositol 
phosphatase isoform 2 
4759276 
RNA, U3 small nucleolar interacting 
protein 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4557719 DNA ligase I 4506007 
protein phosphatase 1, catalytic subunit, 
gamma isoform 
4758496 
H2A histone family, member Y isoform 
2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4557719 DNA ligase I 4503981 
glucosamine-fructose-6-phosphate 
aminotransferase 
4557719 DNA ligase I 4502743 cyclin-dependent kinase 7 
4557719 DNA ligase I 4505331 
N-ethylmaleimide-sensitive factor 
attachment protein, gamma 
4557719 DNA ligase I 8393719 
ubiquitin-conjugating enzyme E2D 4 
(putative) 
4758496 
H2A histone family, member Y isoform 
2 113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
4557719 DNA ligase I 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4507311 suppressor of Ty 4 homolog 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 




4507311 suppressor of Ty 4 homolog 1 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4507369 tyrosine aminotransferase 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4507311 suppressor of Ty 4 homolog 1 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506631 ribosomal protein L30 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506631 ribosomal protein L30 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506631 ribosomal protein L30 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506629 ribosomal protein L29 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4507311 suppressor of Ty 4 homolog 1 113414586 PREDICTED: similar to CG17293-PA 
4557719 DNA ligase I 113426831 
PREDICTED: similar to TBC1 domain 
family member 3 (Rab GTPase-activating 
protein PRC17) (Prostate cancer gene 17 
protein) (TRE17 alpha protein) isoform 1 
4506629 ribosomal protein L29 27482992 
PREDICTED: similar to 60S ribosomal 
protein L29 (Cell surface heparin-binding 
protein HIP) 
4557719 DNA ligase I 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4557719 DNA ligase I 113414586 PREDICTED: similar to CG17293-PA 
4507133 
small nuclear ribonucleoprotein 
polypeptide G 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506203 proteasome beta 7 subunit proprotein 113429091 
PREDICTED: similar to peptidylprolyl 




isomerase A isoform 1 
4557719 DNA ligase I 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4506631 ribosomal protein L30 113414586 PREDICTED: similar to CG17293-PA 
4506629 ribosomal protein L29 113428574 
PREDICTED: similar to 60S ribosomal 
protein L29 (Cell surface heparin-binding 
protein HIP) 
4504523 
heat shock 10kDa protein 1 (chaperonin 
10) 113414586 PREDICTED: similar to CG17293-PA 
4504523 
heat shock 10kDa protein 1 (chaperonin 
10) 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4503729 FK506-binding protein 4 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4503729 FK506-binding protein 4 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4505235 mannose-6- phosphate isomerase 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4505773 prohibitin 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4506019 
alpha isoform of regulatory subunit 
B55, protein phosphatase 2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4505331 
N-ethylmaleimide-sensitive factor 
attachment protein, gamma 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504257 H2B histone family, member A 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504261 H2B histone family, member D 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504269 H2B histone family, member J 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 





alpha isoform of regulatory subunit 
B55, protein phosphatase 2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506019 
alpha isoform of regulatory subunit 
B55, protein phosphatase 2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4504263 H2B histone family, member E 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4505331 
N-ethylmaleimide-sensitive factor 
attachment protein, gamma 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504523 
heat shock 10kDa protein 1 (chaperonin 
10) 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4504523 
heat shock 10kDa protein 1 (chaperonin 
10) 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4505997 protein phosphatase 1D 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4506007 
protein phosphatase 1, catalytic subunit, 
gamma isoform 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4502743 cyclin-dependent kinase 7 113414586 PREDICTED: similar to CG17293-PA 
4502743 cyclin-dependent kinase 7 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
148222882 hypothetical protein LOC644820 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
25777713 
S-phase kinase-associated protein 1A 
isoform b 113414586 PREDICTED: similar to CG17293-PA 
25777711 
S-phase kinase-associated protein 1A 
isoform a 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
21166389 H2B histone family, member L 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 




4502743 cyclin-dependent kinase 7 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4502743 cyclin-dependent kinase 7 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
25777713 
S-phase kinase-associated protein 1A 
isoform b 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
23592238 glucose transporter 14 113414586 PREDICTED: similar to CG17293-PA 
25777711 
S-phase kinase-associated protein 1A 
isoform a 113414586 PREDICTED: similar to CG17293-PA 
23592238 glucose transporter 14 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4502859 CDC28 protein kinase 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
25777713 
S-phase kinase-associated protein 1A 
isoform b 25777711 
S-phase kinase-associated protein 1A 
isoform a 
4502743 cyclin-dependent kinase 7 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
63029943 H2A histone family, member B2 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4758650 kinesin family member 5C 113413289 
PREDICTED: similar to Kinesin heavy chain 
isoform 5C (Kinesin heavy chain neuron-
specific 2) 
58615669 cytochrome c oxidase subunit III 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
58615665 cytochrome c oxidase subunit I 17981855 cytochrome c oxidase subunit I 
58615673 NADH dehydrogenase subunit 5 17981853 NADH dehydrogenase subunit 1 
58615673 NADH dehydrogenase subunit 5 58615663 NADH dehydrogenase subunit 1 
58615673 NADH dehydrogenase subunit 5 17981862 NADH dehydrogenase subunit 4 




58615673 NADH dehydrogenase subunit 5 58615672 NADH dehydrogenase subunit 4 
13128862 histone deacetylase 3 113414586 PREDICTED: similar to CG17293-PA 
62909985 hypothetical protein LOC140711 8923475 thioredoxin-like 4B 
63003905 
protein phosphatase 1 (formerly 2C)-
like 113414586 PREDICTED: similar to CG17293-PA 
51491914 
dual specificity phosphatase and pro 
isomerase domain containing 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
58615672 NADH dehydrogenase subunit 4 17981862 NADH dehydrogenase subunit 4 
62909985 hypothetical protein LOC140711 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
58615666 cytochrome c oxidase subunit II 17981859 cytochrome c oxidase subunit III 
58615669 cytochrome c oxidase subunit III 58615666 cytochrome c oxidase subunit II 
58615669 cytochrome c oxidase subunit III 17981856 cytochrome c oxidase subunit II 
58615669 cytochrome c oxidase subunit III 17981859 cytochrome c oxidase subunit III 
4557851 
solute carrier family 2 (facilitated 
glucose transporter), member 2 113414586 PREDICTED: similar to CG17293-PA 
58615666 cytochrome c oxidase subunit II 17981856 cytochrome c oxidase subunit II 
13128862 histone deacetylase 3 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
63029943 H2A histone family, member B2 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
58615663 NADH dehydrogenase subunit 1 17981853 NADH dehydrogenase subunit 1 
32813443 
CTD (carboxy-terminal domain, RNA 
polymerase II, polypeptide A) small 
phosphatase 1 isoform 2 113414586 PREDICTED: similar to CG17293-PA 
17981859 cytochrome c oxidase subunit III 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
32813443 
CTD (carboxy-terminal domain, RNA 
polymerase II, polypeptide A) small 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 




phosphatase 1 isoform 2 
4507129 
small nuclear ribonucleoprotein 
polypeptide E 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4507129 
small nuclear ribonucleoprotein 
polypeptide E 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
30065643 
protein phosphatase 2A, regulatory 
subunit B' isoform b 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
29725611 
protein phosphatase 2A, regulatory 
subunit B' isoform b 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
30065643 
protein phosphatase 2A, regulatory 
subunit B' isoform b 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
29725611 
protein phosphatase 2A, regulatory 
subunit B' isoform b 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
32813443 
CTD (carboxy-terminal domain, RNA 
polymerase II, polypeptide A) small 
phosphatase 1 isoform 2 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
32813443 
CTD (carboxy-terminal domain, RNA 
polymerase II, polypeptide A) small 
phosphatase 1 isoform 2 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4507129 
small nuclear ribonucleoprotein 
polypeptide E 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
17981859 cytochrome c oxidase subunit III 17981856 cytochrome c oxidase subunit II 
29725611 
protein phosphatase 2A, regulatory 
subunit B' isoform b 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
30065643 
protein phosphatase 2A, regulatory 
subunit B' isoform b 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4505947 
DNA directed RNA polymerase II 
polypeptide G 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
4507129 
small nuclear ribonucleoprotein 
113414586 PREDICTED: similar to CG17293-PA 






RNA pseudouridylate synthase domain 
containing 3 14249470 
RNA pseudouridylate synthase domain 
containing 4 
31542539 
DnaJ (Hsp40) homolog, subfamily A, 
member 3 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
32967280 
ubiquitin-conjugating enzyme E2A 
isoform 1 32967276 ubiquitin-conjugating enzyme E2A isoform 2 
10190696 zinc finger protein 304 113413881 
PREDICTED: similar to zinc finger protein 
114 
8923475 thioredoxin-like 4B 113414586 PREDICTED: similar to CG17293-PA 
15431295 ribosomal protein L13 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
8923475 thioredoxin-like 4B 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
21361394 
adaptor-related protein complex 4, 
sigma 1 subunit 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
19923732 
general transcription factor IIH, 
polypeptide 3, 34kDa 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
19923732 
general transcription factor IIH, 
polypeptide 3, 34kDa 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
8923475 thioredoxin-like 4B 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
8923475 thioredoxin-like 4B 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
15431295 ribosomal protein L13 113414586 PREDICTED: similar to CG17293-PA 
5802970 AFG3 ATPase family gene 3-like 2 113414586 PREDICTED: similar to CG17293-PA 




21396484 H2B histone family, member H 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
8393719 
ubiquitin-conjugating enzyme E2D 4 
(putative) 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
15431295 ribosomal protein L13 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
15431295 ribosomal protein L13 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
19923732 
general transcription factor IIH, 
polypeptide 3, 34kDa 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
21361394 
adaptor-related protein complex 4, 
sigma 1 subunit 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
19923732 
general transcription factor IIH, 
polypeptide 3, 34kDa 113414586 PREDICTED: similar to CG17293-PA 
5802970 AFG3 ATPase family gene 3-like 2 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
113419590 
PREDICTED: similar to 40S ribosomal 
protein S28 113414586 PREDICTED: similar to CG17293-PA 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113427093 
PREDICTED: similar to ribosomal protein 
L31 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 29742309 
PREDICTED: similar to ribosomal protein 
L31 
88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 88982349 
PREDICTED: similar to 40S ribosomal 
protein S26 
113420084 
PREDICTED: similar to 40S ribosomal 
protein S26 88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 
89041601 
PREDICTED: similar to 40S ribosomal 
88980535 
PREDICTED: similar to 40S ribosomal 




protein S26 isoform 1 protein S26 
113420393 
PREDICTED: similar to 40S ribosomal 
protein S26 113420084 
PREDICTED: similar to 40S ribosomal 
protein S26 
113420393 
PREDICTED: similar to 40S ribosomal 
protein S26 88982349 
PREDICTED: similar to 40S ribosomal 
protein S26 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113413585 
PREDICTED: similar to APG4 autophagy 4 
homolog B isoform a 
29742309 
PREDICTED: similar to ribosomal 
protein L31 113414586 PREDICTED: similar to CG17293-PA 
113427093 
PREDICTED: similar to ribosomal 
protein L31 113414586 PREDICTED: similar to CG17293-PA 
4758754 napsin A preproprotein 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
113427613 
PREDICTED: similar to ribosomal 
protein L31 113414586 PREDICTED: similar to CG17293-PA 
113422777 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 89042897 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 
protein) (SIG-20) 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4504265 H2B histone family, member G 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
4504271 H2B histone family, member K 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
113420393 
PREDICTED: similar to 40S ribosomal 
protein S26 88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 
113430282 
PREDICTED: similar to 40S ribosomal 
protein S26 88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 





PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 
protein) (SIG-20) 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
88982349 
PREDICTED: similar to 40S ribosomal 
protein S26 88980535 
PREDICTED: similar to 40S ribosomal 
protein S26 
113420084 
PREDICTED: similar to 40S ribosomal 
protein S26 88980535 
PREDICTED: similar to 40S ribosomal 
protein S26 
113420084 
PREDICTED: similar to 40S ribosomal 
protein S26 89041601 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 1 
89041601 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 1 88982349 
PREDICTED: similar to 40S ribosomal 
protein S26 
51467029 
PREDICTED: similar to 40S ribosomal 
protein S26 113414586 PREDICTED: similar to CG17293-PA 
113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 113414586 PREDICTED: similar to CG17293-PA 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 51467029 
PREDICTED: similar to 40S ribosomal 
protein S26 
113430282 
PREDICTED: similar to 40S ribosomal 
protein S26 89025350 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 2 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113418084 
PREDICTED: similar to DNA primase large 
subunit, 58kDa 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113418086 
PREDICTED: similar to DNA primase large 
subunit, 58kDa 
51467029 
PREDICTED: similar to 40S ribosomal 
protein S26 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 
protein) (SIG-20) 51467029 
PREDICTED: similar to 40S ribosomal 
protein S26 
89041601 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 1 89025350 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 2 





PREDICTED: similar to 40S ribosomal 
protein S26 isoform 2 88980535 
PREDICTED: similar to 40S ribosomal 
protein S26 
113426831 
PREDICTED: similar to TBC1 domain 
family member 3 (Rab GTPase-
activating protein PRC17) (Prostate 
cancer gene 17 protein) (TRE17 alpha 
protein) isoform 1 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 
protein) (SIG-20) 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113419590 
PREDICTED: similar to 40S ribosomal 
protein S28 
113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 113414586 PREDICTED: similar to CG17293-PA 
4506651 ribosomal protein L36a-like protein 113414586 PREDICTED: similar to CG17293-PA 
89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 89042328 
PREDICTED: similar to ribosomal protein 
S18 isoform 4 
89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 41150652 
PREDICTED: similar to ribosomal protein 
S18 isoform 1 
4505289 diphosphomevalonate decarboxylase 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 
protein) (SIG-20) 113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
113428574 
PREDICTED: similar to 60S ribosomal 
protein L29 (Cell surface heparin-
27482992 
PREDICTED: similar to 60S ribosomal 
protein L29 (Cell surface heparin-binding 




binding protein HIP) protein HIP) 
113430282 
PREDICTED: similar to 40S ribosomal 
protein S26 113420393 
PREDICTED: similar to 40S ribosomal 
protein S26 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 89035017 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 2 
113418086 
PREDICTED: similar to DNA primase 
large subunit, 58kDa 113414586 PREDICTED: similar to CG17293-PA 
113418084 
PREDICTED: similar to DNA primase 
large subunit, 58kDa 113414586 PREDICTED: similar to CG17293-PA 
4506651 ribosomal protein L36a-like protein 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 
protein) (SIG-20) 113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506651 ribosomal protein L36a-like protein 113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
4506651 ribosomal protein L36a-like protein 113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113418682 
PREDICTED: similar to postmeiotic 
segregation increased 2-like 2 
89035017 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 2 113414586 PREDICTED: similar to CG17293-PA 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113414586 PREDICTED: similar to CG17293-PA 





PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 88943041 
PREDICTED: similar to peptidylprolyl 
isomerase A (cyclophilin A)-like 4 
113418682 
PREDICTED: similar to postmeiotic 
segregation increased 2-like 2 113414586 PREDICTED: similar to CG17293-PA 
113430282 
PREDICTED: similar to 40S ribosomal 
protein S26 89041601 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 1 
113430282 
PREDICTED: similar to 40S ribosomal 
protein S26 88980535 
PREDICTED: similar to 40S ribosomal 
protein S26 
4506651 ribosomal protein L36a-like protein 113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
113427529 
PREDICTED: similar to large subunit 
ribosomal protein L36a 113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 89040714 
PREDICTED: similar to kidney-specific 
protein (KS) 
113426831 
PREDICTED: similar to TBC1 domain 
family member 3 (Rab GTPase-
activating protein PRC17) (Prostate 
cancer gene 17 protein) (TRE17 alpha 
protein) isoform 1 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
89041601 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 1 88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 
88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 88980535 
PREDICTED: similar to 40S ribosomal 
protein S26 
113430282 
PREDICTED: similar to 40S ribosomal 
protein S26 113429703 
PREDICTED: similar to 40S ribosomal 
protein S26 
4758754 napsin A preproprotein 89041736 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
113429703 
PREDICTED: similar to 40S ribosomal 
protein S26 88982349 
PREDICTED: similar to 40S ribosomal 
protein S26 





PREDICTED: similar to 40S ribosomal 
protein S26 113420084 
PREDICTED: similar to 40S ribosomal 
protein S26 
113420084 
PREDICTED: similar to 40S ribosomal 
protein S26 88982349 
PREDICTED: similar to 40S ribosomal 
protein S26 
89025350 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 2 88987217 
PREDICTED: similar to 40S ribosomal 
protein S26 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113427613 
PREDICTED: similar to ribosomal protein 
L31 
113422526 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 88953906 
PREDICTED: similar to 40S ribosomal 
protein S28 
113422526 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 88959151 
PREDICTED: similar to 40S ribosomal 
protein S28 
89034184 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 2 88953906 
PREDICTED: similar to 40S ribosomal 
protein S28 
113423050 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 89034184 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 2 
113423050 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 88959151 
PREDICTED: similar to 40S ribosomal 
protein S28 
113422526 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 89034184 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 2 
89034184 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 2 88959151 
PREDICTED: similar to 40S ribosomal 
protein S28 
88959151 
PREDICTED: similar to 40S ribosomal 
protein S28 88953906 
PREDICTED: similar to 40S ribosomal 
protein S28 
113423050 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 88953906 
PREDICTED: similar to 40S ribosomal 
protein S28 
113423050 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 113422526 
PREDICTED: similar to 40S ribosomal 
protein S28 isoform 1 
113420393 
PREDICTED: similar to 40S ribosomal 
protein S26 89025350 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 2 





PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 113414263 
PREDICTED: similar to aortic preferentially 
expressed gene 1 
89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 
protein) (SIG-20) 89042891 
PREDICTED: similar to adaptor-related 
protein complex 1 sigma 2 subunit 
113431146 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 
protein) (SIG-20) 113427613 
PREDICTED: similar to ribosomal protein 
L31 
113427613 
PREDICTED: similar to ribosomal 
protein L31 113418826 
PREDICTED: similar to 60S ribosomal 
protein L26 (Silica-induced gene 20 protein) 
(SIG-20) 
4506651 ribosomal protein L36a-like protein 113427044 
PREDICTED: similar to large subunit 
ribosomal protein L36a 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 27482992 
PREDICTED: similar to 60S ribosomal 
protein L29 (Cell surface heparin-binding 
protein HIP) 
113429703 
PREDICTED: similar to 40S ribosomal 
protein S26 89025350 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 2 
113429091 
PREDICTED: similar to peptidylprolyl 
isomerase A isoform 1 113428574 
PREDICTED: similar to 60S ribosomal 
protein L29 (Cell surface heparin-binding 
protein HIP) 
113429703 
PREDICTED: similar to 40S ribosomal 
protein S26 89041601 
PREDICTED: similar to 40S ribosomal 
protein S26 isoform 1 
113429703 
PREDICTED: similar to 40S ribosomal 
protein S26 88980535 
PREDICTED: similar to 40S ribosomal 
protein S26 
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R ARMED L LKR R F FY DQ S FA I Y - - - - - - -GG I T GQYD FG PMGCA LK SNMI NTWRQ F FV L E EQML EVDC S I LT P E PV LKA SGHVD
R KAVVNT L ER R L FY I P S FK I Y - - - - - - - SGVAG L FDY G P PGCA I K SNV L S FWRQH F I L E ENML EVDC PCVT P EVV LKA SGHVD
R EN L E SV LKR R F F FA PA F E LY - - - - - - -GGV SG LY DY G P PGCA FQAN I VDVWRKH F I L E EDML EVDCTMLT PY EV LKT SGHVD
R T V LD SMLR R R L FY T P S FD I Y - - - - - - -GGV SG LY DY G P PGT A L LNN I VD LWR KH FV L E EDML EVDCTMLT PH EV LKT SGHVD
R T L F E S L LKR R L FY T E S F E I Y R T SGN LTGD SRG LY DY G P PGCA LQ SN I VD LWR KH FV LQ EDML E LDCT I LT P E EV FKT SGHVD
RAKMED L I K R R F FY DQ S FA I Y - - - - - - -GG I T GQ FD FG PMGCA LK SNMI H LWKK F F I LQ EQML EV EC S I LT P E PV LKA SGHV E
R AKMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I I QTWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
R LK L ED L LKR R F FY DQ S FA I Y - - - - - - -GGVTG LY D FG PMGCA LKANMLQQWRKH F I L E EGML EVDCT S LT P E PV LKA SGHVD
R LK L ED L LKR R F FY DQ S FA I Y - - - - - - -GGVTG LY D FG PMGC S LKANMLQ EWR KH F I L E EGML EVDCT S LT P E PV LKA SGHVD
RD S L EQT LKR R F F FA P S F E I Y - - - - - - -GGVAG L FD FG P PGCA FQNNV I DAWRKH F I L E EDML EV EATMLT PHDV LKT SGHVD
R EK L E SV LR GR F FY A PA FD LY - - - - - - -GGV SG LY DY G P PGC S FQANVVDQWRKH F I L E EDML EVDCTMLT PY EV LKT SGHVD
RAKMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I I QTWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
RQQMEDT LKR R F FY GQA F E LY - - - - - - -GGV SG LY D FG PVGCMLKNN I I S EWKQH F I LHDQML E I ECTMLT P E PV LR A SGH I E
K ST LDA L LAR R F F FA P S F E I Y - - - - - - -GGVAG LY DY G PTG SA LQAN I LDAWRKHY I I E EDML E LDT T I MT L SDV LKT SGHVD
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -ML E I SAT C LT PY N P LKA SGHVD
R EA L EN L LKR R F F I A P S F E I Y - - - - - - -GGVAG L FDY G P PGCA LK S EV E S FWR RH FV LA EDML E I SAT C LT PY N P LKA SGHVD
R T KMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I LQVWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
R E S L EQV LKR R F F FA PA F E I Y - - - - - - -GGV SG LY DY G P PGCA LQAN I MDTWRKH F I L E EDML EVDCTMLT PH EV LKT SGHVD
RAG L ED LMKR R F F I T Q S F S I Y - - - - - - -GGQAG LY DY G P PGCAVKAN L I N LWRQH FV LN EDMS EVDCV SVT P EQV LKA SGHVA
RAKMED L LKR R F FY DQ S FA I Y - - - - - - -GG I T GQYD FG PMGCA LK SN I LA LWRQY FA L E EQML EVDC S I LT P E PV LKA SGHV E
R AKMED L LKR R F FY DQ S FA I Y - - - - - - -GG I T GQYD FG PMGCA LK SN I L S LWRQY FA L E EQML EVDC S I LT P E PV LKA SGHV E
QQQ I EQ I LKKR F F I T Q SAY I Y - - - - - - -GGV SG LY D LG P PG L S I K T N I L S LWR KH FV L E EDML E I ET T TML PHDV LKA SGHVD
KAK LD E I LKQRNMV I Q SY E I Y - - - - - - -GG I AG LY DMG P LGCA LKQN I LQ FWR KH FT T Y EN F F EV EG P I LT PKCV LAA SGHTA
R VKMEDT LKR R F FY DQA F S I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I I QAWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
RAKMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I I QTWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
R E S L E SV LKR R F FY A PA F E LY - - - - - - -GGV SG LY DY G P PGC S FQAN I VDVWRKH FV L E EDML EVDCTMLT PY EV LKT SGHVD
R T E F EDT CR R R F FY G LA FD PY - - - - - - -GGTAG LY D LG PTMCAMK SNMLH FWRQH FV I E E SMC EVDT T C LT P E EV FKA SGHVT
R AKMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I I QTWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
RGA LDT I LR R RMFY T P S F E I Y - - - - - - -GGV SG LY DY G P PGCA LQAN I I DAWR KH FV L EDDML EVDC SV LT PADV LKT SGHVD
Y EKV F E LAKR RG F LWN S F E LY - - - - - - -GG SRG FY DY G P LG ST LKR R I EQVWR E FY V I Q EGHME I EC PT I G I E EV F I A SGHVG
R VKMEDT LKR R F FY DQA FA I Y - - - - - - -GG EC E - - - -G PG LG S LA PWAV S SDR SV LR L PQ S LAGR R C S LGWP E - - - - - - - - - -
R AKMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I I QAWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
KGA L E SMLR R RMF FA P S FD I Y - - - - - - -GGVAG LY DY G P PGCA LQAN I I D I WR KH FV L E EDML EVDCTA LT PHDV LKT SGHVD
RQAVVNT L ER K L FY I P S FK I Y - - - - - - -R GVAG LY DY G P PGCAVKANV LA FWRQH FV L E ENML EVDC PCVT P EVV LKA SGHV E
R AK LGQ L L EGR L FY I P S FK I Y - - - - - - -GGVAG LY DY G P PGCAVK SNVQQ FWRQH FV L E E SML EV EC PAVT P E PV LR A SGHV E
R AKMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I I QTWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
R EA L EQV I K R R F I Y Q PA F S LY - - - - - - -GGVAG LY DY G PVGCA I KT N I EQYWR EH F I I E ED L F E I AAT I LT P E PV LKA SGHVD
R E S L EQV LKR R F F FA PA FD I Y - - - - - - -GGV SG LY DY G P PGCA FQANVVDTWRKH FV L E EDML EVDCTMLT PHDV LKT SGHVD
R T K L EN LVKR K F FY TN S F E I Y - - - - - - -GGA SG L FDY G P SGC L LK S E L EN LWRCH F I Y Y D EML E I SG SCVT PY QV LKT SGHVD
R T K I DN LAKR K L FY TN S F E I Y - - - - - - -GG S SG L I DY G P SGC L LK S E L EN LWR Y H F I FY D EML E I SAT C I T PY T V LKT SGHVD
R SK L E S L I K R R L FY TN S F E I Y - - - - - - -GGV SG L I DY G P SGC L LKY E L EK LWRNH FV FY D EML E I KGT C I T PY SV LKT SGHVD
RQAVVNT L ER R L F F I P S FK I Y - - - - - - -R GVAG LY DY G P PGCAVK SNV LA FWRQH FV L E ENML EVDC PCVT P EVV LKA SGHVD
RAKMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PVGCA LKNN I I QTWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
RDK L E ST LR R R F FY T P S F E I Y - - - - - - -GGV SG L FD LG P PGCQ LQNN L I R LWR EH F I ME ENMLQVDG PMLT PY DV LKT SGHVD
R TQ F E E LMKKR F F F S P S FQ I Y - - - - - - -GG I SG LY DY G P PG SA LQ SN LVD I WR KH FV I E E SML EVDC SMLT PH EV LKT SGHVD
RAKMEDT LKR R FY Y DQ SY A I Y - - - - - - -GGV SG LY D FG PTGCAMKAN F I N I WRNH F I I E EGML EVD SA I LA P ENV FKA SGHV E
R T KMEDT LKR R F FY DQA FA I Y - - - - - - -GGV SG LY D FG PMGCA LKNN I LQVWRQH F I Q E EQ I L E I DCTMLT P E PV LKT SGHVD
R KY F ED L I K R R Y F FNQG F E I Y - - - - - - -GGVAG LY DY G P PGCA I KNN L LK LWR EH F I L E EDML E I S ST C I T PY PV FKA SGHVD
KVDC EN L LR R R F FY TN S F E I Y - - - - - - -GG SAG L FD FG P PGCA LK S E L ER LWR EH FVV FD EML EV SCT C I T PH PV LK S SGHVD
KVDC EN L LR R R F FY AN S F E I Y - - - - - - -GG SAG L FD FG P PGCA LK S E L ER LWR EH F I V FD EML EV SC SC I T PH PV LK S SGHVD
RATA ED L EV SG F FWV P S F E I Y - - - - - - -G SVAG I Y D LG PT GCA I ER N F LQKWRDH FV L EDDML EVR C SA LT PR PV LDA SGHT E
R S E F EDT CR R R F F FG LA FD PY - - - - - - -GG SAG LY DMG P P LCAMKAN L LAHWRQH FV LA E SMC EVDT T C LT PQ EV FVT SGHVT
R A E F EDT CR R R F F FG LA FD PY - - - - - - -GG SAG LY D LG P P LCAMKAN L L SYWRQH FV L E ENMC EVDT T S LT P E EV FKA SGHVV
R SQ L EV LMT KR F FY I Q S F E I Y - - - - - - -GGVGG LY DY G PTGAA LQAN I I NQWRNH F I I E E EML E LDT T I MT L SDV LKT SGHVD
R ET LDAV LKR R F FY A PA F E I Y - - - - - - -DGV SG LY DY G P PGCA LQT R I I DTWRDH FV L EDDML EVDT TMLT PH EV LKT SGHVD
























































R FAD LMT KDVKNG EC FR LD P I T GND LT E P I E FN LMFGTQ I G P LR P ET AQG I FVN FKR L L E F -NQGR L P FAAAQ I GN S FR N E I S
K FTD LMVKD EKTGTCY R AD PDT KN P L SD PY P FN LMFQT S I G PMR P ET AQG I FVN FKD LY Y Y -NGKK L P FAAAQ I GQA FRN E I S
K F SDWMCQD PK SG E I FR AD PVTG ET L E P PKA FN LMF ET A I G P LR P ET AQGQ F LN FNK L L E F -NNGKT P FA SA S I GK S FR N E I S
K FADWMCKD PKTG E I FR AD PT TDGN L L P PVA FN LMFQT S I G P LR P ET AQGQ F LN FQK L L E F -NQQ SMP FA SA S I GK S FR N E I S
K F EDWMCKD FKKGD F LR AD PDGDA PV S S PV P FN LMFKT T VG P LR P ET AQGQ F LN FKK L LDY -NQN SMP FA SA S I GK S FR N E I S
R FAD LMT KD I KT G EC FR LD P I SGND LT P P I E FN LMFNTQ I G P LR P ET AQG I FVN FKR L L E F -NQGR L P FAAAQ I GN S FR N E I S
K FAD FMVKD LKNG EC FR AD PT TGND L S P PV P FN LMFKT F I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
R FADWMVKDT KNG EC FR AD P I T GND LT E P I A FN LMF PTQ I G P LR P ET AQG I FVN FKR L L E F -NQGK L P FAAAQ I G LG FRN E I S
R FADWMVKDMKNG EC FR AD P I T GND LT E P I A FN LMF PTQ I G P LR P ET AQG I FVN FKR L L E F -NQGK L P FAAAQ I G LG FRN E I S
R F SDWMCKD LKTG E I FR AD P ST GGK L E P PV E FN LMFDTA I G P LR P ET AQGQ F LN FNK L L E F -NNDKMP FA SA S I GK S FR N E I A
K F SDWMCRD LKTG E I FR AD PVTG E P L E P PMA FN LMF ET A I G P LR P ET AQGQ F LN FNK L L E F -NNGKT P FA SA S I GK S FR N E I S
K FAD FMVKDVKNG EC FR AD PNTGND L S P PV S FN LMFKT F I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
R FAD LMVKD EKTGAC FR AD PVTGN E I SD PMD FN LMFQT T I G P LR P ET AQG I F LN FKR L L E F -NQGK L P F SAVQ I GMS FRN E I S
K FADWMVKDVKNG E I Y R AD PT TGN EV S E PV E FN LMF E SN I G P LR P ET AQGH FVN FAR L L E F -NNGKV P FA SAQ I GK S FR N E I A
R FTD SMI T D I K T N EY Y R AD P - SGG EWS E PY P FN LMFR T K I G PMR P ET AQG I FVN FKR LY EY -NGKK L P F SVAQ I G LG FRN E I A
R FTD SMI T D I K T N EY Y R AD P - SGG EWS E PY P FN LMFR T K I G PMR P ET AQG I FVN FKR LY EY -NGKK L P F SVAQ I G LG FRN E I A
K FADYMVKDVKNG EC FR AD P ST GND LT P P I S FN LMFQT S I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
K FADWMCRD LKTG E I FR AD PATDG P L E L P I E FN LMF ET A I G P LR P ET AQGQ F LN F SK L LDC -NN EKMP FA SA S I GK S FR N E I S
K FAD FMVKD EVT KA F FR AD P ET GNA LT E PY P FN LMFQTQ I G P LR P ET AQG I FT N FGK LY EY -NGKK L P FAAAQ I GNA FRN E I A
R FAD LMVKDVKTG EC FR LD P LT GND LT E P I E FN LMFATQ I G P LR P ET AQG I FVN FKR L L E F -NQGK L P FAVAQ I GN S FR N E I S
R FAD LMVKDVKTG EC FR LD P LT GND LT E P I E FN LMFATQ I G P LR P ET AQG I FVN FKR L L E F -NQGK L P FAVAQ I GN S FR N E I S
K FCD I LV FD EV SGDC FR ADT - LGNK L SK SQQ FN LMFGTQ I GY LR P ET AQGQ F LN FKK LC EY -NNDK L P FA SA S I GKAY RN E I S
K F SDYMVKD LKNGCCY R AD PDTGND L S E P LA FN LMFATD I G P LR P ET AQG I FTMFKRN L E F -NGGKV P FGVTQ I GNV FRN E I A
K FAD FMVKDMKNG EC FR AD P I T GND L S P PV S FN LMFKT S I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
K FAD FMVKDVKNG EC FR AD P I T GND L S P PV S FN LMFKT F I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
K F SDWMCKD PKTG E I FR AD PV SGDK L E P PR A FN LMF ET A I G P LR P ET AQGQ F LN FNK L L E F -NNGKT P FA SA S I GK S FR N E I S
R FNDVMVRDT VTG EC I R AD P -KGN P F SD P F P FN LMFATH I G PMR P E LAQG I I LN FKR LMD SGNAQRMP FAGACVGTA FRN E I A
K FAD FMVKDVKNG EC FR AD P I T GND L S P PV S FN LMFKT F I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
K FADWMCKD PKTGD I FR AD PATG L L PT P PV S FN LMF ST S I G P LR P ET AQGQ F LN FAK L L EY -NNQQMP FA SA S I GK SY RN E I S
G F SD P LC ECMNCK EA FR AD P ECGG E F EDAY E FN LMFKT T I G P LR P ET AQGMFVD FQR L SR F -Y RDK L P FGAVQ I GK SY RN E I A
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - SWAWR R EVAG LC PAWPR A L LC - - - - LGT T - PGGR LAVA - - - - - - - - - - - - -
K FAD FMVKDVKNG EC FR AD PT TGND L S P PV P FN LMFQT F I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
K FADWMCKD PKNGD I LR AD PATGVQ P E P PVA FN LMFQTA I G PMR P ET AQGQ F LN FAK L L EY -NAGNMP FA SA S I GK SY RN E I A
K FTD LMVKD EKTGTCY R AD PDT KN P L SD PY P FN LMFQT S I G PMR P ET AQG I FVN FKD LY Y Y -NGQK L P FAAAQ I GQA FRN E I S
K FTD LMVNDVVT KDC FR AD PVTGND L S E PY P FN LMF PTQ I G P LR P ET AQG I FVN FRD L LY Y -NGGK L P FAAAQ I GQ S FRN E I A
K FAD FMVKDVKNG EC FR AD P I T GND L S P PV S FN LMFKT F I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
R FT D L LVCD SKTGTGY R AD P ET GND LTD PT P FN LML PT I I G P LR P ET AQGMF LN FAR L L EQ -NGGR V P FGAAQ I G LG FRN E I A
K FADWMCKD LKTG E I FR AD PATGGK L E P PV E FN LMF ET A I G P LR P ET AQGQ F LN FAK L L E F -NN EKMP FA SA S I GK S FR N E I A
R FTD LMI R DVVTNDCY R AD P - LKND L S E P F P FN LMFQT K I G P LR P ET AQG I FVN FKK L L EY -NGGKT P FAGAQ LG LG FRN E I S
R FT D LMI R DAVTGD FY R AD P -GKND FVG P F P FN LMFQT R I G P LR P ET AQG I FVN FKK L L EY -NGGKMP FAGAQ I G LG FRN E I S
R FT D LMI KD I VT KDCY R AD P - EKND L SD P F P FN LMFQT K I G P LR P ET AQG I FVN FKK L L EY -NGGKMP FAGAQ I G LG FRN E I S
K FTD LMVKD EKTGTCY R AD PDT KN P L SD PY P FN LMFQT S I G PMR P ET AQG I FVN FKD LY Y Y -NGNK L P FAAAQ I GQA FRN E I S
K FAD FMVKDVKNG EC FR AD PT TGND L S P PV P FN LMFQT F I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
K FTDWMCRN PKTG EY Y R AD PVTNDV LDA LT S FN LMF ET K I GA LR P ET AQGQ F LN FNK L L E I -NQGK I P FA SA S I GK S FR N E I S
K FADWMCKD PATG E I FR AD PATNG E L ET PRQ FN LMF ETQ I G P LR P ET AQGQ F LN F SR L L E F -NNGKV P FA SAMVGKA FRN E I S
R FAD FMVKDGKTG EC FR AD PT TNND L SD PME FN LMFAT A I G P LR P ET AQG I FVN FKR L L E F -NQGR L P FGAAQ I GT A FRN E I S
K FADYMVKDVKNG EC FR AD PT TGND LT P P I S FN LMFQT S I G P LR P ET AQG I F LN FKR L L E F -NQGK L P FAAAQ I GN S FR N E I S
R FT D LMVKDVKNGAGHRAD PDTGN E LG F P E P FN LMFGT P I G P LR P ET AQGMFVN FNR LN E F -NGGR I P FAAAQ I G LG FRN E I A
R FTD LMVKN L SNGDCY R AD P - EGD E F SK P F P FN LMF ST S I G P LR P ET AQG I FVN FNR L L E F -NGGK I P FAAAQ I G LG FRN E I S
R FT D LMVKN L SNGDCY R AD P - EGND F SK P F P FN LMF ST S I G P LR P ET AQG I FVN FT R L L E F -NGGK I P FAAAQ I G LG FRN E I S
K FND LMLTDMT T KA LY R AD P - EGN E F S E PA P FN LMFNT R VG P LR P ET AQG I FVN FT R L LNA -NRG S L P FAAAQVGAGY RN E I S
R FNDVMVRDT VTG EC I R AD P -KGNA L SD P F P FN LMF ST S I G PMR P E LAQG I I LN FKR L LDTGNAQRMP FACA S I GT A FRN E I A
R FNDAMVRDT VTG EC I R AD P -KGNA L S E P F P FN LMF ST S I G PMR P E LAQG I I LN FKR L LD SGNAQRMP FAGAC I GT A FRN E I A
K FADWMCKDT KTG E I FR AD P E SGN EV S E PV E FN LMF E SY I G P LR P ET AQGH FVN FQR L L E F -NNGR V P FA SAQ I GK S FR N E I S
K FADWMCRD LA SG E I FR AD PVTGG P L EK PME FN LMF ET A I G P LR P ET AQGQ F LN FNK L LDC -NNT KMP FA SA S I GK S FR N E I S
























































PR SG L I R VR E FTMC E I EH FCD PQ -AKNH PK F ENVADT VMT LY SACNQAV - -A SG LVAN ET LGY FMAR I QMY LHR I G I L P ER LR
PRQG L LR VR E FT LA E I EH FVD P E -NK SH PK F SDVAK L E F LMF PR E EQAV - -AKGT VNN ET LGY F I GR VY L F LT R LG I DK ER LR
PR SG L LR VR E F LMA E I EH FVD P E -NKNH PR FD EVKN LK LK F L PKGVQAV - -A SGMI DNQT LGY F I AR I Y Q F LT K I GVD E EK LR
PR AG L LR VR E F LMA E I EHY VD P EGGKKHHR F E EVKD I EMA F LNRNVQAV - - ET GMVDN ET LGY F I AR I Q L F L LK LGVD PNK LR
PR SG L LR VR E F LMA E I EH FVD P EGGKKHAK FD LVKD LQ L S F LDR ATQAV - - S SKMVDN ET LGY F LGR I Y I F L LK I GVDTNKVR
PR SG L LR VR E FTMC E I EH FCD - - -VK EH PK F E SVKNTQML LY SADNQAV - - SKG I VNN ET LGY FMAR I HMYMLAVG I D PKR LR
PR SG L I R VR E FTMA E I EH FVD P S - EKDH PK FQNVAD LY LY LY SAKAQAV - - EQGV I NN SV LGY F I GR I Y LY LVKVGV S P EK LR
PRQG L I R VR E FTMC E I EH FVD P E -DKR F PK FAKVAD EK LV L F SACNQAV - -ANKT VAN ET LGY YMARCHQ F LMKVG I DGR R LR
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FRQHMGN EMAHY ACDCWDA EC LT - SY GWI ECVGCADR SAY D LTQHTNAT - - - - - - -GVK LVA EKK L PA PKAA I GKA FKK EAKA
FRQH LAN EMAHY AADCWDA E I E S - SY GWI ECVG I ADR SAY D LR AH SDK S - - - - - - -GT P LVA E EK FA E PKK E LG LA FKGNQKN
FRQHMSN EMAHY ATDCWDA E LKT - SY GWI ECVGCADR SAY D LT VHANKT - - - - - - -KT A LVVR EK LDV PKK L FG PK FR KDA PK
FRQHMAN EMAHY AADCWDA E L LT - SY GWI ECVGCADR SAY D LT VHKNKT - - - - - - -GA P LVVR E PR A E PKKK FG PR FKKDGKA
FRQHMAN EMAHY ATDCWDA E LQT -T Y GWI ECVGCADR SAY D LT VH SR KT - - - - - - -K E P LVVR E PR R E PK PK LG P L FKKNAKA
FRQHMGN EMAHY ACDCWDA EC L S - SY GWI ECVGCADR SAY D LTQHT KAT - - - - - - -G I R LAA EKK L PA PKAA I GKA FKKD SQA
FRQHMEN EMAHY ACDCWDA E SKT - SY GWI E I VGCADR SCY D L SCHARAT - - - - - - -KV P LVA EK P LK E PKGA I GKAY KKDAK L
FRQH L SN EMAHY AQDCWDA E I LT - SY GWI ECVGNADRACYD LQQHY KAT - - - - - - -NVK LVA EKK L P E PMA L LGKKY KK EAKK
FRQH L SN EMAHY AQDCWDA E I LT - SY GWI ECVGNADRACYD LQQHY KAT - - - - - - -NVK LVA EKK L P E PMA L LGK S FKKDAKK
FRQHMSN EMAHY A SDCWDA E L ET - SY GWI ECVGCADR SAY D L SVH SAR T - - - - - - -G EK LVARQT LA E PKKK FG PK FR KDAGT
FRQHMAN EMAHY AADCWDA E LKT - S FGWI ECVGCADR SAY D LT VHANKT - - - - - - -K EK LVVRQK L ET PKK L FG PK FR KDA PK
FRQHMEN EMAHY ACDCWDA E SKT - SY GWI E I VGCADR SCY D L SCHARAT - - - - - - -KV P LVA EK P LK E PKGA I GKAY KKDAK L
FRQHMQN EMAHY ACDCWDA ECKT - SY GWV ECVGCADR SCY D LKCH SQAA - - - - - - -KVN L SA ER P L P E PKQAVGKA FKKDAKK
CRQHMAN EMAHY ATDCWD F E I Q S - SY GWI ECVGCADR SAY D LT VH SVR T - - - - - - -KQ P LR VQQR LDQ PAKA FGMK FKKDATM
FRQH L ST EMAHY A SDCWDA EV LT - SY GWI ECAGHADR SCY D L LQH SKAT - - - - - - -KTD L FA S EKY D E PK P L I GKT FKQ EA S L
FRQH L ST EMAHY A SDCWDA EV LT - SY GWI ECAGHADR SCY D L LQH SKAT - - - - - - -KTD L FA S EKY D E PK P L I GKT FKQ EA S L
FRQHMDN EMAHY ACDCWDA ET KT - SY GWI E I VGCADR SCY D L LCHARAT - - - - - - -KV P LVA EK P LK E PKGA I GKAY KKDAK F
FRQHMSN EMAHY AADCWDA E LHT - SY GWI ECVGCADR SAY D L SVH SAR T - - - - - - -N EK LVVRQ P L P E PKKK FG PK FR KDAGT
FRQHQKN EMAHY AQDCWDA E I L S - SY GWV ECVGHADR SCY D LKVHAT E S - - - - - - -K SN L SAY E E FK E P PGA I SKKHRAAV S P
FRQHMSN EMAHY ACDCWDA E I LT - SY GWV ECVGCADR SAY D LGQHTAAT - - - - - - -GVR LVA EKR L PA PKQA LGKT FKK EAKN
FRQHMSN EMAHY ACDCWDA E I LT - SY GWV ECVGCADR SAY D LGQHTAAT - - - - - - -GVR LVA EKR L PA PKQA LGKT FKK EAKT
FRQHKKD EMAHY AKGCWDA E I Y T - SY GWI ECVG I ADR ACY D L SCH EDG S - - - - - - -KVD LR CKR R LA E PKK EWGAK LRDR F SV
FRQH LKT EMAHY AKDCWDA E I R L - SY GWV ECVGHADRGD FD L SNHARC S - - - - - - -KVDQ SV F I AY D E PKGVMGKKY KKD SQK
FRQHMEN EMAHY ACDCWDA E SKT - SY GWI E I VGCADR SCY D L SCHARAT - - - - - - -KV P L I A EK L LK E PKGA I GKAY KKDAKV
FRQHMEN EMAHY ACDCWDA E SKT - SY GWI E I VGCADR SCY D L SCHARAT - - - - - - -KV P LVA EK P LK E PKGA I GKAY KKDAK L
FRQHMAN EMAHY AADCWDA E LQT - SY GWI ECVGCADR SAY D LT VH SNKT - - - - - - -K EK LVVR EA L ET PKK L FG PK FR KDA PK
FRQHQ ST EMAHY AQDCWDA E L LT - SY GWI ECVG I ADR SAY D LTQH SNA S - - - - - - -KKD LCAR E EY D E PKG L I GKT FGKKAG E
FRQHMEN EMAHY ACDCWDA E SKT - SY GWI E I VGCADR SCY D L SCHARAT - - - - - - -KV P LVA EK P LK E PKGA I GKAY KKDAK L
FRQHMAN EMAHY ACDCWDA E L LT - SY GWI ECVGCADR SAY D L SVHAKKT - - - - - - -NA P L I V RQR L P E PKKK FG PK FKKDAKA
FRQH LTD EMAHY A I DCWDA E I ET DR FGWV E I VG I ADR TDYD LKAHAR V S - - - - - - -KTD LY VY V EY D E PMGK LG P L FKGKAKA
FRQHMDN EMAHY ACDCWDA EAR T - SY GWI E I VGCADR SCY D LT CH SR AT - - - - - - -KV P LVA EK L LR E PKAA I GR T Y KKDAR L
FRQHMEN EMAHY ACDCWDA E SKT - SY GWI E I VGCADR SCY D L SCHARAT - - - - - - -KV P LVA EK P LK E PKGAVGKAY KKDAK L
FRQHMGN EMAHY ACDCWDA E L LT - S SGWV ECVGCADR SAY D LT VHAKKT - - - - - - -GA P LVVR ET L ET P SKK FG PT FR KDAKT
FRQH L PN EMAHY AADCWDA E I EC - SY GWI ECVG I ADR SAY D LR AH SDK S - - - - - - -GV P LVAH EK F SK PKKD LG LA FKGNQKM
FRQH LKH EMAHY AADCWDA E I QC - SY GWI ECVG LADR SA FD LKAH SDK S - - - - - - -KVD LVAY ER FDK PKKV LGKA FKKDAK P
FRQHMEN EMAHY ACDCWDA E SKT - SY GWI E I VGCADR SCY D L SCHARAT - - - - - - -KV P LVA EK P LK E PKGA I GKAY KKDAK L
FRQHQAD EMAHY S SDCWDA E I EM- S SGWV ECVG LADR SAY D LNAH S EAT - - - - - - -GQK LQAAR K FKV PKQK I GK E LKKDGMA
FRQHMGN EMAHY A SDCWDA E LQT - SY GWI ECVGCADR SAY D L SVHAAR T - - - - - - -NA S LVVRQ P L P E PKKK FG PK FKKDGGA
FRQH LKT EMAHY ANDCWDA E I LT - S FG F I EVVGHADR SAY D LQHHMKY T - - - - - - -GAN LY AC EKY N E PKAK I GHT FK S EQNK
FRQH L PT EMAHY ANDCWDA E I LT - SY G F I EVVGHADR SAY D LKNHMKVT - - - - - - -GAN LY AC EKY DT PKAKMGMK FK SQQNV
Y RQH L EK EMAHY ANDCWDA E I LT - SY GY I ECVGHADR SAY D LKHHMNAT - - - - - - -G SN LY GCQKYDK PKAK I GMK FK SDQNK
FRQH LAN EMAHY AADCWDA E I E S - SY GWI ECVG I ADR SAY D LR AHTDK S - - - - - - -GV P LVAH EK F S E PKK E LG L S FKGNQKK
FRQHMEN EMAHY ACDCWDA E SKT - SY GWI E I VGCADR SCY D L SCHARAT - - - - - - -KV P LVA EK P LK E PKGAVGKAY KKDAK L
FRQH LKN EMAHY ATDCWDG E I LT - SY GWI ECVGCADRAA FD LT VH SKKT - - - - - - -GR S LT VKQK LDT PKK F FG SK FKQKAK L
FRQHMSN EMAHY ACDCWDA E I QC - SY GWI ECVGCADR SAY D L SVH SKAT - - - - - - -KT P LVVQ EA L P E PR KK FG PR FKRDAKA
FRQHMFN EMAHY ATDCWDA ET KT - SY GWV ECVGNADR SCY D LT CHAKH S - - - - - - -KVAMVA EKK L P E PK SVMGKA FKK EAKV
FRQHMDN EMAHY ACDCWDA ET KT - SY GWI E I VGCADR SCY D LACHAR VT - - - - - - -KV P LVA EK P LK E PKGA LGKAY KKDAK I
FRQHMSN EMAHY ACDCWDA E I E F - SHG FK ECVG LANR SA FD L E SHT KG S - - - - - - -GVK L LAAR R L P E PKK E I FKA LKGDGN E
FRQHMAN EMAHY A SDCWDA E I LT - SY GWV EVVGHADRMAYD LMCH SK ST - - - - - - -N SQ LVAHHR Y DN PK P E I GKA FK SDQK I
FRQHTAN EMAHY A SDCWDA E I LT - SY GWV EVVGHADRMAYD LMCH SK ST - - - - - - -N SQ LVAHHR Y DT PK P E I GKA FKADQK I
FRMHR KN EMAHY AR ECWDA E I Y T KT LGWL ECVG I ADRQ SWD L SRHAKY T T KKGDA E S S P LY L SA P LDT PK SA I GK I FR KDAK E
FRQH LRN EMAHY AQDCWDA E L LT - SY GWV ECVGVADR SAY D LTQH SGAT - - - - - - -KKD LCAR E E FA E PKGA I GKA FGKNAGD
FRQHQRD EMAHY AQDCWDA E L LT - SY GWV ECVG I ADR SAY D LTQH SAA S - - - - - - -KKD L FAR E E FA E PKGA I GKA FGKNAG E
FRQHMSN EMAHY A SDCWDA E I HT - SY GWI ECVGCADR SAY D LT VH SKR T - - - - - - -KKD LVVQKAHK E PKKN LG PK FKKDAK F
FRQHMSN EMAHY ATDCWDA E LHT - SY GWI ECVGCADR SAY D L SVH EAR T - - - - - - -KVK LQVQQK LDA PKKK FG P L LKKAAK P
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L S FVDKD - - -Q L E PGC SV L LNHKVHAVVGV LGDDTD PMVT VMK L EKA PQ ET Y AD I GG LDTQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDKD - - -Q L E PGC S I LMHNKV L SVVG I LQD EVD PMV SVMKV EKA P L E SY AD I GG L EAQ I Q E I K EAV E L P LT H P E LY ED I G
L S FVDK E - - - L L E PGC SV L LHHKTMS I VGV LQDDAD PMV SVMK I DK S PT E SY ND I GG L EAQ I Q E I K EAV E L P LT H P E LY E EMG
MS FVDKD - - - L L E PGA S I L LHHK SV SVVGV LT E E SD P LV SVMK LDKA PT E SY AD I GG L E SQ I Q EVR E SV E L P L LH P E LY E EMG
MS FVDKD - - - L L E PGA S I L LHHK SV SVVGV LT E E SD P LV SVMK LDKA PT E SY AD I GG L ETQ I Q EVR E SV E L P L LH P E LY E EMG
- - - - - - - - - - - - - - - - - - - - - -KVHAVVGV LGDDTD PMV SVMK L EKA PQ ET Y AD I GG LDTQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
MS FVDK E - - -Q L E PGC SV L LNHKNHAV I GV L SDDTD PMV SVMK L EKA PQ ET Y ADVGG LDQQ I Q E I K EAV E L P LT H P EY Y E EMG
MS FVDK E - - -Q L E PGC SV L LNHKNHAV I GV L SDDTD PMV SVMK L EKA PQ ET Y ADVGG LDQQ I Q E I K EAV E L P LT H P EY Y E EMG
MS FVDKG - - - L L E PGC SV L LHHKT VAVVGV LQDDAD PMV SVMK LDK S PT E SY AD I GG L E SQ I Q E I K E SV E L P LT H P E LY E EMG
L S FVDK E - - - L L E PGC SV L LHHKTMS I VGV LQDDAD PMV SVMK I DK S PT E SY SD I GG L E SQ I Q E I K E SV E L P LT H P E LY E EMG
L S FVDKD - - - L L E LGC SV L LNHKVHAV I GV LMDDTD P LV I VMKV EKT PQ ET Y AD I R A LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDKD - - - L L E PGCT V LMNHKVHAVVG F LGDDVD P LVT VMK L EKA PK E SY AD I GG LDTQ I T E I K E SV E L P LT H P EY Y E EMG
MS FVDKD - - - L L E PGC SV L LHHKTHAVVGV LADDTD PMV SVMK LDKA PT E SY AD I GG L E SQ I Q E I K E SV E L P LT H P E LY E EMG
L S FVDKN - - -Q L E PG S SV L LHNKVY SVVG I MND EVD P LV SVMKVDKA P L E SY AD I GG L EQQ I Q E I K EAV E I P LT H P E LY DD I G
L S FVDKN - - -Q L E PG S SV L LHNKVY SVVG I MND EVD P LV SVMKVDKA P L E SY AD I GG L EQQ I Q E I K EAV E I P LT H P E LY DD I G
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
MS FVDKG - - - L L E P SC SV L LHHKT V S I VGV LQDDAD PMV SVMK LDK S PT E SY AD I GG L E SQ I Q E I K EAV E L P LT H P E LY E EMG
MS FVDK S - - -K LY LGAT V L LNNKT L SVVGV I DG EVD PMVNVMKV EKA PT E SY SD I GG L EAQVQ EMK EA I E L P LT H P E LY E E I G
L S FVDKD - - -Q L E PGC SV L LNHKVHAVVGV L SDDTD PMVT VMK L EKA PQ ET Y AD I GG LDTQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDKD - - -Q L E PGC SV L LNHKVHAVVGV L SDDTD PMVT VMK L EKA PQ ET Y AD I GG LDTQ I Q E I K E SV E L P LT H P EY Y E EMG
MS FVDKD - - - L L E PGCT V L LNY KDN SVVGV L EG EMD PMVNVMK L EKA P S ET Y AD I GG L E EQ I Q E I K E SV E L P LT N P E LY Q EMG
L S I VDR E - - - L L E PGVQV LTHNHNKA I VGV LQND ED PHV SVMKVDKA P L E SY ADVGG L EKQ I Q E I K EAV E L P L SH P E LY E E I G
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMK L EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDK E - - - L L E PGC SV L LHHKTMSVVGV LQDDAD PMV SVMKMDK S PT ENY SD I GG L EAQ I Q E I K EAV E L P LT H P E LY E EMG
MS FVDK E - - -Q L E LGC SV L LHDRQH S I VGV LKDDVD P LV SVMKVDKA P EDT Y AD I GG L EQQ I Q E I K EAV E F P L SH P E LY D E I G
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
MS FVDKD - - - L L E PGA SV L LHHK SV S I VGV LTDDAD P LV SVMK LDKA PT E SY AD I GG L EQQ I Q EVR E SV E L P L LH P E LY E EMG
LTQ I P E EC LGK I E PGMR VAVN -GAY S I I S I V SR AADVRAQVME L I N S PGVDY SMI GG LDDV LQ EVR E SV E L P LT E P E L F ED LG
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
MS FVDKD - - - L L E PGA SV L LHHK SV S I VGV LTDDTD PAV SVMK LDKA PT E SY AD I GG L EQQ I Q EVR E SV E L P L LH P E LY E EMG
L S FVDKD - - -Q L E PGC S I LMHNKV L SVVG I LQD EVD PMV SVMKV EKA P L E SY AD I GG LDAQ I Q E I K EAV E L P LT H P E LY ED I G
A S FVDK S - - -Q L E PGCAV L LHHKN SAVVGT LADDVD PMV SVMKVDKA P L E SY ADVGG L EDQ I Q E I K EAV E L P LT H P E LY ED I G
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
MS FVDKD - - -Q L E PGC SV L LNQR SY AVVG I MQD E I D P L LNVMKVDKA P L E SY AD I GG L EQQ I Q E I K EAV E L P LT H P E I Y EDMG
MS FVDKG - - - L L E PGC SV L LHHKT V SVVGV LQDDAD PMV SVMK LDK S PT E SY AD I GG L E SQ I Q E I K EAV E L P LT H P E LY E EMG
L S FVDKD - - - L L E PGC SV L LNNKTN SVVG I L LD EVD P LV SVMKV EKA P L E SY AD I GG L E SQ I Q E I K EAV E L P LT H P E LY ED I G
L S FVDKD - - - L L E PGC SV L LNNKTN SVVG I L LD EVD P LV SVMKV EKA P L E SY AD I GG L E SQ I Q E I K EAV E L P LT H P E LY ED I G
L S FVDKD - - - L L E PGC SV L LNNKTN SVVG I L LD EVD P LV SVMKV EKA P L E SY AD I GG L E SQ I Q E I K EAV E L P LT H P E LY ED I G
L S FVDKD - - -Q L E PGCA I LMHNKV L SVVG L LQD EVD PMV SVMKV EKA P L E SY AD I GG LDAQ I Q E I K EAV E L P LT H P E LY ED I G
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDK E - - - L L E PGC SV L LHHKTMS I VGV LQDDAD PMV SVMKMDK S PT E SY SD I GG L E SQ I Q E I K E SV E L P LT H P E LY E EMG
MS FVDKD - - -ML E PGC SV L LHHKAMS I VG L L LDDTD PMI NVMK LDKA PT E SY AD I GG L E SQ I Q E I K EAV E L P LT H P E LY E EMG
L S FVDKD - - -Q L E PGCT V L LNHKV LA I VGV LGDDTD PMV SVMK L EKA PQ E SY AD I GG LDTQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDKD - - - L L E PGC SV L LNHKVHAV I GV LMDDTD P LVT VMKV EKA PQ ET Y AD I GG LDNQ I Q E I K E SV E L P LT H P EY Y E EMG
L S FVDKD - - -Q L E PG ST V L LNNR TMAVVG I MQD EVD PMLNVMKV EKA P L ECY AD I GG L EQQ I Q EVK EAV E L P LT H P E I Y EDMG
L S FVDK E - - - L L E PGC SV L LHNKTN S I VG I L LDDVD P LV SVMKV EKA P L E SY DD I GG L E EQ I Q E I K EAV E L P LT R P E LY DD I G
L S FVDK E - - - L L E PGC SV L LHNKTN S I VG I L LDDVD P LV SVMKV EKA P L E SY DD I GG L E EQ I Q E I K EAV E L P LT R P E LY DD I G
S S FVDR K - - -A LQ I GC SV L LH EKA LT I VG L LDDDAN P LVDVMKV ENA P L E S FAD I GG L EDQ I VD I K EAV E L P LT H P EQ FD E I G
L S FVDK E - - -K L E LGC SV L LHDR Y HNVVG L L E SNTD P LV SVMKVDKA PQ ET Y AD I GG L EDQ I Q E I K EAV E F P L SH P E L FD EVG
L S FVDK E - - -K L E LGC SV L LHDRQH SVVGV LQN S I D PHV S I MKV EKA PQ ET Y AD I GG L E EQ I Q E I K EAV E F P L SH P E LY D EVG
MS FVDKD - - - L L E PGC SV L LHHKAMA I VGV L SDDAD PMV SVMK LDKA P S E SY AD I GG L ETQ I Q E I K EAV E L P LT H P E LY E EMG
MS FVDKD - - - L L E PGC SV L LHHKT V SVVGV LQDDAD PMV SVMK LDKA PT E SY AD I GG L E SQ I Q E I K E SV E L P LT H P E LY E EMG
























































I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DAVGT KR Y D SN
I K P PKGV I LY G E PGTGKT L LAKAVAN ST SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VADD L S P S I V F I D E I DAVGT KR Y DAN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LCRQ I FKVAA ENA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LVRQ I FQVAA EHA P S I V F I D E I DA I GT KR Y D ST
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LVRQ I FQVAA EHA P S I V F I D E I DA I GT KR Y D ST
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DAVGT KR Y D SN
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I R P PKGV I LY GC PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PKMVR E L FR VA E ENA P S I V F I D E I DAVGT KR Y D SN
I R P PKGV I LY GC PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PKMVR E L FR VA E ENA P S I V F I D E I DAVGT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LCRQ I FQ I AADHA P S I V F I D E I DA I GT KR Y E ST
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LCRQ I FKVAA ENA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG SQ L I QKY LGNG PK L I R E L FR VV E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y E SN
I R P PKGV I LY GV PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PK LVR E L FR VA E ENA P S I V F I D E I DA I GT KR Y D ST
I K P PKGV I LY G P PGTGKT L LAKAVAN ET SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E ENA P S I V F I D E I DAVGT KRHD SQ
I K P PKGV I LY G P PGTGKT L LAKAVAN ET SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E ENA P S I V F I D E I DAVGT KRHD SQ
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LCRQ I FQ I AG E LA P S I V F I D E I DA I G SKR Y E S S
I K P PKGV I LY G E PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VAD ECA P S I V F I D E I DAVGT KR Y D SQ
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DAVGT KR Y D SN
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DAVGT KR Y D SN
I K P PKGV I LY G L PGTGKT L LAKAVANQT SAT F LR VVGT E L I Q EY LG EG PK LVR E L FR VADMHA P S I I F I D E I DA I GGKR Y NT S
I K P PKGV I LY G P PGTGKT L LAKAVAN ET SAT F LR I VG S E L I QKY LGDG PK LVR E L FQAAKD SA P S I V F I D E I DAVGT KR Y DAH
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHG P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LCRQ I FKVAA ENA P S I V F I D E I DA I GT KR Y E SN
I K P PKGV I LY GV PGTGKT L LAKAVANR T SAT F LR VVG S E L I QKY SG EG PK LVR E L FR VA E EH S PA I V F I D E I DA I GT KR Y DTD
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LVRQ L FQVAA ENA P S I V F I D E I DA I GT KR Y D ST
I E P P SGV L LHGA PGTGKT L I AKA I A SQAKAT F I RMSG SD LVQK FVG EG SR LVKD I FQ LARDK S P S I L F I D E I DAVG SMR T Y DG
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LVRQ L FQVAA ENA P S I V F I D E I DA I GT KR Y D ST
I R P PKGV I LY G E PGTGKT L LAKAVAN ST SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VAD E L S P S I V F I D E I DAVGT KR Y DAH
I K P PKGV I LY GA PGTGKT L LAKAVAN ST SAT F LR I VG S E L I QKY LGDG PK LVR E L FR VAD EMS P S I V FMD E I DAVGT KR Y D SQ
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY G E PGTGKT L LAKAVAN ET SAT F LR VVG S E L I QKY QGDG PK LVR E L FR VA E EHA P S I V F I D E I DAVGT KR Y D SH
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LCRQ I FQ I AG EHA P S I V F I D E I DA I GT KR Y E ST
I K P PKGV I LY G P PGTGKT L LAKAVAN ET SAT F LR VVG S E L I QKY LGDG PK LVR EMFKVA E EHA P S I V F I D E I DAVGT KR Y EAT
I K P PKGV I LY G P PGTGKT L LAKAVAN ET SAT F LR VVG S E L I QKY LGDG PK LVR EMFKVA EDHA P S I V F I D E I DAVGT KR Y EAT
I K P PKGV I LY G P PGTGKT L LAKAVAN ET SAT F LR VVG S E L I QKY LGDG PK LVR EMFKVA EDHA P S I V F I D E I DAVGT KR Y EAT
I K P PKGV I LY G E PGTGKT L LAKAVAN ST SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VADD L S P S I V F I D E I DAVGT KR Y DAH
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LCRQ I FKVAG ENA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PR LVRQ L FNAA E EH S P S I V F I D E I DA I GT KR Y DAQ
I R P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y E SN
I K P PKGV I LY G P PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VA E EHA P S I V F I D E I DA I GT KR Y D SN
I K P PKGV I MY G P PGTGKT L LAKAVAN ET SAT F LR I VG S E L I QKY AG EG PK LVR E L FR VA E EHA P S I V F I D E I DAVG SKR Y NT S
I K P PKGV I LY G P PGTGKT L LAKAVAN ET SAT F LR VVG S E L I QKY LG EG PK LVR EMFKVA EDNA P S I I F I D E I DA I GT KR Y DAT
I K P PKGV I LY G P PGTGKT L LAKAVAN ET SAT F LR VVG S E L I QKY LG EG PK LVR EMFKVA EDNA P S I I F I D E I DA I GT KR Y DAT
VQ P PKGV I L FG P PGTGKT L LAR AVAK ST SAT F LR VVG S E L I QKY LG EG PK LVR E L FKT AH E LA P S I V F I D E I DAVGT KR Y D ST
VK P PKGV I LY GV PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY SG EG PK LVR E L FR VA E EN S P S I V F I D E I DA I GT KR Y DTD
I K P PKGV I LY GV PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY SGDG PK LVR E L FR VA E EN S P S I V F I D E I DA I GT KR Y DTD
I R P PKGV I LY GV PGTGKT L LAKAVANQT SAT F LR VVG S E L I QKY LGDG PK LVR E L FR VAD EHA P S I V F I D E I DAVGT KR Y D SN
I K P PKGV I LY GA PGTGKT L LAKAVANQT SAT F LR I VG S E L I QKY LGDG PR LCRQ I FQ I AA EHA P S I V F I D E I DA I GT KR Y E ST
























































SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KR R I FN I HT ARMT LA EDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I LATNR I E S LD PA L LR PGR I DR K I E F P L PD I K T R R R I FQ I HT SKMT LA EDVN L
SGG ER E I QR TML E L LNQ LDG FD -DRGDVKV I MATNK I E S LD PA L I R PGR I DR K I L F EN PDV ST KR K I LG I HT SKMN L SADVD L
SGG ER E I QR TML E L LNQ LDG FD -DRGDVKV I MATNK I ET LD PA L I R PGR I DR K I L F EN PDQNT KKK I FT LHT SKMS LADDVD L
SGG ER E I QR TML E L LNQ LDG FD -DRGDVKV I MATNK I ET LD PA L I R PGR I DR K I L F EN PDQNT KKK I FT LHT SKMS LGDDVD L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KR R I FT I HT SRMT LADDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADDVT L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV LMATNR I E S LD PA L I R PGR I DR K I E F P L PD EKT KR R I FQ I HT SRMT LGDDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV LMATNR I E S LD PA L I R PGR I DR K I E F P L PD EKT KR R I FQ I HT SRMT LGK EVN L
SGG ER E I QR TML E L LNQ LDG FD -DRGD I KV I MATNK I E S LD PA L I R PGR I DR K I L F EN PDANT KKK I LT I HT SKMS LADDVN L
SGG ER E I QR TML E L LNQ LDG FD -DRGDVKV I MATNK I E S LD PA L I R PGR I DR K I L F EN PD L ST KR K I LG I HT SKMN L S SDVD L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADAVT L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I D S LD PA L I R AGR I DR K I E F PMPD EKT KR R I FN I HT ARMT L SDDVNV
S SG ER E I QR TML E L LNQ LDG FD -T RGDVKV I MATNK I EN LD PA L I R PGR I DR K I E F P L PDT KT KRH I FK LHT SRMS LADDVD I
SGG ERD I QR TML E L LNQ LDG F E -ARGDVKV I MATNK I E S LD PA L I R PGR I DR K I E L PN PDCKT KR R I FQ I HT SKMT L SDDVD L
SGG ERD I QR TML E L LNQ LDG F E -ARGDVKV I MATNK I E S LD PA L I R PGR I DR K I E L PN PDCKT KR R I FQ I HT SKMT L SDDVD L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KR R I FQ I HT SRMT VA EDV S L
SGG ER EVQR TML E L LNQ LDG FD -DRGD I KV I MATNK I E S LD PA L I R PGR I DR K I L F EN PD SNT KKR I LH I HT SKMS LADDVK L
SGG ER E I QR TML E L LNQ LDG FD -AR TDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD I K T KR K I F E I HT AKMN L S EDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KR R I FT I HT SRMT LA EDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KR R I FT I HT SRMT LA EDVN L
SGGR R EVQR TML E L LNQ LDG FD -T RND I KV I MATNK I EA LD PA L I R PGR I DR K I E FGMPDAAT KKK I FD I HT SRMT LD E SVN I
SGG EK E I QR TML E L LNQ LDG FD -T RG EVKV I I AT NR I E S LD SA L I R PGR I DR K I E F P L PD I K T KR K I F E I HT SKMT L E EGVDM
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADDVT L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADDVT L
SGG EK E I QR TML E L LNQ LDG FD -DRGDVKV I MATNK I E S LD PA L I R PGR I DR K I L F EN PD I T T KR K I VG I HT SKMN LA EDVD L
S SGT K EVQR TML E L LTQ LDG FD - S SNDVKV I MATNR I DT LD PA L I R PGR I DR K I E F P F PD EKT KR R I F E I HT SRMS LA EDVD I
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADDVT L
SGG ER EVQR TML E L LNQ LDG FD -DRGDVKV I MATNK I ET LD PA L I R PGR I DR K I L F EN PDQNT KR K I FT LHT SKMS LN EDVD L
T SG SA EVNR TMLQ L LA EMDG FD - PKGNVKVVAATNR I D L LD PA L LR PGR FDR S I EV P L PD EKGR V E I LK I HT R KMK LADDVD F
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADDVT L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADDVT L
SGG ER E I QR TML E L LNQ LDG FD -DRGDVKV I MATNK I E S LD PA L I R PGR I DR K I L F EN PDQNT KR K I FT LHT SKMS LN EDVD L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I LATNR I E S LD PA L LR PGR I DR K I E F P L PD I K T R R R I FQ I HT SKMT LADDVN L
SGG ER E I QR TML E L LNQMDG FD - SR GDVKV I MATNR I E S LD PA L LR PGR I DR K I E F P L PDVKT KRH I FN I HT GRMN L SADVQ L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADDVT L
SGG EK E I QR TML E L LNQ LDG FD - SR ADVKV I LATNK I E S LD PA L I R PGR I DR K I E F P L PDVKNKKK I FQ I HT SKMN LG EDAN L
SGG ER E I QR TML E L LNQ LDG FD -DRGD I KV I MATNK I E S LD PA L I R PGR I DR K I L F EN PDANT KKK I LT I HT SKMS LADDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I D S LD PA L I R PGR I DR K I Q L PN PDT KT KR R I FQ I HT SKMTMS PDVD L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I D S LD PA L I R PGR I DR K I Q L PN PDT KT KR R I FQ I HT SKMTMS PDVD L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I D S LD PA L I R PGR I DR K I Q L PN PDT KT KR R I FQ I HT SKMTMS PDVD L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I LATNR I E S LD PA L LR PGR I DR K I E F P L PD I K T R R R I FQ I HT ARMT LADDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KKR I FQ I HT SRMT LADDVT L
SGG ER E I QR TML E L LNQ LDG FD -DRGDVKV I MATNK I ET LD PA L I R PGR I DR K I L F EN PD L ST KKK I LG I HT SKMN L S EDVN L
SGA ER E I QR TML E L LNQ LDG FDT SQRD I KV I MATNR I SD LD PA L I R PGR I DR K I L F EN PD EAT KR K I FT I HT SKMN LG EDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KR R I FN I HT SRMT L SNDVN L
SGG ER E I QR TML E L LNQ LDG FD - SR GDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P L PD EKT KR R I FQ I HT SRMT VADDVT L
SGG EK E I QR TML E L LNQ LDG FD - SR TDVKV I LATNK I E S LD PA L I R PGR I DR K I E F PV PDMKT KKK I F E I HT SKMA LG E EVN F
SGG EK E I QR TML E L LNQ LDG FD - SQ SDVKV I MATNK I E S LD PA L I R PGR I DR K I Q L PN PD SKT KR K I F E I HT SKMTMSKDVD L
SGG EK E I QR TML E L LNQ LDG FD - SQ SDVKV I MATNK I E S LD PA L I R PGR I DR K I Q L PN PD SKT KR K I F E I HT SKMTMSKDVD L
S SG ER EVQR TML E L LNQ LDG FD -DRGD I KV I MATNR I ET LD PA L I R PGR I DR K I E L P F PDNKT K LK I FQ I HT ANMH LA PDVN L
SGGAK EVQR TML E L LTQ LDG FD - SCNDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P F PD EKT KKMI F E I HT SRMS LA EDVD L
S SGAK EVQR TML E L LTQ LDG FD - S SNDVKV I MATNR I ET LD PA L I R PGR I DR K I E F P F PD EKT KKMI F E I HT SRMS LA EDVD I
SGG ER E I QR T L L E L LNQ LDG FD -T RHDVKV I MATNR I E S LD PA L I R PGR I DR K I E F P L PDQKT KMH I FK LHT SRMN LD SDVD L
SGG ER EVQR TML E L LNQ LDG FD -DRGDVKV I MATNK I E S LD PA L I R PGR I DR K I L F EN PD ST T KR K I MG I HT SKMN LNDDVD L
























































S E L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK E SV LY R KK EGT P - EG LY Y LDAQAT T SMD PR V LDAMMPY LT
E E FVMT KD E F SGAD I KA I CT EAG L LA LR ER RMKVTHVD FKKAK EKVMFKKK EGV P - EG LY Y LDMQAT T P I D PR V FDAMNA SQ I
ET LVT SKDD L SGAD I KAMCT EAG L LA LR ER RMQVT V ED FKQAK ER VMKNKV E EN L - EG LY Y LDMQAT T PTD PR VVDTMLK FY T
D E F I NQKDD L SGAD I R A I CT EAG LMA LR ER RMR VQMDD FR AAR ER I MKT KQDGG PV EG LY Y LDMQAT T PVD PR V LDAML PY LT
D E F I NQKDD L SGAD I R A I CT EAG LMA LR ER RMR VQMDD FR AAR ER I MKT KQDGG PV EG LY Y LDMQAT T PTD PR V LDAML PY LT
S E L I MSKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK E SV LY R KK EGT P - EG LY - - - - - - - - - - - - - - - - - - - - - - -
DD L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMDVQAT T P LD PR V LDAML PY LV
E E F I T AKD E L SGAD I KAMCT EAG L LA LR ER RMR VTMED FQK SK ENV LY R KK EGA P - E E LY Y LDVQAT S PMD PR VVDAML PYMI
E E F I T AKD E L SGAD I KAMCT EAG L LA LR ER RMR VTMED FQK SK ENV LY R KK EGA P - E E LY Y LDVQATA PMD PR VVDAML PYMI
D E I V T GKDD L SGAD I KA I CT EAG L LA LR ER RMQVKA ED FK SAK ER V LKNKV E EN L - EG LNY LDVQAT T PVD PR V LDKML E FY T
EN LVT SKDD L SGAD I QAMCT EAG L LA LR ER RMQVTA ED FKQAK ER VMKNK I E EN L - EG LY YMDMQAT T PTD PR V LDVMLK FY T
DD L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY R KQ EGT P - EG LY YMDVQAT T P LD PR V LDAML PY LV
D EHVQAKDD L SGAD I KA I CT EAG L LA LR ER RMKVT S ED FKK SK ENV LY R KN EGA P -QG LY YMDAQAT T P LD PR V LDKVMSY Y V
E E LVMT KD E L SGAD I KAVCT EAG L LA LR ER RMR VT R TD FT T AR EKV LY GKD ENT P -AG LY Y LDMQAT T PMD PR V LDKML P L FT
E E F I MAKDD I SGAD I KA I CT EAG L LA LR ER RMR VTQ ED LR KAK EKA LY R KKGG I P - EG LY Y FDYQAT T PVD PR V LDKMMP F FT
E E F I MAKDD I SGAD I KA I CT EAG L LA LR ER RMR VTQ ED LR KAK EKA LY R KKGG I P - EG LY Y FDYQAT T PVD PR V LDKMMP F FT
DD L I LAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMD FQAT T PMD PR V LDAML PY QV
D E LVT SKD E L SGAD I KAMCT EAG L LA LR ER RMQVKA ED FKAAK ER V LKNKV E EN L - EG LY Y LDVQAT T PTD PR V LDRML E FY T
E E FVMSKDD L SGAD I KA I CT E SG L LA LR ER RMR VTHTD FKKAK EKV LY R KT AGA P - EG LY Y LDMQ ST T P I D PR V LDAML P LY T
S E L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK E SV LY R KK EGT P - EG LY Y LDAQAT T PMD PR V LDAML PY LT
S E L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK E SV LY R KK EGT P - EG LY Y LDAQAT T PMD PR V LDAML PY LT
E L L I T SK ED L SGAD I KA I CT EAGMI A LR ER R KT VTMKD F I SAR EKV F F SKQKMV S -AG LY F LDVQ ST T PVD PR V LDAML P FY T
E E FVMSKDD L SGAD I KA I CT EAG L LA LR ER RMKVNQ ED FKKAK EKVMY R KK EGV P -DG LY Y LDNNAT TMVD P EV LN SML PY F S
D E L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK EN F LY KKT EGT P - EG LY Y LDVQAT T P LD PR V LDRML PY LT
DD L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMDVQAT T P LD PR V LDAML PY L I
DN LVT SKDD L SGAD I KAMCT EAG L LA LR ER RMQVTAQD FK EAK ER V LKNKV E EN L - EG LY Y LDMQAT T PTD PR V LDTMLK FY T
S E F I HAKD EMSGADVKA I CT EAG L LA LR ER RMKVCQAD F I KGK ENVQY R KDK ST F - SR FY YMDNQAT T P LD PR V LDAML PYMT
DD L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMDVQAT T P LD PR V LDAML PY L I
E E F I AQKDD L SGAD I KA I C S EAG LMA LR ER RMR VQMAD FR AAR ER V LR T KQ EG E P - EG LY Y LDMQAT T PVD PR V LDAML P LY V
EK LAKV LT GK SGA E I SV I V K EAG I FV LR R RGK E I TMAD FMKAY EKVVNVQ E PT I P -QAMFYMDN SAT T PVR K EVV E EML PY LT
DD L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMDVQAT T P LD PR V LDAML PY L I
DD L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMDVQAT T P LD PR V LDAML PY LV
E E F I AQKDD L SGAD I KA I C S EAG LMA LR ER RMR VQMAD FR AAR ER V LR T KQ EG E P - EG LY Y LDMQAT T P I D PR V LDAMMPY FT
E E FVMT KD E F SGAD I KA I CT EAG L LA LR ER RMKVTHAD FKKAK EKVMFKKK EGV P - EG LY YMDMQAT T PVD PR V LDAML P FY L
E E FVMAKD E L SGAD I KA LCT EAG L LA LR ER RMQVTHAD F SKAK EKV LY KKK EGV P - EGMF - - -MQAT T P LD PR V LDAML PY FT
DD L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMDVQAT T P LD PR V LDAML PY L I
D E F I NAKD E L SGAD I KAMCT EAG L LA LR ER RMK I T Q ED FR KAK EK I LY LKKGN I P - EG LY Y LD FQAT T PTDY R V LDAML PY LT
D E LVT SKDD L SGAD I KA I CT EAG L LA LR ER RMQVKADD FK SAK ER V LKNKV E EN L - EG LY Y LDVQAT T PTD PR V LDKMLT F LT
E E FVMSKD E L SGAD I KA I CT EAG L LA LR ER RMK I T QAD LR KARDKA L FQKKGN I P - EG LY Y LD SQAT TMI D PR V LDKML PYMT
E E FVMSKD E L SGAD I KA I CT EAG L LA LR ER RMK I T QVD LR KARDKA LY QKKGN I P - EG LY Y LD SQAT TMI D PR V LDKMMPYMT
E E FVMSKD E L SGAD I KA I CT EAG L LA LR ER RMK I T Q LD LR KARDKA LY QKKGN I P - EG LY Y LD SQAT TMI D PR V LDKMMPYMT
E E FVMT KD E F SGAD I KA I CT EAG L LA LR ER RMKVTHTD FKKAK EKVMFKKK EGV P - EG LY Y LDMQAT S PVD PR V LDAML PY Y L
DD L I MAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMDVQAT T P LD PR V LDAML PY LV
ET LVT T KDD L SGAD I QAMCT EAG L LA LR ER RMQVTA ED FKQAK ER VMKNKV E EN L - EG LY Y LDMQAT T PTD PR V LDTMLK FY T
E E L I QCKDD L SGA E I KA I V S EAG L LA LR ER RMR VVMDD FRQAR EKV LKT KD EGG PAGG LY YMD FQAT S P LDY R V LD SML P F FT
D EY I T SKDD L SGAD I KA I CT EAG LMA LR ER RMKVNN ED FKK SK ENV LY R KT EGT P - EG LY Y LDAQ ST T P LD PR VMDAMMPY SV
DD L I LAKDD L SGAD I KA I CT EAG LMA LR ER RMKVTN ED FKK SK ENV LY KKQ EGT P - EG LY YMD FQAT T PMD PR V LDAML PY QV
DT FVHVKDD L SGAD I KAMCT EAG L LA LR ER RMKVT LDD FT KAKDKV LY LKKGDT P -DG LY Y LD FQAT T P LD FR V LDKMMPYQT
D E FVVNKDD L SGAD I KAMCT EAG L LA LR ER RMQ I TQAD LMKAK EKV L FQKKGNV P -DV LY Y LDNQAT TCVD PR V LD SMMPY LT
D E FVVNKDD L SGAD I KAMCT EAG L LA LR ER RMQ I TQAD LMKAK EKV LY QKKGNV P -DV LY Y LDNQAT TCVD PR V LDAMMPY LT
ME FANT KD E I SGAD I KA I C S EAG L I A LR DGR LMECQAD FR KGR EMVMY R R K EN I P - EG LY Y LDTQAT SV LD PR V FDTMI PY ET
S E F I HAKD EMSGAD I KA I CT EAG L LA LRDR RMKVCQ SD FVKGK ENVQY R KDKGR F - SK FY Y LD LQ ST T P LD PR V LDKML PYMT
S E F I HAK E EMSGAD I KA I CT EAG L LA LRDR RMKVCQAD FVKGK ENVQY R KDK S S F - SK FY Y LD FQAT T P LD PR V LDRML PY LT
E E FVAMKDD L SGAD I K S LVT EAG L LA LR ER RMR VT KKD FT T AR ER V I DR KN EGT P - EG LY Y LDAQ ST T PVD PR VVDKMMPYMT
E E FV S SKD E L SGAD I KAMCT EAG L LA LR ER RMR VT A ED FR T AK ER VMKNKV E EN L - EG LY Y LDMQAT T PTD PR V LDVMLNY Y T
























































AY Y GN PH SR THAY GWET E EAV EKAR AQVA S L I GA -D PK EVV FT SGAT E SNN I SVKG I GR FKKH I I T TQT EHKCV LD SCR A L EG
H EY GN PH SR TH LY GWEA ENAV ENARNQVAK L I EA - S PK E I V FV SGAT EANNMAVKGVMH FKKHV I T TQT EHKCV LD SCRH LQQ
G LY GN PH SNTH SY GWET SQ EV EKAR KNVADV I KA -D PK E I I FT SGAT E SNNMA LKGVAR FKNH I I T T R T EHKCV L EAAR SMKD
G I Y GN PH SR THAY GWE S EKAV EQAR EY I AK L I GA -D PK E I I FT SGAT E SNNMS I KGVAR FKKH I I T SQT EHKCV LD SCRH LQD
G I Y GN PH SR THAY GWE S EKAV EQAR EHVAK L I GA -D PK E I I FT SGAT E SNNMS I KGVAR FKKH I I T TQT EHKCV LD SCRH LQD
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -HKCV LD SCR A L EG
NY Y GN PH SR THAY GWE S EAAMECARQQVA S L I GA -D PR E I I FT SGAT E SNN I A I KGVAR FKKH L I T TQT EHKCV LD SCR S L EA
ND FGN PH SR TH SY GWKA E EGV EQAR KY VAD L I KA -D PRD I V FT SGAT E SNN LA I KGVAK FKNH I I T LQT EHKCV LD SCR Y L EN
ND FGN PH SR TH SY GWKA E EGV EQAR EHVAN L I KA -D PRD I I FT SGAT E SNN LA I KGVAK FKNH I I T LQT EHKCV LD SCR Y L EN
G LY GN PH S ST HAY GWETDK EV EKAR T Y I ADV I NA -D PK E I I FT SGAT ETNNMA I KGV PR FKKH I I T TQT EHKCV LD SARHMQD
G LY GN PH SNTHAY GWETNK EV ET ARDHVAKV I R A -D PK E I I FT SGAT E SNN LA I KGVGR FKKH I I T T R T EHKCA L EAARGMI N
NY Y GN PH SR THAY GWE S EAAMEHARQQVA S L I GA -D PR E I I FT SGAT E SNN I A I KGVAR FKKH L I T TQT EHKCV LD SCR S L EA
SY Y GN PH SR THAY GWQA EDAV EVARQQVADV I NA -D PR E I I FT SGAT E SNN LAVKGVGR FKKH I I T TQ I EHKCV LD SCR A L EN
EQY GN PH SR THAY GWEA EKAVD EARQQVAQ LVGA -Q PKD I V FT SGAT E SNNML I KG I AK FKKH I I T TQT EHKCV LD SCRWL ST
EK FGN SH SR THGY GWEA E EAV ENAR TN I AN L I KC - L PK E I I FT SGAT E SNNT I I R GVCD I KNH I I T TQ I EHKCV L ST LR E L E L
EK FGN SH SR THGY GWEA E EAV ENAR TN I AN L I KC - L PK E I I FT SGAT E SNNT I I R GVCD I KNH I I T TQ I EHKCV L ST LR E L E L
NY Y GN PH SR THAY GWE S E SAMEKAR KQVAG L I GA -D PR E I V FT SGAT E SNNMS I KGVAR FKMH I I T TQ I EHKCV LD SCR V L ET
G LY GN PH S ST H SY GWETDK EV EKAR KY VADV I NA -D PK E I I FT SGAT E SNNMAVKGV PR FKKH I I T TQT EHKCV LD SARHMQD
ENY GN PH SKTHAY GWT SND LV EDAR EKV SK I I GA -D SK E I I FT SGAT E SGN I A I KGVAR FKNH I I T T VT EHKC I LD SCRH L EM
N FY GN PH SR THAY GWET E SAV EKAR EQVAT L I GA -D PK E I I FT SGAT E SNN I AVKGVAR FKRHV I T TQT EHKCV LD SCR A L EN
NY Y GN PH SR THAY GWE S ET AV EKAR EQVAN L I GA - ET K E I I FT SGAT E SNN I AVKGVAR FKKHVVT TQT EHKCV LD SCR A L EN
T V FGN PH SR THR Y GWQA EAAV EKAR SQVA S L I GC -D PK E I I FT SGAT E SNN LA LKGV SG FAAH I I T LQT EHKC I LDT CRN L E E
E I Y GN PN S - LHA FGQKAR KA L SD S LD I I Y EC I GA SDDDT V L I T AN ST EGNNT V LKTMLAR RNK I I V SQ I EH P S I S E S EKY LK E
GCY GN PH SR THAY GWE S EAAT ER AR RQVAD L I GA -D PR EV I FT SGAT E SNNMA I KGVAR FKKH I I T TQT EHKCV LD SCR S L EA
NY Y GN PH SR THAY GWE S EAAMER ARQQVA S L I GA -D PR E I I FT SGAT E SNN I A I KGVAR FKKH L I T TQT EHKCV LD SCR S L EA
G LY GN PH SNTH SY GWETNK E I EQAR KY I ADV I KA -D PK E I I FT SGAT E SNNMA LKGV SR FRNH I I T T R T EHKCV L EAAR AMKN
E EY GN PN SR THQY GWSA E EAV EKAR RQVAD L I GA - S PK E I F FT SGAT ECNN I A I KGVGN FKNH I I T LQT EHKCV LD SCR Y L EM
NY Y GN PH SR THAY GWE S EAAMER ARQQVA S L I GA -D PR E I I FT SGAT E SNN I A I KGVAR FKKH L I T TQT EHKCV LD SCR S L EA
GVY GN PH SR THAY GWE S EKAV EDARAHVA S L I GA -D PK E I I FT SGAT E SNNMS I KGVAR FKKH I I T TQT EHKCV LD SCRH LQD
EN FGN P - S S I Y E LGK I SKHAV ENAR KR VADA I GA - E EN E I Y FT SGGT E SDNWTVKGVA FAGKH I I T S S I EHHAV LHACAWL EG
NY Y GN PH SR THAY GWE S EAAV EHARQQVA S L I GA -D PR E I I FT SGAT E SNN LA I KGVAR FKKHV I T TQT EHKCV LD SCR S L EA
NY Y GN PH SR THAY GWE S EAAMER ARQQVA S L I GA -D PR E I I FT SGAT E SNN I A I KGVAR FKKH LVT TQT EHKCV LD SCR S L EA
NVY GN PH SR THAY GWETDKAV E EAR KH I AD L I GA -D PK E I I FT SGAT E SNNMS I KGVAR FKKH I I T SQT EHKCV LD SCRH LQD
SR Y GN PH SR TH LY GWE SDAAV E EAR AR VA S LVGA -D PR E I F FT SGAT ECNN I AVKGVMR FR RHVVT TQT EHKCV LD SCR Y LQQ
EQY GN PH SR THMYGWET EDA I EKARG E LA S L I GA -NAK E I V FT SGAT E SNNMS LKGVAR FKKH I I T T T T EHKCV LD SCRQ L ER
NY Y GN PH SR THAY GWE S EAAMER ARQQVA S L I GA -D PR E I I FT SGAT E SNN I A I KGVAR FKKH L I T TQT EHKCV LD SCR S L EA
NQY GN PH SKTH S FGWET EKAV ENAR SQ I AN L I NT -Q PQ S I I FT SGAT E SNNAA LKG LY G FKNH I I T TQT EHKCV LD SCR Y L E E
GMYGN PH S ST HAY GWETDK EV EKAR EY VAAV I KA -D PK E I I FT SGAT ETNNMA I KGV PR FKKH I I T TQT EHKCV LD SARHMQD
Y I Y GNAH SRNH F FGWE S EKAV EDAR TN L LN L I NGKNNK E I I FT SGAT E SNN LA L I G I CT Y KNH I I T SQ I EHKC I LQT CR F LQT
Y I Y GNAH SRNH F FGWE S E EAV EDAR KN I LH L I NGKNNK E I I FT SGAT E SNN LA L I G I CT Y KNH I I T SQ I EHKC I LQT CR Y LQT
Y I Y GNAH SRNH F FGWE S EQAV EDARAN L I K L LNGNNNK E I I FT SGAT E SNN LA L I GT CT Y KNH I I T SQ I EHKC I LQT CR Y LQT
AR Y GN PH SR TH LY GWE SDQAV ET AR SQ I AD L I GA - S PK E I V FT SGAT E SNN I SVKGV I K FKRHVVT TQT EHKCV LD SCRH LQQ
NY Y GN PH SR THAY GWE S EAAMER ARQQVA S L I GA -D PR E I I FT SGAT E SNN I A I KGVAR FKKH LVT TQT EHKCV LD SCR S L EA
G LY GN PH SNTH SY GWETNTAV ENARAHVAKMI NA -D PK E I I FT SGAT E SNNMV LKGV PR FKKH I I T T R T EHKCV L EAAR AMMK
G I Y GN PH SR THAY GWEA EKAV ENARQ E I A SV I NA -D PR E I I FT SGAT E SNNA I LKGVAR FKKH LV SVQT EHKCV LD S LR A LQ E
AY Y GN PH SR TH SY GWE SDDAV EHAR KQVAN L I GA -DAR E I I FT SGAT E SNN I SVKGT AR FKKHV I T TQT EHKCV LD SCR V L EG
NY Y GN PH SR THAY GWE S ET AMET AR KQVAD L I GA -D PR E I I FT SGAT E SNNMA I KGVAR FKRHV I T TQT EHKCV LD SCR V L E S
NMYGN PH SR SH EY GWAT EKAT EDARAQVAD L I GA -D PK E I T FT SGAT E SNNQA LKG LAA FKKH I I T TQ I EHKC I LDT CRN L E E
HA FGN PH SR TH SY GWEA EKAV ET AR ADVAN L I NC - E SKNV I FT SGAT E SNN LA I KG SK S FKNHV I T TQ I EHKCV LQCCRQ L EN
HA FGN PH SR TH SY GWEA EKAV ET AR AD I AN L I NC - E SKNV I FT SGAT E SNN LA I KG SK S FKNHV I T TQ I EHKCV LQCCRQ L EN
Y VHGNAH SKQHG FGQ EAMAAV EKAR K SVAD L I NA -K PN E I I FT SGAT ECNN I A I KGAMGY KKHV I V S S I EHKCV I E SAR A LQK
EMY GN PH SR TH SY GWTA E EAV EKAR TQVAD L I R A - S PKGV F FT SGAT E SNN I A I KGVANY KNH L I T LQT EHKCV LD SCR Y L EM
ER Y GN PH SR THR Y GWTA EDAV EKAR A EVAD L I GT - S PKGV F FT SGAT E SNN I A I KGVAY Y KNH I I T LQT EHKCV LD SCR Y L EM
NQYGN PH SR THAY GWE S EKGV E EGR EH I A S L I GA -D PK E I I FT SGAT E SNNMA I KGVAH FKNH I I T TQT EHKCV LD SCR R LQ E
DMYGN PH SR TH SY GWETDTAV EKAR E E I AA L I GA -D PK E I I FT SGAT E SNNMV I KG I AR FKRH I I T TQT EHKC I LD SCR Y LQD
























































EG FHVT Y L PVQ SNG L I SME E L EKA I T P - ET S LV S I MT VNN E I GVKQ P I A E I GR LCV F FHTDAAQAVGK I P LDVNKMN I D LMS I
EG F EVT Y L PVKTDG LVD L EMLR EA I R P -DTG LV S I MAVNN E I GVVQ PME E I GMI CV P FHTDAAQA I GK I PVDVKKWNVA LMSM
EG FDVT F LNVN EDG LV S L E E L EQA I R P - ET S LV SVMSVNN E I GVVQ P I K E I GA I CV F FH SDAAQAY GK I P I DVD EMN I D L L S I
EG F EVT Y L PVQNNG L I RMED L EAA I R P -DT A LV S I MAVNN E I GV I Q P L E E I GK LCV F FHTDAAQAVGK I P LDVNK LN I D LMS I
EG FDVT Y L PVQ SNG L I RME E L EAA I R P -DT A LV S I MAVNN E I GV I Q PME E I GK LC I F FHTDGAQAVGK I P LDVNK LN I D LMS I
EG FR I T Y L PVQQNG I I N LKD L EDA I T P - ET S LV S I MT VNN E I GVRQ P I EA I GA I CV F FHTDAAQAVGKV P LDVNTMN I D LMS I
EG FKVT Y L PVKK SG I I D LK E L EAA I Q P -DT S LV SVMT VNN E I GVKQ P I K E I GQ I CVY FHTDAAQAVGK I P LDVNDMK I D LMS I
EG FKVT Y L PVDKGGMVDMEQ L EQ S I T P - ET C LV S I MFVNN E I GVVQ P I KQ I G E LCVY FHTDAAQATGKV P I DVND LK I D LMS I
EG FKVT Y L PVDKGGMVDMEQ LTQ S I T A - ET C LV S I MFVNN E I GVMQ P I KQ I G E LCVY FHTDAAQATGKV P I DVN EMK I D LMS I
EG F EVT Y L PV S S EG L I N LDD LKKA I R K -DT V LV S I MAVNN E I GV I Q P LK E I GK I CV F FHTDAAQAY GK I P I DVN EMN I D L L S I
EG FDVT F L SVDNQG L I DMK E L E EA I R P -DT C LV SVMAVNN E I GVMQ P LK E I GA LC I Y FHTDAAQAY GKV P I DVN EMN I D L L SV
EG FQVT Y L PVKK SG I I D LK E L E SA I Q P -DT S LV SVMT VNN E I GVKQ P I A E I GQ I CVY FHTDAAQAVGK I P LDVNDMK I D LMS I
EG FKVT Y L PVK PNG I VD LKV L E E S FQ P -DT S LV S I I FVNN E I G - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
QG F EVT Y L PV L PNG LV S I N E LKAA LR P -DT S LV S I MAVNN E I GV I Q P LA E I SQA I P L FHTDAAQAVGK I P I DV EA LG I DAMS I
KG FR VT Y LKVNNKG L I S L E E L EK S I I PG ET I LA S I MHVNN E I GV I Q PMN L I G E I CV L FH SDVAQG LGK I N I DVDKWNAD F L S L
KG FR VT Y LKVNNKG L I S L E E L EK S I I PG ET I LA S I MHVNN E I GV I Q PMN L I G E I CV L FH SDVAQG LGK I N I DVDKWNAD F L S L
EG FD I T Y L PVK SNG L I D LKQ L EDT I R P -DT S LV S I MA I NN E I GVKQ PVK E I GH LCV F FHTDAAQAVGK I PVDVTDWKVD LMS I
EG F EVT Y L PVN E EG L I S LDD LR K S I R K -DT S LV S I MAVNN E I GVVQ P LK E I GK I C I F FHTDAAQAY GK I D I DVN EMN I D LMS I
EG FKVT Y L PVG ENG LVD L E L LKNT I T P -QT S LVT I MAVNN E I GVVQ P I K E I GK I CV F FHTDAAQAVGK I P I DVNDMN I D L L S I
EG FKVT Y L PV LANG L I D LQQ L E ET I T S - ET S LV S I MT VNN E I GVRQ PVD E I GK LCV F FHTDAAQAVGKV P LDVNAMN I D LMS I
EG FT VT Y L PVQTNG I I D LKQ L E EA LT P - ET S LV S I MAVNN E I GVKQ P I D E I GR LCV F FHTDAAQAVGK I PMDVNAMN I D LMS I
NGV EVT Y L PVGNDGVVD I DDVKK S I K E -NT V LV S I GAVN S E I GT VQ P LK E I GMLCV L FHTDAAQGVGK I Q I DVN EMN I D L L SM
RG I EV I KMPVN EDGVVD PKD L ER L I DD -KT A LV SCMWVNN ETG L I MPV E E LCK I AA L FH SDATQAMGK I KV SVKDV PVDY LT F
EG FQ I T Y L PVQKNG L I D LK E L EAA FQ P -DT S LV SVMAVNN E I GVKQ P I R D I G E I CV F FHTDAAQAVGK I P LDVND SK I D LMS I
EG FQVT Y L PVQK SG I I D LK E L EAA I Q P -DT S LV SVMT VNN E I GVKQ P I A E I GR I CVY FHTDAAQAVGK I P LDVNDMK I D LMS I
EGY E I T F LNVD EQG L I N L E E L EAA I R P - ET C LV SVMAVNN E I GVMQ P LK E I G E LCV F FHTDAAQAY GK I P I DVN EMK I D LMS I
EG F EVT Y L PVQKNG I LD LKV L EAA I K P -T T C LV SCMAAHN E I GV LQ P I R E I GA LCV L FHTDAAQA LGKVKVDVNADN I D LMSM
EG FQVT Y L PVQK SG I I D LK E L EAA I Q P -DT S LV SVMT VNN E I GVKQ P I A E I GQ I CVY FHTDAAQAVGK I P LDVNDMK I D LMS I
EG F EVT Y L PVQN SG LVD LK E L EAAMR P - ET A LV S I MT VNN E I GV I Q PV E E I GKMC I F FHTDAAQAVGK I PMDVNAMN I D LMS I
QG F EVT Y L PVDR Y GMV S P E E LKNA I R D -DT I L I S I MLANN E I GT I Q PV E E I GK I S I Y FHTDAVQA I GHV P I DVKKMNVD L L S L
EG FQVT Y L PVQK SG I I D LK E L EAA I Q P -DT S LV S I MT VNN E I GVKQ P I AD I GR I CVY FHTDAAQA I GK I P LNVNDMK I D LMS I
EG FR VT Y L PVQK SG I I D LK E L EAA I Q P -DT S LV SVMT VNN E I GVKQ P I A E I R Q I CVY FHTDAAQAVGK I P LDVNDMK I D LMS I
EG F EVT Y L PVK S SG L I DMA E L EAA I R P -DT A I V S I MAVNN E I GV I Q P L E E I GK LC I F FHTDAAQAVGK I PVDVNAMN I D LMS I
EG F EVT Y L PVR PDG LVDVAQ LADA I R P -DTG LV SVMAVNN E I GVVQ P L E E I GR I CV P FHTDAAQA LGK I P I DVNQMG I G LMS L
EG FDVT Y L PVK ENG LVD LK E L EAAMRD -DTA I V SVMAVNN E I GV I Q P LKA I G E LC I F FHTDGAQAVGKV PMDVNDMN I D LMS I
EG FQVT Y L PVQK SG I I D LK E L EAA I Q P -DT S LV SVMT VNN E I GVKQ P I A E I GR I CVY FHTDAAQAVGK I P LDVNDMK I D LMS I
KGV EVT Y L PVD SNG L I S LQQ LQ E S I K S -NT LCV SVMLVNN E I GV I QN LK E I SR I CVY VH SDMAQA I AK I PVDVQD LD I D LG S I
EG FDVT Y L PVD EHG L I S LDD LKAA I R K -DT I LV SVMAVNN E I GVVQ P LK E I GK I C I F FHTDAAQAY GK I D I DVNDMN I D L L S I
KG F EVT Y LK PDTNG LVK LDD I KN S I KD -NT I MA S F I FVNN E I GV I QD I EN I GN LC I L FHTDA SQAAGKV P I DVQKMN I D LMSM
KG F EVT Y LK P E PNG I VK L ED I EKN I K E -NT I MA S F I HVNN E I GV I QD I EN I G L LCV I FHTDA SQA I GK I P I DVQKMN I D L L SM
KG F EVT Y LK PDANG L I K L ED LKN S I K E -NT I LA S F I Y VNN E I GV I QD I EN I GK I C I I FHTDA SQAVGK I K I DVQK LN I D L L S L
EG F EVT Y L PVGNDG I VD L EK LKG S I R P -DTG LV SVMAVNN E I GV I Q PME E I G E I CV P FHTDAAQA LGK I P I DVDKWNV S LMS L
EG FR VT Y L PVQK SG I I D LK E L EAA I Q P -DT S LV SVMT VNN E I GVKQ P I A E I GQ I C LY FHTDAAQAVGK I P LDVNDMK I D LMS I
EG F EVT F LNVDDQG L I D LK E L EDA I R P -DT C LV SVMAVNN E I GV I Q P I K E I GA I C I Y FHTDAAQAY GK I H I DVN EMN I D L L S I
EG F EVT F L PVQTNG L I N LD E LRDA I R P -DT VCV SVMAVNN E I GVCQ P L E E I GK I CV F FH SDAAQGY GK I D I DVNRMN I D LMS I
EG FD I T Y L PVK PNG I I D LK E L EAA FR P -DT V LC S I MA I NN E I GVKQ PMKQ I G EMCV F FHTDAAX AVGK I PVDVNDMK I D LMS I
EG F SVT Y L PVQKNG LVD L E L L EA S I R P -DT S L L SVMT VNN E I GVQQ P I D E I GR I CV F LHTDAAQAVGK I P I NV SDWKVD LMS I
QGY E I T Y L PVQKNG LVD L EV FKNA I R P -DT LVA S I I LVHN E I GV I QD I K T I GK I CV F FHTDAAQA LGK I P I NVD EMN I D LMSM
EGY SVT Y LK PDKY GMI L PD LVR KN I R P - ET F LC SV I HVNN E I GV I QN I S E I GR I CV I FHTDAAQ S FGK L P I D LKN LDVD L L S I
EGY SVT Y LK PDKY GMI L P E EVR KN I R P - ET F LC SV I HVNN E I GV I QD I A E I GKVCV I FHTDAAQ S FGK L P I D LKN L EVD L L S I
EG FDAT F LQVGKDGR VD PK EVAKN I R P -DTG LV SCMLVNN E I G S I N PVQ E I SK I CVWFHTDAAQG FGK I P I DVKK I GAN FMS I
EG F EVT Y L PV EKNG I VN LQK L E EA I R P -T T A LV SCMY VNN E I GV I Q P I G E I GK I CV L FHTDAAQAVGK LD I DVDRDN I D LMSV
DG F EVT Y L PV EKNG LVN LQK I E EA I R P -T T A LV SCMY VHN E I GV I Q P I S E I GN LCV L FHTDAAQA LGKV S I DV ERDN I D LMS L
EG F EVT Y L PVQ SNG L I D LKQ L E EA LR P -T T A LV S I MT VNN E I GV I Q P I K E I GQ L L P F FHTDAAQAAGK I R LDVN E LG I D LMS L
EG F EVT Y L PV L S SG L I DMKQ L EAA I R P -DT A LV S I MAVNN E I GV I Q P I A E I GA LCV F FHTDAAQAVGK I P I DVNADK I DVMS I
























































SGHK I Y G PKG I GA LY V -R R -K PR VR V EA I Q SGGGQ ERG LR SGT V PT P LAVG LGAAC E I AAR EMAYDHRWME F L SKR LNGD - - P
SAHK I Y G PKGVGA LY V -R R -R PR I R L E P LMNGGGQ ERG LR SGTGATQQ I VG FGAAC E LAMK EMEY D EKWI KG LQ ER LNG S - -M
S SHK I Y G PKG I GA LY V -R R -R PR VRME P L L SGGGQ ERG FR SGT L P P P LVVG LGHAAK LMV E EY EY D SAHVR R L SDR LNG S - -A
S SHK I Y G PKG I GACY V -R R -R PR VR L E P I I SGGGQ ERG LR SGT LA PH LVVG FG EACR I A SQDMEY DR KHV ER L SKR LNGD - -A
S SHK I Y G PKGMGACY V -R R -R PR VR L E P I I SGGGQ ERG LR SGT I A PH LVVG FG EACR I AY EDMEY D SKH I AR L SKR LNGD - - P
SGHKVY G PKGVGA LY I -R R -R PR VR V E P I Q SGGGQ ERGMR SGT V PT P LVVG L - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
SGHK I Y G PKGVGA I Y I -R R -R PR VR V EA LQ SGGGQ ERGMR SGT V PT P LVVG LGAAC EVAQQ EMEY DHKR I SK LA ER LNGD - - P
SGHK I Y G PKGAGA LY V -R R -R PR VR V EAQMSGGGQ ERG LR SGT VAA P LC I G LG EAAR I AGR EMEMDKAHV ER L SRMLNVD - - E
SAHK I Y G PKGAGA LY V -R R -R PR VR I EAQMSGGGQ ERG LR SGT VAA P LC I G LG EAAK I ADK EMAMDKAHV ER L SQMLNGD - -A
S SHK I Y G PKG I GACY V -R R -R PR VR LD P I I T GGGQ ERG LR SGT LA P P LVAG FG EAAR LMKQ E S S FDKRH I EK L S SK LNGCNDA
S SHK I Y G PKG I GA LY V -R R -R PR VR L E P L L SGGGQ ERG LR SGT LA P P LVAG FG EAAR LMH E EY NAD I AH I DK L S SK LNG S - -A
SGHK I Y G PKGVGA I Y I -R R -R PR VR V EA LQ SGGGQ ERGMR SGT V PT P LVVG LGAAC EVAQQ EMEY DHKR I SK LADR LNGD - - P
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
SGHK LY G PKGVGAAY V -R R -R PR VR L E P L I HGGGQ ERG LR SGT VAA P LVVG LG EACR I A EN EMAADHAR I KA L SDR LNGD - - -
SAHKVY G PKG I GA FY I -R S -K PR R R I K P L I FGGGQ ERGMR SGTMPV P LAVG FG EACK I A S S EMN SD S I HVK S LY DK LNGC - -G
SAHKVY G PKG I GA FY I -R S -K PR R R I K P L I FGGGQ ERGMR SGTMPV P LAVG FG EACK I A S S EMN SD S I HVK S LY DK LNGC - -G
SAHK I Y G PKGVGA L FV -R R -R PR VR L E P LQ SGGGQ ERG LR SGT V PT P LAVG LGAAC E I AQQ E L EY DHKR V S L LANR LNGD - - P
S SHK I Y G PKG I GACY V -R R -R PR VR LD P I V T GGGQ ERG LR SGT LA P P LVAG FG EA SR LMK E EMD - - - - - - - - - - - - - - - - - - -
SGHK I Y G PKGVGA L FV -R R -R PR VR I E P I T T GGGQ ERG I R SGT V P ST LAVG LGAACD I A LK EMNHDAAWVKY LY DR LNGD - - L
SGHK I Y G PKGVGA LY V -R R -R PR VR L E P I Q SGGGQ ERG LR SGT V PA P LAVG LGAAA E L S LR EMDYDKKWVD F L SNR LNGD - -A
SGHK I Y G PKGVGA LY V -R R -R PR VR L E P I Q SGGGQ ERG LR SGT V PA S LAVG LGAAA E L SQQ EMEY DKKWI D F L SNR LNGD - -A
CAHK I Y G PKG I GA LY V -R R -R PR VRMV P L I NGGGQ ERG LR SGT VA S P LVVG FGKAA E I C SK EMKRD F EH I K E L SKK LNG S - - -
T AHK FHG PKGVGA L F I -R AGK P - - - I T P L LHGG EQMGG LR SGT I DT P SVVGMAVA LKKATHD I N I ENT Y VR K LRDK LVGK - - P
SGHK I Y G PKGVGA I Y V -R R -R PR VR L E P LQ SGGGQ ERG LR SGT V PT P LAVG LGAAC EVAQ E EMEY DHKR I SQ LA ER LNGD - -R
SGHK I Y G PKGVGA I Y I -R R -R PR VR V EA LQ SGGGQ ERGMR SGT V PT P LVVG LGAAC EVAQQ EMEY DHKR I SK L S ER LNGD - - P
S SHK I Y G PKG I GA I Y V -R R -K PR VR LD P L I SGGGQ ERG LR SGT LA P P LVAG FG EAAR LMMK EY END SNH I KR L SDK LNG S - -A
S SHKVY G PKGCGA LY V -R R -R PR VR LR S PV SGGGQ ERGVR SGT VAAA LVVGMGAAC EVAMK EWKRDAAHT ER LQ ER LNGD - - L
SGHK I Y G PKGVGA I Y I -R R -R PR VR V EA LQ SGGGQ ERGMR SGT V PT P LVVG LGAAC EVAQQ EMEY DHKR I SK LA ER LNGD - - P
SGHK I Y G PKG I GACY V -R R -R PR VR LD P I I SGGGQ ERG LR SGT LA P P L I VG FG EACR I AKQ EMEY D SKR VKY L SDR LNGH - - P
SGHK FGG PKGCGA LY I -R K - - -GT K I EA F LHGGAQ ER KR R AGT ENV P S I VG LGKA I G LATG EME ETNK P L L EMR ER LNGH - - P
SGHK LY G PKGVGA I Y I -R R -R PR VR V EA LQ SGGGQ ERGMR SGT V PT P LVVG LGAAC EVAQ E EMENDHKR I SMLA ER LNGD - - P
SGHK LY G PKGVGA I Y I -R R -R PR VR V EA LQ SGGGQ ERGMR SGT V PT P LVVG LGAAC E LAQQ EMEY DHKR I SK LA ER LNGD - - P
S SHK I Y G PKG I GACY V -R R -R PR VR LD P I I SGGGQ ERG LR SGT LA P P LVVG FG EACR I AK E EMPY D SKR I KH L SDR LNGD - - P
SAHK I Y G PKGVGA LY L -R R -R PR I R V E PQMSGGGQ ERG I R SGT V PT P LVVG FGAAC E I AAK EMDYDHR RA SV LQQR LNG S - -M
SGHK FY G PKG I GA LY V -R R -R PR VRME P I I NGGGQ ERG LR SGT L PT P L I VG I G EAAR VAQK E LQRD E EHVNR LAKR LNGD - -R
SGHK I Y G PKGVGA I Y I -R R -R PR VR V EA LQ SGGGQ ERGMR SGT V PT P LVVG LGAAC EVAQQ EMEY DHKR I SK L S ER LNGD - - P
SAHK LY G PKG I GA LY V -R R -K PR VR LQQ I I HGGGQ ERG LR SGT LA PH LCVG FGKAA E I A LT E L PY D I QHVDK LY NR LNG S - - L
S SHK I Y G PMG I GACY V -R R -R PR VR LD P I I T GGGQ ERG LR SGT L S P P LVAG FG EAAR LMK E EMDYDKAH I T R L SNK LNG SNN P
SGHK LY G PKG I GA LY I K R K -K PN I R LNA L I HGGGQ ERG LR SGT L PT H L I VG FG EAAKVC S L EMNRD EKKVR Y F FNY VNGC - -Q
SGHK LY G PKG I GA LY I K R K -K PN LR LNA L I HGGGQ ERG LR SGT L PT H L I VG LG EAAN LG S I EMNRDHKKMK F F FDY VNGC - -Q
S SHK LY G PKGVGA LY I K R K -K PN I R LNA I I HGGGQ ERG LR SGT L PT H L I VG LG EAAN I C L S EMDRDNKKMN F F FNY VNGC - -Q
SGHK I Y G PKGVGA LYM-R R -R PR I R V E PQMNGGGQ ERG I R SGT V PT P LVVGMGAAC E LAKK EMEY DDKR I R A LH ERMNG S - -V
SGHK LY G PKGVGA I Y I -R R -R PR VR V EA LQ SGGGQ ERGMR SGT V PT P LVVG LGAAC E LAQQ EMEY DHKR I SK LA ER LNGD - - P
S SHK I Y G PKG I GA I Y V -R R -R PR VR L E P L L SGGGQ ERG LR SGT LA P P LVAG FG EAAR LMKK E FDNDQAH I KR L SDK LNG S - - P
SAHK I Y G PKG I GAAY V -R R -R PR VR L E P L I SGGGQ ERG LR SGT LA P SQVVG FGT AAR I CK E EMKY DY AH I SK L SQR LNGD - - P
SGHK I Y G PKG I GA LY V -R R -R PR VR V EA LQ SGGGQ ERGMR SGT L PA P LVVG LGAAC EV SQQ EMEY DHKR I SA L S ER LNGD - - P
SGHK I Y G PKGVGA LY V -R R -R PR VR L E P LQ SGGGQ ERG LR SGT V PT P LAVG LGAAC SVAQQ E I EY DHQR V SMLANR LNGD - - P
S SHKVY G PKG I GG LY V -R R -K PKVR I L P I I NGGGQ ERG LR SGT LA PH LCVG FG EAC E I AKR EMDNDKKH I QR L S EK FNGD - -K
SGHK I Y G PKGVGA L FV -R T -K PR I R LQ P I I DGGGQ ERG LR SGT L PT A LVVG LGT AAK I AKMEMKRDQ LHMEN L F FK LNG S I K P
SGHK I Y G PKGVGA L FV -R T -K PR I R LQ P I I DGGGQ ERG LR SGT L PT A LVVG LGT AAK I AKMEMERDHRHMEN L F FK LNG S I K P
SGHK I HG PKG I GA LY V - S S -R PR SR V E P I I NGGGQ ERN I R SGT LAV P L I VG LGKAA E I AKR EMKYD S PY I E S LGKH LNG S - - L
S SHK I Y G PKGCGA LYM-R R -R PR VR VR S PV SGGGQ ERGVR SGT I AT P LAVG LGAAC E LAKV EMKRD S ER I AQ L SKR LNGD - -V
S SHK I Y G PKGCGA LYM-R R -R PR VR VR S PV SGGGQ ERGVR SGT VAT AQVVGMGAACA I AKV EMERD SAH I SR L SKR LNGD - - L
S SHK LY G PMG I GACY I -R R -R PR VR L E P I I NGGGQ ERG LR SGT LA P P L I AG FG EAAR LAKQ E LAY DHAH I SK L SQR LNGD - - -
SGHK LY G PMG I GACY V -R R -R PR VR L E P I I T GGGQ ERG LR SGT LAA P LVAG FG EAAR LCRQ EMPY DTAH I KK L SDK LNGD - -A
























































VQ SY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T I E EVDY T A EKC I
D SR Y VGN LN L S FAY V EG E S L LMG L - -K EVAV S SG SACT SA S L E P SY V LR A LGVD EDMAHT S I R FG I GR FT T K E E I DKAV E LT V
DHR Y PGCVNV S FA FV EG E S L LMA L - -RD I A L S SG SACT SA S L E P SY V LHA I GRDDA LAH S S I R FG I GR FT T EA EVDY V I KA I T
ER HY PGCVNV S FAY I EG E S L LMA L - -KD I A L S SG SACT SA S L E P SY V LR A LG S SD E SAH S S I R FG I GR FT TD S E I DY V LKAVQ
DRHY PGCVN I S FAY I EG E S L LMA L - -KD I A L S SG SACT SA S L E P SY V LR A LG S SD E SAH S S I R FG I GR FT TD S E I DY V LKAVQ
- - - - - - - - - - - - - - - -G E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG LGR FT T I E EVDY T A EKT I
EHHY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T E E EVDY T V EKC I
KHAY PGCVN L S FAY V EG E S L LMA L - -K S I A L S SG SACT SA S L E P SY V LR A I G S E ED LAH S S I R FG LGR FT T E E EVKHT I D LCV
RHAY PGCVN L S FAY V EG E S L LMA L - -K S I A L S SG SACT SA S L E P SY V LR A I G S E ED LAH S S I R FG LGR FT TD E EVKHT I D LC I
K SQY PGCVNV S FAY I EG E S L LMA L - -KD I A L S SG SACT SA S L E P SY V LHA LGADDA LAH S S I R FG I GR FT T EA EVDY V I QA I N
EKR Y PGCVNV S FAY V EG E S L LMA L - -RD I A L S SG SACT SA S L E P SY V LHA LGKDDA LAH S S I R FG I GR FT T E E EVDY V LKA I T
EHHY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T E E EVDY T V EKC I
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
VNGY PGCVN L S F SY V EG E S L LMA L - -KD I A L S SG SACT SA S L E P SY V LR A LGAA EDMAH S S LR FG I GR FT T E E E I D LVVQR I V
VNRMFGN LN L S FT GV EG E S LMMK L - -Y S LA L S SG SACT SA S L E P SY V LR A I GVG EDVAHT S I R FG LGR FT KH EDVDKAVK E I V
VNRMFGN LN L S FT GV EG E S LMMK L - -Y S LA L S SG SACT SA S L E P SY V LR A I GVG EDVAHT S I R FG LGR FT KH EDVDKAVK E I V
DQR Y PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GAD ED LAH S S I R FG I GR FT T E E EVDY T A EKC I
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -VC - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - I FV - - - - - - - - - - - - -
NAR Y Y GN LN I S F SY V EG E S L LMA I - -KDVAC S SG SACT S S S L E P SY V LR S LGV E EDMAH S S I R FG I GR FT T EQ E I DY T I E I LK
KAT Y NGC LN L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T V E EVDY T ADKC I
VAT Y NGC LN L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GAD ED LAH S S I R FG LGR FT T V E EVDY T ADKC I
EKG F PGCVNV S F P FV EG E S L LMH L - -KD I A L S SG SACT SA S L E P SY V LR A LGRDD E LAH S S I R FG I GR FTMAK E I D I VANKT V
E LR V PNT I LVA FKGV EG EAMLWD LNKHG I AA ST G SACA S E S LQAN PT FKAMK FG ED L SHTG I R L S L SR FNT E E E I DY T I D I I K
EHR Y PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GAD ED LAH S S I R FG I GR FT T E E E I DY T VQKC I
KHHY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T E E EVDY T V EKC I
DHR Y PGCVN I S FAY V EG E S L LMA L - -RD I A L S SG SACT SA S L E P SY V LHA LGKDDA LAH S S I R FG I GR FT TD E E I DY V I KA I T
KHR L PGN LN I S F SCV EG E S L LMGM- -RDVAV S SG SACT SA S L E P SY V LR A LGVDA ENAHT S I R FG I GR FT T AK EVD LV I E ECV
EHHY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T E E EVDY T V EKC I
DH FY PGCVNV S FAY V EG E S L LMA L - -KD I A L S SG SACT SA S L E P SY V LR A LGN SD E SAH S S I R FG I GR FT T ER E I DY V LKAVQ
T ER LANNVNVT F EY I EG E S L L L L LNAKG I FA ST G SACN ST S L E P SHV LT ACGV PH E I VHG S LR L S LGRMNT L EDVDR V L EV L P
QQHY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T E E EVDY T A EKC I
KQHY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V FR A I GTD ED LAH S S I R FG I GR FT T E E EVDY T A EKC I
NH FY PGCVNV S FAY V EG E S L LMA L - -KD I A L S SG SACT SA S L E P SY V LR A LGN SD E SAH S S I R FG I GR FT T EQ E I DY V LKAVT
EHR Y PGN LN L S FAY V EG E S L LMG L - -K EVAV S SG SACT SA S L E P SY V LR A LGV E EDMAHT S I R FG I GR FT T E E EVDRA I E LT V
EAR Y HGNVNMS FAY V EG E SMLMG L - -K E I AV S SG SACT SA S L E P SY V LR A LGVN E EMAHT SVR Y G LGR FT T EA EVDRA I EAT V
KHHY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T E E EVDY T V EKC I
EHR Y KGN LNV S FA FV EG E S L I MA I - -KQVAV S SG SACT SA S L E P SY V LR A LGVQ EDMAHT S LR I G I GR FT T EK EVD F L LDQ L S
E SQY PGCVN I S FAY I EG E S L LMA L - -KD I A L S SG SACT SA S L E P SY V LHA LGADDA LAH S S I R FG I GR FT T E E EVDY V I KA I N
I NR Y Y GNMN I S F L FV EG E S L LMS L - -N E I A L S SG SACT S ST L E P SY V LR S I G I S ED I AHT S I R I G FNR FT T F F EVQQ LC I N LV
TNR Y FGNMNV S F L FV EG E S L LMS L - -N E I A L S SG SACT S ST L E P SY V LR S I G I S ED I AHT S I R I G FNR FT T F F EVQQ LC EN LV
I NR Y FGNMN I S F L FV EG E S L LMS L - -ND I A L S SG SACT S ST L E P SY V LR S I G I T E E I AHT S I R I G FNR FT T F F EVQQ LCKN LV
ER R Y AGN LN L S FAY V EG E S L LMG L - -KDVAV S SG SACT SA S L E P SY V LR A LGVD EDMAHT S I R FG I GR FT T E E E I DR A I E LT V
KQHY PGC I N L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GTD ED LAH S S I R FG I GR FT T E E EVDY T VQKC I
DHR Y PGCVNV S FAY V EG E S L LMA L - -RD I A L S SG SACT SA S L E P SY V LHA LGKDDA LAH S S I R FG I GR F ST E E EVDY VVKAV S
K SR Y PGCVN I S FNY V EG E S L LMG L - -KN I A L S SG SACT SA S L E P SY V LR A I GQ SD ENAH S S I R FG I GR FT T EA E I DY A I ENV S
D ET Y PGCVN L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GAQ ED LAH S S I R FG I SR FT T E E EVDY T A EKCV
NQR Y PGCVN L S FAY V EG E S L LMA L - -KDVA L S SG SACT SA S L E P SY V LR A I GAD ED LAH S S I R FG I GRHHR R R SG LHGR KMY L
DQR Y VGN I N I S F E FV EG E S LMMG I - -KQCAV S SG SACT SA S L E P SY V LR A LGVN E E LAHT S LR I G FGR FT TD E EVDY L I N L L S
G ER Y FGN LNMS F E F I EG E S L LMS L - - SN FA L S SG SACT SA S L E P SY V LR S LDV S E E LAHT S I R FG LGR FTME S EVDMA L E S I T
GQR Y FGN LNMS F E F I EG E S L LMS L - - SN FA L S SG SACT SA S L E P SY V LR S LDV S E E LAHT S I R FGMGR FT I E S EVDMA LD S I T
EHRWFGCVN I S F EAV EG E S LMAT I - - PN FGV S SG SACT SA S L E P SY V LKG I GVGD E LAHT S LR I G I SK FT T R E EVDQ FV E L L E
ER R FHGN LN I S FACV EG E S L LMGM- -KKVAV S SG SACT SA S L E P SY V LR A LG I DA ENAHT S I R FG I GR FT T ER EVDVT V E ECA
EKR Y PGN LN I S F SCV EG E S L LMGM- -KNVAV S SG SACT SA S L E P SY V LR A LG I DA ENAHT S I R FG I GR FT T ER E I DVT I E ECV
QNGY PGC LN LT FQY V EG E S L LMA L - -KD I C L S SG SACT SA S L E P SY V LR A LG LND ENAH S S LR FG I GR FT T E E EVDY VADK I I
EHHY PGCVN I S FAY V EG E S L LMA L - -KD I A L S SG SACT SA S L E P SY V LR A LGADDA LAH S S I R FG I GR FT T EA EVDY V LKAVQ
























































KHVT R LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG SAGGK FR I S LG L PVGAV I NCADNTGAKN LY V I AVHG I R GR LNR L PAA
KQV EK LR EMS P L - - - - - - - -Y EMSKR - - - - - -GRGGT SGNK FRMS LG L PVAAT VNCADNTGAKN LY I I SVKG I KGR LNR L P SA
ER V E F LR E L S P L - - - - - - - -WEM- - - - - - - - - SGNGAQGT K FR I S LG L PT GA I MNCADN SGARN LY I MAVKG SG SR LNR L PAA
DR VH F LR E L S P L - - - - - - - -WE - - - - - - - - - - - - - - - - - - - - -MT LG L PCGAVMNCCDN SGARN LY I I SVKGVGAR LNR L PAA
DR VH F LR E L S P L - - - - - - - -WEMSAR - - - - - -GRGGA SGNK LKMT LG L PCGAV LNCCDN SGARN LY I I SVKG I GAR LNR L PAA
RHV ER LR EMS P L - - - - - - - -WE I K T L - - - - - -GRGG SAGAK FR I S LG L PVGAV I NCADNTGAKN LY V I AVQG I KGR LNR L PAA
HHVKR LR EMS P L - - - - - - - -WEMSK L - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L PAA
R ET ER LR E L S P L - - - - - - - -WEMSKR - - - - - -GRGGA SGAK FR I S LG L PVGAVMNCADNTGAKN L FV I SVY G I R GR LNR L P SA
R ETNR LRD L S P L - - - - - - - -WEMSKR - - - - - -GRGGA SGAK FR I S LG L PVGAVMNCADNTGAKN L FV I SVY G I R GR LNR L P SA
ER VD F LR KMS P L - - - - - - - -WE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -MNCADN SGARN LY V LAVKGTGAR LNR L PAA
ER VK F LR E L S P L - - - - - - - -WEM- - - - - - - - - SGNGAQGT K FR I S LG L PT GA I MNCADN SGARN LY I MAVKG SG SR LNR L PAA
HHVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L PAA
- - - - - - - - - - - - - - - - - - - - - -MSX X - - - - - -X X X X X X X X X FR I S L S L PVGAVVNCADNTGAKN LY I I AVKG I R GR LNR L PAA
SVVNK LRDMS P L - - - - - - - -WEMS - - - - - - - - I K SAAAGT K FRMS LG L PVGAVMNCADN SGAKN LY V I SV I G FGAR LNR L PAA
E SVT L LR KMS P L - - - - - - - -WDM-KR - - - - - -GRGAAGGAKMR I T LG LNVGA L I NCCDN SGGKN LY I I AVKGTG SC LNR L P SA
E SVT L LR KMS P L - - - - - - - -WDM-KR - - - - - -GRGAAGGAKMR I T LG LNVGA L I NCCDN SGGKN LY I I AVKGTG SC LNR L P SA
HQVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L P SA
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - LG L PVGAVVNCCDN SGARN LY I V SVKG FGAR LNR L PAA
KNVQR LRDMS P L - - - - - - - -WEM- - - - - - - - - SKAQAVG SNY R V S LG L PVGAVMN SADN SGAKN LY V I AVKG I KGR LNR L P SA
KHV ER LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGGTAGGK FR I S LG L PVGAVMNCADNTGAKN LY V I AVHG I R GR LNR L PAA
KHV ER LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGGTAGGK FR I S LG L PVGAVMNCADNTGAKN LY V I AVHG I R GR LNR L PAA
EAVQK LR EMS P L - - - - - - - -Y EMAA EKKT EV L EKK I S I K PR Y KMT RG I QV ET LMKCADN SGAK I LR C I GVKR Y RGR LNR L PAA
K SVDR LRQ L S ST - - - - - - - -Y AMPKR - - - - - -GAGGRQGNK FR VT CG LNNA ST VNCADNTGAKT LT I I SVKG FHGR LNR L PR A
QHVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I KGADNTGAKN LY I I SVKG I KGR LNR L PAA
QHVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L PAA
ER VD F LR E L S P L - - - - - - - -WEM- - - - - - - - - SGNGAQGT K FR I S LG L PT GA I MNCADN SGARN LY I MAVKG SG SR LNR L PAA
RNV ER LR E L S P L - - - - - - - -WDM-GK - - - - - -DQANVKGCR FR V SVA L PVGAVVNCADNTGAKN LY V I SVKGY HGR LNR L P SA
QHVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L PAA
ER V S F LR E L S P L - - - - - - - -WEM-AK - - - - - - L SR GA PGGK LKMT LG L PVGA I MNCADN SGARN LY I I SVKG I GAR LNR L PAG
E I VQK LRNMS P L - - - - - - - -T P - - - - - - - - - - - - - -MKGMR SN I PR A LNAGAQ I ACVDNTGAKVV E I I SVKKY RGVKNRMPCA
HHVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L PAA
HHVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L PAA
ER VG F LR E L S P L - - - - - - - -WEM-AK - - - - - -Q SRGA PGGK LKMT LG L PVGA I MNCADN SGARN LY I I SVKG I GAR LNR L PAG
HQVKK LRDMS P L - - - - - - - -Y EMSKR - - - - - -GRGG SAGNK FRMS LG L PVAAT VNCADNTGAKN LY I I SVKG I KGR LNR L P SA
RQV EK LR EMS P L - - - - - - - -WEMSKR - - - - - -GGGNA SGT KY KMSY GV PVGAVVNCADNTGAKN LY L I AVKRWG SRQNR L PAA
QHVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L PAA
GAVR K LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGGQVG I K LR I T LACNVGAV LNCADN SGAKN I Y V I ST FG I KGH L SR L P SA
ER V E F LR KMS P L - - - - - - - -WEM- - - - - - - - - SG SGA SGNK FRMS LA L PVGAVMNCADN SGARN LY V LAVKGVGAR LNR L PAA
K SV ER LR S I S P L - - - - - - - -Y EM-KR - - - - - -GR AGT LKNKMR I T L S L PVGA L I NCCDN SGGKN LY I I AVQG FG SC LNR L PAA
K SVKR LR S I S P L - - - - - - - -Y EM-KR - - - - - -GR AGT LKNKMR I T L S L PVGA L I NCCDN SGGKN LY I I AVQG FG SC LNR L PAA
K SVKR LR S I S P L - - - - - - - -Y EM-KR - - - - - -GR AGT LKNKMR I T L S L PVGA L I NCCDN SGGKN LY I I AVQG FG SC LNR L PAA
QQV EK LR EMS P L - - - - - - - -Y EMSKR - - - - - -GRGG SAGNK FRMS LG L PVAAT VNCADNTGAKN LY I I SVKG I KGR LNR L P SA
HHVKR LR EMS P L - - - - - - - -WEMSKR - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L PAA
DR VK F LR E L S P L - - - - - - - -WEM- - - - - - - - - SGNGAQGT K FR I S LG L PVGA I MNCADN SGARN LY I I AVKG SG SR LNR L PAA
RQV S F LR NMS P L - - - - - - - -WDM- SR - - - - - -GRGAA SGT KY RMT LG L PVQA I MNCADN SGAKN LY I V SV FGTGAR LNR L PAA
H EVTQ LR EMS P L - - - - - - - -WE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -GKN LY I I AV SG I GGR LNR L PNA
PC LQT EGD E S SMGDG SGRHR YQ - - - - - - - - - -GRGG S SGAK FR I S LG L PVGAV I NCADNTGAKN LY I I SVKG I KGR LNR L P SA
EKV SK LR EMS P L - - - - - - - -WEAAAR - - - - - -GRGGQVGT KAKV S LG L PVGAVMNCADN SGAKN LY T I AC FG I KGH L SK L P SA
KVV EK LRN L S P L - - - - - - - -Y EM-KR - - - - - -GRGG SGGNK LR VT LG L PVGA L I NCCDN SGGKN LY L I AVKGTGAC LNR L P SA
KVV EK LRN L S P L - - - - - - - -Y EM-KR - - - - - -GRGG SGGNK LR VT LG L PVGA L I NCCDN SGGKN LY L I AVKGTGAC LNR L P SA
HAVKH LRD L S P L - - - - - - - -WEMSKR - - - - - -GR TGQQGT K FAMTAG L PVGAV I NCCDN SGAKNMF I I SV R GHKGR LNR L PAA
R T V ER LR EMS P L - - - - - - - -WDM-GK - - - - - -DKANVKGCR FR V S LA L PVGAVVNCADNTGAKN LY I I SVKGY HGR LNR L PAA
RNV ER LR EMS P L - - - - - - - -WDM-GK - - - - - - EKANVKGCR FR V S LA L PVGAVVNCADNTGAKN LY I I SVKGY HGR LNR L PAA
KVVNK LRDMS P L - - - - - - - -WEM- - - - - - - - - - SKAAVGT K FRMT LA L PVGAVMNCADN SGAKN L FV I AVHG I GAR LNR L PAA
ER VN F LR E L S P L - - - - - - - -WEM- - - - - - - - - - - SGA SGT KY KMSMA L PVGA I MNCADN SGARN LY V I AVKGCGAR LNR L PAA
























































GVGDMFVAT VKKGK P E LR KKVMPAVV I R QR K P FR R RDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
CVGDMVMAT VKKGK PD LR KKV L PAV I V RQR K PWR R KDGV FMY F EDNAGV I VN PKG EMKG SA I T G P I GK ECAD LWPR I A - - - SA
S LGDMVMAT VKKGK P E LR KKVMPA I VVRQ SK PWR R KDGVY LY F EDNAGV I AN PKG EMKG SA I T G PVGK ECAD LWPR I A - - - SN
GVGDMVMAT VKKGK P E LR KKVMPAVVVRQ SK PWR R PDG I Y LY F EDNAGV I VNAKG EMKG SA I T G PVGK EAA E LWPV S S L L F SN
GVGDMVMAT VKKGK P E LR KKVMPAVVVRQ SK PWR R PDG I Y LY F EDNAGV I VNAKG EMKG SA I T G PVGK EAA E LWPR I A - - - SN
G SGDMI VAT VKKGK P E LR KKVMPAVV I R QR K P FR R RDGV F I Y F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMFVC SVKKGK P E LR KKV LQGVV I R QR KQ FR R KDGT F I Y F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - -AN
GVGDMFVC SVKKGK P E LR KKV LQGVV I R QR KQ FR R KDGT F I Y F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - -AN
AAGDMVMAT VKKGK P E LR KKVMPA I V I R Q SK PWR R RDGVY LY F EDNAGV I VN PKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
S LGDMVMAT VKKGK P E LR KKVMPA I VVRQ SKAWR R KDGVY LY F EDNAGV I AN PKG EMKG SA I T G PVGK ECAD LWPR VA - - - SN
GVGDMVMAT VKKGK PX LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVX K ECAD LWPX I A - - - SN
GVGD I V LAT VKKGK P E LR KKVH PAV I I R Q SK SY R R KHGQMI Y F EDNAGV I VNQKG EMKG - - - - - - - - - - - - - - - - - - - - - - - -
AAGDMVMA SVKKGK P E LR KKVMPAV I CRQR K PWR R RDG I F LY F EDNAGV I VNAKG EMKG SA I NG PVAK ECAD LWPR I A - - - SN
S I GDMV LAT VKKGK P E LR KKVWPAV I VRQR KA FR R P EGT F LY F EDNAGV I VN PKG EMKG SA I T G PVGK ECA E LWPKV S - - -AA
S I GDMV LAT VKKGK P E LR KKVWPAV I VRQR KA FR R P EGT F LY F EDNAGV I VN PKG EMKG SA I T G PVGK ECA E LWPKV S - - -AA
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
SAGDMVMAT VKKGK P E LR KK I MPA I VVRQAR PWR R KDGVY LY F EDNAGV I VN PKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMVMAT VKKGK P E LR KKVCTG LVVRQR KHWKR KDGVY I Y F EDNAGVMCN PKG EVKGN - I LG PVAK EC SD LWPKVA - - -TN
GVGDMFVAT VKKGK P E LR KKVMPAVV I R QR K P FR R RDGV F I Y F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMFVAT VKKGK P E LR KKVMPAVV I R QR K P FR R RDGV F I Y F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
A PGD I CVV SVKKGK P E LR KKVHY A I L I R QKK I WR R TDG SH I MF EDNAAV L I NNKG E LR GAQ I AG PV PR EVADMWPK I S - - - SQ
GCGDMVVATCKKGK P EY R KKMHTAV I I R QR R TWR R KDGVT LY F EDNAAV I VNMKG EMKG SA I T G PV SK E SAD LWPK I S - - - SN
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
S LGDMVMAT VKKGK P E LR KKVMPA I VVRQ SKAWR R KDGV F LY F EDNAGV I AN PKG EMKG SAVTG PVGK ECAD LWPR I A - - - SN
A LGDMVMC SVKKGK P E LR KKV LNAV I I R QR K SWR R KDGT V I Y F EDNAGV I VN PKG EMKG SG I AG PVAK E SAD LWPK I S - - -T H
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMVMAT VKKGK P E LR KKVH PAV I V RQ SK PWKR TDGV F LY F EDNAGV I VN PKG EMKG SA I T G PVGK EAA E LWPR I A - - - SN
G I GDMCVV SVKKGT P EMR KQV L LAVVVRQKQ E FR R PDG LHV S F EDNAMV I T D E EG I PKGTD I KG PVAR EVA ER F PK I G - - -T T
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMVMAT VKKGK P E LR KKVH PAV I V RQ SK PWKR FDGV F LY F EDNAGV I VN PKG EMKG SA I T G PVGK EAA E LWPR I A - - - SN
CVGDMVMAT VKKGK PD LR KKVMPAV I VRQR K PWR R KDGVYMY F EDNAGV I VN PKG EMKG SA I T G P I GK ECAD LWPR I A - - - SA
N PG SMVMAT VKKGK PD LR KKV F PA I I V RQR K P I R R K EG L I I Y F EDNAGV I CN PKG EMKG SA I AG PVAK ECAD LWPR VA - - - SA
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
S I GDMV LC SVKQGK PA LR KKVMQAVVVRQR K PY R R R EGY Y I Y F EDNAGV I I N PKG EMKG SA I T G PVGK EAAD LWPK I A - - - SA
SAGDMVMAT VKKGK P E LR KKVMPA I V I R Q SR PWR R KDGVY LY F EDNAGV I VN PKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
S LGDMV LAT VKKGK PD LR KKV LNA I I CRQ SKAWR RH EGY Y I Y F EDNAGV I VN PKG EMKG SA I T G PVAR ECA E LWPK L S - - - SA
S LGDMV LAT VKKGK PD LR KKV LNA I I T RQ SKAWR RH EGY F I Y F EDNAGV I VT PR -RMKG SA I T G PVAR ECA E LWPK L S - - - SA
S LGDMV LAT VKKGK PD LR KKV LNA I I T RQ SKAWR RH EGY F I Y F EDNAGV I VN PKG EMKG SA I T G PVAR ECA E LWPK L S - - - SA
CVGDMVMAT VKKGK PD LR KKVMPAV I VRQR K PWR R KDGV FMY F EDNAGV I VN PKG EMKG SA I T G P I GK ECAD LWPR I A - - - SA
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
S LGDMVMAT VKKGK P E LR KKVMPA I VVRQAK SWR R RDGV F LY F EDNAGV I AN PKG EMKG SA I T G PVGK ECAD LWPR VA - - - SN
SCGDMV LAT VKKGK PD LR KK I MPA I VVRQR KAWR R KDGVY LY F EDNAGV I VN PKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
G LGDMI VAT VKKGK P E LR KKVMPAVV I R QR K P I R R R EG I V LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
GVGDMVMAT VKKGK P E LR KKVH PAVV I R QR K SY R R KDGV F LY F EDNAGV I VNNKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
S I GDMI LC SVKKG S PK LR KKV LQA I V I R QR R PWR R RDGV F I Y F EDNAGV I AN PKG EMKG SQ I T G PVAK ECAD I WPKVA - - - SN
SVGDMV LAT VKKGR PD LR KKV L PAV I V RQR KAWR R R EGY F I Y F EDNAGV I VN PKG EMKG SA I NG PVAK ECA E LWPK I S - - -AA
SVGDMV LAT VKKGR PD LR KKV L PAV I V RQR KAWR R R EGY F I Y F EDNAGV I VN PKG EMKG SA I NG PVAK ECA E LWPK I S - - -AA
SV SD L I VVT CKKGK PA LR KKV SMGVVVRQRA I WR R KDGVV I G FQDNAGV I I NDKG EMKG SA I T G PVAK EAA E LWPKVA - - - SV
A LGDMVMA SVKKGK P E LR R KV LNAV I I R QR K SWR R KDGT V I Y F EDNAGV I VN PKG EMKG SG I AG PVAK EAA E LWPK I S - - -T H
A LGD I VMA SVKKGK P E LR R KV LNAV I I R QR K SWR R KDGT V I Y F EDNAGV I VN PKG EMKG SG I AG PVAK EAAD LWPK I S - - - SH
AAGDMVVA SVKKGK P E LR KKVMPAVVVRQR K PWR R RDGV F LY F EDNAGV I VN PKG EMKG SA I T G PVAK ECAD I WPR I A - - - SN
GAGDMVMAT VKKGK P E LR KKVMPA I VVRQ SK PWR R KDGVY LY F EDNAGV I VN PKG EMKG SA I T G PVAK ECAD LWPR I A - - - SN
























































AG S I - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -MAR KAR I I DVVY NA SNN E L I R T K
ANA I G - - I SR D S I HKKKR KY E LGRQ PANT K L - - S I R VR GGNVKWRA LR LDTGN F SWG S EAVT R KT R I LDVAY NA SNN E LVR TQ
SGVVG - - I SR D SRHKKKR K F E LGRQ PANT K I - -GVR T RGGNKK FR A LR I ET GN F SWA S EGV SR KT R I VGVVY H P SNN E LVR TN
T S S -G - - I SR D SRHKKKR A F EKGRQ PANT R I - -GVR T RGGNR K FR A LR L E SGN F SWG S EG I SR KT R V I VVAY H P SNN E LVR TN
SGVVG - - I SR D SRHKKKR A F EKGRQ P SNT R I - -GVR T RGGNQK FR A LR L E SGN F SWG S EG I SR KT R V I VVAY H P SNN E LVR TN
A S S I G - - I SR DHWHKKKR KY E LGR PAANT R L - -GVR SR GGNT KY R A LR LDTGN F SWG S EC ST R KT R I I DVVY NA SNN E LVR T K
AG S I G - - I SR DNWHKKKR KY E LGR PAANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
AG S I G - - I SR D SWHKKKR K F E LGR PAANT K I - -GVR T RGGN LKY R A LR LDNGN F SWA S EQT T R KT R I VDTMYNATNN E LVR T K
AG S I G - - I SR D SWHKKKR K F E LGR PAANT K I - -GVR T RGGN EKY R A LR LD SGN F SWA S EQT T R KT R I VDTMYNATNN E LVR T K
SGVVG - - I SR D SRHKKKR K F E LGRQ PANT K I - -GVR T RGGNQK FR A LR V ET GN F SWG S EGV SR KT R I AGVVY H P SNN E LVR TN
SGVVG - - I SR D SRHKKKR K F E LGRQ PANT K I - -GVR T RGGNQK FR A LR I ET GN F SWA S EGVAKKT R I VGVVY H P SNN E LVR TN
AG S I G - - I SR DNWHKKKR KY E LGR PAANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
- - -MG - - I SQD SWHKKKR K F E LGR PAANT K I - -GVR T RGGNT K FR G LR LDTGN F SWG S EACAR KT R I I DVMYNA SNN E L LR T K
AGT VG - - I T R D SRHKKKR K F E LGRQ PAMTK LD - SVR T RGGNVKY R A LR LD SGN FAWG S E SVT R KT R L I QVR Y NATNN E L LR TQ
A P S I G - - I SR D SRHKKKR KY EMGR PA SNT K L - -GVR CRGGNKK FR A LR LD SGNY SWG SQGVT R KAR I MEVVY NA SNN E LVR T K
A P S I G - - I SR D SRHKKKR KY EMGR PA SNT K L - -GVR CRGGNKK FR A LR LD SGNY SWG SQG I SR KAR I MEVVY NA SNN E LVR T K
AG S I G - - I SR DNWHKKKR KY E LGR PAANT K I - -G I R VR GGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
SGVVG - - I SR D SRHKKKR K F E LGRQ PANT K I - -GVR T RGGN EK FR A LR I ET GN F SWG S EGVAR KT R LAGVVY H P SNN E LVR TN
AGT I G - - I SR DA LHKKKR KY E LGRQAAKT K I - -C I R VR GGHQK FR A LR LDTGN F SWAT EK I T R KCR I LNVVY NAT SND LVR TN
A S S I G - - I SR D SAHKKKR K F E LGR PAANT K L - -GVR T RGGNT K LR A LR L ET GN FAWA S EGVAR KT R I ADVVY NA SNN E LVR T K
A S S I G - - I SR D SAHKKKR K F E LGR PAANT K L - -GVR T RGGN SK LR A LR L ENGN FAWA S EGVAR KT R I ADVVY NA SNN E LVR T K
A S S I G - - I NHRGDHKKKRNNRAG SQ P S ST K I - -GVR VRGGNR KY KA LR LDMGH FK F I T T GK FRMAK L LQVVY H P S SN E LVR TN
A PT I G - - I T R D SRHKKKKKNTMGRQ PANT R L - -GVR CR Y G I I K R R A LR L ENGN F SWA SQ S I T KGT K I LNVVY NA SDND FVR TN
AG S I G - - I SR DNWHKKKR KY E LGR P PANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
AG S I G - - I SR DNWHKKKR KY E LGR PAANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
SGVVG - - I SR D SRHKKKR K F E LGRQAANT K I - -GVR T RGGNQK FR A LR I ET GN F SWA S EGVAR KT R I T GVVY H P SNN E LVR TN
A PA I G - - I V R SR LHKKRMKA E LGR L PANT R L - -GVR ARGGN FK I R A LR LDTGN FAWA S EA I AHR VR L LDVVY NAT SN E LVR T K
AG S I G - - I SR DNWHKKKR KY E LGR PAANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
SGVVG - - I SR D SRHKQKRAWEAGRQ PA ST K I - -GVR VRGGNT KY R A LR LD SGN F SWG S EGVT R KT R V I AVAY H P SNN E LVR TN
A S I I - - -MRWQG S SR GKR K F EMGR E SA ET R I - - SV PTMGGNR KVR L LQ SNVANVTN PKDGKT VT A P I ET V I DNT ANKHY VR RN
AG S I G - - I SR DNWHKKKR KY E LGR P PANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
AG S I G - - I SR DNWHKKKR KY E LGR PAANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
SGVVG - - I SR D SRHKKKR A F EAGRQ PANT R I - -GVR T RGGNHKY R A LR LD SGN FAWA S EGCT R KT R V I VVAY H P SNN E LVR TN
ANA I G - - I SR D SMHKKKR KY E LGRQ PANT K L - - SVR VRGGN LKWRA LR LDTGNY SWG S EAVT R KT R I LDVVY NA SNN E LVR TQ
A S S I G - - I SR D S LHKKKR KY E LGRQ PANT K L - - SVR CRGGN I KHR A LR LDTGN FAWG S ENCT R KT R I LDVVY NA SNN E LVR T K
AG S I G - - I SR DNWHKKKR KY E LGR PAANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
AG SVG - - I SR D SRHKKKR A F EKGRQAAMTK LV SG I R VR GGN FK FR A LR L S EGN F SWG SQG I AKKAK I V EVVY H P SNN E LVR T K
SGVVG - - I SR D SRHKKKR K F E LGRQ SANT K I - -GVR T RGGNQK FR A LR V ET GN F SWG S EGV SR KT R I AT VVY H P SNN E LVR TN
A SA I G - - I SR DGRHKKKR KY E LGR P P SNT K L - -GVRGRGRNY KY R A I K LD SG S F SWPT FG I SKNT R I I DVVY NA SNN E LVR T K
A SA I G - - I SR DGRHKKKR KY E LGR P P SNT K L - -GVRGRGKN LKY R A I K LD SG S F SWPA FGV SK I T R I I DVVY NA SNN E LVR T K
A SA I G - - I SR DGRHKKKR KY E LGR P P SNT K L - -GVRGRGRNY KY R A I K LD SG S F SWPA FG I SKMT R I I DVVY NA SNN E LVR T K
ANA I G - - I SR D SMHKKKR KY E LGRQ PA ST K L - - S I R VR GGNVKWRA LR LDTGNY SWG S EAVT R KT R I LDVVY NA SNN E LVR TQ
AG S I G - - I SR DNWHKKKR KY E LGR PAANT K I - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
SGVVG - - I SR D SRHKKKR K F E LGRQ PANT K I - -GVR T RGGNKKY R A LR I ET GN F SWA S EG I SKKT R I AGVVY H P SNN E LVR TN
AGT VG - - I T R D SRHKKKR K F E LGRQ P SNT R I - -GVR VRGGNKK FR A LR LD SGN F SWG S EGV SKKT R I I QVAY H P SNN E LVR TN
A ST I GGR I PDDT T R KAHY A L P LAR KKGAK L L - -GVR CMGGN I KR R A LR LDNGN F SWG S EHT T R KT R I I DVVY NA SNN E LVR T K
AG S I G - - I SR DNWHKKKR KY E LGR P PANT K L - -GVR VRGGNKKY R A LR LDVGN F SWG S ECCT R KT R I I DVVY NA SNN E LVR T K
AG SVG - - I SR D SKHKKKR A F EKGR P I SMT K L - -T VR VRGGH LK FR A LR LC EGN F SWG S EN I T R KT K I LDVKY NATNN E LVR T K
A P S I G - - I SR D SRHKKKR KY E LGR P S SNT K L - -GVR CRGGN LK FR A LR LD SGN F SWG SQNVT R KT R VMDVVY NA S SN E LVR T K
A P S I G - - I SR D SRHKKKR KY E LGR P S SNT K L - -GVR CRGGN LK FR A LR LD SGN F SWG SQNVT R KT R VMDVVY NA S SN E LVR T K
A PAVG - - I T RMGD LKKKRN F LAGR P SAQT R I - -GVR VRGGN LKMRA LR L ET GT FAWA S ENCT R KT R I LNVT Y H PADND LVR TN
A PA I G - - I V R SR LHKKRMKA E LGR L PANT K L - -GVR ARGGN FK LR G LR LDTGN FAWGT EA SAQRAR I LDVVY NAT SN E LVR T K
A PA I G - - I V R SR LHKKRMKA E LGR L PAHT K L - -GVR ARGGN FK LR G LR LDTGN FAWGT EA I AQRAR I LDVVY NAT SN E LVR T K
AGT VG - - I T R D SRHKKKR A F E LGRQAANT R I - -GVR VRGGN LKHRA LR L E SGN FAWG S EH I T AKT R V LGVVY NA SNN E LVR TN
SGVVG - - I SR D SRHKKKR K F ECGRQGAVT R I - -GVR T RGGNKK FR A I R I ET GN F SWG S EGT T R KT R V LGV S FH P SNN E L I R T N
























































T LVKNA I I V I DA S P FRQWY E SHY SK SN LR KY VKR - - -QKNAK I D PAV E EQ FNAGR L LAC I S SR PGQVGRADGY I L EGK E L E FY
T LVK SA I VQVDAA P FKQGY LQHY SNHVQR K L EMR - - -Q EGR A LD SH L E EQ F S SGR L LAC I A SR PGQCGRADGY I L EGK E L E FY
T LT K SA I VQ I DAT P FRQWY E SHY SRNA ER KWAAR - - -AGDAK I EGAVD SQ F SAGR LY AC I S SR PGQ SGRCDGY I L EG E E LA FY
T LT K SAVVQ I DAA P FRQWY EAHY SN SVVKKQAAR F - -ADHGKV E PA I EKQ F E SGR LY AV I A SR PGQ SGR VDGY I L EG E E LA FY
T LT K SAVVQ I DAA P FRQWY EAHY SN SVVKKQAAR F - -A EQGKV E SAV ERQ F E SGR LY AVV S SR PGQ SGR VDGY I L EG E E LA FY
T LVKNA I VVVDAT P FRQWY E SHY SQKT AR KY LAR - - -QR LAKV EGA L E EQ FHTGR L LACVA SR PGQCGRADGY I L EGK E L E FY
T LVKNC I V L I D ST PY RQWY E SHY SKK I QKKY D ER - - -KKNAK I S S L L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LVKGA I V SVDAA P FRQWY EAHY SNHT LKKY T ER - - -QKT AAVDA L LT EQ FNTGR L LAR I S S S PGQVGQANGY I L EGK E LD FY
T LVKGA I I SVDAA P FRQWY EAHY SHHTMKKY T ER - - -QKT AAVDA L L I EQ FNTGR L LAR I S S S PGQVGQANGY I L EGK E LD FY
T LT K SAVVQ I DAT P FRQWY ENHY SR KV ER K LAAR - - - SGAAA I E SAVD SQ FG SGR LY AV I S SR PGQ SGRCDGY I L EG E E LA FY
T LT KAA I VQ I DAT P FRQWY EAHY SK SA ER KWAAR - - -AA SAKV E SAVD SQ F SAGR LY AC I S SR PGQ SGRCDGY I L EG E E LA FY
T LVKNC I V L I D ST PY RQWY E SHY SKK I QKKY D ER - - -KKNAK I S S L L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LVKNA I I Q I D ST P FRQWY EAHY SKKTQKKY E ER - - -KK E PKVAQA L E EQ FNQGR I LAC I S SR PGQ SGRCDGY I L EGK E L E FY
T LVKGAVVD I DAT P FRQWY E SHY SNHVKR I L E ER - - -KKVAK I D P L L EQQ FR AGR L LAV I S SR PGQ SGRADGY I L EGK E L E FY
T LVKNA I VV I DAT P FRQ FY LQR Y SGH L LAT R KAR - - - LMNNV I D P LV E EQ FG I GR L LACV S SR PGQCGRCDGY I L EGK E L E FY
T LVKNA I VV I DAT P FRQ FY LQR Y SGH L LAT R KAR - - - LMNNV I D P LV E EQ FG I GR L LACV S SR PGQCGRCDGY I L EGK E L E FY
T LVKNCVV LVD ST PY RQWY E SHY SKKVQKK FT LR - - -R KT AK I S P L L E EQ F LQGK L LAC I S SR PGQCGRADGY V L EGK E L E FY
T LT KAA I VQ I DAT P FKQWF ETHY SR KV ER K LAQR - - - SGA SN I E SAV EHQ FNAGR LY AA I S SR PGQ SGRCDGY I L EG E E LA FY
T LVKG S I VQ I DAT PY KQWY ETHY SA S L LAK LA SR - - -AKGR V LD SA I E SQ I G EGR F FAR I T SR PGQVGKCDGY I L EAK E L E FY
T LVKN S I VV I DAT P FRQWY EAHY S EKVMKKY L ER - - -QKY GKV EQA L EDQ FT SGR I LAC I S SR PGQCGR SDGY I L EGK E L E FY
T LVKN S I VV I DAT P FRQWY E SHY S EKVMKKY L ER - - -QK FGKV EQA L EDQ FT SGR I LAC I S SR PGQCGR SDGY I L EGK E L E FY
T LT K S SVVK I SA E P FKND I K - - - - - - - - - - - - - - - - -DVARDVD P S LH E S F EKGH LY A I I T SR PGQVGMAQGHV LQGD E LK FY
T LVKGA I I E I D PA P FR LWF LK FY SKTMQKKY AKK L EV LKNMK FD EA L L EG FQ SGR V LAC I S SR PGQTG SV EGY I L EGK E LD FY
T LVKNC I V LVD ST PY RQWY EAHY SKK I QKKY D ER - - -KKNAK I A S I L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LVKNC I V L I D ST PY RQWY E SHY SKK I QKKY D ER - - -KKNAK I S S L L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LT KAA I VQ I DAT P FRQWY E SHY SKNT ER KWAAR - - -AA EAK I EHAVD SQ FGAGR LY AA I S SR PGQ SGRCDGY I L EG E E LA FY
T LVKNC I VAVDAA P FKRWY AKHY S PK LQR EWT R R - - -R RNHR V EKA I ADQ LR EGR V LAR I T SR PGQ SGRADG I L L EGA E LQ FY
T LVKNC I V L I D ST PY RQWY E SHY SKK I QKKY D ER - - -KKNAK I S S L L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LT K SAV I Q I DAA P FRQWY EAHY SK SV EKKQA ER F - -AARGKVD SA L EKQ F EAGR V FAVV S SR PGQ SGRCDGY I L EG E E LA FY
I LT KG SV I R T SMGT - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -AR VT SR PGQDGVVNAV L I E - - - - - - -
T LVKNC I V LVD ST PY RQWY E SHY SKK I QKKY E ER - - -KKNAK I S P L L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LVKNC I V L I D ST PY RQWY E SHY SKK I QKKY D ER - - -KKNAK I S S L L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LT K SAVVQ I DAA P FRQWY EAHY SK SV EKKQA ER F - -AAAGKVD PA L EKQ F EAGR LY AV I S SR PGQ SGRCDGY I L EG E E LA FY
T LVK SA I VQVDAA P FKQWY LTHY SNHVVR K L EKR - - -QQT R T LD SH I E EQ FG SGR L LAC I S SR PGQCGRADGY I L EGK E L E FY
T LVK SAV I AVDAA P FR AWY AQHY SK SVTMK LR SR - - -NQKH EVAKA I D EQ FATGR L LA I I T SR PGQCGRADGY V L EGK E L E FY
T LVKNC I V L I D ST PY RQWY E SHY SKK I QKKY D ER - - -KKNAK I S S L L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LT R GV I VQVDAT P FRQWY AKKY SR S L I K K L EQR - - -AKDNA I DA LVQ EQ FTNQR L LVR I T SR PGQ SGRADGY I L EGK E L E FY
T LT KAA I VQ I DAT P FRQWY ENHY SR KV ER K LA SR - - -AGQAA I E SAVDAQ FG SGK LY AA I S SR PGQ SGRCDGY I L EG E E LA FY
T LVKNC I VV I D SH P FT TWY ENT FT Y GV I KK I - - - - - -GK SKN I D P L L L EQ FKQGR V LAC I S SR PGQCGKADGY I I EGD E L L FY
T LVKNC I V L I D SH P FT TWY ENT F SY SV I KK I - - - - - -GK SKQ I D PA L L EQ FKQGR V LAC I S SR PGQCGKADGY I I EGD E L L FY
T LVKNC I V L I D SH P FT AWY ENT F SY SV I KK I - - - - - -GKAKQ I D PA L L EQ FKQGR V LAC I S SR PGQCGKADGY I I EGD E L L FY
T LVK SA I VQVDAA P FKQWY LQHY SNHV I R K L EKR - - -QQVR K LD PH I E EQ FG SGR L LA S I S SR PGQCGRADGY I L EGK E L E FY
T LVKNC I V L I D ST PY RQWY E SHY SKK I QKKY D ER - - -KKNAK I S S L L E EQ FQQGK L LAC I A SR PGQCGRADGY V L EGK E L E FY
T LT KAA I VQ I DAT P FRQWF EAHY SKNA ER KWAAR - - -AA SAK I E S SV E SQ F SAGR LY AC I S SR PGQ SGRCDGY I L EG E E LA FY
T LT K SA I VQ I DAA P FR VWY ETHY SKHVQR KH SAR - - - LGD SKVD SA L ETQ FAAGR LY AVV S SR PGQ SGRCDGY I L EG E E LH FY
T LVKNA I VQ I D ST P FRQWY EAHY SKKVVKK F E ER - - -KKT AKVAQA L E EQ FGTGR L LAC I A SR PGQCGRADGY I L EGK E LD FY
T LVKNC I I LVD S L P FRQWY EAHY SKKTQKKY D ER - - -KKT AK I ST L L E EQ FQQGK L LAC I A SR PGQCGRADGY I L EGK E L E FY
T LVKN S I V E I D ST P FR EWY K LHY SRHVQKR V -KR - - -T KAQA L EKN I E EQ FV SQR I LAC I T SR PGQ SGRADGY I L EGK E L E FY
T LVKNA I VT VD PT P FK LWFKTHY S EKV - - - - - - - - - - - -AG LV PKT L L EQ F S SGR L LAC I S SR PGQCGRCDGY V L EG E E LN FY
T LVKNA I VT VD PT P FK LWFKTHY S EKV - - - - - - - - - - - -AA LV PR T L LDQ F S SGR L LAC I S SR PGQCGRCDGY V L EG E E LN FY
T LARG SVV S I DAA P FKQWY ERQ FTDKMTQRWAAN - - -KDGGVVA P E LVA E FDQGR L LAV I T SR PGQCGRADGY I L EG E E LA FY
T LVKNC I VVVDAA P FR LWY AKHY S SK LKR KWEY R - - -R KHHK I EKA LADQ LR EGR L LAR I T SR PGQTGRADGA L L EGA E LQ FY
T LVKNC I VVVDAA P FK LWY AKHY SD E LKR KWMLR - - -R ENHK I EKAVADQ LK EGR L LAR I T SR PGQTARADGA L L EGA E LQ FY
T LVKGC I VQVDAT P FRQAY EKHY SNNVT R K L ENR - - -R K EGK LD S LV EQQ FGAGR LY AAV S SR PGQ SGRCDGY I L EGK E L E FY
T LT K SA I VQ I DAT P FRQWY E SY Y A EADQAAVAAR - - -QADAK LD PAV EAQ FGAGR LY ACV S SR PGQ SGR VDGY V L EG E E LA FY
























































LKK I KNKKMV LAD LGR K I T NA LH S L SKAT I I N E E -V LD SMLK E I CT A L L EADVN I R LVKK LR ENVRQ SAV FK E LVK LV I MFVG
MKK LQKKKMV LA E LGGR I T R A I QQMSNVT I I D EK -A LN EC LN E I T R A L LQ SDV S F P LVK EMQ SN I K EQA I F S E LCKMVVMFVG
VR R LT AKKMV LAD LGKR I NAAVAQA LNNDTDDY VAGV ETMLKA I VT A L L ENDVN I K LV S SVR SN I KQKT V F E E LCA LVVMFVG
QRA I R K - -MV LQD LGR R I NAAVND LT R S SN LD EK -A FDDMLK E I CAA L L SADVNVR LVQT LR K S I KQKAV FD E LVA LV I MFVG
QRA I R K - -MV LQD LGR R I NAAVND LT R SNN LD EKQA FDDMI K E I CAA L L SADVNVR LVQ S LR K S I KQKAV FD E LV S LV I MFVG
LR K I K SKR - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
LR K I R AKKMV LAD LGR K I R NA I GK LGQNT V I N E E - E LD LMLK EVCT A L I E SDVH I R LVKQ LKDNVKQKT V FN E L LK LV FMFVG
LR K I R AKKMV LAD LGR K I R NA I GK LGQ ST V I N EG - E LD LMLK EVCT A L I E SDVH I R LVKQ LKDNVKQKT V FN E L LK LV FMFVG
LR R LT AKKMV LAD LG SR LR GA L S SV E SG S - - -DD - E I QQMI KD I C SA L L E SDVNVK LVAK LR GN I KQK I I FD E LCA LV I MFVG
LR R LT AKKMV LAD LGKR I NNAVN SA L SNT EDDY VN S I DGMLKG I ST A L L EADVN I MLV SKVRNN I RQKT V FD E LCG L I I MFVG
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
QR K I KAR KMV LAD LGR K I NNA LR S L SNAT I I N E E -V LQ SML S E I CR A L L E SDVN I R LVKK LR ENVRQ SAV FR E LVK LV I MFVG
HHK LQ I R KMV LAD LGT R LHGAWNQ L SKA SV I DDK -V I DGV LK E LCAA L L E SDVNVK LVA S LR T KVKQKAV FD E LVA LV LMAVG
KKK L EKKK - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
KKK L EKKKMV LAD LGGQ LA SA I R K FQ S ST I AD EA -A I D LC LK E I AT A L LKADVNVK LVAQ LRNN I KQ SAVV E E LVN I V I V FVG
LR K I KAKKMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCAA L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
LR R LT AKKMV LAD LG SR LR GA L SNV E SG S - - - ET - E I Q SMI KD I CNA L L E SDVN I K LVAK LRDN I KQK I V FD E LC S LV I MFVG
QR R LQKKKMV LAD LGNQ L S SA LR S LN ET T I VN ED -T I NQ L LK EVGNA L SK SDV SMS L I I QMR KN I KKQVV FD E L I R L I VMFVG
LKK I K SKKMV LAD LGR K I T T A LH S L SKAT V I N E E -A LN SMLK E I CAA L L EADVN I R LVKQ LR ENVRQ SAV FK E LVK LVVMFVG
LKK I K SKKMV LAD LGR K I T T A LH S L SKAT V I N E E -A LN SMLK E I CAA L L EADVN I R LVKQ LR ENVRQ SAV FK E L I K L I I MFVG
ADK FNKK S -MI T E LGR S I T NT L SN L L S S PATDQH - - I ET A I R E I CN S L I L SNVN PR Y V SD LRD E LRQNAVY ER LVD LVVV FVG
SKK I SDKKMV L SQ LG S S LVT A LR KMT S ST VVD E E -V I NT L LK E I ET S L LG EDVN P I F I R QMVNN I KKD SV F E E L I N LV LMMVG
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK L I I MFVG
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
LR R LT AKKMV LAD LGKR I NNAVTNA I SN EQTDY ET T VQ SMLK E I AT A L L ENDVN I R LV SR LR EN I KQKT V FD E LCN LV I MFVG
LKR L EKKKMV LA E LGQK I GQA I HRMSAK SMLG ED -DVK E LMN E I AR A L LQADVNVT I VKK LQV S I R QNAV FNG LKR I VVMFVG
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
QR K LHK - -MV LQD LGR R I NAAV SD LT R A PN LD EK -A - - - - - -K I CAA L L EADVNVR LVGQ LR K S I KQKAV FD E LV S LV I MFVG
- - - - - - - -MVMEK LGD S LQGA LKK L I GAGR I D ER -T VN EVVKD I QR A L LQADVNVK LVMGMSQR I K I R I V Y Q E LME I T I MMVG
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
QR K LHK - -MV LQD LGR R I NAAV SD LT R A PN LD EK -A FDGMLK E I C SA L L EADVNVR LVGQ LR K S I KQKAV FD E LVR LV I MFVG
MKK LQR KKMV LAQ LGG S I SR A LAQMSNAT V I D EK -V L SDC LN E I SR A L LQ SDVQ FKMVRDMQ SN I KQQAV FT E LCNMVVMFVG
QKKMMKKKMV LND LGNK I A SA LR S LNAHVVVD E E - L LDAC LKD I T NA L LA SDVAV P LVVRMKKN I V ER AV FK E LT A LVVMFVG
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
I KKV EQKKMV LA E LGK S I NAA LQK L SKA PVVD EA - LVDQ I LG E I AMA L LKADVNAK F I KK LR EDVKQKAVVDG LT RMV I MFVG
LR R LT AKKMV LAD LG SR LR GA L S SV E SA S - - -D E - E I NQMI KDVCTA L L E SDVN I K LVVK LRDN I KQK I I Y D E LVG L I I MFVG
KR KMDKKKMV LT E LGTQ I T NA FR K LQT ST LADDV -V I E EC LK E I I R A L I L SD I NV SY LKD I K SN I KQKY VV E E L I K LV I L FVG
KR KMDKKKMV LT E LGTQ LT SA LQK LQA SAVADD S -A I E EC LK EV I R A L I LAD I N I SY LKD I K SN I KQQY VV E E L I N LV I L FVG
KR KMDKKKMV LT E LGAQ LT SA LQK I QAA PVADDN -V I E EC LK E I V R A L I LAD I NV I Y LKD I K SN I KQKY VV E E L I K LV I L FVG
MKK I QR KKMV LAQ LGG S I SR A I QQMSNAT I I D EK -A LNDC LN E I T R A L LQ SDVQ FK LVRDMQTN I KQQA I FN E LCK I VVMFVG
LR K I KAR KMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCT A L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
LR R LT AKKMV LAD LGKR I N SAVNNA I SNTQDD FT T SVDVMLKG I VT A L L E SDVN I A LV SK LR NN I R QKT V FD E LCK L I I MFVG
LR RMA PKKMV FAD LGR R LN SA LGD F SKAT SVN E E - LVDT L LKN I CT A L L ET DVNVR LVQ E LR SN I KQKAV FD E LC S LV I MMVG
MRKMRAKKMV LAD LGR K I T SA LK S L SNAT I I D ED -V LN SMLN E I CR A L L EADVN I R LVKA LK ENVKQTAV FK E LVK L I I MFVG
LR K I KAKKMV LAD LGR K I T SA LR S L SNAT I I N E E -V LNAMLK EVCAA L L EADVN I K LVKQ LR ENVKQHAV FK E LVK LV I MFVG
I R K LQ SKKMV LAD LGKR I NNA LQQ LNKA PV I D E E - L LNQV LK E I Q LA L LQ SDVNVKY VAK LK SN I I QQAVVQ E LTQMVVMFVG
R R RMDKKKMV LA E L SNQ I TQA FR K LH ST T V I S EA -V I E EV I GD I VR A L LMADVNVK LVHK LK ENVKQK I VVD E LVNMV I MFVG
R R RMDKKKMV LA E L SNQ I T KA FR K LH ST T V I S EA -V I E EV I GD I VR A L LMADVNVK LVHK LK ENVKQK I VVD E LVNMV I MFVG
SDK I AKKK -MLQD LG EK LMG S I KK L S E SKT I D EK -VY VT FMA EVAK S L I AADC SK E I V FD F SR R LK EKAV FN E LVK L I FMMVG
LKK LDKKKMV LA E LGQK I GAA I SKMS SK S FVG ED -DVK E F LN EVAR A L LQADVNVKT VK E LQQNVRQTAV FNG I KKMI VMFVG
LKK L EKKKMV LA E LGQK I GGA I SKMS SK P L LG ED -DVK E F LN EVAR A L LQADVHVT T VK E LQQT I R QT AV F SG LR K I I VMFVG
VR R LKA SKMV L SD LGR R I N SA FQD L SKV PT VDAA - S I DQ L LK SVCNA L I EADVNVK LVAN LR SQVKQKAV FDH LVA LV I MFVG
LKK I V SKKMV L ED LGKR I NGA FAN L SKGGD I D E - -A LDAMLK EVC SA L L E SDVN I K LV SQ LRQKVKQKA L FD E LVN LVVMFVG
























































LQG SGKT T T CT K LAY HYQKKNWK SC LVCADT FR AGAYDQ I KQNAT KAR I P FY G SY T EVD PVT I AQDGV EMFKK EG F E F I I VDT
LQGAGKT T T CT KY AY Y HQKKGY K PA LVCADT FR AGA FDQ LKQNAT KAK I P FY G SY T E SD PVK I AV EGVDT FKK ENCD L I I VDT
LQGAGK ST SC SK LAVY Y SKRG FKVG LVCADT FR AGA FDQ LKQNA I KAK I P FY G SY T ETN PVR VAADGVAK FKK ER F E I I I VDT
LQGAGKT T T CT K LARHYQMRG FKT A LVCADT FR AGA FDQ LKQNAT KAK I PY Y G S LTQTD PAVVAA EGVAK FKK ER F EV I I VDT
LQGAGKT T T CT K LARHYQMRG FKT A LVCADT FR AGA FDQ LKQNAT KAK I PY Y G S LTQTD PA I VAA EGVAK FKK ER F E I I I VDT
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
LQG SGKT T T C SK LAY Y Y QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQG SGKT T T C SKMAY Y YQR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY S E I D PVK I AA EGV EK FT K EG F E I I I VDT
LQG SGKT T T CT KMAY Y YQR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY S E I D PVK I AA EGV EK FTQ EG F E I I I VDT
LQGAGKT T SCT K LAVY Y KKRG FKVG LVCADT FR AGA FDQ LKQNA I KAN I PY Y G SY L E PD PVK I A F EGVQK FKQ EK FD I I I VDT
LQG SGKT T SCT K LAVY Y SKRG FKVG LVCADT FR AGA FDQ LKQNAVKAR I P FY G SY T ETD PVKVAGDG I AK FKK EK FDV I I VDT
LQG SGKT T T C SK LAY Y Y QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQG SGKT T T CT K LAY Y YQR KNWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EAD PVV I A S EGV ET FK E EN F E I I I VDT
I QGAGKT T T CT K LAVHYQR RG FR T C LVCADT FR AGA FDQ LKQNAT KAK I P FY G SY T ETD PVA I A S LGV EK FR K ER FDV I I VDT
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
LQG SGKT T T CT K FANY YQR RGWKTA LVCADT FR AGA FDQ LKQNAT KVK I P FY G SY T ETD PVK I ARDGVR E FR K EGY D L I I VDT
LQG SGKT T T C SK LAY Y FQR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I AA EGV EK FK S EN F E I I I VDT
LQGAGKT T SCT K LAVY Y KKRGY KVG LVCADT FR AGA FDQ LKQNA I K S S I PY Y G SY I ET D PVKVAY EGVVK FKQ EK FD I I I VDT
LQGAGKT T SVT K LAY FY KKKG F ST A I VCADT FR AGA FDQVRHNAAKAK I HY Y G S ET EKD PVVVAR TGVD I FKKDGT E I I I VDT
LQG SGKT T T CT K LAY HYQKRNWK SC LVCADT FR AGAYDQVKQNAT KAR I P FY G SY T E I D PVV I AQDGVDMFKR EG F EMI I VDT
LQG SGKT T T CT K LAY HYQKRNWK SC LVCADT FR AGAYDQ I KQNAT KAR I P FY G SY T E I D PVV I AQ EGVDMFKR EG F EMI I VDT
LQG SGKT T S I CKY AN FY KKKGY KVG I VCADT FR AGA FDQVRQNA LK I KV P F FG S - S EAD PVKVA SAGV ER FR K ER F E L I LVDT
LQGAGKT T T I T K LA LY Y KNRGY K PAVVGADT FR AGAY EQ LQMNAKRAGV P F FG I K E E SD PVKVA S EGVR T FR K EKND I I LVDT
LQG SGKT T T C SK LAY FY QR KGWKTC L I CADT Y R AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQG SGKT T T C SK LAY Y Y QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQG SGKT T SCT K LAVY Y SKRGY KVG LVCADT FR AGA FDQ LKQNA I KAK I P FY G SY T E PN PVKVAKDGVDK FKK EK F E I I I VDT
LQG SGKT T SCT KY AAY FQR KG FKT A LVCADT FR AGAYDQ LRQNAT KAKVR FY G S LT EAD PVA I AK EGVA E LKK EKY D L I I VDT
LQG SGKT T T C SK LAY Y Y QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQGAGKT T T CT K LARHYQ SRG FKAC LVCADT FR AGA FDQ LKQNAT KAK I PY Y G S LT ETD PAVVAR EGVDK FKK ER F EV I I VDT
LQG SGKT T SAAK LAR Y FQR KG LKAGVVAADT FR PGAY HQ LKT LA EK LNVG FY G E EGN PDAV E I T KNG LKA L - - EKY D I R I VDT
LQG SGKT T T C SK LAY Y Y QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQG SGKT T T C SK LAY Y Y QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQGAGKT T T CT K LARHYQ SRG FR VG LVCADT FR AGA FDQ LKQNAT KAK I PY Y G S LT ETD PVVVARDGVDK FKK EK F E I I I VDT
LQG SGKT T T CT KY AY Y HQR KG FK PA LVCADT FR AGA FDQ LKQNAT KAK I P FY G SYME SD PVK I AV EGV ER FKK ENCD L I I VDT
LQGAGKT T T CT K FAHY Y AKKG FK P S LVCADT FR AGA FDQ LKQNAT KAK I P FY G SY T E SD PAT I AAAGVKR F E E EK SD L I I VDT
LQG SGKT T T C SK LAY Y Y QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQG SGKT T T CT KY AY Y YQKKGWKVA LVCADT FR AGA FDQ LKQNAT KVR V P FY G SY T EAD PVQ I AQ EGVNV FKK EA F E I I I VDT
LQGAGKT T SCT K LAVY Y KKRG FKVG LVCADT FR AGA FDQ LKQNA I KA S I PY Y G SY L EQD PVK I AY EGVT K FR S EK FD I I I VDT
LQG SGKT T T CT KY AHY YQKKG FKT A LVCADT FR AGA FDQ LKQNAAKVK I P FY G SY S EVD PVK I ATDGVNA F LKDKY D L I I VD S
LQG SGKT T T CT K FAHY YQKKG FKT A LVCADT FR AGA FDQ LKQNAAKVK I P FY G SY S EVD PVK I A SDGVNA F LK EKY D L I I VD S
LQG SGKT T T CT KY AHY YQKKG FKT A L I CADT FR AGA FDQ LKQNAAKVK I P FY G SY S EVD PVK I ATDGVNT F LKDKY D L I I VD S
LQG SGKT T T CT KY AY Y HQKKGWK PA LVCADT FR AGA FDQ LKQNAT KAK I P FY G SY T E SD PVK I A E EGV ET FKK ENCD L I I VDT
LQG SGKT T T C SK LAY FY QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PV I I A S EGV EK FKN EN F E I I I VDT
LQG SGKT T SCT K LAVY Y SKRG FKVG LVCADT FR AGA FDQ LKQNA I R AR I P FY G SY T ETD PAKVA E EG I NK FKK EK FD I I I VDT
LQG SGKT T T C SK LA LHYQR RG LK SC LVAADT FR AGA FDQ LKQNA I KAR V PY FG SY T ETD PVV I AK EGVDK FKNDR FDV I I VDT
LQG SGKT T T CT K LAY Y YQKKGWKVA L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EVD PV I I AADGV EK FKK EN F E I I I VDT
LQG SGKT T T C SK LAY Y Y QR KGWKTC L I CADT FR AGA FDQ LKQNAT KAR I P FY G SY T EMD PVV I AT EGVDK FKMEN F E I I I VDT
LQGAGKT T T CT KY AY HWQKKGWR TA L I CADT FR AGA FDQ LKQNAT KVR V P FY G SY S ETD PVA I A E EGVKH FKK ENY EMI I VDT
LQGAGKT T SCT K FAY HYQR KGWR TA L I CADT FR AGA FDQ LKQNAAKVK I S FY G SY S EAN PAKVAADGVAR FK E EKY DMI I VDT
LQGAGKT T SCT K FAY HYQR KGWR TA L I CADT FR AGA FDQ LKQNAAKVK I S FY G SY S EAN PAKVAADGVAR FK E EKY DMI I VDT
LQGAGKT T T VT K LAN FY KR RNWR TGV I AADT FR AGAR EQ LMQNAQTAR I PY FVD FT EQD PVQAA LKG I EK FR KDKY E I V I I DT
LQG SGKT T SCT KY AAY FQR KG LKTG LVCADT FR AGAYDQ LRQNAT KAKVR FY G S LT EAD PV I I AK EGV L E LKK EKY D L I I VDT
LQG SGKT T SCT KY AAY FQR KG LKT A LVCADT FR AGAYDQ LRQNAT KAK I R FY G S LT EAD PV I I AK EGVA E L EK EKY D L I I I DT
LQG SGKT T SCT K LA LY Y QKRG FKTG LVCADT FR AGA FDQ LKQNA SK I NV P FY G SY T ETD PVA I SAAGVA S FKQNR F EV I I VDT
LQG SGKT T SCT K LAVY YQR RG FKVG LVCADT FR AGA FDQ LKQNAT KAK I P F FG SY T ETD PVAVAA EGVAK FKK EK F E I I I VDT
























































SGRHKQ E E S L F E EMLAVANAVN PDN I I FVMDAT I GQAC EAQAKA FK EKVD I G SV I I T K LDGHAKGGGA L SAVAATN S P I I F I G
SGRHKQ EA S L F E EMRQVA EAT K PD LV I FVMD S S I GQAA FDQAQA FKQ SVAVGAV I I T KMDGHAKGGGA L SAVAAT K S PV I F I G
SGRHHQ EDA L FQ EMV E I AQ EVK PNQT I MV LDA S I GQAA EQQ SR A FK EAAD FGA I I LT KMDGHAKGGGA I SAVAAT KT PV I F I G
SGRHKQ E E E L FT EMTQ I QNAVT PDQT I LV LD ST I GQAA EAQ SAA FKAT AN FGA I I I T K TDGHAAGGGA I SAVAATHT P I I F LG
SGRHKQ E E E L FT EMTQ I QT AVT PDQT I LV LD ST I GQAA EAQ S SA FKAT AD FGA I I I T K TDGHAAGGGA I SAVAATHT P I I Y LG
- - - - - - - - - - - - - - - - - - - - - - PDN I I FVMDAT I GQAC EAQARA FKDKVD I G SV I I T K LDGHAKGGGA L SAVAATQ S P I I F I G
SGRHKQ ED S L F E EMLQVANA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHKQ EA S L F E EMLQV SNAVT PDNVV FVMDA S I GQAC EAQARA F SQT VDVA SV I I T K LD SHAKGGGA L SAVAVT K S PV I F I G
SGRHKQ EA S L F E EMLQV SNAVT PDNVV FVMDA S I GQAC EAQARA F SQT VDVA SV I I T K LD SHAKGGGA L SAVAVT K S PV I F I G
SGRHRQ E EQ L FT EMVQ I G EAVQ PTQT I MVMDG S I GQAA E SQARA FK E S SN FG S I I LT KMDGHAKGGGA I SAVAAT KT P I V F I G
SGRHHQ E E E L FH EMVQ I SNV I K PNQT I MV LDA S I GQAA EQQ SKA FK E S SD FGA I I LT KMDGHAKGGGA I SAVAATNT P I A F I G
SGRHKQ ED S L F E EMLQVANA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHKQ ED S L F E EMLQVY NAVA PDNV I FVMDA S I GQAC EGQARA FK EKVDVA SV I V T K LDGHAKGGGA L SAVAATQ S P I I F I G
SGRHKQ E S E L F E EMVA I GAAVK PDMT LMV LDA S I GQAA EGQ SR A FKD SAD FGA I I V T K LDGHAKGGGA I SAVAAT KT P I I F LG
- - - - - - - - - - - - -MEQVVMETN PDDVV FVMD SH I GQACYDQAMA FCNAVDVG SV I I T K LDGHAKGGGA L SAVAATGA P I I F I G
SGRHKQ E S S L FV EMEQVVMETN PDDVV FVMD SH I GQACYDQAMA FCNAVDVG SV I I T K LDGHAKGGGA L SAVAATGA P I I F I G
SGRHKQ ED S L F E EMLQV SNAVQ PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHKQ EQ S L FN EMI Q I S EMI V PTQT I MVMDG S I GQAA E SQAKA FK E S SQ FG S I I LT KMDGHARGGGA I SAVAT T KT P I V F I G
SGRHKQD S E L F E EMKQ I ET AVK PDNC I FVMD S S I GQAAY EQATA FR S SVKVG S I I I T KMDGN SMGGGA I SAVAATNT P I I F I G
SGRHKQ E E S L F E EMLAV SNAV S PDN I I FVMDAT I GQAC EAQAKA FKDKVD I G SV I I T K LDGHAKGGGA L SAVAATQ S P I I F I G
SGRHKQ E E S L F E EMLAVANAVN PDN I I FVMDAT I GQAC EAQAKA FKDKVD I G SV I I T K LDGHAKGGGA L SAVAATQ S P I I F I G
SGRHTQ ET E L FT EMKD I I R E I S P S S I V FVMDAG I GQ SA EDQAMG FKR AVDVG S I I LT K I DGT T KAGGA I S SVAAT KC P I E FVG
SGRHKQDK E L FK EMQ SVRDA I K PD S I I FVMDGA I GQAA FGQAKA FKDAV EVG SV I I T K LDGH SNGGGA L SAVAAT K S P I I F I G
SGRHKQ ED S L F E EMLQVANA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHKQ ED S L F E EMLQVANA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHQQ ED S L FQ EMV E I SQAVK PKQT I MV LDA S I GQAA EHQ SKA FK E SAD FG S I I LT KMDGHARGGGA I SAVA STNT P I I F I G
SGRHKQ E SA L F E EMKQV E EAVK PND I V FVMSATDGQAV E EQARN FK EMVAVG SV I V T K LDCQT KGGGA L SAVAAT R S P I V F I G
SGRHKQ ED S L F E EMLQVANA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHRQ E SA L FQ EMMD I QKAVK PD ET I MV LDA S I GQQA EAQAKA FK EAAD FGA I I I T K TDGHA SGGGA I SAVAATHT P I V F I G
AGRHA L EAD L I E EMER I HAVAK PDHK FMV LDAG I GQQA SQQAHA FND SVG I T GV I I T K LDGTAKGGGA L SAV S ET KA P I A F I G
SGRHKQ ED S L F E EMLQVANA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHKQ ED S L F E EMLQV SNA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHRQ E EA L FQ EMMD I QT AVK PD ET I MV LDA S I GQQA EAQAKA FK EAAD FGA I I I T K TDGHAAGGGA I SAVAATHT P I V F I G
SGRHKQ EAA L F E EMRQV S EAT K PD LV I FVMD S S I GQAA FDQAQA FKQ SV SVGAV I VT KMDGHAKGGGA L SAVAAT K S PV I F I G
SGRHKQ E EA L F E EMR E I A SVT E PTMT I FVMD S S I GQ SA SDQAKA FA ST VDVGGV I MT K LDGHAKGGGA I SAV S ET KA P I L F I G
SGRHKQ ED S L F E EMLQVANA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHKQ END L F E EMKQV EAAVK PDD I V FVMD S S I GQAC FDQA LA FKKAVNVG SV I I T K LDGHAKGGGA L SAVAAT E S P I V F I G
SGRHRQ EHQ L FQ EMVQ I G EMI Q PTQT I MVMDG S I GQAA E SQAKA FK E S SN FG S I I LT KMDGHAKGGGA I SAVAAT KT P I V F I G
SGRHKQ EN E L F E EMI QV EN S I Q P E E I I FV I D SH I GQ SCHDQAMA FKN SV S LG S I I I T K I DGHAKGGGA L SAVAATGC P I T F I G
SGRHKQ E S E L F E EMKQV E S S I N P E E I V FV I D SH I GQ SCHDQAMA FKN SVT LG S I I I T K I DGHAKGGGA L SAVA ST GC P I T F I G
SGRHKQ END L F E EMKQV EN S I K P E E I V FV I D SH I GQ SCHDQAMA FKN SVKVG S I I I T K I DGHAKGGGA L SAV SA I GC P I T F I G
SGRHKQ EAA L F E EMRQV S EAT K PD L I I FVMD S S I GQAA FDQAQA FKQMVAVGAV I I T KMDGHAKGGGA L SAVAAT K S PV I F I G
SGRHKQ ED S L F E EMLQV SNA I Q PDN I VY VMDA S I GQAC EAQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT K S P I I F I G
SGRHHQ E E E L FQ EMI E I SNV I K PNQT I MV LDA S I GQAA EQQ SKA FK E S SD FGA I I LT KMDGHARGGGA I SAVAATNT P I I F I G
SGRHQQ EQ E L FA EMV E I SDA I R PDQT I MI LDA S I GQAA E SQ SKA FK ET AD FGAV I I T K LDGHAKGGGA L SAVAAT KT P I V F I G
SGRHKQ ED S L F E EMLQVANVT S PDN I I FVMDA S I GQAC E SQAKA FK EKVDVA SV I I T K LDGHAKGGGA L SAVAAT K S PV I F I G
SGRHKQ ED S L F E EMLQV SNAVQ PDN I VY VMDA S I GQAC E SQAKA FKDKVDVA SV I V T K LDGHAKGGGA L SAVAAT R S P I I F I G
SGRHKQ E S E L FD EMKQVQAAVN PD EC I FVMDG S I GQACYDQAQA FRNAVNVG SV I I T K LDGHAKGGGA L SAVAAT E S P I I F I G
SGRHKQ EDA L FD EMK L I Y DAVQ PD EVV FVMD SH I GQACYDQA SA FNKAVDVG SV I I T K LDGHAKGGGA L SAV SATN S P I I F I G
SGRHKQ EDA L FD EMK L I Y DAVQ PD EVV FVMD SH I GQACYDQAAA FNKAVDVG SV I I T K LDGHAKGGGA L SAV SATN S P I I F I G
SGRHMQ E EA L FA EMKA LAAAVN PH E I I FVMDGT I GQAAYDQA LG FKNAVGVG S I I I T K LD SNAKGGGA L SAVAATN S P I S F I G
SGRHKQ E SA L F E EMKQVQQAVK PND I V FVMSATDGQG I E EQARQ FK EKV P I G SV I V T K LDGQAKGGGA LAAVAMTK S P I V F I G
SGRHKQ E SA L F E EMKQVQ EAVK PND I V FVMSATDGQG I R EQARQ FK EKV PVG SV I I T K LDGHAKGGGA LAAVAMTK S P I V F I G
SGRHKQ EQ E L FD EMR E I DT AVT PD LT I MV LDAN I GQAA EAQ SR A FKQAAGY GA I I V T K LDGHAKGGGA I SAVAAT KT P I MF I G
SGRHRQ E S E L FT EMVD I GAAVK PD ST I MV LDA S I GQAA E PQ SR A FKDA SD FG S I I LT KMDGHAKGGGA I SAVAATNT P I I F I G
























































TG EH I DD L E P FKT K P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN E E L I DK I KHGQ - FT I R DMY EQ FQN I MKMG P F SQ I MGMI
T G EHMD E F EV FDVK P FV SR L LGMGDWSG FVDK LQ EVV P - - -KDQQ P E L L EK L SQGN - FT LR I MY DQ FQN I LNMG P LK EV F SML
TG EHVHD F EK F S PK S FV SK L LG I GD I E S L L EQ FQT V SN - - -K EDT KATMEN I QQGR - FT L LD FQKQMQT I MKMG P L SN LA SMI
T G EH LMD L ER F E PKA FVQK L LGMGDMAG LV EHVQAVT K - -D SAAAK ET Y KH I A EG I -Y T LRD FR EN I T S I MKMG P L SK L SGMI
T G EH LMD L ER F E PKA F I QK L LGMGDMAG LV EHVQAVT K - -D SA SAK ET Y KH I S EG I -Y T LRD FR EN I T S I MKMG P L SK L SGMI
T G EH I DD L E P FKT K P F I K K L LGMGD I EG L LDKVN E LK - - - - LDDND E L L EK LKHGQ - FT LR AMY EQ FQN I MKMG P F SQ I MGMI
T G EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
T G EH I DD F E I FK PK S FVQK L LGMGD I AG LVDMVND I G - - - - I SDNK E LVGR LKQGQ - FT LRDMY EQ FQN I MKMG P F SQ I MVMI
T G EH I DD F E I FK PK S FVQK L LGMGD I AG LVDMVND I G - - - - I QDNK E LVGR LKQGQ - FT LRDMY EQ FQN I MKMG P F SQ I MGMI
T G EHVGD L E I FK PT T F I SK L LG I GD I QG L I EHVQ S LN L -HQD EGHKQT I EH I K EGK - FT LRD FQNQMNN F LKMG P LTN I A SMI
T G EH I HD L EK F S PK S F I SK L LG I GD I EG L F EQ LKT V SN - - -K EDT KATMEN I QQGK - FT L LD FKKQMQT I MKMG P L SN I AQMI
T G EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
T G EH I DD F EMFKTQ P FVR K L LNMGD I EG L I DKVN E LK - - - - LDDN E E L LDK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I MSMI
T G EH LND L ER FA PQ P F I SK L LGMGDMQG LV EHMQDMAR -AN PDRQKD LAKK L EQGK - FT I R DWR EQ L SN I MNMG S I SK I A SMI
T G EH FD E F E P F ET KG FV SR L LG LGD I SG LMAK I N EVV P - - - LDRQ PDMVNR LVQG I - FT LRDMY EQ FQNMLNMG S P SA L L SMI
T G EH FD E F E P F ET KG FV SR L LG LGD I SG LMAK I N EVV P - - - LDRQ PDMVNR LVQG I - FT LRDMY EQ FQNMLNMG S P SA L L SMI
T G EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN E E L I DK LKHGQ - FT LRDMY EQ FQN I MKMG P FGQ I MGMI
T G EHATD L E I FK PT S F I SK L LG I GD I Q S L I EHVQ S LN L -QDD E SHKKT I EN FK EGK - FT LRD FQTQMNN FMKMG P LTN I A SMI
T G EH LTD L E L FD P ST FV SK L LGY GDMKGML EK I K EV I P - - - - - ED ST S LK E I AQGK - FT LR SMQQQ FQQ I MQ LG P I DK LVQMI
T G EH I DD L E P FKT K P FV SK L LGMGD I EG L I DKVN E LK - - - - LDGND E L L EK I KHGH - FT I R DMY EQ FQN I MKMG P F SQ FMNMI
T G EH I DD L E P FKT K P FV SK L LGMGD I EG L I DKVN E LK - - - - LDGN E E L L EK I KHGH - FT I R DMY EQ FQN I MKMG P F SQ I MNMI
T G EGMDD L EA FDAR R FV SRMLGMGDV EG LMEKVG S LG I - - - - -D EK EVVKK LRQGR - FT LGD FY DQ FQK I L S LG P I SK L L EMI
T G EKVN E I E E FDA E S FVR K L LGMGD LKG I AK LAKD FA E - - -NA EY KTMVKH LQ EGT - LT VRDWK EQ L SN LQKMGQ LGN I MQMI
T G EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
T G EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
T G EH I HD F EK F S PK S FV SK L LG I GD I E S LMER FQT V SD - - -QDDAKNT L EN I QQGK - FT L LD FKNQMQT I MKMG P L SN I ANMI
T G EH F ED FD L FN P ER FVQKMLGMGD I GG LMDTMRDAN - - - - I DGN E EVY KR LQDG L - FTMRDMY EH LQNV LKMG SVGK I MEML
TG EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
T G EHMLD L ER FA PQQ F I SK L LGMGDMAG LV EHVQ S LK L - - - - -DQKDT I KH I T EG I - FT I R D LRDQ LQN I MKMG P L SKMAGMI
VG ET P ED F EK F EADR F I SR L LGMGD LK S LMEKA E E S L S - - - - - E EDVNV EA LMQGR - FT LKDMY KQ L EAMNKMG P LKQ I MSML
TG EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
T G EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
T G EHMLD L ER FV PNN F I SK L LGMGDMAG LV EHVQ S LK L - - - - -DQKDT I KH I T EG I - FT I R D LRDQ LQN I MKMG P L SKMAGMI
T G EH I D E F EV FDVK P FV SR L LGMGDWSG FMDK I H EVV P - - -TDQQ P E L LQK L S EGT - FT LR LMY EQ FQN I LKMG P I GQV F SML
TG EH I G E L EA F ET T S FV SK L LGMGD I KG LV EKMN E I V P - - - E E SA EK LMEA FG SGT - FTMR L LY EQ FQN LQNMG P I S S I MSMV
TG EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
EG EH FDD L E S F EA S S FVR R L LG LGD I NK L FQ SVKDVVN - - -MRDQ PQ L I QK LK EGK - F S I R D LQTQ FN SV LK LG S LNQ FMSA I
T G EH I GD L E I FK PT T F I SK L LG I GD I Q S L I EHVQG LN L -QND ENHKQTMEN I K EGK - FT LKD FQNQMNN F LKMG P LTN I A SMI
T G EHVND F EK F EAK S FV SR L LG LGD I SG LV ST I K EV I D - - - I DKQ P E LMNR L SKGK - FV LRDMYDQ FQNV FKMG S L SKVMSMI
T G EH I ND F EK F EAK S FV SR L LG LGD I NG LV ST LK EV I D - - - I EKQ PQ L I NR L SKGK - FV LRDMYDQ FQNV FKMG S L SKVMSMI
T G EHVND F EK F EAK S FV SR L LG LGD I DG LV ST LK EV I D - - - I EKQ PQ L I NR I AKGK - FV LRDMYDQ FQNV FKMG S L SKVMSMI
T G EHMD E F EV FDVK P FV SR L LGMGDWSG FMDK I H EVV P - - -MDQQ P E L LQK L S EGN - FT LR I MY EQ FQN L LKMG P I GQV F SML
TG EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DKVN E LK - - - - LDDN EA L I EK LKHGQ - FT LRDMY EQ FQN I MKMG P F SQ I LGMI
T G EH I HD L EK F S PK S F I SK L LG I GD I E S L F EQ LQT V SN - - -K EDAKATMEN I QKGK - FT L LD FKKQMQT I MKMG P L SN I AQMI
T G EH I ND L ER F S PR S F I SK L LG LGD L EG LMEHVQ S LD F - - - - -DKKNMVKN L EQGK - FT VRD FRDQ LGN I MK LG P L SKMA SMI
T G EH I DD F E P FKT K P F I SK L LGMGD I EG L I DKV S E LN - - - - LDDN E E L I NK LKHG E - FT LRDMY EQ FQN I MKMG P FGQ I MGMI
T G EH I DD F E P FKTQ P F I SK L LGMGD I EG L I DR VND LK - - - - LDDN E E L I DK LKHGQ - FT LRDMY EQ FQN I MKMG P FGQ I MGMI
T G EH F ED L E P FN P E S FVKR L LG LGD I KGMI T T VT EAVD - - -METQGKA I AN I T KGQ - F S I R D FQAQY K S I LK LG S I NQ FMSMI
T G EH FDD F E P FD PK S F I SR L LG FGD I NG L I NT LKDV I N - - - L EDK PD L LDR I A SAK - FT I R DMYDQ FQN L LKMA P I GKVMSML
TG EH FDD F E P FD PK S F I SR L LG FGD I NG L I NT LKDV I N - - - LDDK PD L LDR I A SAK - FT I R DMYDQ FQN L LKMA P I GKVMSML
SG EQ FTD L EWFD PN S FV SR L LG I QD PGV I QR T L E E I D - - - -K EANK E I A EH I QKGQ - F S FR D LY NQY KMV LDVGN FN SMLD S I
T G EH FDD F E L FQ P E S FV SRMLGMGDMRA LVD SMKDAN - - - - I DTD S E LY KR FQDGQ - FT LRDMY EH LQNV LKMG SV SK I MDMI
T G EH F ED F E L FQ P E S FV SRMLGMGDMRA LMDTMKDAN - - - - I DTD S E LY R R FQDGQ - FTMRDMY EH LQNV LKMG SV SK I MNMI
T G EHAAD L E P FR AQ P F I SK L LGMGD I SG LMDKME EMQMNGGQ ERQQ EMLKK I GQGG I F S I R DWR EQ L SN I MGMG P L SK I AGMI
T G EH I HD L EA F S PKQ F I SK L LG I GD LQG LMETMQ S LN L - - - - -DQKKTMEH I Q EG I - FT LAD LRDQMGNMLKMG S L S S I AGMI
























































- - - - - - - P -G F SQD FMT KG -G EQ E SMAR I K R LMTMMD SMSDG E LDR VT R VAQG SGVMER EVRD L I GGMNG LQNMMDY R SQME L
- - - - - - - P -G I SA EMMPKG -H EK E SQAK I K R YMTMMD SMTND E LDRMMR I AR G SGRQVR EVMEMLGGMGG LQ S LMD FT -D L E L
- - - - - - - P -GMSG -MMSG I - S ED ET SR KMKKMVY V LD SMSR E E L ERMLR VARG SGT SV F EV EMI LAAMPDMADMMD F S -Y LK L
- - - - - - - P -G L SN - LT AG L -DD EDG S LK LR RMVY I FD SMTAA E LDRMVR I ACG SGT T VR EV ED L LGGM-D LQ SMMD F S - S LA L
- - - - - - - P -G L SN - LT AG L -DD EDG SMK LR RMI Y I FD SMTAA E LDRMVR I ACG SGT T VR EV ED L LGGM-D LQ SMMD F S - S L S L
- - - - - - - P -G F SQD LMSKG - S EQ E SMAK FK L LMT I MD S I D E E - - - - - - - - - - - - - - - -RDVKD L I GGMSG LHNMMDY R SQMP L
- - - - - - - P -G FGTD FMSKG -N EQ E SMAR LKK LMT I MD SMNDQ E LDR I QR VARG SGV ST RDVQ E L LGGMAG LQ SMMDY R LQMP L
- - - - - - - P -G FG P E FMNKG -N EQ E SVNR LKRMMTVMD SMSDK E LDR VAR VARG SGC FQQ EVRD L LGGMGG LQNMMDY R KDMP L
- - - - - - - P -G FG S E FMT KG -N EQ E SVNR LKRMMTVMD SMSDK E LDR VAR VARG SG SHQQ EVRD L LGGMGG LQNMMDY R KDMP L
- - - - - - - P -G L SN - I MSQV -GD E ET SKK I KNMI Y I MD SMT I K E L ER I V R VARG SGCAVV EV EMI LGG - - - LAGMMD F S -Y LK L
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YQ EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT ACCT VR KR A LV LCN SGV SV EQWKQQ FWG I MV LD EVHT I PAKMFR R V LT I
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGK S LVGV SAAAR I KK SC LC LATNAV SVDQWAYQ FWG L L LMD EVHVV PAHMFR KV I S I
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I KK SV I V LCT S SV SVMQWRQQ FWG F I L LD EVHVV PAAMFR R VV ST
Y Q EK S L SKMFGNGRAK SG I I V L PCGAGKT LVG I T AACT I KKGT I V LCT S SMSVVQWRN E FWG LMI LD EVHVV PA SMFR KVT SA
YQ EK S L SKMFGNGRAK SG I I V L PCGAGKT LVG I T AGCT I KKGT I V LCT S SMSVVQWRN E FWG LMI LD EVHVV PA SMFR KVT SA
YQ EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AVCT VR KR A LV LCN SGV SV EQWKQQ FWG LVV LD EVHT I PAKMFR R V LT I
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PAKMFR R V LT I
Y Q EK S LR KMFGN SR AR SGV I V L PCGAGKT LVGVT AVT T VNKRC LV LAN SNV SV EQWRAQ FWG L L L LD EVHT I PAKMFR R V LT I
Y Q EK S LR KMFGN SR AR SGV I V L PCGAGKT LVGVT AVT T VNKRC LV LAN SNV SV EQWRAQ FWG L L L LD EVHT I PAKMFR R V LT I
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I R K SV I V LCT S SV SVMQWRQQ FWG F I I LD EVHVV PAQMFR R VVT T
YQ EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I KK SV I V LCT S SV SVMQWRQQ FWG F I I LD EVHVV PAAMFR R VV ST
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PAKMFR R V LT I
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Y Q EMS LAKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I KK SA LV LCT SAV SVAQWKQQ FWG F L L LD EVHVT PADMFR KC I NN
YQ EQA LRMMF SNGRAR SG I I V L PCGAGKT LT G I T AACTMRK S I L I LT T SAVAV SQWK FQ FWG L L I FD EVQ FA PA PA FR R I NG I
Y Q EQA LRMMF SNGRAR SG I I V L PCGAGKT LT G I T AACTMRK SV L I LT T SAVAV SQWK FQ FWG L L I FD EVQ FA PA PA FR R I NG I
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN S SV SV EQWKAQ FWG L I I LD EVHT I PAKMFR R V LT I
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I R K SV I V LCT S SV SVMQWRQQ FWG F I I LD EVHVV PAAMFR R VVT T
YQ EK S L SKMFGNGRAR SG I I V L PCGAGK S L SG I T AACT VKK S I LV LCT SAV SV EQWKYQ FWG LV L LD EVHVV PAAMFR KV LT V
YQ EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT ACCT VR KR A LV LCN SGV SV EQWKQQ FWG I MV LD EVHT I PAKMFR R V LT I
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT ACCT VR KR A LV LCN SGV SV EQWKQQ FWG I MV LD EVHT I PAKMFR R V LT I
Y Q E I C LNKMFGNGRAR SG I I V L PCG SGKT I VG I T A I ST I K KNC LV LCT SAV SV EQWKQQTWG L LV LD EVHVV PAMMFR R V L S L
HQ ER A LQQ I FDN EMAR SG I VV L PCGAGKT LT A I AAC SK I K R ST I V LT HT TQ SV FQWK E E FWG F I I FD EVHG ST TDN I EK FVCK
YQ EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PAKMFR R V LT I
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PAKMFR R V LT I
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I KK SV I V LCT S SV SVMQWRQQ FWG F I I LD EVHVV PAAMFR R VV ST
Y Q I EAVDAA I HDGT LN SGC L L L PCGAGKT L LG I MLMCKVKK PT LV LCAG SV SV EQWK SQ I Y G L L I LD EVHVMPA E S FR G S LG F
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PAKMFR R V LT I
Y Q EK S L SKMFGNGRAK SG I I V L PCGAGKT LVG I T AACT I K R GV I V LCT STMSVVQWRD E FWG LMI LD EVHVA PAKMFR R VT SA
YQA EA LVAWS EN - - EKWGV LV L PT G SGKT L LG I R A I AGCNT PA LV I V PT LD L L EQWKTQ L FG L LV FD EVHH L PAAGY R S I A E F
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PAKMFR R V LT I
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PARMFR R V LT I
Y Q EQ S L SKMFGNGRAK SG I I V L PCGAGKT LVG I T AACT I KKGV I V LCT S SMSVVQWRQ E FWG LML LD EVHVV PADV FR R V I S S
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGK S LVGV SAACR I KK SC LC LATNAV SVDQWA FQ FWG L L LMD EVHVV PAHMFR KV I S I
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGK S LT G I AAAAR I R K SC LC LCT S SV SVDQWAAQ FWGCML LD EVHVV PAAMFR KV I G I
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PGKQAGA E LR V
YQ LR AAKT V I MGDY AK SG L I V L PCGAGKT LVGV LCMS L I K S ST V I I CD SNV SV EQWKR E I WG I C I VD EVHR L PAVQ FQNV LKQ
YQ EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I R K SV I V LCT S SV SVMQWRQQ FWG F I I LD EVHVV PAAMFR R VVT T
YQ EKA LR KMF SNGR SR SG I I V L PCGVGKT LT G I T AA ST I KK SA L F LT T SAVAV EQWKKQ FWG L LV FD EVQ FA PA P S FR R I ND I
Y Q EKA LR KMF SNGR SR SG I I V L PCGVGKT LT G I T AA ST I KK S S L F LT T SAVAV EQWKKQ FWG L LV FD EVQ FA PA P S FR R I ND I
Y Q EKA LR KMF SNGR SR SG I I V L PCGVGKT LT G I T AA ST I KK S S L F LT T SAVAV EQWKKQ FWG L LV FD EVQ FA PA P S FR R I ND I
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGK S LVGV SAACR I KK SC LC LATNAV SVDQWA FQ FWG L L LMD EVHVV PAHMFR KV I S I
Y Q EK S LR KMFGNGRAR SGV I V L PCGAGK S LVGVT AACT VR KR C LV LGN SAV SV EQWKAQ FWG LMI LD EVHT I PAKMFR R V LT I
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I KK SV I V LCT S SV SVMQWRQQ FWG F I I LD EVHVV PAAMFR R VV ST
Y Q EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I KK SV I V LCT S SV SVMQWRQQ FWG F I L LD EVHVV PAAMFR R VVT T
YQ EK S LR KMFGNGRAR SGV I V L PCGAGKT LVGVT A SCT VR KR CMV LCT SGVAV EQWR SQ FWG LMI LD EVHT I PAKQ FR R V LTQ
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Y Q ER A LKN I F I QKKAR SG L I I L PCGAGKT I VGV I A I ER I KQ ST V I I CD SDV SVDQWRD E LWGVCV I D EVHK L PANT FQNV LKQ
YQ ER A LR RMF SNGRAR SG I I V L PCGAGKT LT G I VAACT VR K S I FV LT T SAVAV EQWI KQ FWGML I FD EVQ FV PA PA FR R I N E I
Y Q ER A LR RMF SNGRAR SG I I V L PCGAGKT LT G I VAACT VR K S I FV LT T SAVAV EQWI KQ FWGML I FD EVQ FV PA PA FR R I N E I
Y Q EKA LT KMF SGGR S I SG I I V L PCGAGKT LVG I AA LAT I NK PT V I VCNNR LT VKQWYNQ I WG L L I LD EVQD SAANT FRNVTD I
Y QVA S L ER FR SGNKAHQGV I V L PCGAGKT LT G I GAAAT VKKR T I VMC I NVMSV LQWQR E FWG L L L LD EVHTA LAHN FQ EV LNK
YQVA S L ER FR CGNKAHQGV I V L PCGAGKT LT G I GAAT I LKKR T I VMC I NV I SV LQWQR E FWG L L L LD EVHAA LAHH FQ EV LNK
YQ EK S LAKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I KK SC LV LCT S SV SVMQWRQQ FWG F I L LD EVHVV PA SMFR R V LT K
YQ EK S L SKMFGNGRAR SG I I V L PCGAGKT LVG I T AACT I R K SV I V LCT S SV SVMQWRQQ FWG F I I LD EVHVV PAAMFR KVVTN
























































VQ SHCK LG LT AT L LR EDDK I AD LN F L I G PK LY EANWL E LQKRGY I AR VQCA EVWC PMA P E FY R EY LY VMN PAK FR ACQY L I R Y
T K SHCK LG LT AT LVR ED EK I T D LN F L I G PK LY EANWLD LVKGG F I ANVQCA EVWC PMTK E F FA EY LY VMN PNK FR AC E F L I R F
I AAHAK LG LT AT LVR EDDK I SD LN F L I G PK LY EANWME L SQKGH I ANVQCA EVWC PMTA E FY Q EY LY I MN PT K FQACQ F L I QY
I ATQ SK LG LT AT L LR EDDK I KD LN F L I G PK LY EANWME LA EQGH I AKVQCA EVWC PMT T E FY T EY LY I MN PR K FQACQ F L I DY
I ACQ SK LG LT AT L LR EDDK I KD LN F L I G PK LY EANWME LA EQGH I AKVQCA EVWC PMT T E FY S EY LY I MN PR K FQACQ F L I DY
VH SHAK L - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
VQAHCK LG LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQN SGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
VQAHCK LG LT AT LVR EDDK I T D LN F L I G PK I Y EANWME LQKAGH I AKVQCA EVWC PMT SA FY SY Y LAVMN PNK FR I CQ F L I K F
VQAHCK LG LT AT LVR EDDK I T D LN F L I G PK I Y EANWME LQKAGH I AKVQCA EVWC PMT SA FY SY Y LAVMN PNK FR I CQ F L I K F
I AAHAK LG LT AT LVR EDDK I DD LN F L I G PK LY EANWMD LAQKGH I ANVQCA EVWC PMTA E FY Q EY LY I MN PT K FQACQ F L I HY
I AAHAK LG LT AT LVR EDDK I SD LN F L I G PK LY EANWME L SQKGH I ANVQCA EVWC PMTA E FY Q EY LY I MN PT K FQACQ F L I QY
VQAHCK LG LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQNNGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
FKVHAK LG LT AT LVR EDDR I GD LGY L I G PK LY EANWMD LAKNGH I AT VQCA EVWC PMT P E FY R EY LHAMN PNK I QACQ F L I NY
VKAHCK LG LT AT LVR EDD L I QD LQWL I G PK LY EANWME LQDRGY LAKA LC S EVWC PMTA SY Y R EY LWVCN PNK LR VC E F L I RW
VKAHCK LG LT AT LVR EDD L I QD LQWL I G PK LY EANWME LQDRGY LAKA LC S EVWC PMTA SY Y R EY LWVCN PNK LR VC E F L I HW
VQAHCK LG LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQNNGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I R F
I AAHAK LG LT AT LVR EDDK I DD LN F L I G PK LY EANWMD LAQKGH I ANVQCA EVWC PMT S E FY Q EY LY I MN PT K FQACQ F L I HY
T KAHCK LG LT AT L LR ED EK I QD LN F L I G PK LY EANWLD LQKAG F LANV SC S EVWC PMTA E FY K EY LY TMN PNK FR AC EY L I R F
VQ SHCK LG LT AT L LR EDDK I AD LN F L I G PK LY EANWL E LQKKGY I AR VQCA EVWC PMS P E FY R EY LY VMN P SK FR SCQ F L I K Y
VQ SHCK LG LT AT L LR EDDK I AD LN F L I G PK LY EANWL E LQKKGY I AR VQCA EVWC PMS P E FY R EY LY VMN P SK FR SCQ F L I K Y
V SHHCK LG LT AT LVR EDDK I ED LN F L I G PK LY EADWQD L SAKGH I AR V SC I EVWCGMTGD FY R EY L S I MN PT K FQVC EY L I NK
I KAQCK LG LT AT L I R EDDR I R D L E FMI G PMLY EA SWQ E LAKQGY I ANAKC F EV I C PMT KT Y Y SAY LAQ LN PNK I DACKY L L EQ
VQAHCK L E LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQN SGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
VQAHCK LG LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQNNGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
I AAHAK LG LT AT LVR EDDK I SD LN F L I G PK LY EANWME L SQKGH I ANVQCA EVWC PMTA E FY Q EY LY I MN PT K FQACQ F L I QY
VDAKGV I G LT AT Y VR EDHK I LD L FH LVG PK LY D I SMET LA SQGY LAKVHCV EVR T PMT K E FG L EY LAAAN PNKMMCVR E LVRQ
VQAHCK LG LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQNNGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
LK SH SK LG LT AT L LR EDDK I SD LN F L I G PK LY EANWME L S LGGH I AR VQCA EVWC PMPT E FY R EY LY I MN PMK FQACQY L I NY
SAA PCR LG LT AT Y ER EDG LHT E LNR LVGGKVY EKKV S E LA -GGH LA PY T I K R FAVT LT EK EQR EY LA FN SN SK I EK LR E I L EQ
VQAHCK LG LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQNNGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
VQAHCK LG LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQNNGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
I K SH SK LG LT AT L LR EDDK I SH LN F L I G PK LY EANWME L S EKGH I AKVQCA EVWC PMPT E FY D EY LY AMN PR K FQACQY L I NY
T K SHCK LG LT AT LVR ED ER I T D LN F L I G PK LY EANWLD LVKGG F I ANVQCA EVWC PMTK E F FA EY LY AMN PNK FR AC E F L I R F
T KAHCK LG LT AT LVR EDDKVDH LN F L I G PK LY EANWLD LQRDGH I ANVQCV EVWC PMTA E F FR KY LY CMN PNK FMACQ F LMQ F
I LAHCN LR L LAT A FGHHD PV LD F L FT H LQ S I F EWAWWLT PNNGY I AKVQCV EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
I KCA I K I G LT AT L LR EDQK LDN LY FMI G PK LY E EN L I D LMTQG F LAK PH I I E I QCDMP P I F LQ EY LHTGN PGKY KA LQ F L I KN
I AAHAK LG LT AT LVR EDDK I HD LN F L I G PK LY EANWMD LAQKGH I ANVQCA EVWC PMT S E FY Q EY LY I MN PT K FQACQ F L I HY
VK SHCK LG LT AT LVR ED L L I R D LHWI I G PK LY EANWV E LQNKG F LAKA LCK E I WC SMPC S FY KY Y LY T CN PR K LMMC EY L I K Y
VK SHCK LG LT AT LVR ED L L I R D LQWI I G PK LY EANWV E LQNKG F LAKA LCK E I WC SMP S S FY KY Y LY T CN PR K LMMC EY L I K Y
VK SHCK LG LT AT LVR ED L L I R D LQWI I G PK LY EANWV E LQNKG F LAKA LCK E I WC SMP S S FY KY Y LY T CN PR K LMMC EY L I K Y
T K SHCK LG LT AT LVR ED ER I T D LN F L I G PK LY EANWLD LVKGG F I ANVQCA EVWC PMTK E F FA EY LY VMN PNK FR AC E F L I R F
VQAHCK LG LT AT LVR EDDK I VD LN F L I G PK LY EANWME LQNNGY I AKVQCA EVWC PMS P E FY R EY LY TMN PNK FR ACQ F L I K F
I AAHAK LG LT AT LVR EDDK I GD LN F L I G PK LY EANWME L SQKGH I ANVQCA EVWC PMTA E FY Q EY LY I MN PT K FQACQ F L I QY
I AAHT K LG LT AT LVR EDDK I DD LN F L I G PKMY EANWMD LAQKGH I AKVQCA EVWCAMT T E FY N EY LY I MN PKK FQACQ F L I DY
VQAHCK LG LT AT LVR EDDK I AD LN F L I G PK LY EANWME LQNKG F I AR VQCA EVWC PMA P E F FR EY LY VMN PNK FR ACQ F LVR F
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Y K FH FK LG LT AT PY R ED EK I I N L FYMI G PK LY E ENWYD LV SQG F LAK PY CV E I R C EMSQ LWMS EY I HT SN PR K FKT L EY L I K V
I R SHCK LG LT AT LVR EDD L I R D LQWL I G PK LY EANWL E LQQKGY LAKV I CK E I WC PMTA P FY R EY LWSCN PVK L I T C EY L LR F
I R SHCK LG LT AT LVR EDD L I R D LQWL I G PK LY EANWL E LQ EKGY LAKV I CK E I WC PMTA P FY R EY LWSCN PVK L I T C EY L LK F
AKAHT R LG LT AT L I R EDDK I SD LR Y LVG PK LY EANWL E L S EQGY LAR VKC F EVT V PMTA S FY KY Y LC S SN PNK I R T VAG I I K F
VKY KCV I G L SAT L LR EDDK I GD LRH LVG PK LY EANWLD LT R AG F LAR V ECA E I QC P L PKA F LT EY VVC LN PY K LWCTQA L L E F
VKY KCVVG L SAT L LR EDDK I GD LRH LVG PK LY EANWL E LT R AG F LAR V ECA EVQC P L P L P F FR EY VVC FN PY K LWCTQA L L E F
I KAH SK LG LT AT LVR ED EK I D E LN F LVG PK LY EANWMD LAAKGH I AT VQCA EVWC PMT P E FY R EY LY CMN PNK FQACQ F L I DY
I AAHAK LG LT AT LVR EDDK I DD LN F L I G PK LY EANWMD LAQKGH I ANVQCA EVWC PMT S E FY Q EY LY I MN P SK FQAAQ F L I NY
























































H E -KRG - -DKT I V F SDNV FA LKHY - -A I KMNK PY I Y G PT SQN ER I Q I LQN FK FN PKVNT I FV SKVADT S FD L P EANV L I Q I S S
H EQQRG - -DK I I V FADN L FA LT EY - -AMK LR K PMI Y GAT SH I ER T K I L EA FKT SKT VNT V F L SKVGDN S I D I P EANV I I Q I S S
H E -KRG - -DK I I V F SDNVY A LQ EY - -A LK LGK P F I Y G ST PQQ ERMN I LQN FQY NDQ I ST I F L SKVGDT S I D L P EAT C L I Q I S S
H E -KRG - -DKV I V F SDNVY A L ER Y - -A LK LNKAY I Y GGT PQN ERMR I L EN FQHN EQVNT I F L SK I GDT S LD L P EAT C L I Q I S S
H E -KRG - -DKV I V F SDNVY A LQR Y - -A LK LNKAY I Y GGT PQN ERMR I L EN FQHN EQVNT I F L SK I GDT S LD L P EAT C L I Q I S S
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -R RN - -DK I I V F SDNV FA LKR Y - -A I EMQK P F LY G ET SQN ERMK I LQN FQY N PR VNT I FV SKVADT S FD L P EANV L I Q I SA
H E -R RN - -DK I I V F SDNV FA LKR Y - -A I EMQK P F LY G ET SQN ERMK I LQN FQY N PR VNT I FV SKVADT S FD L P EANV L I Q I SA
H E -KRG - -DK I I V F SDNVY A LQ EY - -A LR LGK P F I Y G ST PQQ ERMK I LQN FQHNDQ I NT I F L SKVGDT S I D L P EAT C L I Q I S S
H E -R RG - -DK I I V F SDNVY A LQ EY - -A LK LGK P F I FG ST PQQ ERMN I LQN FQY NDQ I NT I F L SKVGDT S I D L P EAT C L I Q I S S
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
- - - - - - - - - - - - - - - - -V FA LK EY - -AVRMGK PY I Y G PT TQG ER LQ I LQN F I HN PKVNT I F I SKVGDN S I D L PAANV L I QV S S
H E - SR G - -DKV I V F SDNV FA L EAY - -AKK LGK S F I HGGT P EG ER LR I L SR FQHD PQ LNT I F L SKVGDT S I D L P EAT C L I Q I S S
H E -QRG - -DK I LV F SD S L FA L I N I - -AVA LKK P FVCG SVDT L ER I K I LQQ FK EN PN FNT I F L SKVGDNA I D I P LANVV I Q I S F
H E -QRG - -DK I LV F SD S L FA L I N I - -AVA LKK P FVCG SVDT L ER I K I LQQ FK EN PN FNT I F L SKVGDNA I D I P LANVV I Q I S F
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -KRG - -DK I I V F SDNVY A LQGY - -A LK LGK P F I Y G ST SQQ ERMK I LQN FQHNDQVNT I F L SKVGDT S I D L P EAT C L I Q I S S
H E -QRG - -DK I I V F SDNVY A LQKY - -AKG LGR Y F I Y G PT SGH ERMS I L SK FQHD PT VR T I F I SKVGDT S I D I P EAT V I I QV S S
H E -QRG - -DKT I V F SDNV FA LKHY - -A I KMNK P F I Y G PT SQN ER I Q I LQN FK FN SKVNT I FV SKVADT S FD L P EANV L I Q I S S
H E -QRG - -DKT I V F SDNV FA LKHY - -A I KMNK P F I Y G PT SQN ER I Q I LQN FK FN SKVNT I FV SKVADT S FD L P EANV LVQ I S S
H E - SR G - -DK I I V F SD SVY A LKAY - -A LK LGK P F I Y G PT GQT ERMR I LKQ FQTN PV I NT I F L SKVGDT S I D L P EAT C L I Q I S S
HK -AHG - -DK I I I FCN E LK PAG FY K EK LK LQKCYMDGNT S E EHR RN L LDQ FR RD - E I SV I FC SK I GDVG LD L PDA SVA I Q L S S
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LGK PY I Y G PT AQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -KRG - -DK I I V F SDNVY A LQ EY - -A LK LGK P F I Y G ST PQQ ERMN I LQN FQY NDQ I NT I F L SKVGDT S I D L P EAT C L I Q I S S
H L -DAG - -AK I L LCCDH I ML LK EY - -G E L LNA PV I CG STQHK ER LMI F SD FQ ST SK I NV I CV SR VGDV SVN L PNAN I V I QV S S
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -ARG - -DK I I V F SDNVY A LKKY - -A SV L SKCMI Y GGT SN S ERQ L I LKN FQHN P E I NT L F L SK I GDT S LD L P EAT C L I Q I S S
H - - -R E - -DR V F I FT EHNR LVHR I - - SNT F F I PA I T Y R T PAK ERN S I L EK FR -T G SY R AVVT SKV LD EG I DV P EAN I G I - I V S
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -ARG - -DK I I V F SD E LY S LKQY - -A LK LNKV F I Y GGTGQA ERMQV L EN FQHN PQVNT L F L SK I GDT S LD L P EAT C L I Q I S S
H EQQRG - -DK I I V FADN L FA LT SY - -AMK LR K PMI Y G ST SHV ER T R I LHQ FKN S SDVNT I F L SKV - - - - - - - - - - - - - - - - - -
H EQQR K - -DKV I V F SDN I FA LR EY - -AT A LR R P L I Y GDT SHA ER T R V LHA FKY SN E I NT I F L SKVGDN S I D I P EANV I I Q I S S
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -MLG - -HK I I V FCD S L L I LNY Y - -A L L LGY PV I DGD LNTD EKNK I F S I FKN SN E I K T I FV SR VGDTG I D I P SA SVG I E I GY
H E -KRG - -DK I I V F SDNVY A LQ EY - -A LK LGK P F I Y G ST PQQ ERMQ I L SN FQHNDQ I NT I F L SKVGDT S I D L P EAT C L I Q I S S
H E -QNN - -DK I I V F SDN I FA L LH I - -AKT LNK P F I Y GK L S P I ER I A I I NK FKHD S S I NT I L L SKVGDNA I D I P I ANVV I Q I S F
H E -QNN - -DK I I V F SDN I FA L LH I - -AKT LNK P F I Y GK L S P I ER I A I I NK FKND SN I NT I L L SKVGDNA I D I P I ANVV I Q I S F
H E -QNN - -DK I I V F SDN I FA L LH I - -AKT LNK P F I Y GK L S P I ER I A I I NK FKND ST I NT I L L SKVGDNA I D I P I ANVV I Q I S F
H E EQR R - -DK I I V FADN L FA LT EY - -AMK LHK PMI Y GAT SHA ER T K I LHA FKT S S EVNT V F L SKVGDN S I D I P EANV I I Q I S S
H E -R RN - -DK I I V FADNV FA LK EY - -A I R LNK PY I Y G PT SQG ERMQ I LQN FKHN PK I NT I F I SKVGDT S FD L P EANV L I Q I S S
H E -R RG - -DK I I V F SDNVY A LQ EY - -A LKMGK P F I Y G ST PQQ ERMN I LQN FQY NDQ I NT I F L SKVGDT S I D L P EAT C L I Q I S S
H E -KRG - -DK I I V F SDNVY A LR AY - -A I K LGKY F I Y GGT PQQ ERMR I L EN FQY N E LVNT I F L SKVGDT S I D L P EAT C L I Q I S S
H E -QRN - -DKV I V F SDNV FA LKHY - -A I AMGR PY I Y G PT SQG ERMQ I LQN FQHN PAV ST I F I SKVGDN S FD L P EANV L I Q I S S
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
H E - ER G - -DK I LV FCDR PMI I DY Y - -GN I LKY PV I Y GDV SQD ER KK I FN L FKV SNQ I NT I F L SR VGDTA I D L PQANVG I Q I GM
H E - SR G - -DKV I V F SDN L FA L LHA - -AK L LNR P F I Y GKV S SA ER I V I LNK FKN ET T FNT I F L SKVGDNA LD I PCANVV I Q I S F
H E - SR G - -DKV I V F SDN L FA L LHA - -AK L LNR P F I Y GKV S SA ER I I I LNK FKN ET T FNT I F L SKVGDNA LD I PCANVV I Q I S F
H E -R RG - -DKV LV FCD I I H I L I H L - -AG L LHC P E I HG ET P ENVR S S I FH E FKNG SKVNT L I L S SVGDKA I D L P SA SVVVQVC S
HR -NR S P PDKV I I FCDQ I DG I QY Y - -AQH LHV P FMDGKT SDMER EN L LQY FQH SDN I NA I I L SR VGDVA LD I PCA SVV I Q I SG
HR -NR S P PDKV I I FCDD L EGVQY Y - -ARH LNV P FMDGKT T EV ER EN L LQY FQH SND I NA I I L SR VGDVA LD I PCA SV I I QV SG
H E -NRG - -DK I I V F SDNVY A LVAY - -AHK LKK P F I HGGTAH L ERMR I LQN FQHN P LVNT I F L SKVGDT S I D L P EAT C L I Q I S S
H E -KRG - -DK I I V F SDNVHA LKAY - -A LK LGK F F I FGGT PQQ ERMK I LKN FQY NDQVNT I F L SKVGDT S I D L P EAT C L I Q I S S
























































HGG SR RQ EAQR LGR I LR AKA F FY T LV SQDT EMGY SR KRQR F LVNQ -GY SY KVY FK LR SAAVA E LKK S P -DT - - - - -H PY PHK F
HAG SR RQ EAQR LGR I LR AKA F FY S LV STDT EMY Y ST KRQQ F L I DQ -GY S FKVY Y ENR LKY LAA EKAK - -G E - - - - -N PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y ST KRQA F LVDQ -GY A FKVY F EAR SRQ I Q E LR KTQ - E P - - - - -N PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMFY S SKRQA F LVDQ -GY A FKVY F E I R SKR I NK LR ET K -Q P - - - - -D PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMFY S SKRQA F LVDQ -GY A FKVY F E I R SKR I NK LR ET K -N P - - - - -D PY PHK F
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY FK I R SQA I HQ LKVN - -G E - - - - -D PY PHK F
HGG SR RQ EAQR LGR I LR AKA F FY S LV SQDT EMGY SR KRQR F LVNQ -GY AY KVY FNMRVRMI EAR R AA - -G E - - - - -N P F PHK F
HGG SR RQ EAQR LGR I LR AKA F FY S LV SQDT EMGY SR KRQR F LVNQ -GY AY KVY FNMRVRMI EAR R AA - -GD - - - - -N P F PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y ST KRQA F LVDQ -GY A FKV F F E I R SRQ I S E LR EKN -NAD P SA FN PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y ST KRQA F LVDQ -GY A FKVY F EAR SRQ I L E LR KTH - S P - - - - -N PY PHK F
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY FK I R SQA I HQ LK I N - -G E - - - - -D PY PHK F
HGG SR RQ EAQR LGR I LR AKA F FY S LV SQDT EVAY ST KRQR F LVDQ -GY S FKAY LQ I R KNT I T T LRQN - -N I - - - - - E PY PHK F
H FG SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMFY S SKRQG F L I DQ -GY A FKV FH EMR Y K E I AK LR ET K -Q P - - - - -N PY PHK F
N FA SR RQ EAQR LGR I LR PKA F FY S L L SKDT EMEY ADKRQQ F I I DQ -GY SY R VY TDNR Y KMMEC I KDA - -GR - - - - - P FY PHK F
N FA SR RQ EAQR LGR I LR PKA F FY S L L SKDT EMEY ADKRQQ F I I DQ -GY SY R VY TDNR Y KMMEC I KDA - -GR - - - - - P FY PHK F
HGG SR RQ EAQR LGR V LR AKAY FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY FK I R SQA I QA LKGT - -A E - - - - -D PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y ST KRQA F LVDQ -GY A FKVY F E I R SRQ I D E LRQAN - LADG SA FN PY PHK F
HY G SR RQ EAQR LGR I LR PKA F FY S LV SKDT EMY Y ST KRQQ F L I DQ -GY S FKVY K ENR T KQ LT SAD I - - -GV - - - - -N PWPHK F
HGG SR RQ EAQR LGR I LR AKA F FY T LV SQDT EMSY SR KRQR F LVNQ -GY SY KVY FK LR SAAVQ E LKR S P -AT - - - - -D PY PHK F
HGG SR RQ EAQR LGR I LR AKA F FY T LV SQDT EMSY SR KRQR F LVNQ -GY SY KVY FK LR SAAVQ E LKQ SA -D S - - - - -H PY PHK F
H FG SR RQ EAQR LGR I LR AKVY FY S LV SKDT EMFY S SKRQQ F L I DQ -GY T FT I - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
S SG SR RQ EAQR LGR I LR AKAY FY T LT SKDT EMY F SQR RQR VMRQN -GY T FKV L F LNR CKDV E EY QKA - -GH - - - - -N PWPHK F
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY Y K I R SHA I QQ LKGT - -N E - - - - -D PY PHK F
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY Y K I R SQA I HQ LKVN - -G E - - - - -D PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y ST KRQA F LVDQ -GY A FKVY F EAR SRQ I N E LR KTH - S P - - - - -N PY PHK F
HGG SR RQ EAQR LGR I LR PKAWFY S I I ST DT E I NY AAHR T A F LVDQ -GY T CR I Y F E SR LAMVK EMG L L - -G - - - - - -AAY PHKY
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY FK I R SQA I HQ LKVN - -G E - - - - -N PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y SAKRQA F LVDQ -GY A FKVY F E I R SR EVNGML EN P SG P - - - - -N PY PHK F
GTG SKR AY VQR LGR I LR KKAV LY E I I AG ET ET GT AR R R K EA L S SG -KR T SKA FDD SK LAK LNG I I SQ - -G L - - - - -D PY PY R F
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY Y K I R SQA I QQ LK I S - -G E - - - - -D PY PHK F
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY Y K I R SQAVQQ LKVT - -G E - - - - -D PY PHK F
H FG SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y S SKRQA F LVDQ -GY A FKVY Y E I R T RQVN E L LKN P - ET - - - - -N PY PHK F
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -Q - - - - - - -Y Y ENR LKA LD S LKAT - -GV - - - - -N PY PHK F
HAG SR RQ EAQR LGR I LR PKA F FY S LV STDT EMY Y ST KRQQ F L I QQ -GY A FKVY TQNR I NKV L SAKAK - -G E - - - - - S PY PHKY
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY Y K I R SQA I HQ LKVN - -G E - - - - -D PY PHK F
LGG SR RQKVQR LGR VMR PKA F FY S LA SKDT E S EY SY KRQKY I T EQ LG LNT E L FH ENR SKQV LA LKQT K -D P - - - - -N PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y ST KRQA F LVDQ -GY A FKVY F E I R SRQ I N E LR E SN -N EN PT A FN PY PHK F
N FA SR RQ EAQR LGR I I R PK S F FY S LV SKDT EMCY SDKRQR F L I NQ -GY AY NVY F ENR SK F I QDQKDK - -G I - - - - -N PY PHK F
N FA SR RQ EAQR LGR I I R PK S F FY S LV SKDT EMCY SDKRQR F L I NQ -GY AY NVY Y ENR SK FVQ EQKAK - -G I - - - - -N PY PHK F
N FA SR RQ EAQR LGR I I R PK S F FY S LV SKDT EMCY SDKRQR F L I NQ -GY AY NVY F ENR SK L I L SQQ EK - -G I - - - - -NT Y PHK F
HAG SR RQ EAQR LGR I LR AKA F FY S LV STDT EMY Y ST KRQQ F L I DQ -GY S FKVY Y ENR LKY LDAQKG E - -GK - - - - -NMY PHK F
HGG SR RQ EAQR LGR V LR AKA F FY S LV SQDT EMAY ST KRQR F LVDQ -GY S FKVY Y K I R SQAVQQ LKV S - -G E - - - - -D PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y ST KRQA F LVDQ -GY A FKVY F ET R SRQ I Q E LR KTH - E P - - - - -N PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y S SKRQA F L I DQ -GY A FKVY F ENR SR T I ME LRQT K -D P - - - - -N PY PHK F
HGG SR RQ EAQR LGR I LR AKA F FY T LV SQDT EMFY S LKRQR F LVNQ -GY S FKT Y FK I R SQAV EA LKAA - -GD - - - - -H PY PHKY
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -Y FK I R SQA I E E LKGA - -G E - - - - -D PY PHK F
H FK SR RQ EVQR LGR I MR AKA FWY T LV SKGT ET SY C LARQKC L I NQ -G FKY E I Y Y ENR CKAVQD LMT TG -K P - - - - -Y PY PHK F
N FA SR RQ EAQR LGR I LR PKA F FY S LV SKDT EMV FADKRQQ F I I DQ -GY AY NV - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
N FA SR RQ EAQR LGR I LR PKA F FY S LV SKDT EMV FADKRQQ F I I DQ -GY AY NVY Y LNR L ET V EQWRKN - -G - - - - - -T AY PHK F
NY GARMQ E SQR LGR V LR PKA F FY SC I SDMTD LKY SAR RQQ F LVDQ -GY VY E PY HDR R LA EVT KQV EAH -R KD L S L P S PY PHK F
LGA SR RQ EAQR LGR I LR PK SY FY T LV SQDT E I SQ SY ERQ SWLRDQ -G F SY R VY Y DT R LAMVK EMG P L - -G - - - - - -AAY PHK F
LGA SR RQ EAQR LGR I LR PK SY FY T LV SQDT EVQQ SY GRQ SWLRDQ -G FAY R VY FDT R LAMVK E LG L L - -G - - - - - -AAY PHK F
H FG SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMFY ST KRQQ F L I DQ -GY A FR VY Y ER R FR T I SA LR E SK -N P - - - - -D PY PHK F
HY G SR RQ EAQR LGR I LR AKA F FY S LV SKDT EMY Y ST KRQA F LVDQ -GY A FKVY F E I R SRQ I DA LRQ SK -T P - - - - -N PY PHK F
























































SVT V S LG E F I ER Y - - - SG - LQDG ET LD -DVT V SVAGR VHA I R E SGVK L I F FD LR - - - - - -G EG LK LQV F F E ET AR LR RGD I I G
AV SMS I PKY I ET Y - - -G S - LNNGDHV E -NA E E S LAGR I MSKR S S S SK L F FY D LH - - - - - -GDD FKVQV F LK LH SNAKRGD I VG
NVT I G L PA F LNKY - - -AH - LQRG ET L P - E ER V S I AGR I HAKR E SG SK LR FY V LH - - - - - -ADGV EVQVY EQDHG L LKRGD I VG
QVTDD LR EY LKT Y - - -DG - LAKG EQK P -DVT VR I AGR I Y T KR S SG SK L F FY D I R - - - - - -A EGVKVQV F EAQH EH LR RGD I VG
QVTDD LR KY LTDY - - - EG - LAKG EQK P - EVAVR I AGR I Y T KR A SGAK L I FY D I R - - - - - -A EGVKVQV F EAQH EH LR RGD I VG
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
HVD I S LT H F I Q EY - - - SH - LQ PGDH LT -D I T LKVAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQV F I R I NNK LR RGD I I G
NVT I S LT D F I AKY - - - S P - LQN EQ -VA -D E I V SVAGR I H SKR E SG SK LV FY D I H - - - - - -G EGTH I Q I FVT LHDR I K R GD I VG
NVT I S LT D F I T KY - - -T P - L EK EQ -VV - E E I V SVAGR I H SKR E SG SK LV FY D I H - - - - - -G EGTH I Q I FVT LHDR I K R GD I VG
NVT T K I P E FV EKY - - -AH - LQRG ET LK -DVT V SV SGR I MT KR E SG SK LK FY V LK - - - - - -GDGV EVQ I F E SMH E I LR R GD I I G
QV S I SN P E F LAKY - - -AH - LKRG ET L P -N E I V S I AGR I HAKR E SG SK LK FY V LH - - - - - -GDGV EVQVY ENDHD L I K R GD I VG
HVD I S LT H F I E EY - - -GH - LQ PGDH LT -D I T LKVAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQV F I H I NNK LR RGD I I G
HV S I S L SDY V EKY - - -NN - I EVG SH LN -DQQV S I AGR I HAKR EAG PK L I FY DVR - - - - - -GDGVK LQVYQ E I N ER T R RGD I I G
NVTHAV PK FV E EWGK EGK - L EKG ET AQ LN E P I S LAGR VY T I R E S S SK LR FY D LK - - - - - -ADGVKVQ I Y LDTHDR I R R GD I I G
K I SMS L PAY A LKY - - -GN -V ENGY I DK -DT T L S L SGR VT S I R S S S SK L I FY D I F - - - - - -C E EQKVQ I F SV SH S E I R R GDVVG
K I SMS L PAY A LKY - - -GN -V ENGY I DK -DT T L S L SGR VT S I R S S S SK L I FY D I F - - - - - -C E EQKVQ I F SV SH S E I R R GDVVG
HVD L S LT E F I ER Y - - -NH - LQ PGDH LT -DVV LN L SGR VHAKR A SGAK L L FY D LR - - - - - -G EGVK LQV FVH I NNK LR RGD I I G
HV S I Q L PA FA EKY - - -KD - LKKG E S LK -DV EVKV SGR I MGKR E SG SK LK FY V LK - - - - - -GDGVQ I Q I Y EKMH EY LR RGD I I G
EV SHQ L PK FV E E F - - - SV - L EKDG E P S -TQVV S I AGR V L SKR AAG SG LV FY D I T - - - - - -G E FNKVQVY VK I NG L LR R GD I I G
HV S S S L ED F I AKY - - EN S - LK EG ET L E -NVK L SVAGR VHA I R E SGAK L I FY D LR - - - - - -G EGVKVQV F E I DT SK LR R GD I I G
NV S I S L EN F I EQY - - - SG - LTDG ET L E -KV S L SVAGR VHA I R E SGAK L I FY D LR - - - - - -G EGVK LQV F ETDTAK LR RGD I I G
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -MSMR LH - - - - - -AR FC F FVVT - - - - - - SNG E S LQVR EQMAK F LR R GDVVG
NV S I T V P E F I AKY - - - SG - L EK SQ -V S -DD I V SVAGR V L SKR S S - SA LMF I D LH - - - - - -D SQT K LQ I FV S LT KMI Y R GD I CG
HVD L S L SD F I ER Y - - - SH - LQ PGDH LT -D I T V SVAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQVY FR I NNK LR RGD I I G
HVD I S LT D F I QKY - - - SH - LQ PGDH LT -D I T LKVAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQV F I H I NNK LR RGD I I G
QV SVT L P E F L SKY - - -AN - LKRG ET L P - E EKV S I AGR I HAKR E SG SK LK FY V LH - - - - - -GDGV EVQVY EDDH S L I K R GD I VG
HRQY T I PQY R R KY - - -A P L LT E PDT S L -D ET VT I AGR I I NKR S SG SK LH F I T I Q - - - - - -GDME I VQV FA E I H SK LKRGD I I G
HVD I S LT D F I QKY - - - SH - LQ PGDH LT -D I T LKVAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQV F I H I NNK LR RGD I I G
LVDY D P SQ FDKD F - - -KH - LK SGDVDK -T R E I R I AGR I FT KR S SGNK L I FY D I K T G SDT T T TG SKMQ I F EQQH EH LGRGDV I G
EKNGD I C E I LVK F - - - ED - F EKN EG L S - - - -VR T AGR LY N I R KHG -KMI FAD LG - - - - - -DQTGR I QV FAT FKN LMD SGD I I G
HVDT S LT H F I EQY - - -NN - LQ PGDH LT -D I T VR VAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQV F F P I NNK L PR GD I FG
HVD I S LTQ F I Q EY - - - SH - LQ PGDH LT -DVT LKVAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQV FVH I NNK LR RGD I I G
QVNYDD SN FV E E F - - -G S - LKT G ET L P - EK E LR I AGR I Y N I R T AG SK L I FY D I R T SADT K S I GT RMQV F EKQHAH LR RGD I I G
LAN I T VADY I EKY - - -K S -MNVGDK LV -DVT EC LAGR I MT KR AQ S SK L L FY D LY - - - - - -GGG EKVQV F I K FH ST LKRGD I VG
HVDT R VG E F I EK Y - - - SG - LADGT T A E -G E SA SVAGR I MSKR A SGKK LY FY D L I - - - - - -ADGKK I QV FQK I H SAT R RGD I VG
HVD I S LT D F I QKY - - - SH - LQ PGDH LT -D I T LKVAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQV F I H I NNK LR RGD I I G
QVD LT I AQ FRDKY - - -G P LCT EKGK I H - ED FV SVAGR VVT I R SMGAK LMFY D LQ - - - - - -G EGT K I QV F EKVHT L I K R GD I I G
HRN I T L P E FA EKY - - - S S - LT R G ET LQ -DV EVKVTGR I MT KR E SGAK LR FY V LK - - - - - -GDGV EVQ I Y EKMH EY LR RGDV I G
ER T I S I P E F I EK Y - - -KD - LGNG EH L E -DT I LN I T GR I MR V SA SGQK LR F FD LV - - - - - -GDG EK I QV FA ECY DK I R R GD I VG
ER T I T V P E FV EKY - - -QN - LA SG EH L E -NT V LNVTGR I MR V SA SGQK LR F FD LV - - - - - -GDGAK I QV FA EAY DK I R R GD I VG
ER T I T I PD F I EK Y - - -KD - LQNG EH L E - ET I LNMTGR I MR V S S SGQK LR F FD LV - - - - - -GDGKR I QV FV ECY DK I K R GD I VG
FVT L S I P EY I DKY - - -GG - L SNG EH L E -DV SV S LAGR I MSKR S S S SK L F FY D LH - - - - - -G LGAKVQV F SK LH S SVKRGD I VG
HVD I S LTQ F I Q EY - - - SH - LQ PGDH LT -D I T LKVAGR I HAKR A SGGK L I FY D LR - - - - - -G EGVK LQV FVH I NNK LR RGD I I G
HV S I SN P E F LAKY - - -AH - LKKG ET L P - E EKV S I AGR I HAKR E SG SK LK FY V LH - - - - - -GDGV EVQ LY EKDHD L LKRGD I VG
QVT I T L P E F I AKY - - - EG - LARG ET K P - EV EVAVAGR V LG LR T AGNK LR FY E I H - - - - - -ADGKK LQV FAAQH EH LR RGD I I G
HVT I S LT D F L EKY - - -DY - LKA ED - I A -D EV L S L SGR VHAKR A SGAK L I FY D LR - - - - - -G EGVK LQV FT R LN EK I R R GD I I G
HVDV S LT E F I EK Y - - -KN - LQ PGDQ LT -D -AVKVAGR VHAKR V SGAK L L FY D LR - - - - - -G EGVK LQV FVA I NNK LR RGD I I G
DV SH S I SQ F I E E F - - -D PK LT ENGQT I -DT I V T I GAR I T S FR A SGKA L I FY QVQ - - - - - -Q EGKK LQV F E E I N S L FKR GD I I G
- - -MS LK EY VDKY - - - EH - L EAG EH L E -N E LV S I AGR V SR I A S S S SK LR F LD I K - - - - - - S EGT K LQV FNDT Y NN I KR GD I I G
HVNMS LK E FVGKY - - -DH - L EAGAH L E -N E LV S I AGR V SR I A S S S SK LR F LD I K - - - - - - S EGT K LQV FNDT Y NN I KR GD I I G
NV SHT FKQ FY AQ F - - - EH - LKAG E E L P -DVKV SVA SR I AQ LR AHG -N LY F F EMY - - - - - - E ST FK LQ L FK E EV S S FH LGD I VG
HRDY T L PA FR EC F - - -K PMLQ EKGQR L -DKVVT I AGR I VVKR S S S SK LH F LA LQ - - - - - -GDG EV LQV FAD I H SK I K R GD I I G
DRQY T I PA FKAR F - - -A PQ L S EKGQR V - E EVVA I AGR I VNKR S SG SK LN F LT LQ - - - - - -GDADT VQV FAAVHGR I R R GD I I G
HV S I S L S E F I SK Y - - - EGK L EAGQH LD -Q E EV S I AGR LHNMR S SGQK LR FY D LH - - - - - -G EGVKVQV F FA I H E L LR R GDVVG
NVT T KVD E FV EKY - - -KG - LARG E I KK -D E EV SVAGR VHT LR AAG SK LR FY V LH - - - - - -Q EGKT VQ I DWG I HD L I R R GDV I G
























































VTGV PG E L SAMAR R I K L L S PC LHML PG LKDK ET R FRQR Y LD L I LNNNVRN I FVT R A L I I SY VR R F FDN LG F L EV ET PMMNMI P
V I G F PG E L S I F PR S F I L L SHC LHMMPV LKDQ E SR Y RQRH LDMI LNV EVRQ I FR T R AK I I SY VR R F LDNKN F L EV ET PMMNMI A
V EGY VG E I SV FV SR I Q L LT PC LHML PG FKDQ ET R Y R KR Y LD L I MNKDARGR F I T R SK I I T Y I R K F LDNRD F I EV ET PMMNV I A
VVG F PG E L S I FAT EVV L LA PC LHA I PG FQDK EQR FRQR Y LD L I MN ER SRNV FVT R SK I V R Y VRN F FD SRD F I EV ET PMMNA I A
I VG F PG E L S I FAT EVV L L S PC LHA I PG LQDK EQR FRQR Y LD L I MNDK SRNV FVT R SK I V R Y I R N F FDNRD FV EV ET PMMNA I A
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -MY K EVRQ I FY T R AK I I AY VR R F LDNMG F L EV ET P LMNMV P
VQGN PG E L S I I PY E I T L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND FVRQK F I I R SK I I T Y I R S F LD E LG F L E I ET PMMN I I P
FT GQAG E L S L I PK EV LQ LT PC LHML PG LKDK E LR FR KR Y LD L I LN PR VKDN FV I R SK I I T F LR R Y LDN LG F L EV ET P I MNQ I A
FT GR AG E L S L I PN E I LQ LT PC LHML PG LKDK E LR FR KR Y LD L I LN PR VKDN FV I R SK I I T F LR R Y LDN LG F L EV ET P I MNQ I A
VTGY PG E L SV FAT KVQ L LT PC LHML PG FKDQ EAR Y R KR Y LD L I MND S SR ER FR VR SK I I QY I R K F LDNRD FV EV ET P I LNV I A
V EGY VG E I SV FVKR I E L LT PC LHML PG FKDQ ET R Y R KR Y LD L I MNKD SR KR F I T R SK I I K Y I R K F LDNRD F I EV ET PMMNV I A
VKGN PG E L S I I PY E I T L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND FVRQK F I I R SK I I T Y I R S F LD E LG F L E I ET PMMN I I P
V I GH PG E L S I V PNT I E I L S PC LHML PG LKDK ET R Y RQR Y LD L I MNDQT RQK F I T R AK I I SY I R S F FDQMG F L EV ET PMMNMVA
VTG I PG E L S L S I S S I Q L L S PC LH L L PGVVD L ET R Y R KR Y LD L I MN P ST RD I FVT R SKV I NY I R KY LDAQG F L EV ET PMMSMI A
FT G F PG E L S L F SK SVV L L S PCY HML PG LKDQ EVR Y RQR Y LD LMLN E E SR KV FK LR SR A I K Y I R NY FDR LG F L EV ET PMLNMI Y
FT G F PG E L S L F SK SVV L L S PCY HML PG LKDQ EVR Y RQR Y LD LMLN E E SR KV FK LR SR A I K Y I R NY FDR LG F L EV ET PMLNMI Y
VRGN PG E L S I I PV EMT L L S PC LHML PG LKDK ET R FRQR Y LD L I LND FVRQK FVT R SK I I T Y LR S F LDQ LG F L E I ET PMMN L I P
VT GY PG EV SV FAT SVQ L LT PC LHML PG FKDQ EAR Y R KR Y LD L I MN E ST RDR FKVR SQ I I S F I R K F LDT RD FT EV ET PMMNV I A
AKGT PG E L S L FAT EV I L L S PC LHML PG LTD P ET R FRQR Y LDMI CN E SVKKN F I I R SKV I QGVR R Y LDN LG F I EV ET PMMNMI A
VVGH PG E L SVMP S E I K L L S PC LHML PG LKDK ET R Y RQR Y LD L I LNNNVR EK FQ I R AK I I SY VRQ F LDR LG F L E I ET PMMNMI A
VKGH PG E L S I MPT E I K L L S PC LHML PG LKDK ET R Y RQR Y LD L I LNNKVR EN FQ I R AK I I SY VRQ F LDR LG F L E I ET PMMNMVA
FTGN P L EA SV FATD I I V LT PC LR T I PG LKD P ET I Y R KR YMD L L I NR E SR NR FQKR AQ I I GY I R S F LD SR G F L EV ET PMMN L I P
FT GH PG E L S L I P I SGMI L S PC LHML PG LGDQ ET R FR KR Y LD L I VN P E SVKN FV LR T KVVKAVR KY LDDKG F L EV ET P I LNT I P
VVGN PG E L S I I PY E I T L L S PC LHML PG LKDK ET R Y RQR Y LD L I LNDY VRQK F I T R AK I V T Y I R S F LD E LG F L E I ET PMMN I I P
VQGN PG E L S I I PY E I T L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND FVRQK F I I R SK I I T Y I R S F LD E LG F L E I ET PMMN I I P
V EGY VG E I SV FV SR I Q L LT PC LHML PG FKDQ E LR Y R KR Y LD L I MNKDARNR F I T R SK I I SY VR K F LDT RN F I EV ET PMMNV I A
I AGK PN E F S LKAT E I T L L ST CY HML PG L S S F EQR FRQR Y LD F I VNRDN I KT F I QR AN I I K Y I R K F FD ERD FV EV ET PV LNQ I A
VQGN PG E L S I I PY E I T L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND FVRQK F I I R SKMVT Y I R S F LD E LG F L E I ET PMMN I I P
I VG F PG E L S L FAT EVVQ L S P S LH L L PG FTDG EKR FRMR Y LD FMFNDK SR EV LWQR SR I VKY I R D F FHDR R F I EV ET PMMT S I A
I QG E LG EN S I SV S E F S L L SK S LCA L PG LKDV ET R Y R KR Y LD L I VNA EKR E I FVMR SK L I S E I R R F LADR E F L E F ET P I LQT VY
V PGN PG E L S L I PH E I T L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND FVRQK F I T R SK I I T Y I R S F LD E LG F L E I ET PMMNV I P
V EGN PG E L S I I PQ E I T L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND FVRQK F I V R SK I I T Y I R S F LD E LG F L E I ET PMMN I I P
I VG F PG E L SV FAT EVQ L L S PC LHML P P FADA EQRARMR Y LDMLWNDR SR ET LWQR SRMVR Y I R D F FH ER R F I EV ET PMMHA I A
VCGY PG E L S I F PKK I VV L S PC LHMMPV LRDQ ET R Y RQR Y LD LMVNH EVRH I FKT R SKVV S F I R K F LDG LD F L EV ET PMMNMI A
VKGT PG E L S L F P SN F E I LT PC LKML PG LKDV ET R FRMR F LD LMMNN EVRDT FY I R SN I I R Y I R KY LDDRD F L EV ET PMMNMI A
VQGN PG E L S I I PY E I T L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND FVRQK F I I R SK I I T Y I R S F LD E LG F L E I ET PMMN I I P
VKGN PG E L S I A PG F I Q L L S PT LHML PG FKDH EQR Y RMR Y LD L I MNKKVRD I F LT R S SV I KQ LR EY FDGKG F I EV ET P S LNV I Q
VTGY PG EV SV FAT SVQ L LT PC LHML PG FKDQ EAR Y R KR Y LD L I MNDAT RDR FKVR SK I I GY I R K F LDNRD FV EV ET P I LNV I A
I VG F PG E L S I F PK ET I L L SAC LHML PG LKDT E I R Y RQR Y LD L L I N E S SR HT FVT R T K I I N F LR N F LN ER G F F EV ET PMMN L I A
I VG F PG E L S I F PK ET I I L S PC LHML PG LKDT E I R SRQR Y LD LMI N E ST R ST F I T R T K I I NY LR N F LNDRG F I EV ET PTMN LVA
I I G F PG E L S I F PK ET I V L S PC LHML PG LKDT E I R Y RQR Y LD L L I N E ST RNV F I T R T K I I N F LR N F LNNQG F I EV ET P SMN LMA
I T G F PG E L S I F PT S FMV L SHC LHMMP I LKDQ ET R Y RQR Y LD LMLN S EVRQ I FKT R SK I I K Y I QN F LDD LD F L EV ET PMMNMI P
V EGN PG E L S I V PR EMT L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND FVRQK F I I R SK I I T Y I R S F LD E LG F L E I ET PMMN I I P
V EGY VG EV SV FV SR VQ L LT PC LHML PG FKDQ ET R Y R KR Y LD L I MNKDARNR F I T R S E I I R Y I R R F LDQR K F I EV ET PMMNV I A
I R GY PG E L S I FARQCV L L S PC LRML PG LKD L E I R HRQR Y LD L I MNR ST RDR FVMR SR I I QY I R H F FD SRD FMEV ET PMMNMI A
VKGR PG E L S I L P S E I T L L S PC LHML PGVTNK ET R FRQR Y LD L I MNDY VRDK F I T R SK I V SY LR R F FD E LG F L EV ET PMMNMI A
VCGN PG E L S I I PK EMI L L S PC LHML PG LKDK ET R Y RQR Y LD L I LND SVRQK F I T R SK I I T Y LR S F LDQMG F L E I ET PMMN I V P
I T GK PG E L S I A PT K LQ L L S PC LHML PG LKDMET R Y R KR Y LD L I MNN S SRNN F I T R T K I I SY I R R Y LDDRN F L EV ET PQMNMI P
LT G F PG E L SV F PK SVK I L S PC LHML PG LKDNDVR FRQR Y LD LMMNDD S LKVMK LR SR I I DY LR K F LT SR G F F EV ET PMLKT T S
LT G F PG E L SV F PK SVQ I L S PC LHML PG LKDNDVR FRQR Y LD LMMNDD S LKVMK LR SR I I DY LR K F LT SR G F F EV ET PMLKT T S
A EG F PG E L SVVVT K LV L LA PC L FQMPK L ED L EVR Y RQR F FD L I VNR ENRQ I F ET R CKVVKMI R G F LDD LD FT EV ET P I MWKTA
VRGV PG E F SMSAY E I T L L ST C FHML PG L S SV EQR FRQR Y LD L I VNR ENAKT F I LR SK I I SY I R S F FDQKD F L EV ET PMLNQ I A
VKGVAG E F SMNA F E I T L L ST CY HML PG L S S I EQR FRQR Y LD F I VNR EN I QT FVT R SKV I R Y I R N F F ED LN F L EV ET PV LNQ I A
VTGV PG E L S I F P S S I K L L S P S LKML PG FTDT EQRHR KR Y LD L I MNNHVRD I FVKR AK I I NY VR R F LDN LG F L EV ET PMMNQ I A
I R GY PG E L SV FCK E LV L LT P S LHML PG FKDV ET R FRQR Y LD L I MND ST R ER F I V R SK I I QY I R K F LDNKD F I EV ET PMMN I I A
























































GGATAK P F I T HHND LNMD L F LR I A P E LY LKMLT VGG LDR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYND I I D I T QQ L L
GGAAAR P FVTHHND LDMR LYMR I A P E LY LKQ L I VGG L ER VY E I GKQ FRN EG I D LT HN P E FT T C E FYMA FADY ND LMEMT EVML
GGATAK P FVTHHND LDMQMYMR I A P E L F LKQ LVVGGMDRVY E I GRQ FRN EG I DMTHN P E FT T C E FY QAY ADVY D LMDMT E L L F
GGATAK P F I T HHND LDMN L FMR VA P E LY LKML I VGG L ER VY E LGRQ FRN EG I D LT HN P E FT T C E FYWAY ADVYDVMN LT E E L I
GGAT AK P FVTHHND LDMN L FMR VA P E LY LKML I VGG L ER VY E LGRQ FRN EG I D LT HN P E FT T C E FYWAY ADVYDVMN LT E E LV
GGATAK P F I T HHN E LNMD LYMR I A P E LY HKMLVVGG LDR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYND LMT I T E S I L
GGAVAK P F I T Y HN E LDMN LYMR I A P E LY HKMLVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHD LME I T EKMI
GGATAK P F I T HHND LDMN L F LR VA P E LY HKMLVVGG I DR VY EVGR L FR N EG I D LT HN P E FT T C E FYMAY ADY EDV I Q LT ED L L
GGATAK P F I T HHND LDMN L F LR VA P E LY HKMLVVGG I DR VY EVGR L FR N EG I D LT HN P E FT T C E FYMAY ADY EDV I Q LT ED L L
GGATAK P FT THHND LNMEMFMR I A P E L F LK E LVVGGMDRVY E I GRQ FRN EG I DMTHN P E FT T C E FY QAY ADVY D LMDMT E LMF
GGATAK P FVTHHND LDMDMFMR I A P E L F LK E LVVGGMDRVY E I GRQ FRN EG I DMTHN P E FT T C E FY QAY ADVY D LMDMT E L L F
GGAVAK P F I T Y HN E LDMN LYMR I A P E LY HK I LVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHD LME I T EKMI
GGATAK P F I T HHND LDMD LYMRVA P E LY LKMLVVGG LDR VY E I GR L FR N EG I DMTHN P E FT SC E FYMAY ADY ED LMK I S ET L I
GGAT AK P FVTHHND LK LD L FMR I A P E LY LK E LVVGG LDR V F E I GR V FRN EQ I DMTHN P E F S I C E FYMAY ADMYD I MDMT E E L I
GGAAAR P F I T Y HN E L ETQ LYMR I A P E LY LKQ L I VGG LDKVY E I GKN FRN EG I D LT HN P E FT AME FYMAY ADY Y D LMD LT E E L I
GGAAAR P F I T Y HN E L ETQ LYMR I A P E LY LKQ L I VGG LDKVY E I GKN FRN EG I D LT HN P E FT AME FYMAY ADY Y D LMD LT E E L I
GGAVAK P F I T Y HND LNMN LYMR I A P E LY HKMLVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHD LME I T EK L L
GGATAK P FVTHHND LNMDMFMR I A P E L F LK E LVVGGMDRVY E I GRQ FRN EG I DMTHN P E FT T C E FY QAY ADVY D LMDMT E L L F
GGAAAK P F LT HHNA LNMD L FMR I A P E LY LKQ LVVGGMDRVY E I GKQ FRN ED I DHTHN P E FT T C E FYMAY ADYND LY TMT EQ L L
GGATAK P FVTHHND LKMD L FMR I A P E LY HKMLVVGG LDR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADY AD I MD I T EQ LV
GGATAK P FVTHHN E LKMD L FMR I A P E LY HKMLVVGG LDR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADY ADVMD I T EQ L I
GGAAAK P F I T HHN E LK LD LYMR V S P E LY LKK LVVGG L ER VY E I GKQ FRN EG I D LT HN P E FT SC E FYMAY ADYND LMEMT E E L I
GGAT AR P F I T HHNQ LD I QMYMR I A P E LY LK E LVVGG I NR VY E I GR L FR N EG I DQTHN P E FT T C E FYMAY ADYND I MKMT E E L L
GGAMAK P F I T Y HN E LDMK LYMR I A P E LY HKMLVVGG LDR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADY RD LME I T EK L L
GGAVAK P F I T Y HN E LDMN LYMR I A P E LY HKMLVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHD LME I T EKMV
GGATAK P FVTHHND LDMDMYMR I A P E L F LK E LVVGGMDRVY E I GRQ FRN EG I DMTHN P E FT T C E FY QAY ADVY D LMDMT E I MI
GGAAAR P FVTHHND LNQTMF LR I A P E LY LK E LVVGGMDRVY E I GKQ FRN EG I D LT HN P E FT SC EAYWAYMDYHDWMTAT ED L L
GGAVAK P F I T Y HN E LDMN LYMR I A P E LY HK I LVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHDVME I T EKMV
GGATA L P FVTHHN EY D LDMFMR I A P E LY LKMLVVGGYNKV F E I GKN FRN EGCD LTHN P E FT T I EAY AAY Y DMYDVMDY T E E LV
GGANAR P FKT FHNC LGQN L F LR I A P E LY LKR LVVGGY EKV F E I SKN FRN ED I DT THN P E FTMI EVY EAY RDY NDMMD LT EA L I
GGAVAK P F I T Y HN E LDMN LYMR I A P E LY HKMLVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHD LME I T EKMI
GGAVAK P F I T Y HN E LDMN LYMR I A P E LY HKMLVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHD LME I T EKML
GGATA L P FVTHHND LDMDMFMRVA P E L F LKKMI VGQ FGKV F EMGKN FRN EG I D LT HN P E FT S I E FYWAY ADVY D LMS I T E E LV
GGAAAR P FVTHHN E LNMR LYMR I A P E LY LK E LVVGG LDR VY E I GKQ FRN EG I D LT HN P E FT T C E FYMAY ADYND L I E LT ETML
GGATAR P F I T HHND LNMT LYMR I A P E LY LKQ LVVGG I ER VY E I GRQ FRN EG I DMTHN P E FT T C E FY QAY ADYDD LMQMT E EMI
GGAVAK P F I T Y HN E LDMN LYMRVA P E LY HKMLVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHD LME I T EKMV
GGATAK P FKT FHN S LHRD L FMR VA P E LY LKML I VGG LDR VY E I GKN FRN EG I DQTHN P E FT AME FYWAY CDYND LMTVT E EV L
GGATAK P F I T HHND L SMDMFMR I A P E L F LK E LVVGGMDRVY E I GRQ FRN EG I DMTHN P E FT T C E FY QAY ADVY D LMDMT E LMF
GGANAR P F I T HHND LD LD LY LR I AT E L P LKML I VGG I DKVY E I GKV FRN EG I DNTHN P E FT SC E FYWAY ADYND L I KWS ED F F
GGANAK P F I T HHND LD LD LY LR I AT E L P LKML I VGG I DKVY E I GKV FRN EG I DNTHN P E FT SC E FYWAY AD FY D L I KWS ED F F
GGA SAR P F I T HHND LD LD LY LR I AT E L P LKML I VGG LDR VY E I GKV FRN EG I DNTHN P E FT SC E FYWAY ADY Y D L I KWS E E F F
GGAAAR P FKTHHND LNMK LYMR I A P E LY LK E LVVGG LDR VY E I GKQ FRN EG I D LT HN P E FT T C E FYMAY ADYND LME LT EKML
GGAVAK P F I T Y HN E LDMN LYMR I A P E LY HKMLVVGG I DR VY E I GRQ FRN EG I D LT HN P E FT T C E FYMAY ADYHD LME I T EKML
GGATAK P F I T HHND LDMDMYMR I A P E L F LKQ LVVGG LDR VY E I GRQ FRN EG I DMTHN P E FT T C E FY QAY ADVY D LMDMT E LMF
GGATAK P FVTHHND LDMD LYMR I A P E LY LKMLVVGG LDR VY E I GRQ FRN EGAD LTHN P E FT S I E FY QAY ADY Y D LMDT T E E L L
GGATAK P F I T HHND LNMD L FMR VA P E LY LKMLVVGG LQR VY E I GRQ FRN EG I D LT HN P E FT T L E FYMAY ADYND LMD I A ER L L
GGAVAR P FVT Y HND LDMN LYMR I A P E LY HKMLVVGG I DR VY E I GRQ FRN EG I DMTHN P E FT T C E FYMAY ADYHD LME I T EK L L
GGAAAR P FVTHHND LNMD I FMR I A P E LY LKN LVVGG F ER VY E I GKQ FRN EG I DR THN P E FT S I E LY QAY ADY EDMMK LT ED L L
T GA SAK P F I T HHN E LD LD L FMR I A P E L P LK L I I I GG F EKV F E I GKC FRN EG I D PTHN P E FT SC E FYWAY ADYHD LMK LT E E L L
T GA SAK P F I T HHN E LD LD L FMR I A P E L P LK L I I I GG F EKV F E I GKC FRN EG I D PTHN P E FT SC E FYWAY ADYHD LMK LT E E F L
GGATAK P F I T HHNA LD I D LWLR VA P E L F LKMLVVGGMNRVY E LGKQ FRN EG I D LT HN P E FT SC E FYMAY ADYND LMD LT EK LY
GGAAAR P F I T HHN E LNQTMY LR I A P E LY LKK LVVGG LDR VY E I GKQ FRN EG I D LT HN P E FT SV E SYWAY ADYNDWMET T E E L L
GGAAAR P F I T HHN E LNQRMY LR I A P E LY LK E LVVGGMDRVY E LGKQ FRN EG I D LT HN P E FT SV EAYWAY ADYNDWMRT T ED L F
GGATAK P FVT Y HND LK LD L FMR I A P E L F LK E LVVGG LDR VY E I GR V FRN E S I DQTHN P E F S I C E FYMAY ADMYD LMD I T E SMI
GGATAK P FVTHHND LN LDMYMR I A P E LY LKQ LVVGGMER VY E I GRQ FRN EG I DQTHN P E FT T C E FY EAY ADVY D LMET T E L L F
























































SGMVHA I HG FT P P FR R I SMI S S L E EAVQ F LDA LCVKH EV - ECK P PR T AAR L LDK LVG E F L E ET C I N - PT F I CDH PQ I MS P LAK
SGMVK E LT G FT P P FR R I EMI G E L E EANKY L I DACAR FDV -KC P P PQT T AR L LDK LVG E F L E PT CVN - PT F I I NQ P E I MS P LAK
S EMVK E I T G FAR PWKR I NMI E E L E ET G E F LKK I L SDNKM-DC P P P LT NARMLDK LVG E - L EDT C I D - PT F I FGH PQMMS P LAK
SG LVKHVTGWKA PWR R V EMI PA L E ET G E F LKR V LKKTGV - EC S P P LT NARMLDK LVG E F I E ET CVN - PT F I T GH PQMMS P LAK
SG LVKH I T GWKA PWR R V EMI PA L E ET G E F LKR V LKKTGV - EC S P PMTNARMLDK LVG E F I E ET CVN - PT F I T GH PQMMS P LAK
SGMVQ S I HG FT P P FAR V PMMAT L E EAND F LNK LCNTHQ I - EC S P PR T T AR L LDK LV SV F L E E EC I N - PT F I LDH PQ I MS P L SK
SGMVKH I T G FT P P FR K I SMV E E L E ET R R I LDD I CVAKDV - EC P P PR T T AR L LDK LVG E F L EVT C I N - PT F I CDH PQ I MS P LAK
S SMV LA I KG FT P P FKR VNMY EG LA EARQT FDK LCRDNNV -DC S E PR T T AR L LDK LVG EY L E ST F I S - PT F L I GH PQ I MS P LAK
S SMVMS I KG FT P P FKR VHMYDG LA EAR EV FDK LCRDNNV -DC SA PR T T AR L LDK LVG EY L E ST F I S - PT F L I GH PQ I MS P LAK
S EMVK E I T G F SR PWKR VNMI E E L E ET G E F LKKV LKDNN L - EC S P P LT NARMLDK LVG E - L EDA S I N - PT F I FGH PQMMS P LAK
S EMVK E I NG FAR PWKR I NMI E E L E ET G E F LQKV LKDNN L - EC P P P I T NARMLDK LVG E - L EDT C I N - PT F I FGH PQMMS P LAK
SGMVKH I T G FT P P FR R I SMV E E L E ET R K I LDD I C LAR AV - EC P P PR T T AR L LDK LVG E F L ET T C I N - PT F I CDH PQ I MS P LAK
SGMVKQ I CGY T P P FR R LRML PD L EGAQAR LD E I CVK LGV - EC P P PR T T AR L LDK LVGDY L EVNC I N - PT F I T EH P E I MS P LAK
EGMVK S LT G FAR PWKR FDMI G E L ENTNK F LR E LC EKHNV -DCA E PKTN SR L LDK LVG EY I ENQCVN - P S F I VGH PQVMS P LAK
SG LV L E I HG FT T PWKR F S FV E E I E EN I D FMV EMC EKHK I - E L PH PR T AAK L LDK LAGH FV ET KCTN - P S F I I DH PQTMS P LAK
SG LV L E I HG FT T PWKR F S FV E E I E EN I D FMV EMC EKH E I - E L PH PR T AAK L LDK LAGH FV ET KCTN - P S F I I DH PQTMS P LAK
SGMVKH I T G FT P P FR R I SMTQ E L E EMR K F LDD LCVQK EV - EC P P PR T T AR L LDK LVGD F L EVKC I N - PT Y I CDH PQ I MS P LAK
S EMVKK I T G FT R PWKR VNMI E E L E ET GK F LKQ I L I DHK L -DC S P P LT NARMLDK LVG E - L EDA S I N - PT F I FGH PQMMS P LAK
Q S I VMS I HG F S S PWR K I DMI AD L E ECR E F LVKT CR ER KV - EC SA PQT T AR L LDK LVG EY L EVQC I N - PT F I I NH P E I MS P L SK
SGMVKA I R G FT P P FKR V SMI KT L E ET NQ F L SQ LCAKHQV - EC PA PR T T AR L LDK LVG E F I E E FCVN - PT F I C EH PQ I MS P LAK
SGMVK S I R G FT P P FKR V SMI KT L EAT TD F L SQ LCVKHQV - EC PA PR T T AR L LDK LVG E F I E E EC I N - PT F I C EH PQ I MS P LAK
SGMV ENMFG FKR P FR V I S I L E E LN ET L EK L L SACDK EG L - SV EK PR T L SR V LDK L I GHV I E PQCVN - PT FVKDH P I AMS P LAK
GNMVKD I T G FT A P FKR I SY VHA L E EA LT F LKKQA I R FNA - I CA E PQT T AR VMDK L FGD L I EVD LVQ - PT FVCDQ PQ LMS P LAK
SGMVKH I T G FT P P FR R I SMVD E L E ET R R F FDD LCAVRNV - EC P P PR T T AR L LDK LVG E F L EVT C I N - PT F I CDH PQ I MS P LAK
SGMVKH I T G FT P P FR R I NMV E E L E ET R K I LDD I CVAKAV - EC P P PR T T AR L LDK LVG E F L EVT C I N - PT F I CDH PQ I MS P LAK
S EMVK E I T G FT R PWKR I NMI E E L E ET G E F LKKV LKDNKM-DCA P P LT NARMLDK LVG E - L EDT C I N - PT F I FGH PQMMS P LAK
Y G LAV E LHG F SK P FKR LH I I P E L EAG I Q F LMD LCKKHKA -DC P P PY T A PR L LDA L I A E F L E P ECHD - PC F I CDH PR VMS P LAK
SGMVKH I T G FT P P FR R I SMI E E L E ET R K I LDD I CVAKAV - EC P P PR T T AR L LDK LVG E F L EVT C I N - PT F I CDH PQ I MS P LAK
SG LVKH LTGWAR PWKR VK I MP E L E ET NQ F LRD L LK EKN I - ECT P P LT NARMLDK L I G EY L E ET C I N - PT F LMEH PQ LMS P LAK
S E LV FR LT G LR S PWKR I SMEGA LKH S L E E LKQ I A I QNR I EDY EKAK SHG E F LA L L F EG LV EDK LVN - PT F I Y D F PV EN S P LAK
SGMVKN I T G FT P P FR R I SMV E E L E ET R K I LDD I CVARDV - EC P P PR T T AR L LDK LVG E F L EVT C I N - PT F I CDH PQ I MS P LAK
SGMVK S I T G FT P P FR R I SMV E E L E ET R K I LDD I CVAKAV - EC P P PR T T AR L LDK LVG E F L EVT C I S - PT F I CDH PQ I MS P LAK
S S LVK E LT GWEA PWR R V EMI PA L E ET NA F LQR I CKKMNV - EC P P P LT NARMI DK LT G E F I E ET C I N - PT F I L EH PQMMS P LAK
SGMVK E LT G FT P P FR K I DMI E E L E EANKY L I DACAKY DV -KC P P PQT T T R L LDK LVGH F L E ET CVN - PT F I I NH P E I MS P LAK
SGMVY A I KG FT P P FR R I SMV SG L E EN ED F LK E L I K K LGV - EMS P PY T T ARMLD E LVG EY L E SQ LVN - PG F I CDH PQ I MS P LAK
SGMVKH I T G FT P P FR R I NMV E E L E ET R K I LDD I CVAKAV - EC P P PR T T AR L LDK LVG E F L EVT C I N - PT F I CDH PQ I MS P LAK
S S I V LK LKG FT P PWPR V SMMA E L E EANA F FV EQAKKHKV - EC SN PR T T AR L I DK LVGH F L EVN FRN - PT F L I DH PQ LMS P L SK
S EMVK E I T G F SR PWKR VNMI E E L E ET GK F LKQ I L I DNK L -DCT P P LT NARMLDK LVG E - L EDA S I N - PT F I FGH PQMMS P LAK
SQ LVY H L FG FT P PY PKV S I V E E I E ET I EKMI N I I K EHK I - E L PN P PT AAK L LDQ LA SH F I ENKY NDK P F F I V EH PQ I MS P LAK
ST LVMH L FG FT P PY PKV S I V E E L E ET I NKMI N L I K ENK I - EMPN P PT AAK L LDQ LA SH F I ENQY PNK P F F I I EH PQ I MS P LAK
SK LVY H L FG FT P PY PK I S LV E E L E ET I NKMI N I I K ENN I - EMPN P PT AAK L LDQ LA SH F I EN I Y QNQ P F F I I EH PQ I MS P LAK
SGMVK E LT G FT P P FR R I DMI E E L E EAT KY LVAAC EK F EV -KC P P PQT T T R L LDK LVGH F L E ET CVN - P S F I I NH P E I MS P LAK
SGMVR S I T G FT P P FR R I SMV E E L E ET R K I LDD I CVAR AV - EC P P PR T T AR L LDK LVG E F L EVT C I S - PT F I CDH PQ I MS P LAK
S EMVK E I T G F SR PWKR I NMI E E L E ET G E F LKK I LVDNK L - EC P P P LT NARMLDK LVG E - L EDT C I N - PT F I FGH PQMMS P LAK
SG LVKD LTG F SR PWR R I NMI EY L E EANA F LRD LCAKHGV - ECA P PQTC SR L LDK LVG E F I E S EC I N - PT F I I GH PQMMS P LAK
SGMVK FVTG FT P P FR R V SMI N E LQ ETNK F LDD LCR KH EV - ECT S PR T T AR L LDK LVG EY I ET QC I S - PT F I MDH P E I MS P L SK
SGMVKH I T G FT P P FR R L SMTHD L E ET R K F FDN LCA EKGV - EC P P PR T T AR L LDK LVG E FME ET C I S - PT F I CDH PQ I MS P LAK
S S LVMK LTG FT P P FKR V PMMET L S EAR E F FDK LCVQHNV -AC SA PR ST T R L I DK LVGH F I EVDCKN - PT F LMEH PQ I MS P LAK
S S LV F E L FG FT P P FQR V SMV E E L E ENV EKY LT A I K EAG L -DMPK P PV PAK L I DQ LVGHY I EDQ I VK - PT F I VD F PQCT S P L SK
S S LV F E L FG FT P P FNKV SMV E E L E ENV EKY LT A I K EAG L -DMPK P PV PAK L I DQ LVGHY I EDQ I VK - PT F I VD F PQCT S P L SK
QK I VMEVKG F S S PWQR I DMI E E L E EVR E L L EKKCK E LDV -DV P P PMT VARMLDKMVGK FV E P LCVN - PT FMCNH PQVMS P LAK
Y GMVMH LY G FNR P FKR LH I V PK L E EAN S F F LD I CKKNQV - ECN P P FT T T R L LDA LV SHY L E PQCHD - PT F LCDH PR I MS P LAK
Y G LAMH I HG FNK P FKR LY I I P E L E S SNA F LQ E LC SKH EV - ECT P P LT T AR L LDA L I SHY L E P ECQD - PT FVCDH PR VMS P LAK
SG LVKAVTG F ST PWKR FDMI K E L E ET R KWL SD LAAKHNV -DC S E PR T S SR L I DKMTG E F I ET QC I N - P S F I VGH PQVMS P LAK
S EMVK E I T G F SR PWKR LD I I GT L E ET NQ F LQ EQ LKKVG L -VCT P P LT NARMLDK L I GDY L EDT C I N - PT F LY GH P EMMS P LAK
























































Y HR SATG LT ER F E L FVMR K EVCNAY T E LND PAVQR ER F EQQAADKAAGDD EAQ LVD EN FCT A L EY G L P PT GGWGMG I DR LTMF
WHR SK SG LT ER F E L F I NKH E LCNAY T E LND PVVQRQR FADQ LKDRQ SGDD EAMA LD ET FCNA L EY G LA PT GGWG LG I DR L SML
H SRDQ PG LC ER F EV FVAT K E I CNAY T E LND P FDQRAR F E EQARQKDQGDD EAQ L I D ET FCNA L EY G L P PT GGWGCGVDR LAMF
Y HRQHAG LC ER F EA FVCKK E I VNAY T E LND P FDQR LR F E EQARQKDQGDD EAQ L I D EN FCT S L EY G L P PT GGWGMG I DR LVMF
Y HRQNVG LC ER F EA FVCKK E I VNAY T E LND P FDQR LR F E EQARQKDQGDD EAQ I I D EN FCT S L EY G L P PT GGWGMG I DR LVMF
Y HRDV PG LT ER F EVY VAKK E I CNAY T E LND PATQR ER F E EQAKNRAAGDD ET P PTD EA FCT A L EY G L P PT GGWG LGVDR LTMF
WHR SK EG LT ER F E L FVMKK E I CNAY T E LND PVRQRQ L F E EQAKAKAAGDD EAMF I D ET FCT A L EY G L P PT GGWGMG I DR VTMF
WHR S I PG LT ER F E L FAVT R E I ANAY T E LND P I T QRQR F EQQAKDKDAGDD EAQMI D ET FCNA L EY G L P PT GGWGMG I DR L SMI
WHR S I PG LT ER F E L FAVT R E I ANAY T E LND P I T QRQR F EQQAKDKDAGDD EAQMI D ET FCNA L EY G L P PT GGWGMG I DR L SMI
KDRN I PG LC ER F EV FVAT K E I CNAY T E LND P FDQRAR F E EQARQKAQGDD EAQMVD ET FCNA L EY G L P PT AGWGCG I DR LAMF
Y SRDQ PG LC ER F EV FVAT K E I CNAY T E LND P FDQRAR F E EQARQKDQGDD EAQ L I D ET FCNA L EY G L P PT GGWGCG I DR LAMF
WHR SK EG LT ER F E L FVMKK E I CNAY T E LND PVRQRQ L F E EQAKAKAAGDD EAMF I D EN FCT A L EY G L P PT AGWGMG I DR VTMF
WHR S I KG LT ER F E L FVNKK E I CNAY T E LND PMI QRQR F EQQA LDKAAGDD EAQMVD EN FCT A L EY G L P PT GGWGMG I DR LTMF
Y DR SR PG LC ER F EA F LCT K E I CNAY T E LND P FDQR ER FMEQVRQK EQGD E EAQGVD ET F LDA L EY G L P PT GGWG LG I DR LVMF
WHR EK P EMT ER F E L FV LGK E LCNAY T E LN E P LQQR K F F EQQADAKA SGDV EAC P I D ET FC LA L EHG L P PT GGWG LG I DR L I MF
WHR EK P EMT ER F E L FV LGK E LCNAY T E LN E P LQQR K F F EQQADAKA SGDV EAC P I D ET FC LA L EHG L P PT GGWG LG I DR L I MF
WHR SQKG LT ER F E L FVMKK E I CNAY T E LND P I R QR E L F EQQAKAKA EGDD EAMF I D ET FCT A L EY G L P PT AGWGMG I DR LTMF
KDRDNVG LC ER F EV FVAT K E I CNAY T E LND P FDQRQR F E EQARQKAQGDD EAQMVD ET FCNA L EY G L P PT AGWGCG I DR LAMF
Y HR EK PQ LT ER F E L FVNT K E I CNAY T E LNN P FVQ I ER FA EQAKAKAAGDD E SML I DKV FT T S L EY G L P PT GG FG LG I DR FAML
Y HR S I PG LT ER F E L FVAKK E I CNAY T E LND PVVQR ER F EQQA SDKAAGDD EAQ LVD EN FCT S L EY G L P PT GG FGMG I DR LAMF
Y HR SA PG LT ER F E L FVAKK E I CNAY T E LND PVVQR ER F EQQA SDKAAGDD EAQMVD EN FCT A L EY G L P PT GG FGMG I DR LTMF
NHR SKAG LT ER F E L F I NCK E I CNAY T E LNN P F EQR ER F LQQTQD LNAGDD EAMMND ED FCT A L EY G L P PT GGWG I G I DR LVMY
Y HR S E P E LT ER F E L F I LK R E I ANAY T E LNN P I VQR SN F EQQAKDKAAGDD EAQ LVD EV F LDA I EHA F P PT GGWG LG I DR LAML
WHR I HRG LT ER F E L FVMKK EVCNAY T E LND P FQQRQ L F EDQAKAKAAGDD EAMF I D EN FCT A L EY G L P PT AGWGMG I DR FTMF
WHR SK EG LT ER F E L FVMKK E I CNAY T E LND PMRQRQ L F E EQAKAKAAGDD EAMF I D EN FCT A L EY G L P PT AGWGMG I DR VAMF
Y SRDQ PG LC ER F EV FVAT K E I CNAY T E LND P FDQRAR F E EQANQKAQGDD EAQ LVD ET FCNA L EY G L P PT GGWGCG I DR LAMF
WHRND PR LT ER F E L FVNKK E LANAY T E LNN P I VQR E E F LKQVRNRDKGDD E SME I D EG FVAA L EHA L P PT GGWG LG I DR LVMF
WHR SK EG LT ER F E L FVMKK E I CNAY T E LND PVRQRQ L F E EQAKAKAAGDD EAMF I D EN FCT A L EY G L P PT GG FGMG LDR VAMF
Y HR T EKG I S ER F EG FVCKK E I CNAY T E LNN P FDQR LR F E EQARQKAQGDD EAQMI D EN F LR S L EY G L P PT AGWG LG I DR LCMF
NHR EK EG FV ER F E L F LNGWE LANGY S E LND P L EQ EKR F E EQDKKR K LGD L EAQT VDYD F I NA LGY G L P PT GGMG LG I DR LTMI
WHR SKNG LT ER F E L FVMKK E I CNAY T E LND PVRQRQ L F E EQAKAKAAGDD EAMV I DDN FCT A L EY G L P PT AGWGMG I DR LTMF
WHR SK EG LT ER F E L FVMKK E I CNAY T E LND PVRQRQ L F E EQAKAKAAGDD EAMF I D EN FCT A L EY G L P PT AGWGMG I DR LTMF
Y HR SKNG LC ER F EA FVCKK E I ANAY T E LNN P FDQR LR F E EQARQKDQGDD EAQ LVD E S F LNA L EY G L P PT GGWG LG I DR LAMF
WHR SR PG LT ER F E L FVNKH EVCNAY T E LND PVVQRQR F E EQ LKDRQ SGDD EAMA LD ET FCT A L EY G L P PT GGWG LG I DR LTML
Y HRN I PGMT ER F E L FVNT K E LCNAY T E LND P I DQR ER FD EQAKAK S SGDD EAML I D EV FVQ S L EY G L P PT GGWG LGVDR LTML
WHR SK EG LT ER F E L FVMKK E I CNAY T E LND PMRQRQ L F E EQAKAKAAGDD EAMF I D EN FCT A L EY G L P PT AGWGMG I DR VAMF
VHRQY PG LT ER F E L FVNY H E LCNAY T E LND P FVQKA L FQKQV EDAAKGDD EAMGYD EG F I K S L EHA L P PT AGWG LG I DR FVML
KDRN I PG LC ER F EV FVAT K E I CNAY T E LND P FDQRQR F E EQARQKAQGDD EAQ LVD EV FCNA L EY G L P PT AGWGCG I DR LAMF
Y HR T K PG LT ER L EMF I CGK EV LNAY T E LND P FKQK EC FK LQQKDR EKGDT EAAQ LD SA FCT S L EY G L P PT GG LG LG I DR I TMF
Y HR SK PG LT ER L EMF I CGK EV LNAY T E LND P FKQK EC F SAQQKDR EKGDA EA FQ FDA PY CT S L EY G L P PT GG LG LG I DR I TMF
Y HR SK PG LT ER L EMF I CGK EV LNAY T E LND P FKQK EC FA SQQKDK EKGDT EA FHCDAA FCT S L EY G L P PT GG LG LG I DR I TMF
WHR SK PG LT ER F E L FVNKH E LCNAY T E LND PVVQRQR F EAQ LKDRQ SGDD EAMA LD ET FCMA L EY G L P PT GGWG LG I DR LAML
WHRCK EG LT ER F E L FVMKK E I CNAY T E LND PVRQRQ L F E EQAKAKAAGDD EAMF I D EN FCT A L EY G L P PT AGWGMG I DR VTMF
Y SRDQ PG LC ER F EV FVAT K E I CNAY T E LND P FDQRAR F E EQARQKDQGDD EAQ LVD ET FCNA L EY G L P PT GGWGCG I DR LAMF
Y HR SDAG LC ER F EA FVAT K E I CNAY T E LND I FDQRAR F E EQARQKAQGDD EAQ I I D EN FCT A L EY G L P PT GGWGMGVDR LVMF
WHR S I PG LT ER F E L FVAR K E I CNAY T E LND PMVQR ER FATQAKDHAAGDD EAQ L I D EN FCT A L EY G L P PT GG FG LG I DR LAMF
WHR S EKG LT ER F E L FVMKK E I CN SY T E LND SVRQR E L F EQQAKAKA EGDD EAMF I D ET FCT A L EY G L P PT AGWGMG I DR LCMF
Y HR SK PNVT ER F E L FVNY Y E LCNA FT E LND P FKQR K I FVQQ I E EKNKGDV EAMGYDKD FCDC L EHA L P PT GGWG LG I DR LVML
WHR SK ENVC ER F E L F I CGK E L I N SY T E LND P I T QR EC FKQQQKAKD LGDD EAQ P PD EA FCT A L EY G L P PT AGWG I G I DR LAMF
WHR SK ENVC ER F E L F I CGK E L I N SY T E LND P I T QRDC FKQQQKAKD LGDD EAQ P PD EA FCT A L EY G L P PT AGWG I G I DR LTMF
WHR T K PG I V ER F EV F I NG L EY ANAY T E LNC PMVQR E L F LDQ LKAKAAKDD EAMPY DDT FCT A L EY A L P PT AGWGCGVDR LVML
WHR KD LR L S ER F E L F I NKK E I CN SY T E LN S P LVQR E E F ERQ LRDR EKGDD EAMD I D EGY VQA L EY A L P PT GGWG LG I DR LVMY
WHRND PQ LT ER F E L F LNKK E LCNAY T E LNN P I VQR E E FMKQ LRNK EKGDD EAMD I D EG FVQA L EHA L P PT GGWG LG I DR LVMF
RHRD I PG LC ER F EV FVAT K E I CNAY T E LND PWVQRAN F E EQ SRQKDQGDD EAQG I DHV F I DA L EHG L P PT GGWG LG I DR LVMF
Y SRDR PG I C ER F EV FVAT K E I CNAY T E LND P FDQRQR F E EQARQKDAGDD EAQ LVD ET FCT A L EY G L P PT AGWGCGVDR LTMF
























































LTD SNN I K EV L L F PAMK PRQAA EAHRQT RQYMQ -KWI K PGMTMI E I C E E L ENT ARG LA F PT GC SRNHCAAHY T PNAGD - PT V L
LTD S LN I K EV L F F PAMR PR R AA EVHRQVR KY VR - S I V K PGMLMTD I C ET L ENT VRG I A F PT GC S LNWVAAHWT PN SGD -KT V L
LTD SNT I R EV L L F PT LK PR KGA E I HR R VR RH LQ -NR LR PGQT LT EVV E LV ENAT RG I G F PT GV S LNHCAAH FT PNAGD -T T V L
LTDNY S I K EV LA F P FMK ERQAA EVHRQVRQY AQ -KT I K PGQT LT E I A EG I EDAVRGMG F PCG L S I NHCAAHY T PNAGN -KMV L
LTDNY S I K EV LA F P FMK ERQAA EVHRQVRQY AQ -KT I K PGQT LT E I A EG I E E SVR GMG F PCG L S I NHCAAHY T PNAGN -KMV L
LTD SNN I K EV L L F PAMK PRHAA EAHRQT R KH I R -NWI K PGMTMI D I C E E L EKT ARG LA F PT GC SRNHCAAHY T PNTGD -T T V L
LTD SNN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EKMEDC SRG LA F PT GC S LNNCAAHY T PNAGD -T T V L
LTDNNN I K EV L L F PAMR PR R SA EAHRQVRQY VK - SWI K PGMSMI E I C ER L ET T SR G LA F PT GC S LNHCAAHY T PNAGD -T T V L
LTDNNN I K EV L L F PAMR PR R SA EAHRQVR KY VK - SWI K PGMTMI E I C ER L ET T SR G LA F PT GC S LNHCAAHY T PNAGD -T T V L
LTD SNT I R EV L L F PT LK PR KGA E I HR R VRHKAQ - S S I R PGMTMI E I AN L I ED SVRG I G F PT G L S LNHVAAHY T PNTGD -K L I L
LT D SNT I R EV L L F PT LK PR KGA E I HR R VR KNVQ -NK LK PGML LT EVAD I I ENAT RG I G F PT G L S LNHCAAHY T PNTGD -KT V L
LTD SNN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNNCAAHY T PNAGD -T T V L
LTD SNN I K EV L L F PAMK PRQAA ETHRQVRHHVQ - E F I K PG L SMI E I C ER L EQA SRG LA F PT GC S LNNCAAHY T PNAGD -KT V L
LTDC SN I K EV L L F PAMR PR R AG EVHRQVRAY AQ -KA I K PGMTMT E I AN L I EDGT RG I G F PT G L SVN EVAAHY T PN PGD -KQV L
LADKNN I K EV I L F PAMRNR R AA EVHRQVR KYMQ - S I I R P EMK L I DMCN I L E SKVKGWG F PT GC S LNHCAAHY T PN PHD - FT K L
LADKNN I K EV I L F PAMRNR R AA EVHRQVR KYMQ - S I I R P EMK L I DMCN I L E SKVKGWG F PT GC S LNHCAAHY T PN PHD - FT K L
LTD SNN I K EV L L F PAMK PRQAA EAHRQVR KY VQ - SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNHCAAHY T PNAGD - PT V L
LTD SNT I R EV L L F PT LK PR KGA E I HR R VRHKAQ - S S I R PGMNMT E I AD L I EN SVRG I G F PT G L S LNHVAAHY T PNAGD -KT V L
MSDT Y N I K EV I L F PAMK PR R AA EVHRQVR KY VQ -G I VK PG LG LT E LV E S L ENA SR G I A F PT GV S LNH I AAH FT PNTGD -KT V L
LTD SNN I K EV L L F PAMK PRQAA EAHRQT RQYMQ -R Y I K PGMTMI Q I C E E L ENT ARG LA F PT GC S LNHCAAHY T PNAGD - PT V L
LTD SNN I K EV L L F PAMK PRQAA EAHRQT RQYMQ -R F I K PGMTMI Q I C E E L ENT ARG LA F PT GC S LNHCAAHY T PNAGD - PT V L
LTDAAN I R DV I F F PTMK PR R AA EAHR R AR Y R VQ - S I V R PG I T L L E I V R S I ED ST R G I G F PAGMSMN SCAAHY T VN PG EQD I V L
LADVDN I K EV I L F PTMR PR KAAA I HK SVRQWAQ -QWI K PGMSD L FVA EN I ER KVRGMA F PCG L SVN SCAAH FT PN PND P L S FY
LTD S SN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNNCAAHY T PNAGD - PT V L
LTD SNN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNNCAAHY T PNAGD -T T V L
LAD SNT I R EV L L F PT LK PR KGA E I HR R VR E SVR -NK I K PGMT LT E I AN LV EDGT RG I A F PT G L S LNHCAAH FT PNAGD -KT V L
LT SQ SN I K EV L L F PAMK PR EAA EVHRQVR TWAQ - SWI K PG L S LMLMTDR I EKK LNGQA F PT GC S LNHVAAHY T PNTGD EKVV L
LTD SNN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNNCAAHY T PNAGD -T T V L
LT NNAT I R EV LA F P FMRDRHGA EAHRQAR RWAH -KHVK PGMS LTD I ANG I ED SVRGMG F PT G L S I NHCAAHY T PNAGN -KMV L
LAG L E S I K EV I L F PQMKR R EAGR I LK I V R T EAA -DMI R VGN S L L EVA E FV EKKT I - -A F PCN I SR NQ EAAHAT PKAGD -QDV F
LTD SNN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNNCAAHY T PNAGD - PT V L
LTD SNN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNNCAAHY T PNAGD -T T V L
LTDNY S I R EV LA F P F LR ER HAA EVHRQVRQWAQ -K S I K PGQT LT E I A EN I ED SVRGMG F PT G L S I NHCAAHY T PNAGN -KMV L
LTD SQN I K EV L L F PAMK PR R AA EVHRQVR KHMR - S I LK PGMLMI D LC ET L ENMVRG I A F PT GC S LNWVAAHWT PN SGD -KT V L
LADKNN I K EV L L F PAMK PRQCA EVHR EVRQY I S -DWVK PGMKY I DVC ET L EN SVRGVA F PT GC SKNHVAAHWT PNGGC - E SV I
LT D SNN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNNCAAHY T PNAGD -T T V L
LTDTQN I Q EV L L F PAMK PR KAA ECHRQVRQY AQAK L LK PGNK L I D I C EK L EDMNRG I A F PT GC S LN FCAAHY T PNNGD -NT I L
LT D SNT I R EV L L F PT LK PR KGA E I HR R VRHKAQ - S S I R AGMSMT E I AD L I EN SVRG I G F PT G L S LNHVAAHY T PNTGD -K L S L
LT NKN S I KDV I L F PTMR PR KAA ECHRQVR KHMQ -A F I K PGKKMI D I AQ ET ER KT KGWG F PT GC S LNHCAAHY T PNY GD - ET V L
LT NKNC I KDV I L F PTMR PR KAA ECHRQVR KY I Q -AY VQ PGR KMI D I VK ET EKKT KGWG F PT GC S LNHCAAHY T PNY GD - ET V L
LT NKN S I KDV I L F PTMK PR KAA ECHRQVR KY I Q - SY I K PGR KMI D I VQKT EQKT KGWG F PT GC S LNNCAAHY T PNY GD - ET V L
LTD SQN I K EV L L F PAMK PRQAA EVHRQVR KYMK - S I LK PGMLMMD LC ET L ENT VRG I A F PT GC S LNWVAAHWT PN SGD -KT V L
LTD SNN I K EV L L F PAMK PR EAA EAHRQVR KY VM- SWI K PGMTMI E I C EK L EDC SR G LA F PT GC S LNNCAAHY T PNAGD -T T V L
LTD SNT I R EV L L F PT LK PR KGA E I HR R VR R A I K -DR I V PGMK LMD I ADMI ENT T RG I G F PT G L S LNHCAAH FT PNAGD -KT V L
LTD SNT I R EV L L F PHMK PR R AA EVHRQARQY AQ - SV I K PGMSMMDVVNT I ENT T RG I G F PT GV S LNHCAAHY T PNAGD -T T I L
LT D SNN I K EV L F F PAMK PRQAA EAHRQVR KHVQ -G F I K PGMTMI D I C ER L ET A SR G LA F PT GC SRNHCAAHY T PNAGD -T T V L
LTD SNN I K EV L L F PAMK PRQAA EAHRQVRAY VR - SWI K PGMTMI D I C EK L EDC SR G LA F PT GC S I NHCAAHY T PNAGD - PT V L
LTDN I Y I Q EV L L F PAMK PR KAA ECHRQVR KY CQ -Q L I R PGKK L I D I C E S I E EMNRG I A F PT GC S LNHVAAHY T PNNGD - FT T I
L SDKNN I KV F I GV I I I V -R R AA EVHRQVR R Y I Q - SV I R PGV SC LD I VQAV E SKT KGWG F PT GC S LN SCAAHY T PNY GD -KT V F
LADKNN I K EV I F F PTMR PR KAA EVHRQAR R Y I Q - SV I K PG L SC LD I VQA L E FKT KGWG F PT GC S LN SCAAHY T PNHGD -KT I F
LT NQV S I R EV L L F P LMK PR EGA E I HR R VR RWAMENV I K PGVK LY DMCAQ I E EAVRG LA F PCGC S I NNCAAHY T PMYNTDQR V L
LT SQNN I K EV L L F PAMK PR CAA EVHRQVR R Y AQ - S F I K PG I S L L SMTDR I EKK L EGQA F PT GC S LNHVAAHY T PNTGD -KCV L
LT SQAN I K EV L L F PAMK PRHAA EVHRQVR R Y AQ - S F I K PG I S L I SMTDR I ER KV EGQA F PT GC S LNHVAAHY T PNTGD -KT V L
LTD SN S I K EV LA F PANK PR R AA EVHRQVRQY AQ - SA I K PGMTMT E I A E LV EDGT RG I G F PT GV SVN ECAAHY T PNAGD -KR V L
LT N SNT I K EV L L F PAMK PR KGA E I HR VVR KY AR -DN I KAGMTMT S I A EMI ED SVRGQG F PT GV S LNHCAAHY T PNAGD -K I V L
























































LY DDVT K I D FGTH I KGR I I DCA FT L S FN P - -KY DK L L EAVK EAT ET G I R EAG I DVR LCD I GAA I Q EVME SY EV E LDGKT YQVK
QYDDVMK LD FGTH I DGH I I DCA FT VA FN P - -MFD P L LAA SR EAT Y TG I K EAG I DVR LCD I GAA I Q EVME SY EV E I NGKV FQVK
RH EDVMKVD FGVQVNGH I I D SAWT VT FD P - -R Y D P L L EAVR EAT Y TG I R EAG I DVR LTD I G EA I Q EVME SY EVT LGGQT YQVR
QQGDVMKVD FGAH I NGR I VD SA FTMT FD P - -VY D P L L EAVKDATNTG I R EAG I DVRMSD I GAA I Q EAME SY EV E LNGTMY PVK
QQGDVMKVD FGAH I NGR I VD SA FT VA FD P - -VY D P L LAAVKDATNTG I R EAG I DVRMSD I GAA I Q EAME SY EV E I NGTMY PVK
EY DDVVK I D FGTH I NGR I I DCA FT LH FN P - -R Y D P LVKGVQ EAT EAG I KA SGVDVR LCDVGAAVQ EVME SH EV E LDGQMY - - -
QYDD I CK I D FGTH I SGR I I DCA FT VT FN P - -KY DT L LKAVKDATNTG I KCAG I DVR LCDVG EA I Q EVME SY EV E I DGKT YQVK
QY GDVCK I DY G I HVRGR L I D SA FT VH FD P - -K FD P LV EAVK EATNAG I R E SG I DVR LCDVG EVV E EVMT SH EV E L EGKT Y VVK
QY GDVCK I DY G I HVRGR L I D SA FT VH FD P - -K FD P LV EAVR EATNAG I K E SG I DVR LCDVG E I V E EVMT SH EV E LDGK SY VVK
KKDD I MKVD I GVHVNGR I CD SA FTMT FN EDGKY DT I MQAVK EAT Y TG I K E SG I DVR LND I GAA I Q EVME SY EME ENGKT Y P I K
KY EDVMKVD I GVQVNGH I VD SAWTV S FD P - -QY DN L LAAVKDAT Y TG I K EAG I DVR LTD I G EA I Q EVME SY EV E I KGKT YQVK
QYDD I CK I D FGTH I SGR I I DCA FT VT FN P - -KY DT L LKAVKDATNTG I KCAG I DVR LCDVG EA I Q EVME SY EV E I DGKT YQVK
SY DDVCK I D FGTH I NGR I I DCA FT V S FN P - -KY DR L L EAVKDATNTG I KNAG I DVR LCDVGAA I Q ETME SY EV E I DGKT YQVR
QQHDVMKVD FGVHVNGR I VD SA FTMS F E P - -TWDK L L EAVKDATNTG I R EAG I DVRMCD I G EA I Q EVME SY EV EVNGKVY PVK
TQDD I CK LD FGVQVNGMI I DCA FT VA FND - -V FD P L I Q ST LDATNTG LKVAG I DVMF S E I G SA I E EV I K SY E F EY K SKVY N I K
TQDD I CK LD FGVQVNGMI I DCA FT VA FND - -V FD P L I Q ST LDATNTG LKVAG I DVMF S E I G SA I E EV I K SY E F EY K SKVY N I K
QY DDVCK I D FGTH I NGR I I DCA FT VT FN P - -KY DK L L EAVKDATNTG I KCAG I DVR LCD I G E S I Q EVME SY EVD LDGKT YQVK
NY EDVMKVD I GVHVNGH I VD SA FT LT FDD - -KY D S L LKAVK EATNTGVK EAG I DVR LND I G EA I Q EVME SY EME LNGKT Y P I K
KKDDV LK I D FGTHVNGY I I DCA FT VT FD E - -KY DK LKDAVR EATNTG I Y HAG I DAR LG E I GAA I Q EVME SH E I E LNGKT Y P I R
QY DDVCK I D FGTH I KGR I I DCA FT LT FNN - -KY DK L LQAVK EATNTG I R EAG I DVR LCD I GAA I Q EVME SY E I E LDGKT Y P I K
QY DDVCK I D FGTH I KGR I I DCA FT LT FNN - -KY DK L LQAVK EATNTG I K EAG I DVR LCD I GAA I Q EVME SY EV E LDGKT Y P I K
K EDDV LK I D FGTH SDGR I MD SA FT VA FK E - -N L E P L LVAAR EGT ET G I K S LGVDVR VCD I GRD I N EV I S SY EV E I GGRMWP I R
KTDDVVK I D FGVHVNGH L I D SA FTMTWD P - -A LQ P I LDC SKDATNTG I KN I GVDVR LCD I GDA I E EVMS SY EV E I KGKT YQ LQ
HYDD I CK I D FGT Y Y SGR I I DCA FT VT FN P - -KY DR L L EAVKDATNTG I KCAG I DVR LCDVG EA I Q EVME SY EV E I DGKT YQVK
QYDD I CK I D FGTH I SGR I I DCA FT VT FN P - -KY DT L LKAVKDATNTG I KCAG I DVR LCDVG EA I Q EVME SY EV E I DGKT YQVK
K F EDVMKVD FGVHVNGY I I D SA FT I A FD P - -QY DN L LAAVKDATNTG I K EAG I DVR LTD I G EA I Q EVME SY EV E I NG ETHQVK
T Y DDVMKVD FGTH I NGR I I DCAWTVA FN P - -MFD P L LQAVK EAT Y EG I KQAG I DVR LGD I GAA I E EVME SH EV E I NGKVHQVK
QYDD I CK I D FGTH I SGR I I DCA FT VT FN P - -KY DT L LKAVKDATNTG I KCAG I DVR LCDVG EA I Q EVME SY EV E I DGKT YQVK
EHDDV LKVD I GVHVNGR I VD SA FT VA FN P - -R Y DN L LAAVKDATNTG I R EAG I DAR LG E I G EA I Q ETME SY EV E I DG ET Y PVK
G -NDMVK LD LGVHVDGY I AD SAVT VD L SG - -N SD - I VKA S E EA LAAA I D LMK PGV ST G E I GAA I E ER I H S - - - - - - - - -Y G LK
QYDD I CK I D FGTH I SGR I I DCA FT VT FN P - -KY DT L LKAVKDATNTG I KCAG I DVR LCDVG EA I Q EVME SY EV E I DGKT YQVK
QYDD I CK I D FGTH I SGR I I DCA FT VT FN P - -KY D I L LT AVKDATNTG I KCAG I DVR LCDVG EA I Q EVME SY EV E I DGKT YQVK
Q EDDVMKVD FGVHVNGR I VD SA FT VA FN P - -R Y D P L L EAVKAATNAG I K EAG I DVR VGD I GAA I Q EVME SY EV E I NGQML PVK
QYDDVMK LD FGTH I DGY I VDCA FT VA FN P - -MFD S L LQA SKDATNTGVK EAG I DAR LCDVGAA I Q EVME SY EV E I NGKV FQ I K
DKDDV I K FD FGVQVKGR I I DCA FT KT FND - -MYD P L LKAVN EAT ET G I R SAG I DVR LCD I G EAVQ EVME SHT V E I HGK EY QVK
QYDD I CK I D FGTH I SGR I I DCA FT VT FN P - -KY DT L LKAVKDATNTG I KCAG I DVR LCDVG EA I Q EVME SY EV E I DGKT YQVK
T Y DDVCK I D FGTQVDGWI I DCA FT VA FN P - -VY DT L LQAAKDATDTG I R N SG I DVR LGDVGAA I Q ETME SY EV E I GGKVY KVK
GKDD LMKVD I GVHVNGH I CD SA FTMT LNDTGKY D S I MKAVKDATNTGVK EAG I DVR LND I G EA I Q EVME SY EME LDGKT Y PVK
KY DDVCK LD FGVHVNGY I I DCA FT I A FN E - -KY DN L I KATQDGTNTG I K EAG I DARMCD I G EA I Q EA I E SY E I E LNQK I Y P I K
KY DDVCK LD FGVHVNGY I I DCA FT I A FN E - -KY DN L I KATQDGTNTG I R EAG I DARMCD I G EA I Q EA I E SY E I E LNKK I Y P I K
K EDDVCK LD FGVHVNGY I I DCA FT I A FND - -KY DN L I KATQDGTNTG I K EAG I DARMCD I G EA I Q EA I E SY E I E LNQKVY P I K
QY DDVMK LD FGTH I DGH I VDCA FT VA FN P - -MFD P L L EA SR EATNTG I K E SG I DVR LCDVGAA I Q EVME SY EV E I NGKV FQVK
QYDD I CK I D FGTH I SGR I I DCA FT VT FN P - -KY D I L LKAVKDATNTG I KCAG I D I R LCDVG EA I Q EVME SY EV E I DGKT YQVK
KY EDVMKVDY GVQVNGN I I D SA FT V S FD P - -QY DN L LAAVKDAT Y TG I K EAG I DVR LTD I G EA I Q EVME SY EV E I NG ET Y QVK
K EKDVMKVD I GVHVNGR I VD SA FTMS FD P - -QY DN L LAAVKAATNKG I E EAG I DAR LN E I G EA I Q EVME SY EV E I NGKTHQVK
EY DDVCK I D FGTH I NGR I I DCA FT VT FN P - -KY DQ L LAAVKDATNTG I K EAG I DVR LCDVG ER I Q EVME SY EV E LDGKT YQVK
R Y DDVCK I D FGTH I NGR I I DCA FT VT FN P - -K FDG L L EAVRDATNTG I K FAG I DVR LCDVG ET I Q EVME SY EV E I DGKT YQVK
EY DDVCK I D FGTQV EGR I I DCA FT VA FN P - -KY DK L L EAVK EATNTG I K EAG I DVR I PDVGAA I Q EVME SY EV E I EGKT Y PVK
EKDD I MK LD FGTHVNGY I I D SA FT I A FD E - -KY D P L I E ST K EATNTG LK LAG I DAR T S E LG EA I E EV I E S F E I T LKNR THK I K
HKNDVMK LD FGTHVNGY I I D SA FT I A FD E - -KY D P L I E ST K EATNTGVK LAG I DAR T S E LG EA I Q EV I E SY E I T LKNKTHK I K
GK SDVMK I D FGVA I NGN I I D SA FT VC FD P - -K F E P L L EAAKT ATNTGVK I AG I DARMN E I GDA I Q EV FDA S S I D I DGKHYD I K
MYDDVMKVD FGTQ I NGR I I DCAWTVA FKD - - EY E P L LT AVK EAT Y EGVKQAG I DVR LCDVGAA I Q EVME SY EV E LNGKVY PVK
T Y DDVMKVD FGTQ I NGR I VDCAWTVA FND - - EY A P L L EAVK SAT Y EG I KQAG I DVR LCD I G EA I Q EVME SY EV E I KGKVY PVK
QATDV LKVD FGVHVKGR I VD SA FT LN F E P - -TWD P L LAAVKAATNAG I K EAG I DAR LG E I GA S I Q EVME SH E F EANGKTHR VK
K EDDV LKVD FGVHVNGK I I D SA FT HVQND - -KWQG L LDAVKAAT ET G I R EAG I DVR LGD I G EA I Q ETME SH EV EVDGKVYQVK
























































A I R N LNGH S I S PY R I HA - - - - - -GKT V P I VK - - - -GG E -T T R -ME EN E FY A I ET FG S -T GRG LV SHYMKD FDA P - - -KV P LR L
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SR - - - - - - - -GDDY - - - - - - - - - - - - - - - - - - - -AQMQMKAR LAGAHKGHG L LKKKADA LQMR FRMI L SK I I ET KT LMG EV - -
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SR - - - - - - - -GDDYM- - SGAVG -R E PV F PT RQ - - S LG LMK SK LKGA ETGH S L LKR K S EA LT KR FR E I T R R I D EAKQKMGRV - -
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SR - - - - - - - -GDD F - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -MLK E I V ET KR S I GND - -
SR - - - - - - - -GDD F L - - - - - - - - - - - - - - - L I Y R A LQA I K LK SKGAKQGYD L LKR K SDA L SNK FR GMLK E I V ET KR S I GND - -
SR - - - - - - - -GDDYM- - - SGK E -R I D I F P SRM- -AQT I MKAR LKGAQTGR S L LKKK SDA L SMR FRQ I LR K I I ET KT LMG EV - -
SR - - - - - - - -GDDYM- - SGAGN -R EQV F PT RM- -T LG LMKGK LKGAQQGH S L LKR K S EA LT KR FRD I T QR I DDAKR KMGR V - -
SR - - - - - - - -GDDYM- - - SGKN -R LN I F PT RM- -A LT VMKT K LKGAVTGH S L LKKK SDA LT I R FR R I LAN I V ENKQ LMGT T - -
SR - - - - - - - -GDDYM- - - SGKD -R L P I F P SR G - -AQMLMKAR LAGAQKGHG L LKKKADA LQMR FR L I LGK I I ET KT LMGDV - -
SR - - - - - - - -GDDYM- - - SGKD -R L P I F P SR G - -AQMLMKAR LAGAQKGHG L LKKKADA LQMR FRMI LGK I I ET KT LMGDV - -
T R - - - - - - - -GDDYM- - - -T G E -R I PV F PT RM- -N LR TMET KQK SAQKGH S L LKR K SDA LKVR Y R AV ED EY KR K E LG I NQK - -
SR - - - - - - - - - - - -M- - - - SDK -R Y T V F PT RM- -Q LT T Y KGK LVGAQRGHD L LKR KTDA LNQK FK S I LKK I I E EKMSMKDY - -
SR - - - - - - - -GDDYM- - - SGKD -R I E I F P SRM- -AQT I MKAR LKGAQTGRN L LKKK SDA LT LR FRQ I LKK I I ET K L LMG EV - -
SR - - - - - - - -GDDYM- - - SGKD -R I E I F P SRM- -AQT I MKAR LKGAQTGRN L LKKK SDA LT LR FRQ I LKK I I ET KMLMG EV - -
SR - - - - - - - -GDDYM- - - - S SN -R EQV F PT RM- -T LG LMKT K LKGANQGY S L LKR K S EA LT KR FRD I T KR I DD SKQKMGRV - -
SK - - - - - - - -G SDYM- - - S ST S -R Y PA L P SRM- - S L I A FKT R LKGAQKGH S L LKKKADA L S LR Y R T VMG E LR T AK L EMANQ - -
SR - - - - - - - -GDDYM- - - SGKD -R I E I F P SRM- -AQT I MKAR LKGAQTGRN L LKKK SDA LT LR FRQ I LKK I I ET KMLMG EV - -
SR - - - - - - - -GDDYM- - SGAG E -R EAV F PT RQ - - S LG I MKAK LKGA ETGH S L LKR K S EA LT KR FR E I T KR I D EAKR KMGR V - -
T K - - - - - - - - - - - -M- - - - - - -AQQDVK PT R S - - E L I N LKKK I K L S E SGHK L LKMKRDG L I L E F FK I LN EARNVR T E LDAA - -
SR - - - - - - - -GDDYM- - - ST KD -R I D I F P SRM- -AQT I MKAR LKGAQTGRN L LKKK SDAMT LR FRQ I LKKV I QT KV LMG EV - -
SR - - - - - - - -GDDYM- - - SGKD -R I E I F P SRM- -AQT I MKAR LKGAQTGRN L LKKK SDA LT LR FRQ I LKK I I ET KMLMG EV - -
NQR R R VT EA I T EA EM- - SGAAD -R EAV F PT RQ - - S L - - - - - - - - - - - - - - - - - - - - - - - - - - - - - E I T R R I D EAKR KMGR V - -
SR - - - - - - - -GDDYM- - SGQTQ -R LNVV PT VT - -MLGVMKAR LVGAT RGHA L LKKK SDA LT VQ FR A I LKK I VAAK E SMG EA - -
T R - - - - - - - -G EDYM- - S SAGA -R LNVT PT VT - -T LAV I K SR LAGAQRGHR L LKKKADA LT LR Y RG I LR D I V EAKR K LAT S - -
SR - - - - - - - -GDDYM- - - SGKD -R I E I F P SRM- -AQT I MKAR LKGAQTGRN L LKKK SDA LT LR FRQ I LKK I I ET KMLMG EV - -
SR - - - - - - - -GDDYM- - - - - - - -A EQVV P SRM- -N LA LY KAK I I SAKKGH E L LKKKCDA LKT K FR I VMVA L L ENKK FMGD E - -
T R - - - - - - - -GDDYM- - SGAGN -R EQV F PT RM- -T LG LMKGK LKGAQQGH S L LKR K S EA LT KR FRD I T QR I DDAKR KMGR V - -
SR - - - - - - - -G PD FM- - -GA LD - E ST PV P SR I - -T LQ LMKQKKK SA FQGY S L LKKK SDA L F I H FRDV LKD I VKT KT KVG E E - -
SR - - - - - - - -G PD FM- - -GA LD - E ST PV P SR I - -T LQ LMKQKKK SA FQGY S L LKKK SDA L F I H FRDV LKD I VKT KT KVG E E - -
SR - - - - - - - -G PD FM- - -GA LD - E ST PV P SR I - -T LH LMKQKKK SA FQGY S L LKKK SDA L F I H FRDV LKD I VKT KNKVG ED - -
SR - - - - - - - -GDDYM- - SG SGQ -R LNVV PT VT - -V LGVVKAR LVGAT RGHA L LKKK SDA LT VQ FRQ I LKK I V ST K E SMGDK - -
SR - - - - - - - -GDDYM- - - SGKD -R I E I F P SRM- -AQT I MKAR LKGAQTGRN L LKKK SDA LT LR FRQ I LKK I I ET KMLMG EV - -
SK - - - - - - - -GDDYM- - - - SGN -R EQV F PT RM- -T LG LMKT K LKGANQGY S L LKR K S EA LT KR FRD I T KR I DDAKQKMGRV - -
SR - - - - - - - -GDDYM- - -A SKQ -R ENV F PT RM- -T LT TMKT R LKGAQTGH S L LKR K S EA LKKR FR E I VVN I EQAKQKMGRV - -
SR - - - - - - - -GDDYM- - - - SKD -R I AV F P SRM- -A LT TMK I R LKGAQKGH S L LKKKADA LT LK FRQ I LGK I I ENKT LMG EA - -
SR - - - - - - - -G EDYM- - - SGK E -R I DV F P SRM- -AQT I MKAR LKGAQTGRN L LKKK SDA L SMR FRQ I LR K I I EV SWL S SA I P I
SR - - - - - - - -GDDYM- - - - - - - - SQQ I T P SRM- -T LA I Y KAKT V SAKKGH E L LKKKCDA LKT K FR A I MI A L L ENK LKMD E E - -
SR - - - - - - - -GDDYM- - - - S S L - SV L L I P SRM- -N LQN LKQR RHNAH LGY S L LKR K SDA LT SK FHR L LR AT VQGK ER LV EG - -
SR - - - - - - - -GDDYM- - - - SN L - SV L L I P SRMLVN LQN LKQR RHNAH LGY S L LKR K SDA LT SK FHR L LR AT VQGK ER LV EG - -
SR - - - - - - - -GDDYM- - - - - - - - -AA I I PT RM- - E LQN LK EK LKGAR KGYD L LKKK SDA LTMK FR S L LR E I R DT K L SVGNV - -
SK - - - - - - - -GDDYM- - - - S SN -R Y T A L P SRM- - S L I A FKT R LKGAQKGH S L LKKKADA LA FR Y R T VMD E LR R AK L EVADQ - -
SK - - - - - - - -GDDYM- - - - S SN -R Y PA L P SRM- - S L I S FKT R LKGAQKGH S L LKKKADA LA I R Y R A I MGD LRNAKMEMV EQ - -
SR - - - - - - - -GTDYM- S SGKGQ -R E SV F PT RQ - -A LG SAKT R LKGAQTGH S L LKKKADA LT KR FR T I T HK I D EAKR KMGR V - -
SR - - - - - - - -GDDYM- - - SANN -R EAV F PT RM- -T LGMMKGK LKGATQGHN L LKR K S EA LT KR FRD I T R K I D E SKHKMGR V - -
























































- -MK EAA F S LA EAK FA SG -D FNQVV LQNVT KAQ I K I R T KKDNVAGVT L PV FG LAKGGQQ LQK LKKNYQ SAVK L LV E LA S LQT S
- -MKT S S FA LT EVKY VAGDNVKHVV L ENVK EAT LKVR SR T EN I AGVK L PK FG LARGGQQVRACR VAY VKA I EV LV E LA S LQT S
- -MQTA S F S LA EVT Y ATG EN I GY QVQ E SVANAR FKVGARQ ENV SGVY L PQ FG LGRGGQQVQRAKN I Y T KVV E S LVQ LA S LQT A
- -MQ I AA F S LA EV SY AVGGD I GY QVQ E SAKQAR FR VR AKQ ENV SGV F L PQ FG LGKGGQQVQRCR ET Y AR AV ET LV E LA - - - - -
- -MQ I AA F S LA EV SY AVGGD I GY Q I Q E SAKQAR FR VR AKQ ENV SGV L L PH FG LGKGGMQVQRCR ET Y AR AV ET LV E LA S LQT A
- -MK EAA F S LA EAK FT TG -D FNQVV LQNVT KAQ I K I R SKKDNVAGVT L P I FG LARGGQQ LAK LKKN FQ SAVK L LV E LA S LQT S
- -MR EAA F S LA EAK FT AG -D F ST T V I QNVNKAQVK I R AKKDNVAGVT L PV FG LARGG EQ LAK LKRNY AKAV E L LV E LA S LQT S
- -MK EAA F S LA EAK FT AG -D F SHT V I QNV SQAQY R VRMKK ENVVGV L L PV FG LGKGGAN I AR LKKNY NKA I E L LV E LAT LQTC
- -MK EAA F S LA EAK FT AG -D F SHT V I QNV SQAQY R VRMKK ENVVGV F L PV FG LGKGGAN I AR LKKNY NKA I E L LV E LAT LQTC
- -MQTAA F S LA EVQY ATGDN I SY QVQ E SVQKAR FT VKAKQ ENV SGV F L PT FA LARGGQQVQKAK L I Y SKAV ET LV E LA S LQT A
- -MQTAA F S LA EV SY ATG EN I GY QVQ E SV LNAR FKVKARQ ENV SGVY L PQ FG LGRGGQQVQRAKD I Y SKAV ET LV E LA S LQT A
- -MR EAA F S LA EAK FT AG -D F ST T V I QNVNKAQVK I R AKKDNVAGVT L PV FG LARGG EQ LAK LKRNY AKAV E L LV E LA S LQT S
- -MK EAA F S LA EAK F SGG -D F SHVV LQNVGKAQMKVR SKTDNVAGVK L PV FG L SR GG EQ L SR LKKNY SKAVK L LV E LA S LQT S
- - LQ LA S F S LA EVT Y AAG -D I GY QVQ E SVR KANY T VQARQ ENV SGVV L PA FG L SR GGQQ I QK SRDT Y I KAVGT LV E LA S LQT A
- - I K EA S FA LAKATWAAG -D FKDR I I E SCKR PT VTMEVGT EN I AGVR L P I FGVA SGGQV I Q ST R E I Y MKV LRD LVK LA S LQT A
- - I K EA S FA LAKATWAAG -D FKDR I I E SCKR PT VTMEVGT EN I AGVR L P I FGVA SGGQV I Q ST R E I Y MKV LRD LVK LA S LQT A
- -MR EAA F S LA EAK FAAG -D F ST T V I QNVNKAQVKVR AKKDNVAGVT L PV FG LARGG EQ L SR LKRNY AKAV E L LV E LA S LQT S
- -MQTAA F S LA EVQY ATGDN I SY LVQ E SVQNAR FQVKAKQ ENV SGVY L PT FG LGRGGQQVQKAKMVY T KAV ET LV E LA S LQT A
- -MRDA S F S LAAAKY AAG - E F SN SV I ENV SN PT I AVKMT T ENVAGVH L PT FG L SKGGQQ I NK SR E SH I KAV EA L I A LA S LQT A
- -MK EAA F S LA EAK FT SG -D I NQVV LQNVT KAQ I K I R T KKDNVAGVT L PV FG LARGGQQ LAK LKKNYQ SAVK L LV E LA S LQT S
- -MK EAA F S LA EAK FT SG -D I NQVV LQNVT KAQ I K I R T KKDNVAGVT L PV FG LARGGQQ LAK LKKNYQ SAVK L LV E LA S LQT S
- - I R DA F FR LT EA E F LGA -N LKMF LY E -CQKQNVY VR SR V EQV SGV S L P F F F LDR SGQ S LN ECR EK F L EV L EMLVD LCA LKN S
- -MKA S S F S LV SAKY T AG - E F SHVVVQNVKN ST Y KVK LTQ EN I AGVR L PV FG L SKGGQ SVANARQQY LKA LD S LVK LA S LQT A
- -MR EAA F S LA EAK FT AG -D F ST T V I QNVNKAQVK I R AKKDNVAGVT L PV FG LARGG EQ LAK LKRNY AKAV E L LV E LA S LQT S
- -MR EAA F S LA EAK FT AG -D F ST T V I QNVNKAQVK I R AKKDNVAGVT L PV FG LARGG EQ LAK LKRNY AKAV E L LV E LA S LQT S
- -MQTAA F S LA EVT Y ATG EN I GY QVQ ENVANAR FKVR ATQ ENV SGVY L PQ FG LGRGGQQVQRAK E I Y SR AV ET LV E LA S LQT A
- - I KG SY FT I T QAQ F I AG -D I S LAVQ E S LK I PT Y RME LQV EN I AGVQV P S FG LGKGG EQ I K EAY SA FRHT L S L LVK I A S LQT S
- -MR EAA F S LA EAK FT AG -D F ST T V I QNVNKAQVK I R AKKDNVAGVT L PV FG LARGG EQ LAK LKRNY AKAV E L LV E LA S LQT S
- -MQ I AA F S LA EVT Y AVGGD I GY T VQ E SAK SAR FR I R AKQ ENV SGV L L PA FG LGKGGQQVQRCR ET Y AR AV EA LV E LA S LQT A
- -Y EK ST EK I N LA SAVNG -MVAVK ST A FT AK EY P E I Q L SGHN I MGVVV PK I G I I GT N SY I D ET ADAY E E LV EK I I AAA E L ET T
- -MR EAA F S LA EAK FT AG -D F SAT V I QNVNKAQVK I R T KKDNVAGVT L PV FG LARGG EQVT K LKKNY GKAV E L LV E LA S LQT S
- -MR EAA F S LA EAK FT AG -D F ST T V I QNVNKAQVK I R AKKDNVAGVT L PV FG LARGG EQ LAK LKRNY AKAV E L LV E LA S LQT S
- -MQ I A S L S LA EVT Y AVGGN I GY Q I Q E SAK SAR FR I R AKQ ENV SGV L L PA FG LGKGGQQVQRCR ET Y AR AV EA LV E LA S LQT A
- -MRA S S F S LA EAKY VAGDGVRHVV LQ SVR SA S LR VR SHQ ENVAGVK L PK FG LARGGQQVAACRAAHVKA I EV LV E LA S LQT S
- -MRDAH FAWT RAKY AGGDAVKHAV LDGVDRANVR VMAH EDNVAGVK I PK FG LARGGAR VR EAKA SY G EA I G L L S E LA S LQT A
- -MR EAA F S LA EAK FT AG -D F ST T V I QNVNKAQVK I R AKKDNVAGVT L PV FG LARGG EQ LAK LKRNY AKAV E L LV E LA S LQT S
- -AQ EA L L L I AKAQY AAG - E FHQNVKDAVKR AT I R L E I S S EN I AGVML P EVG LARGGQ S I QR CRDK FKD L LML LVK I A SY QT S
- -MQTAA F S LA EVQY ATGDN I AY QVQ E SVQKAR FQVKAKQ ENV SGVY L PT FG LGRGGQQVQKAK LVY T R AV ET LV E LA S LQT A
- -MRNA S F S LAK SVWAAG -D FKGQ I I EG I K R PVVT L S L ST NNVAGVK L P I FGVAAGGQV I NNT R ENY LQC LNMLVK LA SMQVA
- -MGNA S F S LAKAVWAAG -D FKGQ I I EG I K R PVVT L S L ST NNVAGVK L P I FG I A SGGQV I NNT R ENY LQC LNMLVK LA SMQVA
- -MRNA S FA LAK SVWAAG -D FKGQ I I EG I K R PVVT L S L ST NNVAGVK L P I FGVAAGGQV I NNT R ENY LQC LNMLVK LA SMQVA
- -MKA S S FA LT EAKY VAG EN I KHT V L ENVQTAT LKVR SRQ ENVAGVK L PK FG LARGGQQVQACRAAY VKA I EV LV E LA S LQT S
- -MR EAA F S LA EAK FT AG -D F ST T V I QNVNKAQVK I R AKKDNVAGVT L PV FG LARGG EQ LAK LKRNY AKAV E L LV E LA S LQT S
- -MQTAA F S LA EV SY ATG EN I GY QVQ E SV ST AR FKVR ARQ ENV SGVY L SQ FG LGRGGQQVQRAK E I Y SR AV ET LV E LA S LQT A
- -MQ I AA F SMA EVG FAMGNN I N F E I QQ SVKQ PR LR VR SKQ EN I SGV F L PT FG LGKGGQQ I QKARQVY EKAV ET LVQ LA SY Q SA
- -MK LA S L S LA EAK FAMG -D I SHNV LQNVT KAQT KVR SKK ENVAGVN L PV FG L SR GGQQ I DR LKKNY AKA I E L LV E LA S LQT S
Q FMR EAA F S LA EAK FT AG -D F S I T V I QNVNKAQVKVR AKKDNVAGVT L PV FG LAKGG EQ I SR LKRNY AR AV E L LV E LA S LQT S
- -MQKA F I Q LADAYWAAD -Q FNTNVR E SVKKA LVR I EY S S EN I AGVML PN LG LDKGG F S I QKAK ER FK EA LY L LVKVA S LQT S
- - LKDAT Y S LANAVWSA E -D FK S LV I E SVGR P SVT LK LR G EN I AGV L L PV F S L S SGG SA I Q SVKT TH LAA LD I LV E LA S LQ I S
- - LKDAT Y S LANAVWSA E -D FK S LV I E SVGR P SVT LK LR G EN I AGV L L PV F S L S SGG SA I Q SVKT TH LAA LD I LV E LA S LQ I S
- -AKDA L FAY T EVK FVA S -D I S PT V I Q SVGNMPQ L L LMT I DN I AGVR T PQ FG LARGGQQ I QKAR E E FT K F LD S LVR LA E LQT A
- - I KG SY FT I T QAQ F I AG -D I S LAVQ E S LK L PT Y T LT LR VDNVAGVR V PA FG I GR GG EQ LR EARDA FR ET LK L FVK I A S LQV S
- - I R GAY FT V SKAQ F I AG -D I G LAVQ E S LK L PT Y AMR LR V EN I AGVR V P S FG I GR GG EQ LR EA S EK FR ET LR L LVK I A S LQV S
- -MQQA S F S LA EVQY ATG -D I GY I VQ E SVK SA S FR VR AKQ ENV SGV I L PA FG L SR GGQQV SKAR EVY TQA LKV LV E LA S LQT A
- -MQTAA F S LA EVT Y ATGDN I NY QVQ E SVR SAR LR VR AK E ENV SGVK L P S FG LGRGGQQVQKAKAVY SKAV ET LV E LA S LQT A
























































FVT LD EV I K I T NR R VNA I EH - - - - -V I I PR I DR T LAY I I S E LD E L ER E E FY R LKK I QDKK
F LT LD EA I K T TNR R VNA L EN - - - - -VVK PK L ENT I SY I KG E LD E L ER ED F FR LKK I QGY K
FV I LD EV I KVTNR R VNA I EH - - - - -V I I PR T ENT I AY I N S E LD E LDR E E FY R LKKVQ EKK
- - - -N EV I KVVNR R V - ST S L - - - - - S L E PR T L SN - - - - - - - - - - - - - - - - - - - - - - - - - -
FV I LD EV I KVVNR R VNA I EH - - - - -V I I PR T ENT I K Y I N S E LD E LDR E E FY R LKKV SGKK
FVT LD EV I K I T NR R VNA I EH - - - - -V I I PR L ER T LAY I I S E LD E L ER E E FY R LKK I QDKK
FVT LD EA I K I T NR R VNA I EHG E FK L P FC PR LH PC LR PAR TQA - - - - - - - - - - - - - - - - - -
F I T LD EA I KVTNR R VNA I EH - - - - -V I I PR I ENT LT Y I V T E LD EMER E E F FRMKK I QANK
F I T LD EA I KVTNR R VNA I EH - - - - -V I I PR I ENT LT Y I V T E LD EMER E E F FRMKK I QANK
F I I LD EV I K I T NR R VNA I EH - - - - -V I I PR T ENT I AY I NG E LD EMDR E E FY R LKKVQ EKK
F I I LD EV I KVTNR R VNA I EH - - - - -V I I PR T ENT I AY I N S E LD E LDR E E FY R LKKVQ EKK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T LAY I I T E LD ER ER E E FY R LKK I Q EKK
FVT LD E S I K I T NR R VNA I EH - - - - -V I I PK I ER T I SY I I T E LD EG ER E E F FR LKK I QQKK
FT I LD EV I R ATNR R VNA I EH - - - - -VV I PR L ENT I K Y I N S E LD EMDR E E F FR LKKVQGKK
F F S LD E E I KMTNR R VNA LQN - - - - -VV L PK L EDGMNY I LR E LD E I ER E E F FR LKK I Q EKK
F F S LD E E I KMTNR R VNA LQN - - - - -VV L PK L EDGMNY I LR E LD E I ER E E F FR LKK I Q EKK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T LT Y I I T E LD ER ER E E FY R LKK I Q EKK
F I I LD EV I KVTNR R VNA I EH - - - - -V I I PR T ENT I SY I N S E LD E LDR E E FY R LKKVQ EKK
F I T LD EV I K I T NR R VNA I EY - - - - -VVK PK L ENT I SY I I T E LD E S ER E E FY R LKKVQGKK
FVT LD EV I K I T NR R VNA I EH - - - - -V I I PR I DR T LAY I I S E LD E L ER E E FY R LKK I QDKK
FVT LD EV I K I T NR R VNA I EH - - - - -V I I PR I DR T LAY I I S E LD E L ER E E FY R LKK I QDKK
FR V LN S I LMSTNR R VNA L E F - - - - -N I I PR L ENT V SY I V S E LD EQDRGD F FR LKKVQN LK
F LT LDT V I K I T NR R VNA L EH - - - - -VV I PMTQAT VKY I ET E LD E S ER E E F FR LK L I QNKK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T L SY I I T E LD ER ER E E FY R LKK I Q EKK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T LAY I I T E LD ER ER E E FY R LKK I Q EKK
F I I LD EV I KVTNR R VNA I EH - - - - -V I I PR T ENT I AY I N S E LD E LDR E E FY R LKKVQ EKK
WI T LD I AQKVT SR R VNA L EK - - - - -VV I PR VQNT L SY I T S E LD EQ ER E E F FR LKMVQKKK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T LAY I I T E LD ER ER E E FY R LKK I Q EKK
FV I LD EV I KVVNR R VNA I EH - - - - -V I I PR T ENT I K Y I N S E LD E LDR E E FY R LKKVAGKK
MKR L LD E I EKT KR R VNA L E F - - - - -KV I P E L I ATMKY I R FML E EMER ENT FR LKR VKARM
F I T LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T LNY I V T E LD ER ER E E FY R LKK I Q EKK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T LAY I I T E LD ER ER E E FY R LKK I Q EKK
FV I LD EV I KVVNR R VNA I EH - - - - -V I I PR T ENT I K Y I N S E LD E LDR E E FY R LKKVAAKK
F LT LD EA I K T TNR R VNA L EN - - - - -VVK PR L ENT I SY I KG E LD E L ER ED F FR LKK I QGY K
FVT LD EA I K T TNR R VNA L EN - - - - -Y VT PR LQNT VKY I L S E LD E L ER E E F FR LKKVQAKK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T LAY I I T E LD ER ER E E FY R LKK I Q EKK
FV S LDQV I KVTNR R VNA L EY - - - - -VV I PR FT ATMNY I DME LD EMSK ED F FR LKKV LDNK
F I I LD EV I KVTNR R VNA I EH - - - - -V I I PR T ENT I SY I N S E LD E LDR E E FY R LKKVQ EKK
F F S LD E E I KMTNR R VNA LNN - - - - - I V L PR LDGG I NY I I K E LD E I ER E E FY R LKK I K EKK
F F S LD E E I KMTNR R VNA LNN - - - - - I V L PR LDGG I NY I I K E LD E I ER E E FY R LKK I K EKK
F F S LD E E I KMTNR R VNA LNN - - - - - I V L PR L EGG I NY I I K E LD E I ER E E FY R LKK I K EKK
FMT LDTA I K T TNR R VNA L EN - - - - -VVK PR L ENT I T Y I KG E LD E L ER ED F FR LKK I QG FK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I ER T LAY I I T E LD ER ER E E FY R LKK I Q EKK
F I I LD EV I KVTNR R VNA I EH - - - - -V I I PR T ENT I AY I N S E LD E LDR E E FY R LKKVQ EKK
FV L LGDV LQMTNR R VN S I EH - - - - - I I I PR L ENT I K Y I E S E L E E L ER ED FT R LKKVQKT K
F I T LD EV I K I T NR R VNA I EH - - - - -V I I PR I ENT I SY I T T E LD ER ER E E FY R LKK I Q EKK
FVT LD EA I K I T NR R VNA I EH - - - - -V I I PR I DR T LT Y I V T E LD ER ER E E FY R LKK I Q EKK
F I T LD EV I KVTNR R VNA L EH - - - - -VV I PR FMEVQAY I NQ E LD EMSR ED F FR LKKV LD FK
F I I LN E E I RMTNR R I NA LDN - - - - -V L I P S I DRN L EY I R R E LD EMER E E FY R LKMI KKHK
F I I LN E E I RMTNR R I NA LDN - - - - -V L I P S I DRN L EY I R R E LD EMER E E FY R LKMI KKHK
FNV I DDV LR I T NR R VNAMEC - - - - -V L I PK Y QAA I A FVD ST LD EN ER E E F FR LKKVQ ET I
WMT LDVAQKVT SR R VNA L EK - - - - -VV I PRMENT LNY I S S E LD EQ ER E E F FR LKMI QKKK
WVT LD LAQKVTNR R VNA L EK - - - - -VV I PR VQNT L SY I T S E LD EQ ER E E F FR LKMVQKKK
FV I LD EV I RMTNR R VNA I EH - - - - -V I I PR L ENT I SY I V S E LD EADR E E F FR LKKVQAKK
FV I LD EV I K I T NR R VNA I EH - - - - -V I I PR T ENT I K Y I N S E LD E LDR E E FY R LKKVQDKK
